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Abstract 
 
The effectiveness of Motivational Enhancement Therapy (MET), a brief four 
session form of Motivational Interviewing (MI), provided by diabetes health 
practitioners at a hospital-based clinic, in improving diabetes outcome and self-
management of Type 1 and Type 2 diabetes was evaluated using quasi-experimental 
designs (i.e., non-random control group and multiple baseline designs).   Study 1 
evaluated if MET provided by Diabetes Nurse Educators (DNEs) was effective in 
improving diabetes outcome (i.e., blood glucose and lipids) and diabetes self-
management, and compared its effectiveness to the current standard treatment which 
comprised Patient Education (PE).  Study 2 evaluated if the results of Study 1 could 
be generalised to Dietitians providing the intervention.   Study 3 evaluated the effects 
of MI training and post-training supervised practice on practitioner and patient 
behaviour.  Specific hypotheses (Studies 1-2) were that MI would lead to improved 
diabetes outcome through improved diabetes self-management, and would be more 
effective than PE.  Further, training in MI plus supervised practice was predicted to 
lead to Nurse Educators behaving in ways consistent with MI and as a result the 
participants would exhibit less resistance and increased change talk than participants 
receiving PE (Study 3). 
 
The results suggest that MET was well received by the participants, and 
contributed to improved diabetes outcome (e.g., lowered blood glucose) and diabetes 
self-management (e.g., self-monitoring of blood glucose and dietary compliance), and 
may have been more effective than PE, although high variability made conclusions 
uncertain.  Evidence of generalisation across participants, intervention staff, and 
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outcomes is provided.  Additionally, evidence is provided that with two days training 
plus supervised practice the DNE were able to practice MET to at least a beginning 
level of competency in MI and that as a result the participants behaved in ways 
consistent with MI theory (i.e., showed less resistance and increased change talk).   
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Executive Summary 
 
Diabetes is a major risk factor for nerve damage (leading to impotence and 
foot problems), stroke, heart attack, heart failure and early death. In New Zealand 
diabetes is the leading cause of blindness, kidney failure and lower extremity 
amputation.  Currently diabetes affects approximately 200,000 (i.e., 4%) New 
Zealanders (Ministry of Health, 2006), but it is predicted that there will be a 40% 
increase in the incidence diabetes by the year 2020 (Diabetes New Zealand, 2006). 
 
Treatment of diabetes focuses on establishing and maintaining blood glucose 
levels within the normal range, thereby reducing the risk of complications. This 
requires the person with diabetes to engage in a wide range of self-care behaviours, 
some of which are new behaviours (monitoring blood glucose, injecting insulin) and 
others which involve lifestyle change (dietary modification, physical activity).  PE has 
been the main way in which these changes have been promoted, but education alone 
appears insufficient for some people, and the best method for encouraging adherence 
is unclear.  
 
There is evidence that more patient-centred approaches to health care 
consultations may have better outcomes than traditional advice-giving, particularly 
when lifestyle change is involved.  MI is a directive, patient-centred approach that 
was developed initially as a brief intervention in the addictions field, but is gathering 
increased interest in health settings.  It aims to motivate patients to make changes 
rather than provide detailed, step-by-step advice about behaviour change, and 
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provides a way of working with patients who may not seem ready to make the 
behaviour changes that are considered necessary by the health practitioner.    
 
The aim of the present research was to evaluate the effectiveness of MET, a 
brief four session form of MI, in improving diabetes self-management, and to 
compare MET with PE. The research comprised three interrelated studies.  Study 1 
was an initial treatment evaluation.  Study 2 aimed to test the generalisability of the 
results from Study 1, and Study 3 was an evaluation of the training and therapy 
process. 
 
The research was conducted in a naturalistic setting, with diabetes health 
practitioners providing the intervention to participants with diabetes who had been 
referred for assistance because they had been experiencing difficulties with diabetes 
self-management.  A variety of measures were used.  These included primary 
outcome measures of metabolic control (blood glucose and lipids), and intermediate 
process variables, which comprised diabetes self-management behaviour, 
psychosocial measures (i.e., diabetes knowledge, emotional adjustment, personal 
models of diabetes, motivation to change, and treatment satisfaction), and measures of 
therapy process and treatment integrity.   
 
The research is an example of both practice-based research (Glasgow et al., 
2006) and the scientist-practitioner model of clinical psychology (Raimy, 1950) in 
practice.  Action research methods (Boog, Keune & Tromp, 2003) were used in the 
development of the research, and quasi-experimental designs (non-random control 
group comparison and single-case research design were used. 
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The results tentatively suggest that MET, conducted by nurse educators and 
dietitians in a hospital-based clinic, has promise as an effective intervention to 
enhance diabetes self-management, which contributes to improved diabetes outcome.  
Evidence is also provided that MET was well-received by the participants, and 
contributed to increased motivation, and a decrease in concern about the current 
seriousness of diabetes, concern about future complications and the effect on their 
lives.  Additionally, process measures suggest that during MET the diabetes health 
practitioners behaved in ways consistent with MI, and this in turn appears to have 
elicited behaviour (i.e. fewer types of resistance behaviour, more signs of readiness to 
change, and increased change talk) consistent with predictions from previous MI 
research. The strengths and limitations of the present research are discussed, and 
recommendations are made for future research. 
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Diabetes: Disease and Psychosocial Treatment 
 
 As noted above, this thesis is about a novel intervention (MI) applied to a 
specific chronic health condition, diabetes.  This chapter provides an overview of 
diabetes and its treatment, including diabetes self-management, PE, and psychological 
interventions, as well as an overview of MI, including research on its application to 
health behaviour change and diabetes in particular. 
 
Diabetes 
 
Diabetes is a group of disorders which comprise hyperglycaemica and glucose 
intolerance, due to insulin deficiency, impaired effectiveness of insulin action, or both 
(Harris & Zimmet, 1997).  There are two major categories of diabetes (Amos, 
McCarty & Zimmet, 1997), Type 1 (or insulin dependent diabetes mellitus – IDDM) 
and Type 2 (or non-insulin-dependent diabetes mellitus – NIDDM).   
 
Type 1 diabetes results from a loss of insulin production due to cellular-
mediated autoimmune destruction of pancreatic islet beta-cells (Atkinson & 
MacLaren, 1994).  While Type 1 diabetes can occur at all ages (Molbak, Christau, 
Marner, Borch-Johnsen & Nerup, 1994), it is one of the most common childhood 
diseases in developed countries (LaPorte, Matsushima & Chang, 1995).   
 
Type 2 diabetes involves insulin resistance and insulin deficiency (Reaven, 
Bernstein, Davis & Olefsky, 1976; Turner, Holman, Matthews, Hockaday & Peto, 
1979), although the specific reasons for the development of these are not yet known 
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(Amos et al., 1997).  The diagnosis of Type 2 diabetes usually occurs after 40 years of 
age, although the age of onset is often 10 years earlier (Zimmet, Dowse, Finch, 
Serjeantson & King, 1990).  Type 2 diabetes accounts for 50-85% of diabetes in 
developed countries (World Health Organisation, 1994) and for nearly all diabetes in 
developing countries (Amos et al., 1997), with higher rates of Type 2 diabetes within 
ethnic groups who have experienced a greater degree of westernisation (Amos et al., 
1997) 
 
Diabetes is one of the most common non-communicable diseases globally, and 
is the fourth or fifth leading cause of death in most developed countries, with 
evidence that it is epidemic in many industralised and developing countries (Amos et 
al., 1997).  The prevalence rate of diagnosed diabetes is estimated at 4% of New 
Zealanders 15 years and over, but with Maori and Pacific Island prevalence rates 
about three times higher than for other New Zealanders (Ministry of Health, 2006). 
Maori and Pacific Island people also have a low mean age at diagnosis of diabetes 
compared to Caucasians (McGrath, Parker & Dawson, 1999; Lunt, Lim, Crooke & 
Smith, 1990; Simmons, Gatland, Leakehe & Fleming, 1996).  This means that they 
have a longer lifetime exposure to hyperglycaemia and therefore are at greater risk of 
developing complications related to hyperglycaemia (Moore & Lunt, 2000).   
 
The clinical course and prognosis of diabetes is mainly influenced by the 
duration of diabetes and degree of metabolic control achieved (World Health 
Organisation, 1994).  People with diabetes have reduced life expectancy (Finch & 
Zimmet, 1988; Panzram, 1987), and are at risk of microvascular (retinopathy, 
nephropathy and neuropathy), and macro-vascular (coronary heart disease or stroke) 
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complications, and peripheral vascular disease, such as infection or ulceration 
(Tuomilehto & Rastenyte, 1997).  Diabetes is the leading cause of blindness in 
developed countries (Klein & Moss, 1992), and is the leading known cause of end-
stage renal disease in New Zealand (Excell & McDonald, 2004), although diabetic 
neuropathy is probably the most common complication, occurring in 30-40% of 
people with Type 1 and Type 2 diabetes (World Health Organisation, 1994).  In the 
United States diabetes contributes to a 15-fold increase in the risk of lower limb 
amputation.  Recent studies (i.e., the Diabetes Control and Complications Trial, 
DCCT,  Research Group, 1993; and United Kingdom Prospective Diabetes Study, 
UKPDS, Group, 1998), however, have demonstrated that strict control of blood 
glucose levels improves prognosis by reducing the severity and occurrence of 
complications of diabetes, including retinopathy and nephropathy.   
 
Given that the prognosis is improved by strict control of blood glucose, the 
goal of diabetes (Type 1 and Type 2) treatment is to keep blood glucose levels as 
close to the normal range as possible (Drury, 1979) through the use of medication, 
which may involve oral hypoglycaemics or intensive insulin treatment requiring up to 
four or more injections per day, and a complex self-management regimen, including 
self-monitoring of blood glucose (up to four or more times a day), diet (low in fat and 
sugar, high in fibre) and regular exercise.  People with diabetes are also encouraged to 
be vigilant for symptoms of hypo- or hyperglycaemia, engage in foot care, and attend 
frequent medical appointments.  In addition, because of the relationship between 
diabetes and cardiovascular complications (UKPDS Group, 1998), diabetes 
management also includes an emphasis on reducing cardiovascular risk factors, such 
as hypertension and dyslipidaemia (i.e., a disturbance in lipids).   
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Diabetes Self-Management 
 
Self-management within the health behaviour change literature refers to ‘self-
regulation or self-monitoring behaviours’ (Nieuwenhuijsen, Zemper, Miner & 
Epstein, 2006, p.247), aimed at ‘softening the impact of long-term disease and 
disability by eliminating or reducing impairments, disability, and handicap, 
minimising suffering and maximizing potential years of useful life ( Last, Spasoff, 
Harris & Thuriaux, 2001, p.142).  Being self-regulating means being observant and 
making judgements based on oberservation, and then attempting to change one’s own 
behaviour in order to achieve a desired goal or end point (Clark, Gong & Kaciroti, 
2001).  Self-management behaviour comprises the individual’s efforts to keep the 
disease and its effects under control, which may or may not be consistent with health 
practitioners’ recommendations (Karoly & Kanfer, 1982; Clark et al, 2001).  
 
Diabetes self-management is a complex process in which the individual with 
diabetes engages in a set of skilled behaviours in order to manage their diabetes 
(Gonder-Frederick, Cox & Ritterband, 2002; Goodall & Halford, 1991).  ‘Active 
ongoing decision making’ (Gonder-Frederick et al., 2002, p.613) is an integral part of 
diabetes self-management as individuals with diabetes ‘frequently confront situations 
with multiple response options and no single right solution (Gonder-Frederick et al., 
2002, p.613), as well as there being considerable variability in the individual level of 
self-care required across different aspects of diabetes treatment and over time 
(Gonder-Frederick et al., 2002). 
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The finding from the DCCT (DCCT, 1993) and UKPDS (Turner, Cull & 
Holman, 1996; UKPDS Group, 1998) that strict control of blood glucose levels 
improves prognosis has led to most people with diabetes being expected to follow 
long term, demanding, and intensive treatment regimens that previously were only 
recommended for those who were considered highly motivated and diligent in their 
self-management of their diabetes (Gonder-Frederick et al., 2002).  Perhaps not 
surprisingly, levels of adherence to diabetic regimens is typically low (Ary, Toobert, 
Wilson, & Glasgow, 1986; Grossman, Brink & Hauser, 1987), with diet and exercise 
the most difficult to manage (Glasgow, McCaul & Schafer, 1987).   
 
Since the complications of diabetes result from inadequate glycemic control 
and 99% of diabetes treatment comprises self-management of varying levels (Coles, 
1996), the potential benefits from assisting those with poor self-management are 
considerable (Gage, et al., 2004).  Yet, few predictors of effective diabetes self-
management have been identified (Goodall & Halford, 1991), with demographic 
variables (e.g., gender, ethnicity, income and education), the number and length of 
appointments, treatment satisfaction and knowledge about diabetes self-management 
not usually predicting effective versus less effective self-management (Mazzuca, 
1982; Watts, 1980).  Complex psychological constructs, namely health beliefs 
(Brownlee-Duffleck, Peterson, Simonds, Goldstein, Kilo & Hoette, 1987) and self-
efficacy  (Glasgow, Toobert, Riddle, Donnelly, Mitchell & Calder, 1989; Grossman, 
Brink & Hauser, 1987) have, however, been found to predict diabetes self-
management.  Health beliefs, for example, have been found to account for 41-50% of 
the variance in reported self-management (Harris & Linn, 1985; Wilson, Ary, Biglan, 
Glagow, Toobert & Campbell, 1986), and self-efficacy has been found to have 
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significant effect, even when controlling for the strong predictive effect of past levels 
of self-management (Kavanagh, Gooley & Wilson, 1993).  Additionally, personal 
models of diabetes (Hampson, Glasgow & Toobert, 1990), specifically beliefs about 
the seriousness of diabetes and effectiveness of its treatment, have been found to be 
associated with improved self-management (Brown & Hedges, 1994; Hampson, 
Glasgow & Strycker, 2000).   
 
Studies of diabetes self-management, however, are challenged with the issue 
of reliable measurement (Goodall & Halford, 1991), with diet and exercise the most 
difficult aspects of diabetes treatment to measure (Glasgow et al., 1987).  For 
example, defining poor dietary management is difficult given the complex nature of 
diabetic dietary recommendations (Glasgow, Wilson & McCaul, 1985), and different 
aspects of diet may have different effects on blood glucose (Goodall & Halford, 
1991).  Additionally, self-report, which can be unreliable, has tended to be the main 
means of measuring diet and exercise (Glasgow et al., 1985).  As a result, ‘most 
studies have operationalised self-management as a single global index of compliance 
to treatment’ (p.2), with all aspects of the diabetes treatment combined into this single 
measure of self-management (Goodall & Halford, 1991).  Instead, Goodall and 
Halford (1991) suggest that there needs to be diabetes self-management studies that 
demonstrate measurable improvements in self-management behaviour that lead to 
improvement in blood glucose.   
 
Fulfilling this recommendation has been assisted by technological advances 
that have provided alternative and better validated measures of diabetes self-
management behaviour.  For example, home blood glucose monitors which include 
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memories that record time, date and test results, provide a better validated means of 
measuring blood glucose and testing behaviour (Goodall & Halford, 1991).   
Similarly, activity monitors have been used to measure exercise intensity and duration 
(Glasgow et al., 1987) and ‘sophisticated ambulatory computers’ (Goodall & Halford, 
1991, p.2) have been used to measure both diet and exercise (Burnett, Taylor & 
Agras, 1987).  While these technological advances are welcome, nevertheless they 
have not solved the challenges of self-management in diabetes. 
 
Patient Education 
 
The main widely adopted strategy for assisting with diabetes self-management 
has been through PE, which comprises the provision of knowledge and advice about 
diabetes and diabetes self-management, although PE interventions greatly vary in how 
many sessions are used and how much patient involvement there is.    PE is accepted 
as an important component of chronic disease management (Rosenberg, 1976), and 
has been considered an important component of diabetes treatment (Brown, 1990), 
with the assumption that increased knowledge will lead to improved self-
management.  Research shows that PE does improve patients’ knowledge about 
diabetes (Brown, 1988, 1990, 1992; Padgett, Mumford, Hynes & Carter, 1988), 
however, research suggests that increased knowledge does not necessarily lead to the 
desired changes in self-management behaviour, especially diet and exercise (Estey, 
Tan & Mann, 1990; Rubin, Peyrot & Saudek, 1991; Krug, Haire & Heady, 1991), and 
does not lead to improved metabolic control (Dunn & Turtle, 1988; Raz, Soskolne & 
Stein, 1988; Barth, Gosper, Jupp, Simons & Chisholm, 1990; Bahru & Abdulkadir, 
1993; Wierenga, 1994).   Additionally, PE that is controlling and directive may 
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adversely affect clients’ metabolic control (Sweet, Piziak & Carpentier, 1993), an 
iatrogenic risk for poorer outcome that is clearly a concern. 
 
There is evidence that when patients with chronic diseases are encouraged 
to take an active role in, and question, their care, that the process and outcome of 
treatment is enhanced (Greenfield, Kaplan, & Ware, 1988, Roter, 1987), and that 
this is also true for patients with diabetes (Anderson, Funnell, Barr, Dedrick & 
Davis, 1991; Sweet et al., 1993).  Butler, Peters and Stott (1995), for example, 
suggest that individuals with diabetes are likely to achieve more progress if they are 
encouraged to participate and set their own specific targets for change themselves.  
This has resulted in a move towards more patient-centred, or patient empowerment, 
approaches to PE in diabetes, which enable patients to make informed decisions 
about their diabetes treatment and to be fully responsible members of the health-
care team (Anderson et al., 1991).   Furthermore, as well as PE approaches to 
diabetes developing over the last 10-15 years to include patient empowerment, 
participation and collaboration (Norris, Lau, Smith, Schmid & Engelgau, 2002), 
there has also been a move to include behaviour change counselling techniques, 
such as setting small achievable goals, the use of prompts, and feedback (Funnell & 
Haas, 1995). 
 
Training health professionals in more patient-centred approaches appears to 
have positive effects on their attitudes towards patients with diabetes (Anderson et 
al., 1991; Williams, Freedman & Deci, 1998).  Additionally, patients appear to 
benefit in terms of their perceived ability to communicate with their health care 
practitioner, treatment satisfaction, and emotional well-being (Kinmonth, 
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Woodcock, Griffin, Spiegal & Campbell, 1998).  It is unclear, however, whether 
these more patient-centred approaches lead to improvements in diabetes outcome 
(Gonder-Frederick et al, 2002). 
 
Earlier meta-analyses of diabetes PE (Padgett et al., 1988; Brown, 1988, 
1990, 1992) suggest a moderate, positive effect size (ES), which tended to diminish 
over time.  For example, Brown (1992) found an early moderate effect size of 
d=.46, which peaked at .91 one to six months post-intervention, and then declined 
after six months.   These analyses also suggest that the effect size was greatest for 
knowledge, and least for self-management behaviour.  Brown (1992) in a re-
analysis of previous meta-analysis also found that the effect sizes for both 
knowledge and metabolic control was lowest for patients over 40 years of age (e.g., 
the 95% confidence interval for patients 55-68 years included a zero effect). 
 
Recent meta-analyses of diabetes PE (Norris, et al., 2002; Gary, Genkinger, 
Guallar, Peyrot & Brancati, 2003), however, suggest clinically and statistically 
significant decreases in glycated haemoglobin (HbA1c) post-intervention, but these 
effects also tended to diminish over time.  For example, Norris et al (2002) found 
that while there was a .76% decrease in HbA1c immediately post-intervention, but 
the effect declined to .26% from one month follow-up.  As well as a concern about 
the need for interventions that demonstrate long term change, Gary et al (2003) also 
point out that even the short-term decreases in HbA1c achieved in these studies are 
not at the level (1-2% decrease) achieved with intensive medically-based 
interventions in the DCCT (DCCT Research Group, 1993) and the UKPDS (Turner 
et al, 1996; UKPDS Group, 1998). 
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Research in diabetes health practitioner-patient interaction suggests that 
patients’ and practitioners’ goals often differ (Armstrong, 1991; Marteau, Johnston, 
Baum & Bloch, 1987).  Nevertheless, patients often test out the advice of health 
practitioners when provided with new information, and  initial impressions of success 
or failure are often powerful influences on the patient’s future behaviour (Drummond 
& Mason, 1990; Kelleher, 1988).   Good continuity of care is also valued by patients 
and can positively influence blood glucose control (Kelleher, 1988; Mazzuca, 1983; 
Marteau & Kinmonth, 1988). 
 
Research also suggests that there is considerable diversity in patients’ 
acceptance and understanding of their diabetes (Armstrong, 1991; Drummond & 
Mason, 1990; Kelleher, 1988), and that patients’ belief in the importance of metabolic 
control is often reflected in the level of metabolic control attained (Greenfield et al., 
1988, Murphy, Kinmonth & Marteau, 1992).  Additionally, when considering 
behaviour change, short-term comfort or security is often preferred over long-term 
health (Drummond & Mason, 1990). 
 
A New Zealand survey (Simmons, Swan, Lillis & Haar, 2005) of barriers to 
diabetes care among medical, dietetic and nursing staff involved in the management 
of patients with diabetes found that ‘motivation/denial’, diabetes knowledge, and the 
lifestyle regimen were considered the top three barriers to diabetes care.  Motivation 
was ranked first by those working in specialist diabetes services and General 
Practitioners (GPs). 
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Summing up, the evidence suggests that while PE may be an effective 
intervention for some individuals with diabetes, it may not be an effective intevention 
for all individuals with diabetes, or for an individual all of the time, with between and 
within individual variation in motivation for diabetes self-management.  Thus, while 
PE may be an important component of diabetes care, there needs to be alternative 
approaches which include a focus on motivation for, or ambivalence about, behaviour 
change for those individuals who, while knowing what it is that they need to do to 
manage their diabetes, still struggle with diabetes self-mangement.   
 
Psychological Interventions 
 
 Psychological interventions for diabetes, which typically comprise counselling 
or cognitive behaviour therapy (CBT) use the therapeutic alliance and/or skill-
building to facilitate change in patients’ cognitive, behavioural and emotional 
functioning (Ismail, Winkley & Rabe-Hesketh, 2003; Winkley, Landau, Eisler & 
Ismail, 2006).  This is in contrast to PE which is based on didactic and enhanced 
learning methods (such as behaviour change counselling strategies) which aim to 
improve diabetes self-management through increasing knowledge (Ismail et al, 2003; 
Winkley et al., 2006).  Thus, psychological interventions differ from educational 
interventions in their theoretical basis, the training and clinical skills required, and 
their implication for resources (Ismail et al, 2003; Winkley et al., 2006).   
 
 In meta-analyses of randomised controlled trials (RCTs) of psychological 
interventions to improve glycemic control, Ismail et al (2003) found that for patients 
with Type 2 diabetes HbA1c was lower (mean of .76%) following psychological 
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intervention compared to treatment as usual (TAU, which typically involves medical 
oversight and may include provision of information and advice), PE or control groups.  
In a similar meta-analysis Winkely et al (2006) found similar results for patients with 
Type 1 diabetes, with a mean reduction in HbA1c of .48% for children and 
adolescents, and a .22% decrease for adults.  Both studies also found that 
psychological distress (e.g., depression, stress, binge-eating) was significantly lower 
following psychological intervention for patients with Type 2 diabetes (ES=-.58), and 
children and adolescents with Type 1 diabetes (ES=-.46), but not for adults with Type 
1 diabetes (ES=-.25).   
 
 While these studies suggest that psychological interventions contribute to 
improved metabolic control and psychological well-being, they are typically provided 
by psychologists, sometimes in conjunction with other specialist staff (e.g., nurse 
educators, dietitians), and comprise five or more weekly sessions (Ismail et al, 2003; 
Winkley et al., 2006). As a result, the resource implications for such interventions 
limit the degree to which these can be adopted as routine treatment for diabetes.   
Thus, there is a need for brief interventions, which are individually tailored, and 
culturally sensitive (given the high rates of diabetes among indigenous peoples), 
which can be integrated into routine care (Clark & Hampson, 2001).   
 
MI has been suggested as one such intervention (Carino, Coke & Gulanick, 
2004; Lugoboni, Quaglio, Mezzelani, Pajusco, Casari, & Lechi, 2004; Doherty & 
Roberts, 2002; Stott et al., 1995; Stott, Rees, Rollnick, Pill & Hackett, 1996).  MI 
would provide a means of working with patients with diabetes to help build and 
strengthen motivation, while at the same time providing a patient-centred approach 
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which would address many of the issues noted above.  For example, MI with its 
emphasis on collaboration and agenda setting is likely to mean that the patient’s and 
health practitioner’s goals for treatment are similar.  Additionally, MI is likely to 
include an exploration of the patients health beliefs and  personal models of diabetes, 
and to focus on building self-efficacy, all factors which have been found to be 
predictive of diabetes self-management.  The next section in this chapter provides a 
review of MI. 
 
Motivational Interviewing 
 
MI is defined as "a directive, client-centred counselling style for eliciting 
behaviour change by helping clients explore and resolve ambivalence" (Rollnick & 
Miller, 1995, p.326).  It evolved from Miller's experience with the treatment of 
problem drinkers, and when first described by Miller (1983) was more a style of 
therapy than a set of particular techniques (Miller, 1996).    
 
Miller (1983) conceptualised motivation as a state of readiness for change, 
rather than a static personality-like trait or attribute.   As a state, motivation may 
fluctuate over time or from one situation to another, and can be influenced to change 
in a particular direction.  A lack of motivation, specifically a lack of motivation to 
change expressed as resistance to change, is not seen as inherently unchanging within 
an individual, but rather something that is variable and open to change.  This 
conceptualisation of motivation as a state which is open to change, was in sharp 
contrast to traditional, and, at the time, current, approaches to the treatment of 
addictive behaviours, which saw motivation to change as a personality problem, and 
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denial as something that had to be dealt with through aggressive confrontation (Di 
Cicco, Unterberger & Mack, 1978; Johnson, 1973; Yablonsky, 1965, 1989).   In fact, 
Miller and Rollnick (1991) later suggested that adopting an aggressive and/or 
confrontational style (as in traditional approaches) is likely to produce responses from 
a client (such as arguing) which may then be interpreted by the therapist as denial or 
resistance, thus, creating a "self-fulfilling prophecy" (p.10). 
 
Principles And Techniques 
 
Rollnick and  Miller (1995, p.326) distinguish between the "spirit" of MI and 
specific MI techniques.   Within the spirit of MI, readiness to change is not seen as a 
client trait, but a "fluctuating product of interpersonal interaction" (Rollnick & Miller, 
1995, p.327), and motivation to change is viewed as something which is evoked in the 
client, rather than imposed.  It is the individual's task (not the therapist's) to articulate 
and resolve his or her own ambivalence.  It is the therapist's task to expect and 
recognise ambivalence, and to be directive in helping the client to examine and 
resolve his or her ambivalence.   This distinction between the "spirit" of MI and its 
techniques is important.  It is possible for a therapist to apply the techniques of MI 
without holding to the "spirit" of MI (e.g., the therapist's aim is to manipulate the 
client into agreeing to change).   This, however, would not be MI, and is likely to 
elicit resistance, and therefore have reduced efficacy. 
 
An empathic style (Rogers 1957, 1959), which is known to be the key 
component to effective brief inteventions (Miller, Taylor & West, 1980; Valle, 1981), 
is fundamental to MI, with the underlying attitude being one of acceptance, and belief 
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that ambivalence is normal.  Within this empathic style it is the therapist's task to 
create and amplify any discrepancy between the client's present behaviour and 
important goals, thereby creating cognitive dissonance (Draycott & Dabbs, 1998; 
Festinger, 1957), so that the client him or herself presents the argument(s) for change.  
Without a supportive/empathic style the therapist is unlikely to be able to explore the 
client’s ambivalence without eliciting resistance (Patterson & Forgatch, 1985).   
 
Resistance, if it is encountered, is a signal to change strategy, rather than 
oppose the resistance.  Argumentation or direct persuasion are considered 
counterproductive and should be avoided, as they are likely to produce defensiveness 
or further resistance.   Instead, resistance is acknowledged and explored, using a quiet 
and facilitative style, within a relationship that is more like a partnership than an 
expert/recipient role,  with the view to shifting the client's perceptions. This change in 
perception of resistance as something that is not bad, but is to be expected, and which 
should not be challenged, but be seen as a signal to shift strategies, is likely to 
contribute to clinicians’ reports (van Bilsen, 1996) that they find working with 
difficult patients more enjoyable when using MI.  This should lead to increased 
clinician self-efficacy (Bandura, 1977a), and may also contribute to increases in client 
self-efficacy. 
 
Because client self-efficacy is a general predictor of therapy outcome 
(Bandura, 1977b, 1982), MI aims to support self-efficacy by seeing the client as a 
valuable resource in finding solutions to problems.  While the client is seen as 
responsible for choosing and carrying out personal change, MI also acknowledges 
that, at the same time, the client must have a belief in their ability to change.   That is, 
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without a belief that change is possible change is unlikely to happen.  Within MI it is 
recommended that the therapist also focuses on increasing the client's belief in his or 
her ability to change (e.g., by identifying and acknowledging successful behaviour 
change in the past). 
 
Rollnick and Miller (1995) describe specific, trainable therapist behaviours 
(techniques), which are characteristic of MI.  Seeking to understand the client’s frame 
of reference, particularly via reflective listening, and expressing acceptance and 
affirmation are techniques of MI borrowed from Roger’s (1957, 1959) non-directive 
client-centred therapy.   Going beyond this, the MI techniques of eliciting and 
selectively reinforcing the client’s own self-motivational statements, monitoring the 
client’s readiness to change, ensuring that resistance is not generated by jumping 
ahead of the client, and affirming the client’s freedom of choice and self-
determination, are techniques which distinguish MI from other client-centred 
therapies (Miller & Rollnick, 1991). 
 
These techniques are applied within the context of the ingredients for effective 
brief interventions, using the acronym FRAMES (Miller & Rollnick, 1991; Miller & 
Sanchez, 1994).  The acronym FRAMES stands for Feedback, Responsibility for 
change lies within the individual, Advice-giving, Menu of change options, Empathic 
style, Self-efficacy is enhanced.    In MI, however,  advice is not given without the 
individual's permission and, when given, is accompanied by actively encouraging the 
person to make his or her own choices.   
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Theoretical Basis and Historical Development of MI 
 
MI was not based on any specific theory.  Rather, Miller (1983) drew from 
social psychology, applying theories about: (1) attribution (Kopel and Arkowitz, 
1975) i.e., self-attribution of behaviour change increases the likelihood of 
maintenance of that change; (2) cognitive dissonance (Festinger, 1957) i.e., if a person 
knows various things that are not psychologically consistent (dissonant) with one 
another, he/she will, in a variety of ways (e.g., behavioural or cognitive change), try to 
make them more consistent; (3) self-perception theory (Bem, 1967) i.e., inferences 
arising from self-observation of one’s own behaviour may affect subsequent 
behaviour, attitudes and beliefs; (4) and self-efficacy (Bandura, 1977a, 1977b, 1982) 
i.e., expectations of personal self-efficacy determine whether behaviour change will 
be initiated, how much effort will be expended, and how long it will be sustained in 
the face of obstacles or aversive experiences; and also drew on empathic processes 
from the methods of Rogers (1957, 1959). 
 
Despite the initial lack of empirical data, considerable interest was shown in 
MI after Miller's initial (1983) article.  This was perhaps because MI offered a new 
way of approaching substance abuse problems, which provided hope for working with 
individuals who were previously viewed as unmotivated or resistant, and therefore 
untreatable, or at best difficult to treat.   More recently, interest in MI may also have 
been maintained because it is consistent, at least in superficial ways, with 
postmodernist paradigms, emphasising collaboration and client empowerment (Gerber 
& Basham, 1999).   
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Because of this interest, Miller began to research the processes and outcomes 
of MI, and as a result his initial model was elaborated by Miller and Rollnick (1991), 
and developed further in 1995 (Rollnick & Miller, 1995), with further refinements 
(e.g., the notion of importance and confidence) in 2002 (Miller & Rollnick, 2002).  A 
major development was to link MI to the transtheoretical model (TTM) of change 
(Prochaska & DiClemente, 1982; Prochaska, DiClemente & Norcross, 1992), which 
was developed in parallel with MI (Rollnick & Morgan, 1996).  The TTM describes a 
series of stages which people pass in the course of changing their behaviour.  The 
stages consist of pre-comtemplation, at which time the person has not comtemplated 
having a problem or needing to change; contemplation which is characterised by 
ambivalence about change, with the person oscilating between concern and 
unconcern; determination or preparation when the person appears to have made a 
decision to change and are on the verge of taking action towards behaviour change; 
action during which the person engages in behaviour to bring about change; and 
maintenance in which the challenge is to maintain the behaviour change and prevent 
relapse.  The TTM can therefore be seen as providing a framework for understanding 
the change process itself, and MI as providing a means of facilitating this change 
process (Sobell, Toneatto & Sobell, 1994).   
 
Within the TTM of change, readiness for change is seen as the extent to which 
the individual has contemplated the need for change, and reached a decision balance 
between the pros and cons of change.  Lack of motivation can therefore be viewed as 
a "perceptual" (Miller, 1994, p.115) problem, in which the individual sees no (or 
insufficient) need to change, whereas others (e.g., helping professionals, family) do 
perceive a problem and a need for change.   
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MI aims to alter how the client sees, feels about, and means to respond to, the 
problematic behaviour.   The therapist's response to ambivalence is the key to this.  
The ambivalence is resolved by focusing on the client's wants, expectations, beliefs, 
fears and hopes, with particular emphasis on the inconsistencies between these and 
the problematic behaviour. 
 
Despite Miller (1983) having drawn upon cognitive dissonance theory in 
developing MI, several aspects of dissonance theory are not used in MI, and the 
inclusion of these may improve the effectiveness of MI (Draycott and Dabbs,1998).  
In particular, Draycott and Dabbs (1998) suggest that more attention be given to 
optimal methods for arousing and maintaining dissonance.  They suggest keeping a 
visual record to keep the inconsistencies salient, and generating a decision balance 
sheet (for and against change) early in the session, which then becomes the focus for 
discussion so that cognitions consistent with not making change are removed or 
reduced in importance, using MI techniques, while the importance of cognitions 
supporting change is increased.  They also suggest a greater structure to the way MI is 
delivered, so that the focus is on "invoking and channelling dissonance" (p.362), with 
a greater emphasis on eliciting and exploring cognitions, as in standard cognitive 
therapy (Beck ,1995).   That is, the therapist should initially establish the client’s 
cognitions about the problematic behaviour, so as to assess their current dissonance.  
Following this, the cognitions should be explored in order to reduce the importance of 
cognitions consistent with the problematic behaviour and to increase the importance 
of inconsistent cognitions, while reinforcing statements which recognise dissonance, 
and implying and reinforcing the option of behaviour change.   The therapist, 
however, should take care not to over-structure MI sessions, as this may result in the 
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sessions being therapist driven, rather than client-focused, which in turn may produce 
resistance and thereby reduce efficacy. 
 
Draycott and Dabbs (1998) further suggest that the use of responses other than 
a commitment to behaviour change can be discouraged by the therapist implying the 
response of behaviour change as soon as possible after dissonance is recognised, 
thereby increasing the probability of this response being adopted.  This suggestion, 
however, is at risk of being at odds with the 'spirit' of MI.  In implying the response of 
behaviour change (particularly if this is done early on), the therapist would have to be 
careful that he/she is not perceived as imposing the notion of behaviour change on the 
individual.  The therapist must also take care that by doing so before the client is 
ready for change, he/she does not elicit resistant responses. 
 
Miller and Rollnick (1991) compare MI with skills training approaches, such 
as CBT, implying that these are two contrasting therapies, with CBT being “highly 
prescriptive, offering specific directions, instructions, and assignments” (p.54).  There 
appears, however, to be considerable overlap between MI and CBT, with CBT 
encompassing the ingredients Miller and Rollnick (1991) identified as necessary for 
effective brief interventions (i.e., FRAMES), and both MI and CBT seek to elicit and 
explore the client’s thoughts and feelings, with the view to ultimately effecting 
behaviour change.    
 
In both MI and CBT collaboration between the therapist and client is seen as 
crucial, with the therapist encouraging the client  as much as possible to take an active 
role during the session so that they function as a team (Beck, Rush, Shaw & Emery, 
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1979).   Furthermore, CBT techniques of guided discovery (Beck et al., 1979) and 
Socratic questioning (Overholser,1993), which aim to explore the client's problems 
and help the client draw his or her own conclusions by examining the evidence, 
considering alternatives, and weighing advantages and disadvantages, and the use of a 
graded series of questions, appear to fit well with MI's reflective listening, which 
seeks to understand the client's frame of reference.    Thus, it would appear that MI 
and CBT have much in common, the essential difference being that MI focuses on 
establishing whether the client is ready for change by being in the contemplation of 
preparation stage of change, in a way that is likely to increase the client’s readiness 
for change, whereas CBT assumes that the client is ready for change (i.e., in the 
action stage).  
 
Process of Change  
 
There is growing evidence supporting propositions made from MI theory.  For 
example, MI theory posits that MI will increase client change talk and minimise 
resistance, and that the extent to which clients verbally defend the problematic 
behaviour (i.e., resistance) will be inversely related to behaviour change.  Miller, 
Benefield and Tonigan (1993) found that problem drinkers randomly assigned to MI 
showed 111% more change talk.  In contrast, problem drinkers randomly assigned to 
a confront/direct intervention showed 78% more resistance than those receiving MI.   
Furthermore, level of resistance during intervention predicted poor outcome (i.e., lack 
of improvement in drinking behaviour).  These findings have been further supported 
through psycholinguistic analysis of MI (Amrhein, Miller, Yahne, Palmer & Fulcher, 
2003) which showed robust, atypical increases in change talk and decreases in 
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commitment to drug use during MI, with verbal commitment to drug use during MI 
predicting continued drug use. 
 
MI theory also posits that the extent to which clients verbally argue for change 
(i.e., change talk) will be directly related to behaviour change.  This proposition, 
however, has not been supported, with the frequency of change talk found not to be 
predictive of  behaviour change (Miller et al, 1993; Miller, Yahne & Tonigan, 2003).  
Amrhein et al (2003) suggest that change talk itself is too global a concept, and that 
instead there are natural markers of readiness to change, which involve the client 
expressing a desire, ability, reasons, need and commitment to change, and that what is 
important is not just the frequency, but rather the strength with which these are 
expressed, with the most predictive client speech occuring at the end of the session. 
 
MI theory further posits that the resolution of ambivalence about behaviour 
change is promoted by accurate empathy.  Research again supports this proposition, 
with therapist empathy and Rogerian skill found to be predictive of client outcome 
both in MI (Miller et al., 1980) and more generally in psychotherapy (Valle, 1981).  
MI theory posits that the resolution of ambivalence in a particular direction is 
influenced by the clinician’s differential reinforcement of client speech.  This is 
supported by Sellman, Sullivan, Dore, Adamson and MacEwan (2001) who found that 
MI produced superior outcomes to a non-directive patient-centred intervention.  This 
finding suggests that what facilitates behaviour change in MI is its focus on eliciting, 
and using reflective listening to selectively reinforce, client change talk, rather than it 
simply being a patient-centred intervention. 
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Specific MI Interventions 
 
The principles of MI were incoporated into a brief intervention, called the 
Drinker’s Check-up (DCU) for problem drinkers (Miller, Sovereign & Krege, 1988; 
Miller & Sovereign, 1989), which is an assessment-based strategy, involving a 
comprehensive assessment of the client’s drinking and related behaviours, followed 
by systematic feedback to the client of the findings using a MI communication style.  
The DCU was extended into a four session form of MI by Miller, Zwedben, 
DiClemente and Rychtarik (1992) as one of three interventions for alcohol abuse and 
dependence evaluated in Project MATCH (1993) and called MET.  MET aims to 
motivate clients to make changes, rather than provide step-by-step advice about 
behaviour change.  
 
Additionally, a set (menu) of techniques, which follow the spirit and practice 
of MI, called Brief MI have been developed for use in a single 40 minute session in 
primary care settings, with non-help seeking problem drinkers  (Rollnick, Heather & 
Bell, 1992).  Further studies are currently evaluating whether the spirit of MI can be 
captured in even briefer (e.g., 5-10min) encounters (Stott, Rollnick, Rees & Pill, 
1995). 
 
MI has been provided by telephone consultation (Ludman, Curry, Meyer & 
Taplin, 1999), and in a group format (Ingersoll & Wagner, 1997; Van Horn & Bux Jr, 
2001; Lincourt, Kuettel & Bombardier, 2002).  A group format, while more efficient, 
may compromise the effectiveness of MI as the intervention will not be able to be 
targeted at each individual's specific needs as it is likely that different members of the 
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group will be at different stages of change, at different times during the group 
sessions.  Studies are also currently underway exploring other formats for MI, such as 
computerised or paper self-help manuals. 
 
Areas of application 
 
MI has been used in a variety of settings.  This includes inpatient (Kemp et al., 
1998; Long & Hollin, 1995; Swanson et al., 1999), and outpatient (Aubrey, 1998; 
Bien, Miller & Boroughs, 1993) settings, general hospital ward (Heather, Rollnick, 
Bell & Richmond, 1996) and emergency department (Monti, et al., 1999); general 
medical practice (Rollnick et al., 1992; Rollnick, Kinnersley & Stott, 1997), and the 
home (Tappin et al., 2000).    
 
Similarly, MI has been used with a variety of different populations, including 
offenders on probation (Harper & Hardy, 2000); pregnant women (Handmaker, Miller 
& Manicke, 1999); patients with traumatic brain injury (Bombardier & Rimmele, 
1999); couples (Crous, 1998, Zweben, 1991); and families (Rao, 1999).  Several 
studies (Berg-Smith et al., 1999; Colby et al., 1998; Lawendowski, 1998; Tober, 
1991) also report on the use of MI with adolescents, for whom MI may be particularly 
suited because of its emphasis on personal responsibility and avoidance of an 
authoritarian stance. 
 
MI has also been applied in a number of countries, with Miller and Rollnick 
(1991) citing examples of the application of MI in Australia, England, The 
Netherlands, Scotland, and the United States.   Additionally, it appears likely that MI, 
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with its non-authoritarian stance and emphasis on personal choice, is likely to be 
acceptable to indigenous peoples and ethnic minority groups who seek self-
determination and self-empowerment.   Longshore, Grills and Annon (1999), for 
example, have included MI in a "culturally congruent" (p.1223) intervention for 
African Americans, stating that MI's emphasis on personal choice, and avoidance of 
advice-giving and confrontation as reasons why MI was a culturally congruent 
approach.   
 
 Additionally, MI has been applied to a variety of problems.  As well as being 
used as an intervention for alcohol abuse (Heather et al., 1996; Miller et al. , 1988; 
Miller, Benefield & Tonigan, 1993; Project Match Research Group, 1993; Sellman et 
al., 2001) MI has been applied the treatment of abuse of other substances, such as 
heroin (Saunders, Wilkinson & Allsop, 1991; Saunders, Wilkinson & Phillips, 1995; 
Van Bilsen, 1991; Van Bilsen & Whitehead, 1994), cocaine (Stotts, Schmitz, Rhoades 
& Grabowski, 2001), and marijuana (Stephens, Roffman & Curtin, 2000), as well as 
with substance abusers with dual diagnoses (Martino, Carroll, O'Malley & 
Rounsaville, 2000; Swanson, Pantalon & Cohen, 1999).   It has been suggested that 
MI may be of particular use with individuals dually diagnosed with schizophrenia and 
substance abuse, who are less able to benefit from  confrontational methods typical of 
traditional substance abuse treatment (Bellack & DiClemente, 1999; Carey, 1996), 
and that MI, with its brevity and focus on initiating behaviour change, could readily 
be incorporated into acute inpatient settings (Van Horn & Bux Jr, 2001).      
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MI also appears to hold considerable promise as an adjunct to skills based 
treatments such as CBT or Behaviour Therapy (BT).  Baer, Kivlahan and Donovan 
(1999) suggest that the motivational strategies of MI could be usefully integrated with 
the skills training of CBT so that therapy includes the assessment and support of both 
why the client wants change (motivation) and how change can be achieved (skills).  
MI, then, can been seen as a means of assessing a client's readiness for change and 
preparing him/her for change by resolving any ambivalence as it arises, either at the 
beginning of treatment or through the treatment process.  On the other hand, the skills 
based treatment (i.e., CBT or BT) can be seen as a means of increasing the client's 
confidence and ability to change.    
 
This integration of MI and CBT or BT appears to be occurring in clinical 
practice (Allsop & Saunders, 1991; Kent, 1991), however, studies evaluating the 
effectiveness of MI combined with CBT (Barrowclough et al., 2001; Kemp, Kirov, 
Hayward and David, 1998) or BT (Long & Hollin, 1995; Van Bilsen & Whitehead, 
1994) only report the overall effectiveness of the combined intervention in contrast to 
a control condition.  This means that it is not possible to evaluate the relative efficacy 
of each component or the efficacy of the combined treatment compared to each 
intervention alone (e.g., the efficacy of MI + CBT compared to either MI or CBT).  
 
MI has also been applied to problems such as sexual offending (Mann & 
Rollnick, 1996), conflict over child access (Crous, 1998), attendance at group 
counselling for domestic abusers (Taft, Murphy, Elliott & Keaser, 2001), and as an 
intervention for at-risk couples (Cordova, Warren & Gee, 2001) and families (Rao, 
1999).  Additionally, there has been increasing interest in the use of MI in the 
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treatment of anorexia nervosa and bulimia nervosa, with the recognition that 
ambivalence about treatment is common with eating disorders (Treasure, Katzman, 
Schmidt, Troop, Todd & de Silva, 1999; Feld, Woodside, Kaplan, Olmsted & Carter, 
2001).  These tend to be isolated pilot studies, using quasi-experimental designs 
(mostly non-equivalent control group design), but together they provide support for 
the potential application of MI to a wide range of problems. 
 
Health Behaviour Change.    There has been increasing interest in the 
application of MI to managing chronic illness and health behaviour change (Rollnick 
et al., 1992; Rollnick, 1996; Rollnick, Mason & Butler, 1999).  This includes pain 
management (Jensen, 1996), cardiac rehabilitation (McHugh et al., 2001; Brodie & 
Inoue, 2005), and health behaviour change, such as that required for the prevention 
and management of human immunodeficiency virus  (Foley et al., 2005; Golin et al., 
2006), smoking cessation (Emmons et al., 2001; Valanis et al., 2001), physical 
activity (Harland et al., 1999; van Vilsteren, de Greef & Huisman, 2005; de Blok et 
al., 2006), adherence to asthma medication (Schmaling, Blume & Afari, 2001), 
lifestyle change for hypertension (Woollard et al., 1995),  dietary change for 
hyperlipidaemia (Mhurchu, Margetts & Speller, 1998; Kreman et al., 2006), and daily 
fruit and vegetable intake (Resnicow et al., 2001).  These studies included 
uncontrolled/non-experimental designs, quasi-experimental designs with non-
equivalent control groups, and RCTs (mostly small pilot studies).  Taken together, the 
results provide support for the potential application of MI to a wide range of health 
problems, with MI performing better than no treatment, but significant differences 
were not always achieved when MI was compared to another active treatment (such 
as advice about and support for health behaviour change). 
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Traditionally, health practitioners have encouraged patients to make changes 
through the provision of advice (i.e., information giving with direct persuasion) about 
behaviour change (Tuckett, Boulton, Olsen, & Williams, 1985).  While this works 
with some patients (Wallace, Cutler & Haines, 1988), the evidence of the 
effectiveness of advice giving about lifestyle change is not strong (Rollnick et al., 
1992), with success rates of only 5-10% (Kottke, Battisa, Degriese & Brekke, 1988; 
Bien, Miller & Tolligan, 1993). 
 
Furthermore, there is evidence that patients do not necessarily want advice if it 
is provided in a style that is perceived as being “told what to do" (Stott & Pill, 1990). 
Additionally, advice giving can develop into non-constructive disagreement, with the 
health practitioner placing emphasis on the benefits of change while undervaluing the 
personal costs, and the patient looking closely at the personal implications of change 
and the immediate costs while minimising future benefits (Tuckett et al., 1985).  The 
risk of such an encounter is that the patient becomes resistant to change or resistance, 
if already present, is enhanced (Miller & Rollnick, 1991). 
 
In contrast, there is evidence that more patient-centred approaches to 
health/lifestyle change produce better outcomes (Kaplan, Greenfield & Ware, 1989; 
Stewart & Roter, 1989).  The essential features of these patient-centred approaches 
are that the patient does most of the talking, and that there is a 'meeting between 
experts' (Tuckett et al., 1985), with the concept of reciprocity in the consultation 
(Roter, 1987).  Patient-centred counselling, however, has not been developed into a 
replicable method specifically geared towards negotiating behaviour change in health 
consultations (Rollnick, 1996).   
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MI appears consistent with a number of models of health behaviour, such as 
Locus of Control (Rotter, 1966), the Health Belief Model (Becker, 1974), the Theory 
of Reasoned Action (Fishbein & Azjen, 1975), Social Cognitive Theory (Bandura, 
1977b), Decisional Balance (Janis & Mann, 1977), the Health Action Process Model 
(Schwarzer, 1992), the Self-Regulatory Model (Leventhal, Diefenbach & Leventhal, 
1992), and Self-Determination Theory (Deci, Eghrari, Patrick & Leone, 1994).  All of 
these models, despite differences in their terms and emphasis, share three common 
constructs (Doherty et al., 2000), which are the focus of MI.  These are (1) the 
patient’s expectations about the consequences of engaging in the behaviour; (2) the 
influence of the patient’s perception of, or beliefs about, personal control over the 
behaviour; and (3) the social context of the behaviour. 
 
The Health Belief Model (HBM), for example, suggests that health behaviour 
change depends on the simultaneous occurrence of, first, the belief that one is 
susceptible to a health threat or the medical or social consequences of the health 
threat; second, sufficient health concern is felt to make the issues relevant; and third, 
the belief that a particular health recommendation would be beneficial in reducing the 
perceived threat at an acceptable cost (Rosenstock, 1974).  MI appears to be a process 
by which the preceding three factors for health behaviour change, as postulated by the 
HBM, can be created or enhanced in the patient by the health practitioner.  
Additionally, it has been suggested (Rosenstock, Stretcher & Becker, 1988) that the 
HBM could be improved by drawing upon Bandura's self-efficacy theory (Bandura, 
1977a).  According to this theory, the degree to which an individual develops the 
expectancy that they will be able to perform desired behaviours (i.e., self-efficacy) is 
an important factor in behaviour change (Bandura, 1977a). 
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Self-efficacy has been used to predict health behaviour such as smoking 
cessation, weight reduction, exercise, and cardiac rehabilitation (Fluery, 1992).  As 
mentioned earlier, self-efficacy is an important aspect in MI, with MI attempting to 
increase the patient's belief in his or her ability to change his or her behaviour. 
 
MI, therefore, appears to hold substantial promise for health behaviour 
change.  It is consistent with the call (from patients, and health researchers and 
practitioners alike) for more patient-centred approaches in health care in which the 
health practitioner-patient relationship is a partnership, rather than an expert-recipient 
one.  MI also provides health practitioners with a means of tailoring their 
interventions to suit the patient's degree of readiness for change.  In particular it 
provides practitioners with an effective means of working with patients who are 
ambivalent about, or not ready for, change. 
 
Despite the promise which MI holds for promoting heath behaviour change, 
there are few controlled studies evaluating the efficacy of MI with health problems, 
with clinical innovation remaining ahead of scientific evaluation (Rollnick, 1996).  
The challenge is to develop MI interventions that are useable in health consultations 
(which tend to be brief), are trainable, and are sufficiently specific to enable proper 
evaluation (Rollnick et al., 1992).  With such interventions patients are likely to feel 
listened to and understood by their health practitioner.  Health practitioners, on the 
other hand, are likely to gain a greater sense of achievement from recognising change 
in patients’ readiness as important progress, rather than seeing concrete behaviour 
change as the only goal.  Thus, the resulting MI interventions are likely to contribute 
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to a greater sense of satisfaction for patients and practitioners, as well as helping 
promote health behaviour change. 
 
In particular, MI appears to be potentially useful for promoting chronic disease 
management, such as diabetes self-management.  Many of these diseases in both 
etiology and treatment are related to lifestyle factors such as diet, exercise, and 
smoking, but changing and maintaining such behaviours is difficult, requiring time 
and considerable effort and motivation, and ambivalence about behaviour change is a 
common problem (Rollnick, et al., 1992). 
 
Empirical Support 
  
Reviews and meta-anlyses.  The number of MI publications and MI outcome 
studies has risen exponentially since its development in the mid-late 1980s, with the 
MI website (www.motivationalinterview.org) citing over 400 publications in 2003 
and nearly 70 outcome trials in 2004.  Since 2001 a number of systematic reviews and 
meta-analyses of MI have been published. 
 
The first of these (Dunn, Deroo & Rivara, 2001) was conducted ‘out of 
concern that the popularity of MI had outstripped the evidence for its effectiveness’ 
(p.1726).  This involved a systematic review of 29 RCTs evaluating MI across four 
behavioural domains - substance abuse (n=27), smoking (n=2), HIV risk (n=4), and 
diet/exercise (n=6), of which 26 studies reported adequate information to calculate the 
efffect size.  The most cumulative evidence for the effectiveness of MI was found for 
substance abuse, particularly when MI was used as an enhancement to more intensive 
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treatment, with significant effect sizes reported in 73% (11 out of 15) studies.  Data, 
however, were inadequate to draw conclusions regarding the effect of MI in the other 
domains.   
 
In a meta-analysis of 30 controlled trials of MI (i.e., alcohol problems n=15, 
smoking n=2, drug abuse n=5, HIV risk n=2, diet/exercise n=4, and treatment 
compliance n=1) Burke, Arkowitz and Menchola (2003) found that MI was equivalent 
to other active treatments, such as CBT.  Moderate effects were also found when MI 
was compared to no treatment and/or placebo for alcohol problems (ES=.25 to .53), 
drug addiction (ES=.56), and diet/exercise (ES=.53), but there was no effect for 
smoking and HIV risk.  They also found that higher doses of MI (i.e., more than 60 
minutes of MI) yielded a greater effect size, and the effects of MI did not fade 
significantly over time, with follow-up periods ranging from four weeks to four years 
(mean=18 weeks).   Burke et al (2003) conclude with the recommendation that future 
outcome research includes careful description of the training involved and an 
evaluation of treatment integrity, and call for more process studies in order to assist 
with understanding the links between the process and outcomes of MI. 
 
Burke, Dunn, Atkins and Phelps (2004) enlarged on the studies used by Burke 
et al (2003) with a meta-analysis of 38 controlled trials of MI (alcohol problems n=20, 
drug abuse n=6, smoking n=2, HIV risk n=2, diet/exercise n=4, and n=1 for treatment 
compliance, eating disorders, asthma, and injury-risk behaviour), and again found a 
moderate effect sizes for MI for alcohol abuse (ES=.35 to.53), drug abuse (ES=.56) 
and diet/exercise (ES=.53), and no effect for smoking and HIV risk behaviour.  
Additionally, following on from the recommendations of Burke et al (2003) for an 
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increased understanding of the process of change in MI, they reviewed research in 
which the process of MI was examined.  This research suggested that MI did not 
differentially increase readiness to change in comparison to other active interventions, 
and that it was not yet known whether feedback, MI per se, or the combination was 
essential for an effect, but that challenging or disagreeing by clients produced poorer 
outcomes.  They concluded that controlled studies demonstrate that MI is consistently 
efficacious for substance abuse problems, and has the potential in other problem 
areas, such as medical treatment compliance and health behaviour change, but that the 
evidence for efficacy in these areas is not yet sufficient. 
 
Following on from this Rubak, Sandbeck, Lauritzen and Christensen (2005) 
performed a meta-analysis of 72 RCTs of MI in the treatment of disease (i.e., 
diabetes/asthma n=2, smoking n=8, diet/exercise n=8, alcohol abuse n=23, 
psychiatry/drug addiction n=12), finding a positive effect for MI in three out of four 
studies (including studies involving the treatment of diabetes, asthma, and weight).  
Only 46% of studies, however, used direct health outcome measures, with a positive 
effect obtained in 75% of these studies, although no effect was obtained for HbA1c 
and there was only a very small, non-clinically significant negative effect for total 
cholesterol.  They also found, similar to Burke et al (2003), a dose effect, with more 
than one session of MI producing greater effect, and the longer the follow-up the 
increased likelihood of finding an effect.  For example 36% of studies with a 3-month 
follow-up showed a positive effect compared to 81% of studies with a 12-month or 
longer follow-up.  Also similar to Burke et al (2003, 2004), they recommend that 
future MI reseach more clearly describe the MI training and evaluates treatment 
integrity, but they also recommend that future research use a combination of direct 
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(i.e., health outcome) and indirect measures (i.e., health behaviour), and that MI be 
evaluated in clinical settings. 
 
In another meta-analysis of 72 studies, Hettema, Steele and Miller (2005) 
found that there was wide variability in effect sizes across studies, and within problem 
areas (e.g., effect size of 0 to 3.0 for alchol problems).  Just under half (n=31) of the 
studies in this analysis were from the alcohol treatment area, but the analysis also 
comprised studies reflecting the wide range of applications of MI, including MI 
applied to treatment compliance (n=5), and diet/exercise (n=4).  They also found that 
the effects of MI tended to appear early, with the exception of certain problem areas 
or dependent measures (e.g., diet and exercise) where effects tended to be delayed.   
 
Hettema et al (2005) also found that the effect size did not differ with the 
professional background of the MI practitioner, suggesting that a variety of health 
practitioners, as well as para-professionals may effectively practice MI.  They did, 
however, find that the effect size was reduced by the use of a manual to guide MI 
(from .65 for studies not using a manual to .37 for studies using a manual).   This 
lessening of an effect for manually guided MI may reflect the importance of MI being 
client-centred, with the focus being on using particular MI strategies to match the 
clients’ readiness for change.  A manual, if too prescriptive, or if used in a 
prescriptive way, may reduce the efficacy of MI, hence the above finding.  They also 
found that only 29% of studies comprised post-training supervision and only 36% of 
studies measured treatment integrity.  Additionally, Hettema et al (2005) found that 
the effect size was higher for ethnic minority groups (ES=.79) compared to 
Caucasians (ES=.39).  This finding is consistent with Longshore et al’s (1999) finding 
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that MI was a culturally congruent intervention for African Americans, and suggests 
that MI may be an example of good cross-cultural counselling.   
 
The most recent systematic review (Knight, McGowan, Dickens & Bundy, 
2006) evaluated the effectiveness of MI in physical health care settings only.  This 
comprised a review of eight controlled studies in the areas of diabetes (n=3), asthma 
(n=1), hyperlipidaemia (n=1), hypertension (n=1), and cardiology (n=2).  While the 
strength of conclusions that can be drawn from these studies is limited by the small 
sample sizes, lack of power, and lack of validated measures, Knight et al (2006) found 
that most of the studies did show positive effects.   
 
Empirical studies of MI applied to diabetes.  There has been increased interest 
in MI as a means of promoting treatment adherence in diabetes (Carino, Coke & 
Gulanick, 2004; Lugoboni, Quaglio, Mezzelani, Pajusco, Casari, & Lechi, 2004; 
Doherty & Roberts, 2002; Stott et al., 1995; Stott, Rees, Rollnick, Pill & Hackett, 
1996).  There are, however, only a few outcomes studies.   
 
Smith, Heckemeyer, Kratt and Mason (1997) in a randomised control pilot 
study investigated whether the addition of three MI sessions (conducted by 
psychologists) to a standard (16 week) behavioural weight reduction program for 22 
obese women with Type 2 diabetes would increase adherence to treatment and 
improve glucose control.  It was found that the group receiving MI attended more 
sessions, completed more food diaries, recorded their blood glucose level more often, 
and had better blood glucose control than the group receiving standard treatment.  
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Although both groups lost weight, there were, however, no differences between the 
two groups in the amount of weight reduction.    
 
The effectiveness of Brief MI (i.e, one 30mins session of MI) for patients 
(aged 40-70 years) with Type 2 diabetes was evaluation in a RCT (Clark & Hampson, 
2001; Clark, Hampson, Avery & Simpson, 2004), in which articipants (n=100) were 
randomised to either TAU or Brief MI provided by one of the researchers.  In addition 
to the Brief MI session, participants in the intervention group also received three 10 
minute follow-up phone calls at one, three and seven weeks post-intervention, and 
two extra follow-up sesssions at weeks 12 and 24.  Measures (pre- and post-treatment, 
and 12-month follow-up) included self-report questionnaires regarding diabetes self-
management (Summary of Diabete Self-Care Activities Questionnaire – SDSCAQ), 
fat-related dietary behaviour (Kristal Food Habits Questionnaire and the Block Fat 
Screener), physical activity (Physical Activity Scale for the Elderly), body mass index 
(BMI), waist circumference, and metabolic measures (i.e., total cholesterol, HDL-
cholesterol, LDL-cholesterol, triclycerides, HbA1c).  The results indicated that there 
was a significant reduction in fat intake by the intervention group, which reflected in 
the objective data, with weight maintenance and a significant reduction in wait 
circumferene in the intervention group compared to the control group, which were 
maintained or enhanced over 12-month follow-up.  These changes, however, did not 
contribute to significant improvements in the metabolic (diabetes outcome) measures.  
These results, however, need to be interpreted with caution as the observed changes 
may be attributable to the increased contact (i.e., three 10 minute follow-up phone 
calls at one, and two extra follow-up sesssions) rather than MI per se.  Clark, 
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Hampson, Avery and Simpson (2004) conclude with a call for more research of MI in 
real world conditions, and with less motivated patients. 
 
Viner, Christie, Taylor and Hay (2003) in a non-randomised pilot study 
compared a group intevention for adolescents (n=21, aged 11-17 years) with Type 1 
diabetes with a control group (n=20 randomly selected patients who opted not to 
participate in the intervention group).  The authors described the group (six weekly 
sessions) as a MI plus solution-focused therapy (SFT) group, but it also contained 
elements of CBT.  ‘SFT works with the client to identify what they already do well 
rather than focusing on which is going wrong, e.g., identifying “what helped” during 
periods when their diabetes was under control’ (Viner et al., 2003 p.740). The results 
indicate that, compared to the control group, there was a significant decrease (i.e., 
1.5%) in HbA1c at 4-6 months follow-up for the intervention group, which was partly 
(1.3%) maintained at 7-12 months follow-up, although the difference between the 
groups was not significant.  It is again, however, unclear if the observed 
improvements were due to the intervention itself, or simply resulted from the 
increased contact the intervention group received.  Additionally, it is unclear which 
elements of the group (e.g., MI, SFT or CBT) were the effective ingredients, and the 
authors do not state who provided the intervention and what training was required. 
 
 Another group intervention, comprising MI and externalising conversations (a 
component of narrative therapy which allows the individual to separate the problem 
from the person, by personifying the problem and relating to it as an external entity to 
the person),  for adolescents (13-16 years)  with Type 1 diabetes was evaluated by 
Knight et al  (2003).   In this RCT participants (n=40) were randomised to receive 
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either the intervention (run by a senior registrar in child psychiatry and a community 
psychiatry nurse) or TAU.  Diabetes outcome and self-management data were not 
collected.  Instead, the outcome measures comprised qualitative analysis of 
participants responses to open questions regarding their perceptions of their diabetes.  
The results suggest that, compared to the control group, the intervention group shifted 
their perceptions of diabetes, such that they reported feeling less threatened by, and 
more in control of  their diabetes, were more accepting of their diabetes and felt less 
restricted by it.  The authors argue that these findings are significant given previous 
research which suggests that adaptive shifts in illness perception are a determinant of 
adaptive outcome in chronic illness (Petrie & Wienman, 1997) and engagement in 
self-care (Hampson, Glasgow & Foster, 1995).  Unfortunately, however, they do not 
provide data to support that these changes in illness perceptions did indeed translate to 
changes in diabetes self-management behaviour or outcome.  Additionally, it is again 
unclear which elements of the group (e.g., MI or the externalising conversations) 
contributed to the changes observed. 
 
Another pilot study (Channon, Huws-Thomas, Gregory & Rollnick, 2005; 
Channon, Smith & Gregory, 2005), evaluated the effectiveness of MI with 
adolescents (aged 14-18 years) with Type 1 diabetes.  Participants were selected 
based on their responses to the Readiness to Change Questionnaire (RCQ - based on 
the TTM of change), with those with responses indicating that they were in the 
contemplation, preparation and action stage of change being included in the research.  
MI sessions were conducted by one of the researchers over six months, with the 
frequency (total number of sessions ranging from 1 to 9, with a mean of 4.7) as well 
as the presence of others (e.g., parents or partners) determined by each participant.  
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Self-report questionnaire data of  health (Wellbeing Questionnaire), diabetes 
knowledge (Diabetes Knowledge Test - DKT), self-management behaviour 
(SDSCAQ), beliefs about diabetes (Personal Models of Diabetes Questionnaire – 
PMDQ), and family functioning and behaviour (Family Adaptability and Cohesion 
Evaluation Scales, and Diabetes Family Behaviour Scale) were collected pre- and 
post-intervention.  Additionally, HbA1c data were collected before, during and after 
the intervention.  The results suggest a significant decrease in HbA1c both during 
(i.e., 1.1%) and after (i.e., 0.8%) MI.  In contrast, there was no significant change in 
HbA1c in a comparison group comprising 25 patients who declined to participate in 
the MI and those that were excluded from the study because they were classed as 
being in the maintainence stage of change on the RCQ.  There was no significant 
change in the psychosocial measures of well-being, diabetes self-care, family 
behaviour and process, or diabetes knowledge.  Yet, there was a significant decrease 
in their scores on the PMDQ, suggesting that diabetes was easier to live with.  There 
was also a change in responses to the RCQ for 39% of participants, of which 64% 
indicated a movement towards action, but 27% also indicated a decrease in readiness 
to change.  These results, however, need to be treated with caution due to the small 
number of participants, and the potential for the effect to have arisen from the placebo 
effect of regular contact rather than the MI itself.  The authors also point out the 
inconsistency in the results, with questionnaire data indicating that there was no 
change in diabetes self-management behaviour, yet there were improvements in 
HbA1c.  Consequently, they suggest that future research includes more intensive 
assessment of change and self-management behaviour. 
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 In the largest RCT (n=265) of  MI to-date, Rubak (2005) evaluated the 
effectiveness of MI provided by General Practitioners (GPs) as part of an intensive 
treatment programme for individuals (40-69 years) with newly diagnosed Type 2 
diabetes.  Measures included self-report questionnaires of perceptions of the doctor-
patient relationship (Health Care Climates Questionnaire), self-determined behaviour 
(Treatment Self-Regulation Questionnaire), perceptions of diabetes (Diabetes Illness 
Perception Questionnaire, which incudes the PMDQ), and diabetes self-management 
behaviour (DSCAQ), as well as metabolic measures (i.e, HbA1c, lipids, blood 
pressure) and BMI.  The results suggest that, at one year follow-up, the intervention 
group were more motivated, reported receiving more advice from their GP, and had 
increased beliefs about the effectiveness of diabetes treatment.  There, however, was 
no significant changes in behaviour (smoking, alcohol consumption, and physical 
activity) or physical risk factors (i.e., HbA1c, lipids, blood pressure and BMI).  It is 
also unclear if the observed changes were due to the intensive intervention or the MI 
component. 
 
 In summary, the effectiveness of MI applied to diabetes is unknown, with 
mixed results achieved across studies evaluating MI with diabetes.  Furthermore, 
these previous studies have varied in the measures used to evaluate outcome.  Most, 
but not all (i.e., Knight et al., 2003), studies have included metabolic measures (e.g., 
HbA1c, lipids), which are the primarly measures of importance in terms of diabetes 
outcome.  As well as metabolic measures, most studies (Smith et al., 1997; Clark et al, 
2003; Rubak, 2005, Brug et al., 2007) have used direct or indirect (i.e., 
questionnaires) measures of self-management behaviour, such as SMOBG, physical 
activity, or diet, providing an indication of the process by which any change in 
  60
metabolic data may have occurred.  Less than half of the studies (i.e., Knight et al., 
2003, Rubak, 2005; Channon et al., 2007), however, have included psychosocial 
measures related to diabetes, such beliefs about the effectiveness of treatment or the 
seriousness of diabetes.  Such measures are important to include in any evaluation of 
treatment for diabetes, as an individuals knowledge and beliefs about diabetes and its 
treatment may affect metabolic control (Bradley, 1994; Gonder et al., 2002).  If an 
individual with diabetes is ‘unhappy with their treatment or seriously inconvenienced 
they are unlikely to be conscientious in following the prescribed treatment regimen, 
especially if the perceived benefits do not outweigh the psychological costs’ (Bradley, 
1994, p.12). 
 
Of the studies that measured metabolic control, half (i.e., Smith et al., 1997; 
Viner et al., 2003; Channon et al., 2007) found improvements in HbA1c following 
MI, whereas no such change was found in the other half of the studies (i.e., Clark et 
al., 2004; Rubak, 2005; Brug et al., 2007).  Similarly, of the studies that included 
behaviour change as an outcome measure, half (i.e., Smith et al., 1997; Clark et al., 
2004) found improvements in diabetes self-management behaviour after MI, whereas 
no such change was found in the other half of the studies (i.e., Rubak et al., 2005; 
Brug et al., 2007). The only consistent finding across the previous MI studies, and this 
was in only two studies (Knight et al., 2003; Channon et al., 2007), was a decrease in 
the participants beliefs about their diabetes following MI, particularly their beliefs and 
concerns about the influence of diabetes on life expectancy, quality of life, and daily 
functioning.  Additionally, all but two (i.e., Rubak, 2005; Brug et al., 2007) of these 
studies used specialists (typically a psychologist) to provide the MI intervention rather 
than usual clinical staff, such as dietitians or nurse educators, who work with the most 
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with individuals with diabetes, and the research was not conducted in real world 
conditions, with patients could be considered less motivated, who had been identified 
as experiencing difficulties with diabetes self-management. 
 
Empirical studies of MI training.  While studies have demonstrated that MI is 
effective in reducing problem behaviours, including health-related behaviours, 
evidence is only recently emerging regarding the effectiveness of MI training in 
altering practitioner behaviour consistent with MI theory.  Some earlier studies (Bien, 
Miller & Burroughs, 1993; Carroll, Kadden, Donovan, Zweben & Rounsaville, 1994) 
evaluated the outcome of training in MI, including using treatment adherence ratings 
collected as part of assessment of treatment integrity (Rubel, Sobell & Miller, 2000).  
The results of these studies suggest a change in therapist behaviour post-training 
consistent with MI.  These studies, however, tended to use only global ratings of MI 
consistent and MI non-consistent therapist behaviour, and did not measure client 
behaviour. 
 
The Motivational Interviewing Skills Code (MISC) is a measure of 
proficiency in using MI, but also includes measures of client behaviour that are 
predictive of client behaviour change (Amrhein et al., 2003, Miller et al., 1993).  
There are, however, only three published studies which have utilised the MISC to 
evaluate training in MI.   
 
The first such study evaluated the effectiveness of a 2-day training in MI for 
22 probation counselors (Miller & Mount, 2001).   They reported summary measures 
from the MISC, with significant increases on global ratings of proficiency in MI post-
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training that were maintained at 3-month follow-up, with the total number of MI 
consistent responses increasing 47% from pre-training to follow-up, and a 76% 
increase in the ratio of reflections to questions. 
 
Miller et al (2004) used the MISC in a RCT to evaluate methods (workshop 
only, workshop plus feedback, workshop plus coaching, workshop plus feedback and 
coaching, self-training control).  Analysis of audiotape practice samples at baseline, 
post-training, and 4, 8, and 12 month follow-up using the MISC found that the four 
trained groups showed increased proficiency in MI (although the workshop only 
group showed only marginal gains), whereas the self-training control group did not, 
and that these gains were generally maintained throughout follow-up.  The training 
groups showed significant increase in the global spirit rating; reflection to question 
ratio; percent complex reflections; MI consistent response ratio; and therapist talk 
time.  They also found that the three groups that received feedback and/or coaching in 
addition to the workshop met the standard (i.e., global spirit and % MI consistent 
responses) for proficient MI at 4- and 8-month follow-up, whereas the self-training 
control and workshop only groups did not achieve this standard.  Futhermore, they 
found that client (actors) responses changed in the expected direction post-training, 
with less resistance and more change talk.  Actual client responses at 4-months 
follow-up, however, showed this pattern only for the workshop plus feedback and 
coaching group only, suggesting an advantage in the combined training methods. 
 
In the only clinically-based study of MI training Brug et al (2007), evaluated 
MI training (2 days training, plus 1 day follow-up workshop and ‘on demand’ 
feedback and advice on MI-related issues) of dietitians working with patients newly 
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diagnosed with diabetes.  In this study 38 specialist diabetes care dietitians were 
randomised to MI training (n=18) or no training (n=19).  The outcome measures 
included dietitan counselling behaviour (MISC version 2.0) in the first 15 minutes of 
intervention sessions using transcripts of audio-tapes of sessions one month and 5-6 
months post-training, and patient outcome measures (i.e., self-report questionnaires 
on diet, body mass index, waist circumference, and HbA1c) pre- and post-
intervention.   The results indicted that the dietitians who received MI training were 
significantly more empathic, used more reflections, and talked less than the control 
dietitians.  While patients in both groups showed significant improvements in diet, 
HbA1c, BMI and waist circumference, multiple regression analysis indicated that 
patients who received MI had lower saturated fat intake post-intervention than 
controls, but no effects for HbA1c, body mass index, or waist circumference were 
found.  The authors concluded that standard dietary counselling and MI for patients 
with newly diagnosed diabetes seem similarly effective, but recommended that future 
research evaluate the effectiveness of MI when MI is likely to more relevant, that is, 
after patients with diabetes have had more experience with the difficulties of 
maintaining the necessary behaviour changes. 
 
Ethical considerations in the practice of MI 
 
  Despite the positive outcomes that have resulted from MI, such as reduced 
alcohol and drug use, and improved health, MI has been criticised as being 
"manipulative" and ethically questionable.  The reason for this criticism is that it 
involves intervening when a person is undecided about change (Miller, 1994).  Miller 
(1994) acknowledges that because MI can be applied to persons without their request, 
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consent or knowledge, and because it is effective, then it is, in that sense, 
manipulative, but defends MI as ethically appropriate because outcomes from MI, 
thus far, “would be judged by many to be benevolent” (p.118).    
 
Withers (1995) generally concurs with Miller’s (1994) defense of MI, but 
suggests that because MI “is proving to be such a powerful technique” it should 
therefore be the subject of intense investigation.   In particular, it is recommended that 
any adverse effects of MI should be investigated, and whether there are circumstances 
in which it may be inappropriate, with consideration given to the motives or value 
judgements of the person intervening (the therapist) in determining its ethical 
appropriateness.   
 
This latter point seems crucial.  MI is more likely to be questionned on ethical 
grounds if the therapist is not adhering to the spirit of MI and is engaging in MI with 
the aim of making the client change.  If the aim, however, is to help the client explore 
his or her ambivalence about change, and this involves respectfully reminding the 
client that they are reponsible for choosing whether and how to change, then MI 
seems ethically defendable. 
 
There may also be a problem with informed consent, as acknowledged by 
Miller (1994).   Typically MI starts with the therapist inviting the client to talk about a 
particular behaviour (e.g., drinking alcohol) or concern, but without the explanation 
that the therapist's aim in discussing the behaviour is to explore the client’s motivation 
to change the behaviour, and in such a way that may increase the client's motivation to 
change.  The client is therefore consenting to discuss a particular issue, but without 
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the full knowledge of the potential outcome.  This problem may be able to be 
overcome in settings where the client is coming seeking assistance for a particular 
problem.   MI could then be explained as a way of working with people that helps 
people change their behaviour.   
 
In settings in which the client has been compelled or coerced to attend (e.g., in 
correctional settings), however, such an explanation is likely to be counterproductive 
and produce resistance.   Even in these situations, however, it could be possible to 
inform the client that the intention is to discuss their thoughts and feelings about their 
behaviour, to gain a better joint understanding of the behaviour, not with the intention 
of making the individual change their behaviour, but so that they can make the best 
decisions for themselves regarding the behaviour.  It could also be mentioned that, as 
a result of such discussions, some people decide that they want to change their 
behaviour, and others do not, but that this is the client’s personal choice. 
 
It is clear that ethical concerns about MI are likely to be reduced if the 
therapist emphasises that the client is responsible for choices about their own life, and 
is informed about the limits of confidentiality.  In so doing, the client is empowered to 
decide on how much to disclose, as well as whether, and how, behaviour change will 
occur. 
 
There will be situations where MI may not be ethically appropriate (such as 
with clients with active psychosis who lack insight, or perhaps with individuals with 
very low intellectual functioning) because the client does not have the capacity to 
clearly explore the pros and cons of their behaviour.  Additionally, there may be 
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conflict in applying MI in settings where the medical model predominates, 
particularly if the doctor-patient relationship is a patient-provider relationship (rather 
than patient-centred), where the emphasis is on diagnosis (labelling), and persuading 
the client (trying to convince the client why they should change) and providing advice 
(making suggestions about how they could go about it) about changing problematic 
behaviour, all of which are contraindicated in MI. 
 
Future Research 
 
MI appears to hold considerable promise.  Not only does it appear to be 
effective (i.e., clients change behaviour that they have been engaging in for some 
time), but it  appears to work in relatively small doses (e.g., 1-4 sessions) with 
relatively large effects (i.e., MI produces similar effects to much longer treatments).  
Furthermore, it  appears to be most effective with clients who appear less ready, or 
less motivated, for change, or who are more angry and negative, attributes which are 
often considered markers of poor prognosis. 
 
While MI seems to work by reducing client resistance (Miller et al., 1993), it 
remains unclear as to how it has its effect and what elements of MI are essential 
(Miller, 1996).   Further research needs to establish the process of MI and its key 
components.  For example, little is known on what is the best way to structure 
sessions, or which are the optimal methods for responding to resistance.   
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It is also unclear which individuals would benefit most from MI and which 
specific motivational intervention (i.e., DCU, MET, Brief MI) would be of most 
benefit for a particular individual.  In addition, researchers need to give a clear 
description of the MI intervention they are evaluating, including any modifications 
they have made to fit with the particular target problem or client population. 
   
Further research is also needed into whether there are any advantages of 
integrating MI with CBT or BT.  MI could be viewed as the first stage of intervention, 
particularly with clients in the precontemplation or  contemplation stages of change.  
This could then be followed with CBT or BT when clients are further along the stages 
of change (i.e., in preparation, action or maintenance) and are likely to gain most 
benefit from a more action-oriented approach, focusing on building skills or strategies 
for behaviour change.  
 
There are few controlled studies evaluating the effectiveness of MI with new 
problem areas such as eating disorders, criminal behaviour, or health problems (such 
as diabetes), although MI has been identified as being potentially useful in these 
areas.  Continued outcome research into MI applied to new problem areas, such as 
health behaviour change, is required.  This research should include a description and 
evaluation of the MI training provided to the interventionists, as well as measures of 
treatment integrity. 
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The Present Research 
 
The present research is an evaluation of the effectiveness of MI applied to 
diabetes. The aim was to evaluate the effect of MI on both metabolic and behaviour 
change measures, as well as psychosocial aspects related to diabetes, when the MI 
intervention was provided by usual clinical staff (i.e., nurse educators and dietitians) 
in real world conditions, with patients could be considered less motivated, who had 
been identified as experiencing difficulties with diabetes self-management.   
 
The MI intervention specifically evaluated in the present research was MET.  
MET was chosen as the form of MI to be evaluated because it is a brief, time-limited 
form of MI, and therefore would provide consistency across individuals and studies, 
and would provide participants with time-limited ongoing contact which was 
considered important for behaviour change (Kelleher, 1988; Mazzuca, 1983; Marteau 
& Kinmonth, 1988).    
 
A broad range of outcome measures were used.  Because of its central place in 
the health of individuals with diabetes, measures of metabolic control were used as 
the primary outcome measures.  Given that hyperlipidaemia tends to be an important 
focus of diabetes treatment, metabolic data included lipids as well as blood glucose. 
Diabetes self-management behaviours (e.g., diet, exercise, glucose testing) were also 
included as dependent measures to assess the process of change.    Also, a range of 
psychosocial measures (i.e., knowledge, beliefs, emotional adjustment, treatment 
satisfaction) were included in attempt to assess the broader impact of the intervention.  
Furthermore, consistent with the recommendations of Miller and Rollnick (2002), the 
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research included measures of treatment integrity and a qualitative analysis of the 
process of change itself. 
 
In order to increase the generalisability of the results, the research was 
conducted in a clinical setting, with health practitioners at the setting trained to 
provide MI.  Exclusion criteria were also kept to a minimum and participants included 
patients with both Type 1 and Type 2 diabetes.   This, however, also placed 
constraints on the research design that could be used.  Specifically, in order to be as 
least disruptive as possible to the usual clinic practice, the number of staff who could 
be involved in the research (as interventionists or to assist data collection) was small, 
and there was the expectation that the research would fit in with normal clinic 
protocols (such as existing data collection) as much as possible.  
 
Hence, single-case research design was used (Barlow, Hayes & Nelson, 1984; 
Blampied, 1999, 2000; Hersen & Barlow, 1976), as this required that only a small 
number of staff and patients be involved and, therefore, was more suited to a busy 
clinical setting.  Single-case research design was also considered appropriate because 
the intervention being evaluated was relatively innovative.  This enabled the 
evaluation of MI applied to diabetes management without the need for large numbers 
of individuals being exposed to a relatively novel intervention.  A non-concurrent 
multiple-baseline design across participants (Watson & Workman, 1981), in which 
the intervention is applied in sequence across participants, was used as this was 
particularly suited to a clinical setting where referrals arrive over time and there are 
not necessarily large numbers of potential participants available or needing assistance 
at any one time.    
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 Single-case methodology also had the advantage of preserving the complexity 
of the real-life situation.  For example, while treatment of diabetes has the overall goal 
of reducing blood glucose and cardio-vascular risk factors,  the steps to achieving this 
may involve a number of different self-management behaviours (e.g., diet, exercise, 
medication use, glucose monitoring), which may vary from individual to individual, 
as well as within an individual, across time.  This also enabled patients to commence 
intervention without assumptions having been made that a particular behaviour would 
be the target for change, which is consistent with the spirit of MI.  Additionally, as 
well as only requiring a small number of staff to be involved as interventionists in the 
research, the use of a single-case design also enabled an evaluation of the effect of MI 
training, and comparison with standard practice (PE), without the risk of what was 
learnt from MI training contaminating their standard practice. 
 
The present research is also an example of the scientist-practitioner model of 
clinical psychology in pratice. The 1949 Boulder Conference (Raimy, 1950) defined a 
clinical psychologist as a scientist-practitioner who was a consumer of new research 
findings and an evaluator of clinical interventions, but also as a researcher who 
produced data from his or her own clinical practice to inform the scientific 
community (Barlow et al., 1984).  The intent of the model was to encourage the 
integration of research into clinical practice, with practicing clinical psychologists 
contributing to the evolution of psychological knowledge as well as providing 
psychological services (Haynes, Lemsky & Sexton-Radek, 1987).  The scientist-
practitioner model, however, seems to be infrequently adopted by clinicians (Haynes 
et al., 1987).   
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 It was also hoped that the design of the research would be such that 
practitioners would view the research as being applicable to their clinical situation, 
and, therefore, go some way towards ‘bridging the gap between research and clinical 
practice’ (Anthony, 2005, p. 162; Barlow et al., 1984).  Glasgow et al (2006) point out 
that the questions and concerns of health practitioners are often related to external 
validity.  In particular, practitioners are concerned about whether research findings 
apply to their setting and practice, and their efficiency and cost-effectiveness when 
delivered in everyday clinical settings (Anthony, 2005; Glasgow et al., 2006).    
 
There is generally a slow diffusion of innovations and the slow movement of 
evidence-based clinical interventions into clinical practice (Anthony, 2005; Balas & 
Boren, 2000; Glasgow et al., 2006; Kerner, Rimmer & Emmons, 2005; Leeman, 
Jackson & Sandelowski, 2006; Rogers, 2003).  Furthermore, Leeman et al (2006) 
point out that ‘diabetes self-management exemplies the limitations encountered in 
efforts to translate research findings into practice’ (p.171).  They point out that despite 
the DCCT and UKPDS having ‘shown that improving glycaemic control can prevent 
or delay diabetes-related complications’ (p.171) and the growing body of research on 
diabetes self-management interventions, ‘many patients are not receiving support for 
their self-management’ (Glasgow & Strycker, 2000), and approximately 54% of 
people in the United States with Type 2 diabetes have glycaemic levels greater than 
current target levels for control (Clark et al., 2000)’ (p.171).   
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Consequently, the present research incorporated characteristics of Practice-
based Clinical Trials (PCTs; Tunis, Stryer & Clancy, 2003) and Practical  Behavioural 
Trials (PBTs; Glasgow et al., 2006), which have been suggested as strategies for 
research investigating interventions in clinical practice settings, which may facilitate 
dissemination (Glasgow et al., 2006; Kerner et al., 2005; Tunis et al., 2003).  Tunis et 
al (2003) suggest that PCTs should answer questions of  key stakeholders (e.g. 
clinicians, decision makers), and  assess multiple and relevant outcomes, including 
generalisation, quality of life, and cost.  They also suggest that PCTs should compare 
clinically viable alternative interventions, as “too often, a new generation of trials 
supporting a new treatment fails to perform comparisons against (these) already-
established treamtents (Glasgow et al, 2006).  Tunis et al (2003) further suggest that 
PCTs should recruit a diverse, heterogeneous sample and evaluate robustness across 
key subgroups, and include multiple, representative interventionists and settings.   
Broadening inclusions criteria enables studies to include participants who are more 
representative (e.g., higher risk and mulitmorbid patients) of those seen in clinical 
practice, while the inclusion of more representative interventionists and settings assist 
with addressing questions regarding whether the resources, workloads and time 
dedicated to a given trial versus other duties is comparable enough to allow 
generalisation to real life clinical settings (Glasglow et al., 2006).   
 
Glasgow et al (2006) applied the characteristics of PCTs to what they call 
“practical behavioural trials” (PBTs, p.6) in which either the intervention employs 
behavioural strategies, procedures or theory; or the primary outcome involves 
behaviour change on the part of patients, clinicians, families or larger groups (e.g., 
changes in work place policies and practice).  Glasgow et al (2006), however, suggest 
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that PBTs should also specify the level of training/expertise necessary and the amount 
of training provided and include measures of behaviour change at multiple levels 
(e.g., patient, clinician, system), including implementation of the intervention by 
representative clinical staff.   
  
In addition, participatory action research (PAR) methodology (Boog, Keune & 
Tromp, 2003) was also utilised, as recommended by Glasgow et al (2006).  Carr and 
Kemmis (1986) describe PAR as “a form of self-reflective enquiry undertaken by 
participants in social situations to improve the rationality and justice of their own 
practices, and the situations in which the practices are carried out” (p.162).  Thus, 
PAR can be understood as a cycle of relection, planning, action, and observation 
(McTaggart, 1997). 
 
PAR is typically used in real situations, with a primary focus on solving real 
problems (O’Brien, 2001).  Therefore, those who apply PAR methods are often 
practitioners who wish to improve understanding of their practice, with a cornerstone 
of action research being that knowledge is derived from practice, and practice 
informed by knowledge, in an ongoing process (O’Brien, 2001).  Thus, PAR also 
rejects the notion of researcher neutrality, with the “understanding that the most active 
researcher is often one who has most at stake in resolving a problematic situation 
(O’Brien, 7).   
 
In PAR “you get the people affected by a problem together, figure out what is 
going on as a group, and then do something about it” (Kidd & Kral, 2005, p.187).  
Often, then, the first task in action research is for the researcher to organise a forum in 
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which dialogue is initiated and experiences shared, so that what action research adds 
is “the inclusion of some of the people being studied in the identification of the 
problem and research question” (Kidd & Kral, 2005, p.190).   
 
The author was employed as a Clinical Psychologist at the Diabetes Centre, 
Canterbury District Health Board (New Zealand) when the idea of the research 
developed.  She was frequently referred patients who were described as 
“unmotivated” or struggling with motivation for diabetes self-management from other 
health professionals working at the Centre, and used MI to work successfully with 
these patients.  Training other health practitioners, who typically had first contact with 
the patients, in MI developed as a notion that had the potential to benefit all 
concerned.   The patients would be exposed to a way of working that was likely to 
facilitate their motivation for change and therefore reduce their exposure to what 
potentially could be perceived as a failure experience, the other health professionals 
would feel empowered with another tool for working with people who seemed to be 
struggling with behaviour change, and the Clinical Psychologists would be able to 
focus on assisting patients who had more severe, clinical disorders (e.g., depression, 
anxiety, eating disorders) affecting their diabetes management. 
 
In order to assess whether MI would be an attractive option to the other health 
professionals working at the Centre, and following PAR methods, a teaching session 
which introduced MI was held, after which their thoughts about MI and its potential 
application to their work were sought.  Overall, there was considerable enthusiasm for 
MI and its potential use in diabetes.  In particular, the notion of stages of changes and 
attempting to assess where a patient was with regards to this was considered helpful.  
  75
The MI skills that were considered to be of potential benefit for clinical practice were 
listening to patients more, and eliciting ideas/solutions from patients, rather than 
trying to solve the patients’ problems.    
 
A number of potential barriers to using MI at the Centre were identified 
however.  These included work place issues, such as time pressure and lack of 
flexibility with appointments, but also training needs in terms of specific training and 
ongoing supervision for skills development, as well as questions regarding the 
effectivess of MI and its acceptability to patients.   
 
Consequently, the research programme was developed to answer these 
questions, and those identified in previous MI research, as well as to address areas of 
weakness identified in previous research.  Specifically health practitioners would be 
trained, and receive ongoing supervision, to provide MI, which would be provided 
within a clinical setting to patients experiencing difficulties with diabetes self-
management, and MI would be compared to an active treatment (i.e., PE) using 
outcome measures which include diabetes outcome and self-management behaviour, 
as well treatment integrity. 
 
The main aims of the research, therefore, were to evaluate: (1) if MI was 
effective when applied by health practitioners in a real-life clinical setting with 
patients experiencing difficulties with diabetes self-management; (2) how MI 
compared to the then current standard treatment – PE (Studies 1-2); and (3) the effects 
of MI training on practitioner and patient behaviour (Study 3). Specific hypotheses 
(Studies 1-2) were that MI would lead to improved diabetes outcome (lowered blood 
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glucose and improved lipids) through improved diabetes self-management (e.g. self-
monitoring of blood glucose, dietary compliance, exercise), and would be more 
effective than PE.  Hypotheses for Study 3 were that training in MI, plus supervised 
practice, would lead to the practitioners behaving in ways consistent with MI and as a 
result the participants would exhibit less resistance and increased change talk than 
participants receiving PE.   
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STUDY 1:  TREATMENT EVALUATION 
 
 
The aim of this study was to evaluate the effectiveness of MET when applied 
by DNEs in a real-life clinical setting with patients experiencing difficulties with 
diabetes self-management, and to compare the effectiveness of MET to that of PE.  
Specific hypotheses were that MET would lead to improved diabetes outcome (i.e., 
lower HbA1c and improved lipid profile; Hypothesis 1) through improved diabetes 
self-management (viz self-monitoring of blood glucose, diet, exercise; Hypothesis 2), 
and would be more effective than PE (Hypothesis 3).  Additional hypotheses were 
that MET would be considered an acceptable intervention to participants (Hypothesis 
4), and there would not be any adverse effects from MET on the participants’ 
adjustment to diabetes or beliefs about the seriousness of diabetes or the effectiveness 
of its treatment (Hypothesis 5).  It was also hypothesised that there would be an 
increase in motivation to change in MET participants (Hypothesis 6), whereas PE 
participants would show an increase in knowledge about diabetes (Hypothesis 7). 
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Method 
 
Procedure 
 
Participants 
 
Patients (aged 16-69 years) who had been referred to DNEs at a Diabetes 
Centre (an outpatient service accepting referrals from primary medical practitioners 
(i.e., GPs throughout a major metropolitan area and adjacent rural areas) for further 
assistance with managing their diabetes (Type 1 or Type 2), and who had been 
diagnosed with diabetes for at least 12 months, were approached regarding 
participation in the study.  Participants were not randomly assigned to intervention.   
All participants continued to receive TAU from their GP throughout the study. 
 
Initially, 16 consecutive referrals to the DNEs were approached regarding 
participation in the PE phase.  Of these, five declined to participate.  Another two 
agreed to participate but subsequently withdrew - one because it was considered best 
for her health care that she received an alternative intervention, and the other because 
he did not wish to change to the blood glucose meter being used for the research.  
Thus, there were nine participants in the PE phase. 
 
Once the intervention in the PE phase had been completed and the DNEs had 
received training in MET, 16 consecutive referrals to the DNEs were approached 
regarding participation in the MET phase.  Of these, four declined to participate.  
Another three agreed to participate but subsequently withdrew - one because of work 
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commitments and two because they no longer wished to receive intervention from the 
centre.  Thus, there also were nine participants in the MET phase. 
 
Patients who agreed to participate in the study and who completed PE tended 
to be female Caucasians with Type 2 diabetes, with more males declining to 
participate in the study.  The age range for those who completed PE was 31-64 years, 
with a similar mean age to those who declined participation (Table 1). 
 
Table 1.  Characteristics of participants – PE and MET 
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Participants, mostly Caucasians, with Type 1 or Type 2 diabetes, of either 
gender, completed MET, but more patients with Type 2 diabetes declined 
participation.  The mean age for those completing MET was nine years lower than 
those who declined participation, but similar to those who withdrew from the study 
(Table 1).  There was a statistically significant difference between the PE and MET 
participants in terms of age, with the MET participants (95% CI=34-54 years of age) 
being younger than the PE participants (95% CI=43-55 years).   
 
The MET participants, however, tended to have been diagnosed with diabetes 
for longer (95% CI=10-15 years since diagnosis) than the PE participants (95% CI=3-
11 years), perhaps because there were more participants with Type 1 diabetes (which 
tends to be diagnosed at an earlier age) in the MET phase (Table 2).  While the 
duration of diagnosis was not statistically equivalent between the two groups, it was 
also not significantly different at the .05 level, resulting in statistical indeterminacy. 
 
Table 2.  Duration (years) since diagnosis of diabetes 
 
Participants 95% CI Different  
(.05 level) 
Equivalent 
(Δ=6.33) 
PE 3.2339–11.2105 ns ns 
MET 10.4325–15.1231 ns ns 
 
*Δ=1 standard deviation of PE and MET samples 
ns=not statistically significant at .05 level 
 
For more detailed description (i.e., reason for referral, diabetes complications, other 
health problems, medication and employment status) of PE and MET participants, and 
individual case descriptions see Appendix 1. 
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Staff 
 
Three DNEs agreed to participate in the study, but one subsequently withdrew 
(having obtained alternative employment) at the end of the PE phase.   All of the 
nurses had considerable experience working with diabetes, with the two nurses who 
remained in the study both having worked in diabetes for nine years, and registered as 
nurses for 23 and 25 years respectively. 
 
Intervention 
 
 PE.  The standard intervention provided at the Diabetes Centre at the time that 
this research began, comprised the provision of information and advice about diabetes 
and diabetes self-management.  This was provided within a patient participation and 
collaboration context, which also included behavioural counselling techniques, such 
as setting small achievable goals.  The duration, number and frequency of sessions 
were determined, according to usual clinic practice, by the DNE in consultation with 
each participant however, PE typically comprised 20 minute sessions on a monthly 
basis. 
 
 MET.  Comprised four 30-40 minute sessions of MI plus personalised 
feedback conducted over six weeks (on weeks 1, 2, 4 and 6).  While it was not always 
possible maintain this schedule of appointments (due to illness, holidays, etc), 
appointments were re-scheduled as close to this as possible. 
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Training 
 
The DNEs received two days (12 hours) training in MET provided by two 
trainers experienced in training MI, one of whom was the author.  The training 
consisted of didactic teaching, modelling by the trainers and video-taped 
demonstrations, and role-playing with feedback, using adult education principles 
(Kolb, 1984; Reece & Walker, 1997).  Additionally, the DNEs were provided with a 
manual (Appendix 2) adapted from Sellman, Sullivan and Dore’s (1996) manual, 
which outlined key MI principles, strategies and techniques, and the process for MET.  
 
Design 
 
Two quasi-experimental designs were used, involving both between- and 
within-participant comparisons (Wood, 1981).  A non-equivalent, control group 
design (Wood, 1981), with pre- and post-intervention measures, was used to evaluate 
any difference in effectiveness between MET and PE (i.e., control).  Additionally, a 
non-concurrent multiple baseline design (Watson & Workman, 1981) across 
individuals (n=9 per intervention) was used.   This involved the intervention (PE or 
MET) being applied in sequence to individual participants, while baseline data was 
collected for succeeding individuals.   
 
Usually in a multiple baseline design baseline commences with all individuals 
at once and continues until the behaviour for each person is stable, at which time the 
intervention is applied to only one of them while baseline conditions are continued for 
the others (Kazdin, 1982).  This, however, was not possible due to referrals arriving at 
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the Diabetes Centre over time (i.e., rather than a number of individuals all being 
referred at the same time) and because, for ethical reasons, it was considered 
inappropriate to leave individuals identified with difficulties with diabetes self-
management in extended baseline periods, while waiting for the intervention to be 
applied to preceding participants or for baseline data to become stable.   
 
Nevertheless, this provided an opportunity to test if the results obtained could 
be replicated across individuals.   Replication of an intervention to establish its 
efficacy is considered critical with single-case designs (Sidman, 1960; Chambless & 
Hollon, 1998), with the number of baselines contributing to the strength of the 
demonstration (Kazdin, 1982).  Because of the possibility of inconsistent effects of 
the intervention across individuals Kazdin (1982) suggests the inclusion of several 
baselines beyond a minimum of two or three to clarify the effects of an intervention. 
 
A further variation to a single case design also became possible (Part B) after 
completion of the main PE and MET phases, when the participants who received PE 
were offered (at least 15 months after the completion of PE) the opportunity to receive 
MET, and this was accepted by three participants (Cases 4, 7, and 9) – each of whom 
had been unsuccessfully treated by PE in Part A.  This provided a unique design 
opportunity, allowing the effectiveness of PE and MET to be evaluated within the 
same individual, provided by the same DNE, thereby allowing more direct 
comparison of the two interventions by reducing variables (i.e., therapist effects or 
individual differences) which may have impacted on outcome, with the advantage of a 
lag period between interventions during which any previous effect of treatment could 
be expected to “washout”.   
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Measures 
 
Table 3 provides a summary of the outcome measures.   Diabetes outcome 
(i.e., HbA1c and lipid profile) was the primary outcome measure, with the expectation 
that HbA1c would decrease post-intervention and that the participants’ lipid profiles 
would show improvements consistent with improved metabolic control.  There were 
also a number of intermediate process variables, which included measures of diabetes 
self-management behaviour (i.e., self-monitoring of blood glucose - SMOBG, diet, 
exercise, use of medication), weight, and psychosocial measures assessing beliefs 
about and adjustment to diabetes, diabetes knowledge, readiness to change, and 
treatment satisfaction.  Additionally, measures of treatment integrity and cost were 
included.   
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Table 3.  Summary of outcome measures 
 
Measure Baseline 
 
Intervention 2 week 
post 
3 month 
follow-up 
6 month 
follow-up 
12 month 
follow-up 
Primary outcome       
HbA1C ?  ? ? ? ? 
Lipids ?  ? ? ? ? 
Intermediate 
process variables 
      
SMOBG ? ? ? ? ? ? 
Diet ? ? ? ? ? ? 
Exercise ? ? ? ? ? ? 
Medication ? ? ? ? ? ? 
PMDI ?  ?   ? 
PAID ?  ?   ? 
DKT ?  ?   ? 
SOCRATES ?  ?   ? 
GCC  ?     
TEI   ?    
HbA1c=Glycated Haemoglobin 
SMOBG=Self-monitoring of Blood Glucose 
PMDI=Personal Models of Diabetes Interview 
PAID=Problem Areas in Diabetes 
DKT=Diabetes Knowledge Test 
SOCRATES=Stages of Change Readiness and Treatment Eagerness Scale 
GCC=Goals for Change Checklist 
TEI=Treatment Evaluation Inventory 
 
 
Primary outcome  
 
Baseline, post-intervention and 3-, 6- and 12-month follow-up data were 
collected on diabetes outcome using fasting glycated haemoglobin (HbA1c), which 
measures the average blood glucose over the previous 8-10 weeks (Krishnamurti & 
Steffes, 2001); and fasting lipid tests, including total cholesterol, high density 
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lipoprotein cholesterol (HDL), low density lipoprotein cholesterol (LDL), 
triglycerides, and risk ratio (total cholesterol divided by HDL) which provides an 
estimate of risk of coronary heart disease.    
 
HbA1c and lipid results were graphed for each participant, with the following 
targets:  
HbA1c - less than 7%, which represents tight diabetes control (New Zealand 
Guidelines Group, 2003). 
Total cholesterol - less than 5.5 mmol/L.  Levels greater than this are 
associated with a significantly increased risk of coronary artery disease in all age 
groups (Linton & Fazio, 2003).  
  Triglycerides - less than 1.7 mmol/L.  Levels greater than this are generally 
accepted as an independent risk factor for coronary artery disease (Linton & Fazio, 
2003). 
  LDL cholesterol - less than 2.5 mmol/L.  LDL cholesterol is often calculated 
rather than measured directly although this method is unreliable if levels of 
triglyceride are 4.5 mmol/L or greater (Linton & Fazio, 2003). 
HDL cholesterol - greater than 1.0 mmol/L.  Low levels of HDL cholesterol 
and high levels of LDL cholesterol are associated with an increased risk of 
atherosclerotic vascular disease (Linton & Fazio, 2003). 
    Risk ratio - less than 5.0 mmol/L.  This is calculated by dividing the total 
cholesterol by the HDL cholesterol, with ratios greater the 5.0 mmol/L associated 
with increased risk of coronary artery disease. 
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A 0.5% change in HbA1c, which represents one standard deviation (Butler et 
al, 1995), was considered clinically significant.  This level of reduction in HbA1c has 
been found to be associated with a 25% reduction in the risk of retinopathy (DCCT 
Research Group, 1996).  Due to the complexity in analysing the clinical significance 
of the lipid data, a diabetes physician (who was blind to condition) provided a clinical 
interpretation of the lipid data in terms of whether each participant’s lipid profile 
showed an overall improvement or deterioration, or was essentially unchanged. 
 
Additionally, HbA1c and lipid results were analysed using inferential 
confidence intervals (Tryon, 2001) to evaluate statistical difference and equivalence 
within (i.e., PE participants and MET participants) and between groups (i.e., PE 
compared to MET) over time.  This involved establishing a descriptive 95% 
confidence interval (CI) about each of two means and then concluding that there is: 
 
1. statistical difference (p<.05 level) if the inferential CIs do not overlap   
2.  statistical equivalence if the range (i.e., the lower CI limit of the lesser mean 
to the upper CI limit of the greater mean) fit within the delta (Δ) bound of 
indifference (i.e. the maximum difference that is unimportant or can be 
dismissed on substantive grounds).  The coefficients of variation (CV) for 
HbA1c and lipids were used to calculate delta, thereby accounting for 
biological variation (Fraser, 2001).  The CVs were as follows:  HbA1c=5.6%; 
total cholesterol=15.2%; triglycerides=37.2%; HDL cholesterol=19.7%; and 
LDL cholesterol=25.7%. 
3. statistical indeterminacy in all other cases. 
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Appendix 3 illustrates how statistical difference and equivalence was 
evaluated for independent and dependent means.  Unless otherwise stated, results 
reported as statistically different are those that were found to be both statistically 
different, and not statistically equivalent, at the .05 level.  Similarly, results reported 
as statistically equivalent were ones that were found to be statistically equivalent and 
not statistically different at the .05 level.    
 
Additionally, the effect size for results that were found to be statistically 
different were calculated using Cohen’s d (Cohen, 1992) representing the difference 
between pre- and post-intervention results divided by the standard deviation of the 
mean score at baseline.  The magnitude of the effect was interpreted using Cohen’s 
(1997) guidelines, with d=.2 representing a small effect, d=.5 a moderate effect, and 
d=.8 a large effect. 
 
Furthermore, at the commencement of the study participants were given a 
blood glucose meter (Precision QID) on which they could self-monitor their blood 
glucose.  The meter contained a memory which allowed data to be down-loaded at a 
later date to give a full history of blood glucose levels.   Data from SMOBG were 
graphed for all participants, with the target level set on the meter at 3.5-7.8 mmol/L.  
Due to the considerable variability in self-monitored blood glucose levels, the data 
were smoothed (using Sigmaplot’s running average algorithm, taking a running 
average of three data values in a series) to enable easier detection of trends.  The 
mean and standard deviation for each phase was also calculated to assist visual 
analysis. 
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Intermediate process variables 
 
Diabetes self-management behaviour.  At the end of each PE and MET 
session participants and the DNEs were asked to independently state the goals for 
change using the Goals for Change Checklist (GCC). The GCC (Appendix 4) was 
developed for the study based on common goals for diabetes self-management.  If the 
participant and DNE both selected a diabetes self-management behaviour (e.g., 
increased SMOBG) as a goal for change, then these data were included for analysis. 
 
Because at the commencement of the study, it was unknown what diabetes 
self-management behaviour(s) would be selected by the participants as a target for 
change, all participants were asked to record on a daily basis their diet (i.e., food type, 
amount, cooking method), exercise, and medication use for at least one week at 
baseline, throughout intervention (PE or MET), for two weeks post-intervention, and 
for one week at 3-, 6- and 12-month follow-up.   The request to record this 
information was also consistent with the then current practice at the Diabetes Centre. 
Dietary compliance was assessed as the percentage of meals/snacks per day which 
complied with the recommended diabetic diet (i.e., low fat, low sugar, high fibre).  
Exercise was measured as the number of episodes (irrespective of duration) of 
physical activity (e.g., gardening, walking) per day. 
 
The participants were also weighed (also consistent with the then current 
practice) at baseline, post-intervention and 3-, 6- and 12-month follow-up.   Weight 
was graphed if it was a goal for change for the participant. 
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The memory in the blood glucose meter which the participants were given to 
self-monitor their blood glucose allowed data to be down-loaded to give a full history 
of the frequency of SMOBG.   At baseline, participants were not given any specific 
instructions regarding the frequency in which SMOBG should occur, but were simply 
instructed to engage in SMOBG as per previous medical advice.  Data on the 
frequency of SMOBG from the meters were graphed for all participants.  
 
Psychosocial measures.  The following measures were administered at 
baseline, two weeks post-intervention, and at 12-month follow-up:     
 
Personal Models of Diabetes Interview (PMDI, Glasgow, Hampson, Strycker 
& Ruggiero, 1997) - a comprehensive semi-structured interview designed to assess 
patients’ representations of their diabetes, including beliefs about symptoms, disease 
course, consequences, cause, and treatment effectiveness.  Three composite scores 
(which is the mean of the component items, which were rated on a 5-point Likert 
scale, from 1=not at all to 5=extremely) can be calculated based on the individuals 
responses: cause (i.e., internal or external factors); treatment effectiveness (i.e., beliefs 
about following standard treatment regimens and these regimens on the control of 
diabetes); and seriousness (i.e., beliefs and concerns about the influence of diabetes 
on life expectancy, quality of life, and daily functioning).   
 
Research suggests that personal models for chronic diseases guide an 
individual’s processing of information and subsequent health behaviour such as the 
patient-provider interaction and self-management (Petrie, Weinman, Sharpe & 
Buckley, 1996; Glasgow, Hampson, Strycker & Ruggiero, 1997; Scharloo & Kaptein, 
1997).   In particular, seriousness and treatment effectiveness have been found to be 
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important cognitive dimensions which predict diabetes self-care behaviour and 
outcome (Hampson, et al., 1990; Hampson et al., 1995; Skinner & Hampson, 2001).  
For example, Hampson et al, (1995) found that beliefs about treatment effectiveness 
and disease seriousness in diabetes were prospectively predictive of dietary behaviour 
and physical activity (i.e. higher treatment effectiveness and seriousness scores were 
correlated with improvements in diabetes self-management behaviour).  Additionally, 
low treatment effectiveness, and high seriousness correlated significantly with 
negative affect and several aspects of quality of life.    
 
Problem Areas in Diabetes (PAID, Polonsky et al., 1995) - a 20 item 
questionnaire measuring emotional adjustment to diabetes.  Each item represents a 
unique area of diabetes-related distress, ranging from anger (‘feeling angry when you 
think about having diabetes and living with diabetes’) and interpersonal distress 
(‘feeling that your friends and family are not supportive of your diabetes efforts’) to 
frustration with aspects of diabetes management (‘not having clear and concrete goals 
for your diabetes’).  Patients rate degree to which each item is a problem for them on 
a 6-point Likert scale, from 1 (no problem) to 6 (serious problem).  The score is the 
sum of the 20 PAID items, multiplied by 1.25, giving a final score ranging from 0-
100. 
 
High total scores on the PAID indicate greater levels of diabetes-related 
emotional distress. Welch, Jacobson and Polonsky (1997) recommend a cut-off score 
one standard deviation above the mean (i.e., 54.5 + 23.1) as an overall measure of the 
emotional burden of diabetes or ‘diabetes burnout’.  Scores on the PAID have been 
found to correlate with engagement in self-management behaviour, to significantly 
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predict glycaemic control (i.e. lower scores predict better self-management and 
improved glycaemic control), and to be sensitive to change in diabetes-related distress 
following educational and psychosocial interventions for diabetes (Welch, et al., 
1997; Welch, Weinger, Anderson & Polonsky, 2003).    
 
Diabetes Knowledge Test (DKT) - developed by the Michigan Diabetes 
Research and Treatment Centre (Fitzgerald, Anderson, Funnell, Hiss, Hess, Davis & 
Barr, 1998) as a measure of general knowledge of diabetes, such as diet, blood 
glucose, consequences and insulin.  It consists of 23 items with multi-choice 
responses, the first 14 of which are appropriate for individuals who do not use insulin.  
The total score is the percentage correct responses, which for individuals who use 
insulin is calculated over the whole 23 items, whereas for individuals who do not use 
insulin this is calculated for the first 14 items only. 
 
Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES) - a 
40 item questionnaire developed for use with alcohol abuse (Miller & Tonigan, 1996) 
as a measure of stage of change based on the trans-theoretical model of change 
(Prochaska & DiClemente, 1982; Prochaska et al., 1992), which has been modified 
for use with diabetes by adapting the wording of each item (Trigwell, Grant & House, 
1997). For example, item 1 was changed from ‘I really want to make changes in my 
drinking’ to ‘I really want to make changes in how I look after my diabetes’. 
 
The SOCRATES uses 5-point Likert scales, ranging from 5 (strongly agree) to 
1 (strongly disagree), across five subscales intended to correspond to Prochaska and 
Di Clemente’s (1992) pre-contemplation, contemplation, preparation (or 
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determination), action and maintenance stages of change (Miller & Tonigan, 1996).  
The five subscale scores are calculated by summing the scores for the eight items in 
each subscale.  The motivational stage is then determined according to which subscale 
has the highest score.  If the maximum score is shared by more than one subscale, a 
single stage of change cannot be allocated (Trigwell et al., 1997).  When this occurred 
in the present research, this was noted in the individual case results, and the lowest 
stage of change which shared the maximum score was used for graphical analysis.  
Results were graphed on a scatter plot (Blampied, 2005), with baseline stage of 
change on the x-axis and post-intervention stage of change on the y-axis, and then 
with post-intervention stage of change on the x-axis and 12-month follow-up on the y-
axis.  This meant that if the stage of change was the same at both measurement points, 
then the data point would fall on a diagonal line.  Any change in motivation then, 
would be seen in either the data point falling above (i.e. an increase in stage of 
change) or below (i.e. a decrease in stage of change) this diagonal line.   
 
Treatment credibility - at the end of intervention, treatment credibility was 
measured by participants evaluating the intervention they received using the 
Treatment Evaluation Inventory – TEI (Kazdin, 1984), which was modified so that it 
was suitable for use with adults with diabetes (Appendix 5).  The TEI uses a 7-point 
Likert scale, ranging from 1 (not at all acceptable) to 7 (very acceptable) across four 
dimensions – approval, fairness, humaneness, and effectiveness.  Research has 
demonstrated the factorial integrity and internal consistency of the TEI (Kazdin, 
1980), and that the TEI may be modified to make it more appropriate for use in a 
variety of clinical settings (Reimers, Wacker, Cooper & de Raad, 1992; Kelley, 
Heffer, Gresham & Elliott, 1989). 
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 Questionnaire data were also analysed using inferential confidence intervals 
(Tryon, 2001) to evaluate statistical difference and equivalence within (i.e., PE 
participants and MET participants) and between groups (i.e., PE compared to MET) 
over time.  For the current study Δ was set at one standard deviation.  Additionally, 
the effect size (Cohen, 1992, 1997) was calculated for any statistically significant 
result. 
 
Jacobson and Truax’s (1991) reliable change index (RC) was used to determine 
whether changes that occurred in an individual participant’s questionnaire data were 
clinically significant (see Appendix 6 for an explanation of how RC is calculated).  
An RC greater than 1.96 would be unlikely to occur (p<.05) without actual change.    
 
Treatment integrity 
 
To ensure treatment integrity (Kazdin, 1992) each intervention session was 
audio-taped.  Each MET session was reviewed by the primary author, and feedback 
given to the DNE, to ensure that the therapeutic procedures were carried out as 
intended.  Further, to provide a measure of treatment integrity one audiotape for each 
PE and MET participant (30% of sessions) was randomly selected and reviewed by an 
independent rater and judged as being either a PE or MET session.  The independent 
rater was a clinical psychologist who had worked in diabetes and had training in MI, 
but who was blind to condition. 
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Cost: Resource utilisation 
 
The number of appointments that participants attended (or missed) at the 
Diabetes Centre during intervention and over the course of follow-up were collated 
from their clinical files.  This enabled the interventions to be evaluated, and 
compared, from a resource utilisation perspective. 
 
Results: Part A  
 
The Results of Part A refer to the evaluation of the effectiveness of PE and 
MET with the original 18 participants (i.e., n=9 PE and n=9 MET).  Results from the 
primary outcome measures (i.e., HbA1c and lipids) will be presented first, following 
the results from the intermediate process variables comprising self-management 
behaviour and psychosocial measures.  The results of statistical tests (i.e., group data) 
will be presented first, followed by evaluation of clinically significant change (i.e., 
individual data). 
 
A range of goals were selected by both PE and MET participants (Table 4), 
including dietary, exercise, and SMOBG goals.  More MET participants, however, 
selected increased SMOBG as a goal and more MET participants selected more than 
one diabetes self-management goal. 
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Table 4.  Self-management goals 
 
Goal PE MET 
Increase SMOBG 3 7 
Increase exercise 2 2 
Dietary compliance 2 2 
Regular eating 1 1 
Weight loss 2 1 
 
 
Primary outcome measures:  Diabetes outcome 
 
Blood glucose 
 
Statistical tests of group data.  PE HbA1c results were not statistically 
equivalent at baseline, post-intervention and during follow-up (Table 5), with results 
tending to be lower post-intervention and at 3-, 6- and 12-month follow-up than at 
baseline.  The difference, however, was not statistically significant, resulting in 
statistical indeterminacy.   
 
MET HbA1c results at baseline, post-intervention and follow-up were not 
statistically equivalent (Table 5), with results tending to be lower post-intervention 
and throughout follow-up, similar to PE,   The HbA1c results (with the exception of 
6-month follow-up), however, were also not statistically different, resulting in 
statistical indeterminacy.  The statistically different results at 6-month follow-up 
suggest that the MET participants’ glycaemic control improved from baseline to 6-
month follow-up, with a large (d=1.0) effect size. 
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Table 5.  HbA1c means, inferential confidence intervals and results of statistical tests – PE and MET 
 
Time Mean r 95% CI Different Equivalent 
 
PE     ∆1=.47% 
Baseline 8.867  8.09–9.65   
Post-intervention 7.917 .2525 7.52–8.31 ns ns 
Baseline 8.867  8.51–9.23   
3-month follow-up 8.329 .8153 7.98–8.87 ns ns 
Baseline 8.867  8.03–9.70   
6-month follow-up 7.583 .8880 7.09–8.08 ns ns 
Baseline 8.867  8.49–9.24   
12-month follow-up 8.843 .8700 8.24–9.45 ns ns 
MET     ∆2=.55% 
Baseline 9.767  9.43–10.11   
Post-intervention 9.575 .8761 9.17–9.74 ns ns 
Baseline 9.767  9.18–10.35   
3-month follow-up 8.856 .7705 8.59–9.21 ns ns 
Baseline 9.767  9.40–10.14   
6-month follow-up 8.513 .3437 8.30–8.61 * ns 
Baseline 9.767  9.37–10.16   
12-month follow-up 9.450 .8144 9.00–9.90 ns ns 
r=Pearson’s correlation 
∆1=1 CV of PE baseline mean 
∆2=1 CV of MET baseline mean 
*=statistically significant at .05 level 
ns=not statistically significant at .05 level 
 
 
At baseline, PE participants’ HbA1c results were not statistically equivalent to 
the MET participants’ HbA1c results (see Table 6, PE tended to be lower), although 
the difference was not significantly different, resulting in statistical indeterminacy.  
Post-intervention the PE participants’ HbA1c results had declined to the extent that 
they were statistically different from the MET participants’ results.  At 3-, 6- and 12-
month follow-up, however, the MET participants’ HbA1c results decreased to the 
point were they were not statistically different to the PE participants.  They, however, 
were also not statistically equivalent, resulting in statistical indeterminacy.  
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Table 6.  HbA1C means,  inferential confidence intervals and results of statistical tests – PE vs MET 
 
 Mean 95% CI Different Equivalent 
(∆=.5%) 
Baseline     
PE 8.867 8.04–9.70 ns ns 
MET 9.767 8.86–10.68   
Post-intervention     
PE 7.917 7.48–8.35 * ns 
MET 8.856 8.67–10.25   
3-month follow-up     
PE 8.329 7.50–9.16 ns ns 
MET 8.856 8.41–9.39   
6-month follow-up     
PE 7.583 7.09–8.08 ns ns 
MET 8.513 8.07–8.84   
12-month follow-up     
PE 8.843 7.57–10.18 ns ns 
MET 9.450 8.42–10.48   
Δ=1 CV of mean of PE and MET at baseline 
*=statistically significant at .05 level 
ns=not statistically significant at .05 level 
 
Clinically significant change in individual data.  Three PE (Cases 1, 6 and 8) 
and four MET (Cases 10, 11, 12 and 18) participants had clinically significant 
decreases in HbA1c post-intervention (Figure 1).  For the PE participants the decrease 
in HbA1c tended to be maintained to six month follow-up.  In contrast, there appeared 
to be continued improvements in the MET participants’ HbA1c, such that at 3- and 6-
month follow-up five MET participants had further clinically significant decreases in 
HbA1c, although these changes were not maintained at 12-month follow-up.   
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Figure 1.  Average blood glucose 
 
 
Self-monitored blood glucose data.  Two PE participants (Cases 7 and 8) did 
not engage in SMOBG at baseline, limiting conclusions that can be drawn, and mixed 
results from the remaining PE participants (Figure 2, Table 7).  There was a decrease 
in self-monitored blood glucose during PE for three participants (Cases 2, 4, and 9), 
with Cases 4 and 9 obtaining blood glucose results with-in the target range. Yet, 
another three participants (Cases 3, 5, and 6) had an increase in blood glucose during 
PE.   
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Figure 2.  Results from SMOBG - PE 
 
In four PE participants (Cases 1, 2, 4, and 8), however, self-monitored blood 
glucose appeared to be lower at 3-months compared to baseline.  Furthermore, for 
four of the five PE participants for whom 12-month follow-up data are available, it 
appears that the decreases in self-monitored blood glucose were maintained. 
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Table 7.  Means and standard deviations of self-monitored blood glucose level during baseline,  
                intervention, post-intervention and follow-up – PE and MET  
   
Baseline 
 
Intervention 
2 wk 
follow-
up 
3 mnth 
follow-up 
6 mnth 
follow-up 
12 mnth 
follow-
up 
PE        
Case 1 Mean 10.11 9.45 9.78 6.94 7.22 7.92 
 SD 0.91 1.88 1.39 0.67 1.57 0.78 
Case 2 Mean 12.09 9.64 12.12 10.30 8.34 9.88 
 SD 2.42 0.68 1.39 1.16 1.03 0.41 
Case 3 Mean 10.9 12.66 17.2 11.45   
 SD - 2.23 - 0.54   
Case 4 Mean 11.12 10.22 10.22 8.1 8.0 7.9 
 SD 0.78 1.97 2.62 - - - 
Case 5 Mean 7.20 10.23     
 SD 1.20 2.33     
Case 6 Mean 6.88 10.14 10.10 10.32 10.13 9.4 
 SD 2.15 1.94 1.22 1.19 0.98 1.10 
Case 7 Mean  9.72 6.46 7.0 9.47  
 SD  1.83 0.91 - -  
Case 8 Mean  8.18  6.15 6.59 5.95 
 SD  1.28  1.19 1.01 0.68 
Case 9 Mean 8.69 7.58 8.15 8.4   
 SD 1.23 0.87 0.90 -   
MET        
Case 10 Mean 9.48 10.00 10.96 7.35  9.12 
 SD 4.87 3.95 3.66 2.81  2.15 
Case 11 Mean  7.50 7.99 8.27 10.42  
 SD  2.58 2.04 2.67 3.43  
Case 12 Mean 17.43 17.40 14.57 14.36 12.83 18.91 
 SD 3.48 3.95 3.70 2.88 2.14 2.37 
Case 13 Mean 9.73 9.66 9.57 12.03 14.39 9.45 
 SD 2.52 2.52 2.29 1.77 1.48 2.77 
Case 14 Mean 11.2 7.99 8.16 10.94 10.13 8.83 
 SD - 1.06 2.28 1.06 1.65 1.26 
Case 15 Mean 9.93 7.75 8.19 7.75 9.00 8.64 
 SD 1.63 2.22 2.18 1.27 1.90 2.43 
Case 16 Mean 18.1 13.44  15.47 7.61 11.47 
 SD - 2.77  3.44 0.81 - 
Case 17 Mean 11.2 9.74 9.69 9.07 7.80  
 SD 1.61 1.63 1.63 0.81 1.49  
Case 18 Mean 13.37 8.81 7.57 9.02 8.7 9.55 
 SD 3.88 3.55 2.54 2.73 - 2.29 
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Only one MET participant (Case 11) did not engage in SMOBG at baseline, 
although baseline data were also limited for two other MET participants (Cases 14 
and 16).  The results, however, suggest that there was a downward trend in self-
monitored blood glucose during MET for five (Cases 14, 15, 16, 17 and 18) of the 
MET participants, four (Cases 15, 16, 17 and 18) of whom obtained blood glucose 
results in the target range (Figure 3, Table 7).  In contrast to PE, no MET participants 
showed an increase in self-monitored blood glucose during MET.  Furthermore, 
although the results fluctuated over time (between and within participants), at least six 
of the MET participants had lower self-monitored blood glucose at 12-month follow-
up. 
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Figure 3.  Blood glucose results from SMOBG – MET 
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It therefore appears that MET may have contributed to a decrease in blood 
glucose as measured by SMOBG, which tended to be maintained during follow-up.   
In contrast, the data do not support PE having a positive effect on blood glucose, with 
mixed results obtained during PE (i.e., an equal number showed improvements in 
self-monitored blood glucose as showed a deterioration), although four of the PE 
participants had lower self-monitored blood glucose at 3- and 12-month follow-up. 
 
Lipids 
 
Statistical tests of group data.  Most PE lipid results were not statistically 
equivalent but were also not statistically different to baseline (Table 8), resulting in 
statistical indeterminacy.  A statistically significant difference was, however, obtained 
for triglycerides from baseline to post-intervention and baseline to 12-month follow-
up, with statistically significant decreases in triglycerides, and moderate to large 
effect sizes (d=.88 post-PE and d=.58 at 12-month follow-up) in both instances.  This 
suggests that the participants’ triglycerides decreased post-PE and that this decrease, 
whilst fluctuating over the follow-up period, was maintained at 12-month follow-up.   
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Table 8.  Lipid means, inferential confidence intervals and results of statistical tests – PE 
 
Time Mean r 95% CI Different  Equivalent 
Total cholesterol     Δ = .91 
Baseline 5.575  5.153–5.997   
Post-intervention 5.540 .9421 4.513–5.692 ns ns 
Baseline 5.575  5.131–6.019   
3-month follow-up 5.757 .6717 5.290–6.224 ns ns 
Baseline 5.575  5.185–5.965   
6-month follow-up 5.017 .7840 4.448–5.585 ns ns 
Baseline 5.575  5.116–6.035   
12-month follow-up 5.271 .6556 4.730–5.813 ns ns 
Triglycerides     Δ =  .96 
Baseline 3.085  2.491–3.684   
Post-intervention 1.920 .71381 1.469–1.965 * ns 
Baseline 3.085  2.725–3.450   
3-month follow-up 3.071 .8721 2.741–3.402 ns ns 
Baseline 3.085  2.418–3.757   
6-month follow-up 2.117 .6949 1.728–2.505 ns ns 
Baseline 3.085  2.689–3.486   
12-month follow-up 2.314  1.945–2.684 * ns 
HDL cholesterol     Δ = .30 
Baseline 1.101  .928–1.274   
Post-intervention 1.060 .9379 .955–1.166 ns ns 
Baseline 1.101  .900–1.303   
3-month follow-up 1.021 .8358 .910–1.133 ns ns 
Baseline 1.101  .876–1.326   
6-month follow-up 1.093 .7250 .963–1.223 ns ns 
Baseline 1.101  .896–1.307   
12-month follow-up 1.117 .8877 1.018–1.216 ns * 
LDL cholesterol     Δ = 1.29 
Baseline 5.017  4.588–5.445   
Post-intervention 5.080 .7457 4.658–5.502 ns * 
Baseline 5.017  4.532–5.501   
3-month follow-up 5.200 .7060 4.580–5.820 ns * 
Baseline 5.017  4.621–5.413   
6-month follow-up 4.583 .7862 4.232–4.935 ns * 
Baseline 5.017  4.350–5.776   
12-month follow-up 4.386 .2299 3.884–4.888 ns ns 
Risk ratio     Δ = 1.0% 
Baseline 3.786  3.208–4.303   
Post-intervention 3.600 .9856 3.190–4.010 ns ns 
Baseline 3.786  3.328–4.243   
3-month follow-up 4.257 .9407 3.818–4.696 ns ns 
Baseline 3.786  3.034–4.577   
6-month follow-up 3.000 .8384 3.500–5.015 ns ns 
Baseline 3.786  2.986–4.595   
12-month follow-up 3.529 .8892 2.992–4.065 ns ns 
r=Pearson’s correlation    *=statistically significant at .05 level 
Δ=1 CV of PE baseline mean    ns=not statistically significant at .05 level 
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Statistically equivalent results were obtained for HDL cholesterol between 
baseline and 12-month follow-up, suggesting that at 12-month follow-up the 
participants’ HDL cholesterol had increased such that it was equivalent to baseline.  
LDL cholesterol results post-intervention and at 3- and 6-month follow-up were 
statistically equivalent to baseline, but not at 12-month follow-up.  This suggests that 
there had been a decrease in LDL cholesterol at 12-month follow-up, but the decrease 
was not large enough to be statistically different to baseline, resulting in statistical 
indeterminacy.   
 
Most MET lipid results were not statistically equivalent, but also not 
statistically different to baseline (Table 9), resulting in statistical indeterminacy.  
Statistically significant differences, however, were obtained for total cholesterol and 
LDL cholesterol which were both significantly lower than baseline at 12-month 
follow-up, with large effect sizes (d=.81 for total cholesterol and d=.79 for LDL 
cholesterol).   This suggests that there had been a decrease in the MET participants’ 
total cholesterol and LDL cholesterol from baseline to 12-month follow-up.  
 
Statistically equivalent results were obtained for triglycerides from baseline to 
12-month follow-up, HDL cholesterol from baseline to 3-month follow-up, and LDL 
cholesterol at 3- and 6-month follow-up.    The risk ratio was also statistically 
equivalent from baseline to post-intervention through to 6-month follow-up, but at 12-
month follow-up the risk ratio had decreased such that it was no longer statistically 
equivalent to baseline.  The difference, however, was not statistically significant at the 
.05 level.  
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Table 9.  Lipid means, inferential confidence intervals and results of statistical tests – MET 
 
Time Mean r 95% CI Different  Equivalent 
Total cholesterol     Δ = .85 
Baseline 5.957  5.638–6.277   
Post-intervention 5.267 .9275 4.812–5.722 ns ns 
Baseline 5.957  5.499–6.415   
3-month follow-up 5.338  4.855–5.820 ns ns 
Baseline 5.957  5.557–6.346   
6-month follow-up 5.488 .8445 5.177–5.798 ns ns 
Baseline 5.957  5.430–6.484   
12-month follow-up 5.014 .7211 4.623–5.406 * ns 
Triglycerides     Δ =  1.15 
Baseline 2.586  1.116–4.056   
Post-intervention 1.6 .4007 .883–2.317 ns ns 
Baseline 2.586  1.196–3.976   
3-month follow-up 2.188 .4312 1.476–2.899 ns ns 
Baseline 2.586  1.369-3.802   
6-month follow-up 2.188 .9144 1.782-2.593 ns ns 
Baseline 2.586  2.396–2.775   
12-month follow-up 2.286 .9961 2.120–2.451 ns * 
HDL cholesterol    p Δ = .22 
Baseline 1.541  .937–2.146   
Post-intervention 1.918 .8433 1.110–2.727 ns ns 
Baseline 1.541  1.473–1.610   
3-month follow-up 1.510 .9847 1.452–1.568 ns * 
Baseline 1.541  1.369–1.714   
6-month follow-up 1.563 .8856 1.414–1.711 ns ns 
Baseline 1.541  1.408–1.672   
12-month follow-up 1.447 .8731 1.342–1.553 ns ns 
LDL cholesterol     Δ = 1.14 
Baseline 4.417  3.732–5.109   
Post-intervention 3.500 .5811 2.869–4.131 ns ns 
Baseline 4.417  4.016–4.818   
3-month follow-up 4.200 .8580 3.846–4.555 ns * 
Baseline 4.417  4.109–4.725   
6-month follow-up 4.700 .9680 4.305–5.095 ns * 
Baseline 4.417  4.015–4.318   
12-month follow-up 3.550 .9324 3.282–3.818 * ns 
Risk ratio     Δ = 1.0% 
Baseline 3.667  3.638–3.958   
Post-intervention 3.800 .9630 3.379–4.221 ns * 
Baseline 3.667  3.414–3.919   
3-month follow-up 3.729 .9563 3.416–4.042 ns * 
Baseline 3.667  3.504–3.829   
6-month follow-up 3.663 .9684 3.510–3.816 ns * 
Baseline 3.667  3.183–4.151   
12-month follow-up 2.780 .7290 2.340–3.220 ns ns 
r=Pearson’s correlation    *=clinically significant at .05 level   
Δ=1 CV of MET baseline mean   ns=not statistically significant at .05 level 
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Lipid results for PE participants and MET participants were not statistically 
equivalent at baseline and throughout the study (Table 10).   The difference, however, 
was not large enough to be statistically significant, resulting in statistical 
indeterminacy. 
 
Table 10.  Lipid means, inferential confidence intervals and results of statistical tests - PE vs MET 
 
Mean  95% CI Different  Equivalent 
   Δ=.88 Cholesterol 
 Baseline     
  PE 5.575 4.796–6.354   
  MET 5.957 5.015–6.899 ns ns 
 Post-intervention     
  PE 5.540 3.427–7.653   
  MET 5.267 3.775–6.758 ns ns 
 3-month follow-up     
  PE 5.757 4.937–6.577   
  MET 5.388 4.330–6.430 ns ns 
 6-month follow-up     
  PE 5.017 3.873–6.160   
  MET 5.488 4.728–6.247 ns ns 
 12-month follow-up     
  PE 5.271 4.350–6.193   
  MET 5.014 4.312–5.716 ns ns 
Triglycerides    Δ=1.06 
 Baseline     
  PE 3.085 2.075–4.100   
  MET 2.586 0.940–4/231 ns ns 
 Post-intervention     
  PE 1.920 1.118–2.668   
  MET 1.600 0.790–2.410 ns ns 
 3-month follow-up     
  PE 3.071 2.172–3.971   
  MET 2.188 1.340–3.035 ns ns 
 6-month follow-up     
  PE 2.117 1.545–2.689   
  MET 2.188 1.635–3.521 ns ns 
 12-month follow-up     
  PE 2.314 1.546–3.083   
  MET 2.286 0.763–3.809 ns ns 
HDL cholesterol    Δ=.26 
 Baseline     
  PE 1.101 0.759–1.444   
  MET 1.541 1.093–1.990 ns ns 
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 Mean 95% CI Different  Equivalent 
 Post-intervention     
  PE 1.060 0.828–1.292   
  MET 1.918 1.249–2.588 ns ns 
 3-month follow-up     
  PE 1.021 0.822–1.401   
  MET 1.570 1.110–1.911 ns ns 
 6-month follow-up     
  PE 1.093 0.885–1.302   
  MET 1.563 1.156–1.969 ns ns 
 12-month follow-up     
  PE 1.117 0.943–1.299   
  MET 1.447 1.083–1.811 ns ns 
LDL cholesterol    Δ = 1.22 
 Baseline     
  PE 5.017 4.167–5.866   
  MET 4.417 3.349–5.479 ns ns 
 Post-intervention     
  PE 5.080 4.243–5.917   
  MET 3.500 2.521–4.479 ns ns 
 3-month follow-up     
  PE 5.200 4.118–6.282   
  MET 4.200 3.265–5.136 ns ns 
 6-month follow-up     
  PE 4.583 3.796–5.371   
  MET 4.700 3.912–5.488 ns ns 
 12-month follow-up     
  PE 4.386 3.825–4.946   
  MET 3.550 2.843–4.257 ns ns 
Risk ratio    Δ = 1.0% 
 Baseline     
  PE 3.786 1.800–5.772   
  MET 3.667 2.699–4.634 ns ns 
 Post-intervention     
  PE 3.600 2.123–5.077   
  MET 3.800 2.485–5.115 ns ns 
 3-month follow-up     
  PE 4.257 2.422–6.092   
  MET 3.729 2.574–4.883 ns ns 
 6-month follow-up     
  PE 3.000 2.029–3.971   
  MET 3.663 2.813–4.512 ns ns 
 12-month follow-up     
  PE 3.529 2.235–4.822   
  MET 2.780 1.925–3.636 ns ns 
r=Pearson’s correlation 
Δ = 1CV of mean of PE and MET at baseline 
*=statistically significant at .05 level 
ns=not statistically significant at .05 level 
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 Clinically significant change in individual data.  Lipid results for the PE 
participants showed little change, with only one PE participant’s (Case 8) lipid profile 
showing improvements consistent with improved blood glucose (Figures 4-8).  Three 
MET participants (Case 10, 11, and 12), however, had improvements in their lipid 
profiles, consistent with improved blood glucose (Figures 4-8). 
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Figure 4.  Total cholesterol  
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Figure 5.  Tryglicerides  
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Figure 6.  LDL cholesterol  
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Figure 7.  HDL cholesterol  
 
 
Cases 1 - 3
2
4
6
8
10
Case 1
Case 2
Case 3
Cases 4 - 6
m
m
ol
/L
2
4
6
8
10
Case 4
Case 5
Case 6
Cases 7 - 9
Time
pre post 3 month 6 month 12 month
2
4
6
8
10
Case 7
Case 8
Case 9
Cases 10 - 12 Case 10
Case 11
Case 12
Cases 13 - 15
Case 13
Case 14
Case 15
Cases 16 - 18
Time
pre post 3 month 6 month 12 month
Case 16
Case 17
Case 18
PE METTarget < 5.0 Target < 5.0
 
Figure 8.  Risk ratio 
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Intermediate process variables 
 
Diabetes self-management behaviour 
 
SMOBG.  Only one (Case 8) of the three PE participants who selected 
increased SMOGB as a treatment goal was able to achieve the target set (Figure 9).  
While the frequency of SMOBG was higher than at baseline (during which he did not 
engage in SMOBG), he was not able to maintain his target of four tests per day at 3-, 
6- or 12-month.   
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Figure 9.   Self-management goal: Increase SMOBG – PE  
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Although Case 3 was not able to achieve the target of SMOBG four times per 
day three days per week, it appears that during PE there was an initial increase in 
frequency of SMOBG.  This, however, was not maintained, with no testing occurring 
from approximately one month into PE and during follow-up, although some SMOBG 
did occur at 3-month follow-up.   
 
In contrast, not only was Case 5 not able to achieve her target of engaging in 
SMOBG six times per day, the frequency of SMOBG appears to have decreased 
during PE. SMOBG occurred on approximately 55% of the days during baseline, and 
on one day in which the target of six times per day was achieved (actually exceeded), 
but only occurred on 14% of days during PE and on one day only during 2-week 
follow-up.  Unfortunately, longer term follow-up data are not available.   
 
Therefore, there is no evidence to support PE as having an effect (either 
positive or negative) on the participants’ SMOBG.  In contrast in Figure 10, there is 
evidence that MET contributed to an increase in SMOBG, which was typically 
maintained until at least 3-month follow-up (and up to 6- and 12-month follow-up in 
some instances).  While there was an increase in the frequency in SMOBG with MET, 
it was not always to the target level set by each participant.   
 
  114
Case 14
0
2
4
6
8
Case 10
0
2
4
6
8
Baseline
Intervention
2wk follow up
3m follow up
6m follow up
12m follow up
Case 13
0
2
4
6
8 Case 17
0 20 40 60 80 100 120 140 160 180 200 220 240
Fr
eq
ue
nc
y 
0
2
4
6
8
Case 16
0
2
4
6
8
Case 15
Day
0 20 40 60 80 100 120 140 160 180
0
2
4
6
8
Case 18
Day
300 320 340 360 380 400 420 440 460 480 500
0
2
4
6
8
10
12
14
Target frequency
 
Figure 10.  Self-management goal: increase SMOBG – MET 
 
For example, Case 10, whose target was to engage in SMOBG four times per 
day, increased SMOBG from a mean of once (range 0-2) per day during baseline to a 
mean of three (range 0-5) times per day during MET.  While he did not reach his 
target of four tests per day at 3-month follow-up, the level of SMOBG at 3-month 
follow-up was still higher than at baseline, with a mean of two tests per day (range 1-
3).  SMOBG, however, was not occurring at 6-month follow-up and was variable at 
12-month follow-up. 
 
Case 17, whose goal was to increase SMOBG to three times per day twice a 
week, was infrequently engaging in SMOBG during baseline.  She increased the 
frequency of SMOBG during MET, testing on more than 50% of days, and tested 
three times on two days.  There appears to have been a further increase in the overall 
frequency of SMOBG at 2-week and 3-month follow-up, with testing occurring 93% 
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and 100% of days at 2-week and 3-month follow-up respectively.  Although at 6-
month follow-up there was a decrease towards baseline, the frequency of SMOBG 
increased again at 12-month follow-up to 71% of days in which testing occurred, but 
still not to the target level. 
 
Similarly, at baseline Case 18 was meeting (or exceeding) his target of testing 
twice per day on less than a third of days and was not engaging in SMOBG at all on 
approximately two-thirds of days during baseline.  During MET there was an increase 
in the frequency of SMOBG, with more days in which he met (or exceeded) his 
target, although there were still periods during MET in which he tended not to engage 
in SMOBG.  During 2-week follow-up, the frequency of SMOBG increased to 85% 
of days in which some SMOBG occurred, and the target of testing twice per day was 
achieved on 69% of the days.  This increase in SMOBG, however, does not appear to 
have been maintained at 3-month and 6-month follow-up, with a return to baseline 
levels of SMOBG at 6-month follow-up.  Yet, at 12-month follow-up SMOBG 
occurred on most days and was at or above the target level. 
 
Case 16 was not meeting his target of engaging in SMOBG four times per day 
at all during baseline, and in fact had only one day during baseline in which he 
engaged in SMOBG.  While he achieved (or exceeded) the target on most days in the 
initial stages of MET, he did not maintain this improvement, with no SMOBG for the 
remainder of MET.  At 3- and 6-month follow-up, however, he was engaging in 
SMOBG most days, although not at his target level. 
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Data from SMOBG suggests considerable variability (ranging from 0-6 times 
per day) in the frequency of SMOGB throughout the study for Case 14.  She, 
however, achieved her goal of testing four times a day on 14% of days during MET 
compared to only 6% (one day) during baseline.  The increase in SMOBG, however, 
may not be solely attributable to the effect of MET as there appears to have been an 
upward trend during baseline, suggesting that she was already starting to increase her 
SMOBG prior to MET.  The increased SMOBG appears to have been maintained 
during 2-week follow-up (testing four times per day on 16% of days) and to have 
increased at 3- and 6-month follow-up, with SMOBG occurring four times per day on 
38% and 33% of days, respectively.  There appears to have been a trend towards 
baseline levels at 12-month follow, with no days in which SMOBG occurred four 
times, although at 12-month follow-up there was only one day in which no testing 
occurred, compared to no testing on the majority (73%) of days during baseline. 
 
The evidence, however, for the effectiveness of MET in increasing SMOBG 
was less clear for two MET participants.  Both participants were already achieving 
their target frequency for SMOBG at baseline.  Case 13 was achieving her goal of 
engaging in SMOBG three times per day 57% of the time during baseline, but she 
appears to have had less success achieving this target during MET and follow-up.   
During MET and follow-up, however, there were fewer days in which no testing at all 
occurred, with no SMOBG on 29% of days in baseline, and only 3% and 7% during 
MET and for the two weeks post-MET, and SMOBG was occurring on a daily basis at 
3-, 6- and 12-month follow-up.   
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Similarly, while Case 15 was already meeting or exceeding her target of 
engaging in SMOBG four times per day on 57% of days during baseline, she does not 
appear to have increased the frequency of her SMOBG during MET or follow-up.  
There were some days, however, during MET and at 12-month follow-up in which 
she exceeded her target of testing four times per day, testing 5-8 times in a day, 
whereas this occurred only once in baseline.   Despite this, it appears that the number 
of days in which the target of testing four times a day decreased over the course of the 
study, such that at 6-months follow-up she was not meeting her target at all, although 
at 12-month follow-up the frequency of SMOBG appears to be higher than at 
baseline. 
 
Thus, MET appears to have contributed to increased SMOBG for most, but 
not all, participants for whom this was a goal.  The increase in SMOBG, however, 
was not always to the target frequency and did not tend to be maintained beyond 3-
month follow-up. 
 
Exercise.  The data support MET as a means of increasing participants’ 
exercise, with both MET participants who selected increased exercise as a goal being 
able to do so during MET (Figure 11).  In contrast, the data do not support PE as a 
means of increasing exercise, with only one PE participant (Case 2) increasing her 
exercise, although not to the target level, during PE.  Furthermore, the data suggests a 
decline in the other PE participant’s exercise during PE. 
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Figure 11.  Self-management goal: increase exercise 
   
Case 2’s goal was to increase exercise to at least once per day, which she 
appears to have partially achieved during PE, with a 50% success rate.  While she 
appears to have been meeting her target more frequently at 2-week follow-up, this 
was not maintained at 3- and 6-month follow-up, although at 12-month follow-up her 
exercise level appears to have increased to near target level. 
 
Although Case 6 appeared to be already close to achieving her target of 
exercising once per day at baseline, there does not appear to have been an increase in 
exercise during PE, with the data suggesting a possible decline in the frequency of 
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exercise during PE.  Furthermore, during 2-week follow-up she appears to have 
stopped exercising, and this appears to have been maintained at 3- and 6-month 
follow-up, although the frequency of exercise appears to have returned to baseline at 
12-month follow-up.   
  
In contrast, while Case 11 was already achieving, or exceeding, his exercise 
target most (i.e., 83%) days during baseline, he appears to have further increased his 
exercise during MET, meeting or exceeding his target on 95% of the days (i.e., 
missing his target on only two days during MET).  Additionally, the mean number of 
exercise activities engaged in per day rose from baseline of one per day to two per day 
during MET.  The gains made during MET appear to have been maintained during 2-
week follow-up, with 93% of days in which he met or exceeded the target.   At 3- and 
6- month follow-up, however, the level of exercise appears to have returned to the 
baseline level, and at 12-month follow-up exercise appears to have decreased to 
below baseline. 
 
Similarly, it appears that Case 12 was also able to achieve, and exceed, his 
goal to increase his exercise by attending a water-based exercise programme once per 
week during MET, attending the exercise programme twice per week, compared to 
not at all during baseline.   There also appears to have been an increase in his level of 
exercise in general during MET, with exercise occurring on 46% of days after the first 
week of MET, compared to 33% at baseline.   While he was still meeting his target of 
attending the exercise programme once per week during two-week follow-up, this was 
not maintained at 3-, 6- or 12-month follow-up, and his general level of exercise 
returned to baseline level. 
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Thus, MET also appears to have been a more effective intervention than PE 
for increasing exercise.  Both MET participants who selected increased exercise as 
their self-management goal increased their exercise to or above target during MET.  
The increases in exercise, however, do not appear to have been maintained beyond 2-
week follow-up. 
 
Dietary compliance.  The data do not support PE as a means of increasing 
dietary compliance (Figure 12).  In contrast, the MET participants appear to have 
made improvements in dietary compliance during MET. 
 
During PE there does not appear have been an improvement in dietary 
compliance for Case 7, with considerable variability (range 0-100% compliance) 
during PE.  There, however, appears to have been an improvement in dietary 
compliance during 2-week follow-up, which was maintained throughout follow-up, 
with 41% compliance at baseline compared to 66% compliance during 2-week 
follow-up and again at 12-month follow-up, but there was still considerable variability 
(range 0-100%) in compliance.  Because improvement in dietary compliance did not 
occur during PE, this change cannot be attributed to PE (i.e., some other factor may 
have contributed to this change). 
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Figure 12.  Self-management goal: dietary compliance  
 
Further data in support of PE’s effect on dietary compliance is not available, 
as Case 4 ceased monitoring her food intake during PE, preventing conclusions about 
the effect of PE on dietary compliance being drawn.  The fact that Case 4 stopped 
self-monitoring, however, suggests that dietary compliance may not have been a focus 
and therefore may not have improved. 
 
 
In contrast, dietary compliance for Case 10 improved from a mean of 56% at 
baseline to 68% during the last three weeks of MET.  There appears to have been 
further improvements in dietary compliance at 2-week and 3-month follow-up (mean 
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of 74% and 77%, respectively).  Furthermore, dietary compliance appears to have 
been maintained (although not at the level achieved earlier in follow-up) at 6- and 12-
month follow-up, with a mean of 61%. 
 
Similarly, Case 12 achieved 100% compliance on 50% of days in the last two 
weeks of MET, compared to only one day (16%) during baseline.  There also appears 
to have been further improvement in dietary compliance during 2-week follow-up, 
with no days in which compliance fell below 75%.  Unlike Case 10, the 
improvements, however, do not appear to have been maintained at 3- and 6-month 
follow-up.  Yet, while there was considerable variability at 12-month follow-up, he 
still achieved 100% compliance on three out of the seven days at 12-month follow-up, 
compared to only one day at baseline. 
 
Thus, MET appears to have contributed to increased dietary compliance.  
Additionally, unlike the SMOBG and exercise self-management goals, there is 
evidence that the improvements in dietary compliance (although diminishing) were 
maintained at 12-month follow-up. 
 
Regular eating.  The data on the effect of PE and MET on regular eating is not 
strong as there was only one participant from each intervention who selected regular 
eating as a goal (Figure 13).  The PE participant (Case 7) does not appear to have 
achieved his goal of eating more regularly, with a small decline in meals/snacks 
during PE and 2-week follow-up, from a mean of four meals/snacks per day at 
baseline to three during PE and 2-week follow-up, although there were similar levels 
to baseline for the remainder of follow-up (Figure 13).   
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Figure 13.  Self management goal: regular eating  
 
Unfortunately, Case 14 did not keep a record of her eating during baseline and 
for most of MET, so conclusions about the effect of MET cannot be drawn.  That she 
started keeping a record during MET and maintained this throughout follow-up, 
however, suggests that at least she had started focusing more on her eating. 
 
  
Weight loss.  Three participants (two PE and one MET) also selected weight 
loss as a goal.  While the lack of multiple data points does not enable a true single-
case design analysis, the results were still graphed for analysis (Figure 14).  The data 
  124
suggests that neither intervention had any significant effect on the participants’ 
weight.  
Case 1
Pre Post 3 month 6 month 12 month
W
ei
gh
t (
kg
)
90
92
94
96
98
100
Case 9
Pre Post 3 month 6 month 12 month
90
92
94
96
98
100
Case 11
Pre Post 3 month 6 month 12 month
90
92
94
96
98
100
PE
MET
 
Figure 14.  Self-management goal: weight loss  
 
For example, Case 1’s weight remained stable from baseline to post-PE, and 
then increased by 2kg at 3-month follow-up, although, her weight decreased at 12-
month follow-up to below baseline.  Case 9’s weight increased from baseline to post-
PE, and over the follow-up period. 
 
While Case 11’s weight was higher at 12-month follow-up than at baseline, 
his weight decreased by 1.5kg from baseline to post-MET.  There, however, was not a 
sustained and continued weight loss over follow-up, with his weight fluctuating, but 
gradually increasing over this time. 
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Psychosocial measures 
 
 Statistical comparisons for each psychosocial measure are made within groups 
across time (i.e., PE and MET separately at baseline, post-intervention and 12-month 
follow-up), and between groups across time (i.e., PE compared to MET at baseline, 
post-intervention and 12-month follow-up).  This is then followed by an evaluation of 
individual case data for PE and MET in terms clinically significant change.  
 
Personal Models of Diabetes.  PE Post-intervention and 12-month follow-up 
PMDI treatment effectiveness results were not statistically equivalent to baseline, but 
also were not statistically different, resulting in statistical indeterminacy (Table 11).  
The baseline scores tended to be lower, suggesting the participants tended to consider 
the TAU they received at baseline less effective than PE or the TAU they received at 
12-month follow-up.  Baseline treatment effectiveness results, however, were 
statistically equivalent to post-MET and 12-month follow-up (Table 11), suggesting 
that the participants considered the TAU they received at baseline as effective as 
MET and the TAU they received at 12-month follow-up.   
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Table  11.  PMDI means, inferential confidence intervals and results of statistical tests – PE and MET 
 
Time Mean r 95% CI Different  Equivalent 
PE 
Treatment Effectiveness 
     
Δ=3.688 
Baseline 12.044  10.445–13.644   
Post-intervention 13.578 .6477 12.582–14.574 ns ns 
Baseline 12.044  9.761–14.328   
12-month follow-up 13.275 .1783 11.867–14.633 ns ns 
Seriousness     Δ=2.980 
Baseline 16.667  15.252–18.081   
Post-intervention 17.778 .7891 16.305–19.251 ns ns 
Baseline 16.667  13.691–19.643   
12 month follow-up 14.875 .0806 10.928–18.822 ns ns 
MET 
Treatment Effectiveness 
     
Δ=3.688 
Baseline 14.417  13.630–15.203   
Post-intervention 15.856 .6582 15.063–16.648 ns * 
Baseline 14.417  13.724–15.109   
12-month follow-up 15.700 .7416 14.917–16.483 ns * 
Seriousness     *Δ=2.980 
Baseline 23.889  22.566–25.210   
Post-intervention 21.222 .5892 20.084–22.358 * ns 
Baseline 23.889  21.774–26.004   
12 month follow-up 22.556 -.0474 19.615–25.496 ns ns 
r=Pearson’s correlation 
Δ=1 standard deviation of PE and MET at baseline 
*=statistically significant at .05 level 
ns=not statistically significant at .05 level 
 
 
PE Baseline, post-intervention and 12-month follow-up scores for PMDI 
diabetes seriousness were also statistically indeterminate (Table 11).  Post-PE 
seriousness scores tended to be higher than baseline and 12-month follow-up, 
suggesting that the PE participants tended to be more concerned about the seriousness 
of their diabetes, future complications, and the current consequences of diabetes after 
PE than at baseline or 12-month follow-up. 
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In contrast to the PE participants, the MET participants’ post-intervention 
results on the seriousness of diabetes were lower and statistically different to baseline 
(Table 11), with a moderate effect size (d=.62).   This suggests that MET participants 
were less concerned about the seriousness of their diabetes, future complications, and 
the current consequences of diabetes after MET.  At 12-month follow-up, however, 
the MET diabetes seriousness results were statistically indeterminate.  PE and MET 
treatment effectiveness results were also statistical indeterminate at baseline, post-
intervention and at 12-month follow-up (Table 12).    
 
At baseline, MET participants’ ratings of the seriousness of their diabetes were 
statistically higher than the ratings of the PE participants (Table 12).  This suggests 
that at baseline MET participants were more concerned about the current seriousness 
of their diabetes, future complications, and the effect on their lives.  Post-intervention, 
however, the MET participants’ concern about the seriousness of their diabetes had 
decreased to the extent that their scores were no longer statistically different to the PE 
participants, although the scores were also not statistically equivalent, resulting in 
statistical indeterminacy.  This pattern was repeated at 12-month follow-up. 
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Table 12.  PMDI means, inferential confidence intervals and results of statistical tests – PE vs MET 
 Mean 95% CI Different Equivalent 
Effectiveness:     Δ=3.688 
Baseline     
PE 12.044 9.543–14.546   
MET 14.417 13.019–15.815 ns ns 
Post-intervention     
PE 13.578 12.077–15.078   
MET 15.856 14.499–17.213 ns ns 
12-month follow-up     
PE 13.275 11.817–14.734   
MET 15.700 14.179–17.221 ns ns 
Seriousness:     Δ=2.980 
Baseline     
PE 16.667 13.530–19.803   
MET 23.889 21.806–25.972 * ns 
Post-intervention     
PE 17.778 14.439–21.117   
MET 21.222 19.390–23.048 ns ns 
12-month follow-up     
PE 14.875 10.741–19.009   
MET 22.556 19.678–25.434 * ns 
*Δ=1 standard deviation of PE and MET at baseline 
*=statistically significant at .05 level 
ns=not statistically significant at .05 level 
 
Problem Areas in Diabetes.  The PE participants’ PAID baseline and post-
intervention results were statistically equivalent (Table 13).  This suggests that the PE 
participants’ emotional adjustment to their diabetes remained unchanged (i.e., mean 
score suggesting a moderate level of diabetes-related distress) from baseline to post-
PE.  The 12-month follow-up results, however, were lower than, and statistically 
different to, baseline, with a large effect size (d=.84), suggesting that the PE 
participants’ emotional adjustment to diabetes improved during follow-up (i.e., mean 
score suggesting a low level of diabetes-related distress). 
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Table 13.  PAID means, inferential confidence intervals and outcome of statistical tests – PE and MET  
 
Time Mean r 95% CI Different  Equivalent 
(Δ=23.1) 
PE 
Baseline 
 
34.531 
 
 
 
8.529–43.138 
 
 
 
 
Post-intervention 27.309 .6994 22.084–35.127 ns * 
Baseline 34.531  25.409–46.250   
12-month follow-up 19.125 .5431 14.438–25.250 * ns 
MET 
Baseline 
 
31.250 
  
26.875–36.308 
 
 
 
 
Post-intervention 25.833 .5401 20.304–31.363 ns * 
Baseline 31.250  28.127–34.374   
12-month follow-up 23.722 .7789 19.545–27.433 * * 
r=Pearson’s correlation 
Δ=1 standard deviation from Welch et al (1997) 
*=statistically significant at .05 level 
ns=not statistically significant at .05 level 
 
MET participants’ scores on the PAID post-intervention were statistically 
equivalent to baseline (Table 13), suggesting that there was no change in participants’ 
emotional adjustment to diabetes post-MET (i.e., mean score suggesting a moderate 
level of diabetes-related distress), similar to PE.  At 12-month follow-up, however, 
the PAID results were lower (moderate effect size, d=.60, and a mean score 
suggesting a low level of diabetes-related distress) and statistically different to 
baseline, but were also statistically equivalent, resulting in statistical indeterminacy. 
 
At baseline, PE and MET participants’ PAID results were statistically 
indeterminate (Table 14).  Post-intervention and at 12-month follow-up, however, PE 
and MET participants’ PAID scores were statistically equivalent (Table 14), 
suggesting that both groups had similar emotional adjustment to their diabetes. 
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Table 14.  PAID means, inferential confidence intervals and results of statistical tests – PE vs MET 
 
 Mean 95% CI Different
 
Equivalent  
(Δ=23.1) 
Baseline     
PE 34.531 21.828–49.838   
MET 31.250 24.558–37.941 ns ns 
Post-intervention     
PE 27.309 16.593–40.629   
MET 25.833 17.712–33.955 ns * 
12-month follow-up     
PE 19.531 12.970–26.717   
MET 23.722 15.725–31.719 ns * 
*Δ=1 standard deviation from Welch et al (1997) 
*=statistically significant at .05 level 
ns=not statistically significant at .05 level 
 
 
 
Diabetes Knowledge Test.  Statistically equivalent results were obtained on the 
DKT at baseline and post-intervention, and at 12-month follow-up for both PE and 
MET (Table 15).  This suggests that there was no change in PE and MET participants’ 
knowledge about diabetes during the course of the study.    
 
Table 15.  DKT means, inferential confidence intervals and outcome of statistical tests – PE and MET 
Time Mean r 95% CI Different  Equivalent 
(Δ=16.222) 
PE 
Baseline 
 
60.111 
 
 
 
55.390–64.843 
 
 
 
 
Post-intervention 62.667 .7837 58.319–67.014 ns * 
Baseline 60.111  54.354–65.868        
12-month follow-up 58.250 .7353 54.199–63.301 ns * 
MET 
Baseline 
 
68.333 
 
 
 
63.874–72.792 
 
 
 
 
Post-intervention 72.889 .6534 67.587–78.191 ns * 
Baseline 68.333  63.684–72.983   
12-month follow-up 75.444 .6645 72.223–78.666 ns * 
r=Pearson’s correlation 
Δ=1 standard deviation of PE and MET sample 
*=statistically significant at .05 level 
ns=not statistically significant at .05 level 
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Yet, PE and MET participants’ DKT results were not statistically equivalent at 
baseline or post-intervention, with the MET participants tending to have greater 
diabetes knowledge (Table 16), although the results were not statistically different, 
resulting in statistical indeterminacy.  At 12-month follow-up, however, the MET 
participants’ scores were higher and statistically different to the PE participants’ 
scores, suggesting that the MET participants’ knowledge about diabetes at 12-month 
follow-up was greater than the PE participants’ knowledge. 
 
Table 16.  DKT means, inferential confidence intervals, and results of statistical tests – PE vs MET 
 
 Mean 95% CI Different 
 
Equivalent  
(Δ=16.222) 
Baseline     
PE 60.111 49.895–70.327   
MET 68.333 60.806–75.861 ns ns 
Post-intervention     
PE 62.667 53.382–71.952   
MET 72.889 64.036–81.744 ns ns 
12-month follow-up     
PE 58.250 51.066–65.434   
MET 75.444 70.231–80.657 * ns 
Δ=1 standard deviation of PE and MET at baseline 
*=statistically significant at .05 level 
ns=not statistically significant at .05 level 
 
 
 
 Clinically significant change.   Most (n=6) of the PE participants considered 
PE to be as effective as the TAU they received at baseline and at 12-month follow-up 
(Table 17).  Similarly, most (n=7) MET participants considered MET to be equally as 
effective as the TAU they received at baseline.  Four participants (Case 10, 16, 17, 
and 18) who had received MET, however, considered the TAU they received at 12-
month follow-up more effective than that received at baseline. 
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Table 17.  Clinically significant change on the PMDI, PAID and DKT – PE and MET 
 
 PMDI PAID DKT 
 Treatment Effectiveness Seriousness     
 Post 12-month Post 12-month Post 12-month Post 12-month 
PE         
Case 1 +3.58 +5.69 +2.52 +3.52 -3.83 -2.62  +2.56 
Case 2    -4.03     
Case 3    +3.02     
Case 4  -4.39  -2.52     
Case 5         
Case 6 +5.21   -10.07 -2.82 -3.62 +5.12 +3.84 
Case 7 +5.12 +8.05   -2.22    
Case 8   -2.01 -2.01     
Case 9   +3.02  +3.22    
MET         
Case 10 +3.05 +2.97 -3.83 +4.03 -3.62   +2.38 
Case 11    -2.01 +2.01   +2.38 
Case 12   -2.01 -3.52 -3.02  +4.03 +3.29 
Case 13   -2.52 -3.52  -2.82  -2.38 
Case 14      -2.46 +4.03  
Case 15   -3.52 -4.53 -2.01 -3.22 +2.56  
Case 16  +2.55      +3.84 
Case 17  +5.03       
Case 18 +3.74 +3.38     -2.38  
+ =clinically significant increase in score (i.e., RC>1.96) from baseline 
 - =clinically significant decrease in score (i.e., RC>1.96) from baseline 
NB: empty cell means there was no clinically significant change in the score from baseline 
 
 
Four MET participants (Case 10, 12, 13, and 15) appear to have had a 
decrease in concern about the seriousness of their diabetes post-MET and at 12-month 
follow-up (Table 17).  In contrast, the majority (n=5) of PE participants’ concern 
appears to have remained the same post-PE, with only one participant (Case 8) 
experiencing a decrease in concern post-PE and two (Case 1 and 9) experiencing an 
increase in concern.  Yet three participants (Case 2, 4, and 6) experienced a decrease 
(from baseline) in concern at 12-month follow-up. 
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There appears to have been no change in emotional adjustment to diabetes 
(Table 17) for the majority of PE and MET participants post-intervention (PE n=6, 
MET n=5) and at 12-month follow-up (PE and MET n=7).  Three PE (Case 1, 6 and 
7) and MET (Case 10, 12, and 15) participants, however, did show an improvement in 
emotional adjustment to diabetes post-intervention, while one PE (Case 9) and MET 
(Case 11) appeared to have a deterioration in adjustment to diabetes post-intervention. 
 
Similarly, there appears to have been no change in knowledge about diabetes 
for all but one PE participant (Case 6) post-PE and at 12-month follow-up (Table 17).  
In contrast, although there also appears to have been no change in their knowledge 
about diabetes for five MET participants, three (Case 12, 14 and 15) showed an 
increase in knowledge from baseline to post-MET and four (Case 10, 11, 12, and 16) 
at 12-month follow-up. 
 
 
As Figure 15 shows, an equal number (n=4) of PE participants appear to have 
experienced an increase in motivation to change as experienced a decrease post-PE.  
In contrast, the majority (n=6) of MET participants appear to have had an increase in 
motivation, with only one MET participant’s motivation decreasing post-MET.  Most 
of the PE and MET participants whose motivation to change appears to have 
increased (typically to the action stage of change) following intervention, were in the 
preparation stage of change at baseline, suggesting that they were ready to engage in 
behaviour change at baseline and then moved to actual behaviour change post-
intervention.  The four PE participants whose motivation to change appears to have 
decreased following intervention were spread between the contemplation, action and 
maintenance stages of change at baseline. 
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Figure 15.  SOCRATES: Stages of change  
 
 
Treatment Credibility 
 
On the TEI, both interventions were rated highly overall by the participants, 
with mean credibility ratings of 83% and 89% for PE and MET respectively, 
suggesting that both interventions were considered to have high credibility (Table 18).   
On no items was MET rated less than a four out of seven, whereas PE was rated less 
than a four on three items (items 5, 6 and 10), relating to how much the procedures 
were liked, the likely effectiveness of the treatment and the participants’ general 
reaction to the treatment.   While total TEI scores were not statistically equivalent for 
PE and MET, they were also not statistically different, resulting in statistical 
indeterminacy (Table 19). 
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Table 18.  TEI: summary of results  
 
Mean Range Item 
PE MET PE MET 
1 5.667 6.444 4–7 4–7 
2 5.447 6.444 4–7 4–7 
3 6.222 6.111 4–7 4–7 
4 6.333 6.111 4–7 4–7 
5 4.778 6.111 3–7 4–7 
6 5.222 5.778 3–7 4–7 
7 5.0 6.333 4–7 5–7 
8 6.111 6.889 4–7 4–7 
9 6.889 6.333 6–7 4–7 
10 5.556 6.556 1–7 5–7 
Total 83% 89% 66-100% 74-100% 
 
 
 
Table 19.  TEI: inferential confidence intervals and results of statistical tests – TEI total score 
 
 95% CI Different Equivalent 
(∆=8.963) 
PE 
 
MET 
52.129–64.760 
 
58.609–65.613 
 
 
ns 
 
 
Ns 
∆=1 standard deviation of PE and MET samples 
ns=not statistically significant at .05 level 
 
Treatment Integrity 
 
Ninety four percent of the audiotapes reviewed by the independent rater, blind 
to condition, were accurately identified as either PE or MET sessions.  All MET 
sessions were correctly identified as MET and one PE was incorrectly identified as 
MET.  This suggests that these were distinct interventions. 
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Cost: Resource Utilisation 
 
MET and PE were statistically different both in the number of appointments 
taken for the intervention and in the duration of these appointments, with MET taking 
more appointments and of longer duration than PE (Table 20).   They were equivalent, 
however, in terms of the number of additional appointments attended over the course 
of the study.  Yet, PE participants tended to miss more appointments than MET 
participants, although the difference was not large enough to be statistically 
significant. 
 
Table 20.  Resource utilisation inferential confidence intervals and results of statistical tests  
                  – PE and MET 
 
Appointments Mean 95% CI Different  Equivalent 
Total attended 
PE 
MET 
 
2.667 
4.000 
 
 
2.123–3.21 
4.000 
 
 
* 
 Δ=0.7 
 
ns 
Duration (mins) 
PE 
MET 
 
22.909 
40.528 
 
 
20.102–25.716 
38.434–42.620 
 
* 
 Δ=8.8 
 
ns 
Extra 
PE 
MET 
 
2.444 
2.444 
 
 
1.081–3.808 
1.495–3.695 
 
 
ns 
Δ=2.4 
 
* 
Missed 
PE 
MET 
 
1.222 
1.111 
 
 
0.453–1.991 
0.028–1.202 
 
 
ns 
Δ=1.7 
 
ns 
Δ=1 standard deviation of PE and MET samples 
*=statistically significant at .05 level 
ns=not statistically significant at .05 level 
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Results – Part B 
 
 Part B comprises the results of the three participants who received PE, but 
then, once the follow-up period was completed for PE, agreed to extend their 
participation in the study to include receiving MET from the same DNE from whom 
they have previously received PE. 
 
Diabetes Outcome 
 
There was no clinically significant change in HbA1c results for all three 
participants post-PE (Figure 16).  There was, however, a clinically significant 
decrease in HbA1c post-MET for one participant (Case 4) which was followed by 
further clinically significant decreases over the course of follow-up, such that at 6-
month follow-up her HbA1c was near the 7% target.  Similarly, there was no 
clinically significant change in all three participants lipid profiles post-PE (although 
Case 9’s lipid profile improved over the course of follow-up), but post-MET there 
again was an improvement in Case 4’s lipid results (Figure 17-19).   
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Figure 17. Average blood glucose and total cholesterol  
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Figure 18.  Triglycerides and HDL cholesterol  
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Figure 19.  LDL cholesterol and risk ratio  
 
Self-monitored blood glucose data 
 
During PE there appears to have been an improvement in self-monitored blood 
glucose level for Case 4 from baseline in the latter part of PE, with self-monitored 
glucose levels falling within the target range (Figure 20).  While the 2-week follow-up 
data shows a trend back to the higher levels obtained during baseline, the data 
(although limited) suggest that the improvement in self-monitored blood glucose level 
may have been maintained throughout follow-up.  Yet, there appears to have been a 
return to pre-PE baseline levels by the time baseline for MET was initiated (Figure 
20).  During MET self-monitored glucose results were quite variable, with some 
falling within the target, but the majority above this level.  At 2-week follow-up the 
self-monitored glucose level appears similar to baseline, but there appears to have 
been downward shifts in the self-monitored glucose level at both 3- and 6-month 
follow-up. 
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Figure 20.  Results from SMOBG 
 
Unfortunately, Case 7 did not engage in SMOBG during baseline for PE, so 
comparisons with PE and pre-intervention levels are not possible (Figure 20).  During 
PE there does not appear to be any change in the blood glucose level.  There, 
however, appears to have been an improvement at 2-week and 3-month follow-up, 
with most of the results in the target range, but this does not appear to have been 
maintained at 6-month follow-up.  Although data from SMOBG are limited for MET, 
there does not appear to have been a change in the level of self-monitored blood 
glucose during MET or at 3-month follow-up. 
 
Data from SMOBG for Case 9 suggest a decrease in self-monitored blood 
glucose level towards the end of PE, falling within the target range at the end of PE 
(Figure 20), although the data was already trending downwards at baseline.   There 
appears to be a trend towards baseline level during 2-week follow-up, which was 
maintained at 3-month follow-up.  Unfortunately, SMOBG did not occur at 6- and 12-
  141
month follow-up.   Data from SMOBG for MET, however, suggest an increase in 
self-monitored blood glucose level at baseline, but a downward trend during MET, 
with at least 50% of SMOBG data in the target range during MET (Figure 20).  While 
this improvement appears to have been maintained during 2-week follow-up, there 
appears to have been a return to baseline level at 3-month follow-up.   
 
Intermediate process variables 
 
Self-management behaviour 
 
 All three participants chose dietary (compliance or regular eating) or weight 
loss as target behaviours for change during PE, whereas during MET, all three chose 
increased SMOBG as one of their goals for change.  The data suggest that, whereas 
all three participants were unsuccessful in changing their target behaviour during PE 
(Figure 21-23), they all increased the frequency of SMOBG during MET, although 
the increase was not maintained during follow-up for at least one participant (Case 9). 
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Figure  21.  Self-management goals - Case 4 
 
Case 4.  Her goal during PE was to improve dietary compliance.  It is unclear, 
however, whether she achieved the goal of improved dietary compliance during PE as 
she ceased monitoring her food intake during PE.  Self-monitoring at 2-week follow-
up suggested deteriorating dietary compliance, but an improvement in dietary 
compliance at 3-month follow-up (Figure 21).    
 
During MET she had two goals (i.e., to increase the frequency of SMOBG to 
four times per day, three days per week, and engage in daily exercise). The frequency 
of SMOBG increased from a baseline of no testing (with the exception of one day in 
which two tests occurred) to 50% of days in which testing occurred between 1-4 times 
during MET, including two days during MET in which she tested four times per day 
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(Figure 24).   Furthermore, the increase in SMOBG appears to have been maintained 
at 2-week and 3-month follow-up, with testing (1-2 tests per day) occurring on 
approximately 50% of days, and there appears to have been further improvement at 6-
month follow-up with testing (1-4 tests) occurring on every day.   
 
Unfortunately, baseline data was not collected for the frequency of exercise, 
so conclusions cannot be drawn regarding her goal of exercising daily (Figure 21).  
Yet, there appears to be a trend towards daily exercise during follow-up, with exercise 
occurring on all but one day at 2-week follow-up, four days out of seven at 3-month 
follow-up and daily 6-month follow-up. 
 
Case 7.  He had two goals during PE – to eat more healthily and more 
regularly (i.e., six times per day).  Firstly, in terms of eating more healthily, there does 
not appear have been an improvement in dietary compliance during PE (Figure 22), 
with considerable variability (range 0-100% compliance).  There, however, appears to 
have been an improvement in dietary compliance during 2-week follow-up, which 
was maintained throughout follow-up, although there was still considerable variability 
(range 0-100%) in compliance. Additionally, he does not appear to have achieved his 
second goal of eating more regularly, with the number of meals/snacks consumed 
during PE and at follow-up similar to baseline.  Self-monitoring at 6-month follow-
up, however, indicated he was eating four times per day (Figure 22).   
 
  144
PE 
C
om
pl
ia
nc
e 
(%
)
0
20
40
60
80
100
Baseline
Intervention
2wk follow up
3m follow up
6m follow up
12m follow up
PE
N
um
be
r o
f m
ea
ls
/s
na
ck
s
0
1
2
3
4
5
MET 
Day
0 20 40 60 80 100 120 140 160
Fr
eq
ue
nc
y 
0
1
2
3
4
Regular Eating
Dietary Compliance
SMOBG
Target frequency
 
Figure 22.  Self-management goals – Case 7 
 
His goals during MET were to take his medication as directed and to increase 
SMOBG to two times every second day.  Unfortunately, he did not record data on his 
medication use, so his achievement of this goal cannot be assessed, although notes on 
the clinical file indicate that during MET he reported that he was taking his 
medication whereas previously he had not.  Additionally, there appears to have been 
an increase in SMOBG, from no testing pre-MET to testing at least once every second 
day (with one day in which testing occurred twice) in the initial stages of MET 
(Figure 22).  This increase, however, was not maintained beyond the first two weeks 
of MET, with a return to no testing for the remainder of MET and two-weeks post-
MET.   Yet, there was again an increase in SMOBG at 3-month follow-up with testing 
(1-3 times) occurring five days out of seven.  Unfortunately, he lost his meter before 
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the 6-month data could be downloaded, so it is uncertain what was happening with 
regards to SMOBG at this point. 
 
Case 9.  She had two goals during PE – to eat more healthily and lose weight.  
She, however, did not self-monitor her food intake.  Consequently, conclusions 
cannot be drawn regarding dietary compliance.  She did not achieve her second goal 
of losing weight, with her weight increasing from baseline to post-PE and over the 
follow-up period (Figure 23).   
 
Case 9 had two goals during MET – again, to eat healthily, and to increase the 
frequency of SMOBG to four times a day, three days per week.  Once again she did 
not record her food intake and so conclusions cannot be drawn regarding dietary 
compliance.  There, however, appears to have been an increase in SMOBG from no 
testing at baseline (with the exception of one day in which she tested four times) to 
testing on approximately 50% of days for most of MET, and she achieved her goal of 
testing four times per day, three days per week in the first week of MET (Figure 23).  
The frequency of testing, however, declined back to baseline level by the end of 
MET.  She was testing more frequently 2-weeks post-MET, but at 3- and 6-month 
follow-up the frequency of SMOBG had decreased to baseline level. 
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Figure 23.  Self-management goals – Case 9 
 
 
Psychosocial measures 
  
PMDI results suggest that two (Case 4 and 9) of the participants considered 
PE was equally effective as the TAU they received at baseline, whereas Case 7 
considered PE to be more effective than TAU (Table 21).  Similarly, two participants 
(Case 4 and 7) considered MET to be as effective as the TAU they received at 
baseline, whereas Case 9 considered MET to be more effective than TAU at baseline.   
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Table 21.  Clinically significant change (RC) on the PMDI, PAID, DKT and TEI  – Cases 4, 7 and 9  
     for PE and MET 
 
 PMDI PAID DKT TEI 
 Treatment Effectiveness Seriousness     
 Post Follow-up Post Follow-up Post Follow-up Post  
Case 4         
 PE  -4.39  +2.52     
 MET  +2.93  -2.82   +3.84 +2.68 
Case 7         
 PE +5.12 +3.58   -2.22    
 MET    -5.54    +2.34 
Case 9         
 PE   +3.02 -2.01 +2.82 -3.22   
 MET +2.24 -4.03  +2.01 +2.01 -2.82 -3.84  
+ =clinically significant increase in score (i.e., RC>1.96) from baseline 
 - =clinically significant decrease in score (i.e., RC>1.96) from baseline 
NB: empty cell means there was no clinically significant change in the score from baseline 
 
There was no change in the participants concern about the seriousness of their 
diabetes after both interventions, apart from Case 9 whose score on the PMDI 
indicated an increase in concern post-PE (Table 21).  Mixed results were obtained for 
diabetes seriousness at follow-up for PE, whereas two (Case 4 and 7) of the 
participants were less concerned about the seriousness of diabetes at follow-up. 
 
There was also no clinically significant change in the participants’ knowledge 
about diabetes post-PE as indicated by their scores on the DKT (Table 21).  Post-
MET the results, however, were mixed.  Mixed results were also obtained for the 
three participants on the PAID post-PE, whereas two of participants scores remained 
unchanged post-MET, suggesting no change in emotional adjustment to diabetes post-
MET (Table 21).   
 
 
 Two (Case 7 and 9) of the three participants scores on the SOCRATES 
suggested a decrease in motivation to change following PE, whereas motivation to 
change remained unchanged or increased (Case 9) following MET (Figure 24). 
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Figure 24.  Stages of change (SOCRATES)  
 
Treatment credibility 
 
Both interventions were rated highly on the TEI by all three participants, 
suggesting that both were considered highly credible interventions, with mean 
credibility ratings of 58% and 63% for PE and MET respectively.  MET, however, 
was given a clinically significant higher rating than PE for two (Case 4 and 7) of the 
participants. 
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Cost: Resource utilisation 
 
 As in Part A, MET comprised more appointments than PE.  Participants also 
attended more additional appointments during the MET phase than during the PE 
phase.  Participants, however, missed fewer appointments during the MET phase 
(Table 22).   
 
Table 22.  Resource utilisation during the course of the study – PE and MET 
 
Appointment PE MET 
Total attended 2.667 4.000 
Extra 1.667 2.333 
Missed 1.667 0.667 
 
 
Summary 
  
  The findings of this within-subject comparison of PE and MET, consistent 
with Part A findings, suggest that MET led to improved diabetes self-management, 
whereas the evidence did not support PE as a means of improving diabetes self-
management.  When the participants received PE, they either did not record data 
relevant to the treatment goal (e.g., dietary compliance) or, when data was available, 
there did not appear to be any improvement in diabetes self-management, with the 
exception of Case 7 who showed some improvement in dietary compliance at 2-week 
follow-up which was maintained throughout follow-up.  In contrast, each participant 
when he/she received MET appears to have made some progress towards at least one 
diabetes self-management goal, which for all participants was increased SMOBG.   
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Furthermore, for one of the participants (Case 4) there was evidence that the 
changes in diabetes self-management behaviour achieved with MET may have led to 
improved metabolic control, with clinically significant decreases in HbA1c over the 
course of the MET phase such that her blood glucose at 6-months post-MET was near 
the 7% target.  Participants’ lipid profiles did not appear to be improved with either 
intervention, although one participant (Case 9) had a marked improvement in her lipid 
profile 3-, 6- and 12-months post-PE, which cannot be entirely attributed to 
medication as her medication for dyslipidaemia had been stopped 12-months post-PE.   
 
The results on the psychosocial measures were also similar to those in Part A.  
Both interventions tended to be considered as effective as TAU at baseline, and did 
not appear to have altered the participants’ concern about the seriousness of their 
diabetes, future complications, and the effect on their life immediately post-
intervention.  There, however, was a decrease in concern for two of the three 
participants at 6-month follow-up after MET.   There was no evidence that PE or 
MET increased the participants’ knowledge about diabetes, and no evidence that 
either intervention affected the participants’ emotional adjustment to diabetes.  
There did, however, appear to have been a deleterious effect on participants’ (n=2) 
motivation to change following PE, whereas their motivation tended to remain 
unchanged (n=2) or improved following MET.  Lastly, both interventions were rated 
highly in terms of treatment credibility.  The participants, however, tended to rate 
MET higher than PE. 
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Discussion 
 
Group data suggest that both interventions may have contributed to clinically 
significant improvements in glycaemic control.  The mean decrease in HbA1c for 
both interventions over the course of the study was .70% and .67% for PE and MET 
respectively.  This is higher than the mean reduction of .43% reported in recent meta-
analyses of educational and behavioural interventions for Type 2 diabetes (Gary et al., 
2003) and of MI applied to disease (Rubak et al., 2005).   
 
The decreases in HbA1c in the current study, however, were not to the level of 
statistical difference, apart from one exception (i.e., MET at 6-month follow-up).  
This lack of statistical significance may be due to a lack of power because of the small 
number of participants in each group.  Despite the lack of power, there was a 
statistically significant improvement in glycaemic control from baseline to 6-months 
after MET.  This suggests that the effect of MET on glycaemic control continued up 
to 6-months post-intervention.   
 
Yet in the current study, HbA1c results for both groups at 12-month follow-up 
were statistically equivalent to baseline, suggesting that the decreases were not 
maintained at 12-month follow-up.  This result in itself, however, is still clinically 
significant as it contrasts with the natural history of diabetes, which is for blood 
glucose to rise over time (Yudkin, 2005). 
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A recent meta-analysis of research on self-management education for Type 2 
diabetes found that the mean decrease in HbA1c was .76% post-intervention but fell 
to only .26% with follow-up of 4-months or greater (Norris et al., 2002).  The findings 
of the current study that effect for PE decreased over time, from .95% post-PE to 
.02% at 12-month follow-up, is consistent with this meta-analysis, although the effect 
on HbA1c in the current study appears to have not been lost until after 6-months. 
 
The mean decrease in HbA1c of .67% for the current study compares 
favourably with the results of recent meta-analyses of psychological interventions for 
Type 2 (Ismail et al., 2004) and Type 1 (Winkley et al., 2006) diabetes.  Winkley et al 
(2006), for example, found only a mean decreased of .22% in HbA1c after 
psychological intervention for adults with Type 1 diabetes.  While the mean decrease 
of .67% in the current study is less than the .76% reported by Ismail et al (2004) for 
psychological interventions with Type 2 diabetes, the psychological interventions in 
the meta-analysis were considerably longer (i.e., mean of 11 sessions, range from 5-
50 sessions) than the MET provided in the current study (i.e., four sessions).  
Additionally, most (i.e., 86%) of the psychological interventions in the meta-analysis 
used specialists (typically psychologists) to provide the intervention, whereas in the 
current MET was provided study by DNEs.  Thus, it could be argued that MET is 
more cost-effective, and certainly is more amenable to wider scale application than 
intensive, specialist-provided psychological interventions. 
 
While the group data did not show a decrease in HbA1c (a measure of the 
average blood glucose over the previous 8-10 weeks) 2-weeks post-MET, this was 
may have been a function of the relatively short time (10 weeks) from baseline to 
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post-test in most cases.   Nevertheless, the decrease in HbA1c in the current study of 
1.25% 6-months post-MET is comparable with the mean decrease in HbA1c of 1.2% 
reported in the three other studies (Smith et al., 1997; Viner et al., 2003; Channon et 
al., 2007) which found statistically significant decreases in HbA1c following MI with 
patients with diabetes.  It should also be noted that these other studies tended to 
comprise longer MI (i.e., mean of 4.7 sessions, but up to 16 sessions, for up to 6-
months), which was conducted by specialist interventionists rather than usual clinical 
staff, as in the current study. Moreover, in contrast to the current study, the two 
studies that evaluated the effectiveness of MI provided by usual clinical staff (Clark et 
al., 2004; Rubak, 2005) found there was no statistically significant decrease in HbA1c 
following MI.   
 
Consistent with the group data finding of a statistically significant decrease in 
HbA1c at 6-months follow-up, the individual data suggests clinically significant 
decreases (i.e., 0.5%) in HbA1c for four of the MET participants post-intervention, 
which extended to five MET participants at 6-month follow-up.  The data from the 
self-monitored blood glucose levels, however, were less clear.  This in part was due to 
the data itself being highly variable and therefore difficult to analyse, but may also 
have been a function of the nature of the participants testing which contributed to this 
data being a less reliable measure of overall blood glucose.  For example, rather than 
testing their blood glucose at regular times, some participants reported testing when 
they thought their level was likely to be low, as this made them feel less anxious and 
would please their health practitioner(s), while others reported times when they tested 
(and sometimes repeatedly) because they were anxious that their blood glucose may 
have been high. 
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The failure of the improvements in glycaemic control to be maintained at 12-
month follow-up, raises the possibility that some form of booster session(s) may be 
necessary 6-12 months after MET, and perhaps regularly thereafter.  Therefore, it is 
recommended that future research investigates whether the addition of booster 
sessions to MET contributes to further, or maintenance of, improvements in 
glycaemic control.   
 
Group data also suggest that both interventions may have contributed to 
statistically significant improvements in the participants’ lipid results.  There was a 
statistically significant decrease in the PE participants’ triglyceride results from 
baseline to post-PE and at 12-month follow-up, whereas there was a statistically 
significant decrease in the MET participants’ total cholesterol and LDL cholesterol at 
12-month follow-up.  This finding for MET is similar to that reported for MI on total 
cholesterol and LDL cholesterol in relation to cardiovascular disease (Kreman et al., 
2006), although the statistically significant decrease occurred 3-months after MI, 
whereas the statistically significant decreases in the current study were not achieved 
until 12-month follow-up. 
 
The multiple-baseline data suggest the mechanism by which the improvements 
in metabolic control may have been achieved.  MET appears to have led to somewhat 
improved diabetes self-management, particularly increased SMOBG, in most cases.  
In contrast, the mixed results observed did not support PE as a means of improving 
diabetes self-management.  Thus, it is likely that the improvement in self-
management behaviour (e.g., SMOBG) with MET contributed to the clinically 
significant improvements in diabetes outcome (HbA1c and lipids).   
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  There appears to have been a differential effect on readiness for change (as 
measured by the SOCRATES) with the two interventions.  That is, while the MET 
participants’ motivation (with one exception) either increased or remained unchanged, 
PE appears to have led to an equal number (n=4) of participants becoming less 
motivated (i.e., more resistant to change). This finding is consistent with previous 
research suggesting that advice-giving may lead to resistance (Miller & Rollnick, 
1991; Patterson & Forgatch, 1985, Stott & Pill, 1990).   
 
It could be expected that advice-giving, in particular to individuals who are 
not ready to change their behaviour (i.e., in the pre-contemplation or contemplation 
stage of change), may have a negative effect on motivation as these individuals have 
not made a decision to change.  The results of the current study, however, suggest that 
there was no particular stage of change which was more vulnerable to the deleterious 
effects of advice-giving on motivation, with participants who became more resistant 
to change being assessed at baseline to be in a range of stages of change (i.e., 
contemplation through to maintenance).  In contrast, participants who were in the 
preparation stage of change at baseline, tended to show increased motivation after 
either intervention.  This suggests that, having decided to change, PE participants 
were more receptive to advice. 
 
Further research as to whether there is a stage of change when advice-giving 
(PE) may or may not be beneficial is recommended.  This may then enable health 
practitioners to be more targeted as to whom they give advice to, and when advice is 
provided. PE might then be given to individuals who are most receptive to advice and 
therefore more likely to benefit from it. Those individuals who are less likely to 
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benefit from advice would be given some other form of intervention, such as MET, 
which focuses on the individual’s motivation to change.  
 
Of concern is that one participant receiving MET became less motivated to 
change.  Further analysis suggests that the quality of MET provided to this participant 
was not below the standard received by the other participants.  It is most likely, then, 
that extraneous factors (such as other life events) may have influenced the change in 
motivation.   
 
The above results regarding motivation to change should be treated with some 
caution, however.   A limitation of the SOCRATES is that it measures motivation to 
change diabetes self-management generally, rather than motivation to change specific 
self-management behaviours.   The SOCRATES as a global measure would not 
necessarily pick up changes in motivation to change specific behaviours, even though 
such behaviour-specific motivational changes may occur. 
 
Additionally, the TTM of change (Prochaska & DiClemente, 1982; Prochaska 
et al., 1992) upon which the SOCRATES is based has been questioned as to whether 
it is a “valid description and explanation of the process of change” (Sutton, 2001, 
p.175), and the SOCRATES has been criticised for failing to distinguish between 
different stages in the TTM.  While the SOCRATES, “does not appear to measure the 
stage of change constructs as conceived by Prochaska and DiClemente ..., the scales 
of the SOCRATES seem better understood as continuously distributed motivational 
processes that may underlie stages of change” (Miller & Tonigan, 1996, p.84).   
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Individual case data suggest that PE had little effect on the PE participants’ 
knowledge about diabetes as measured by the DKT, with no clinically significant 
changes in the scores obtained for all but one participant.  Yet, despite the provision 
of information not being a focus of MET, three MET participants had clinically 
significant increases in diabetes knowledge post-MET, and four at 12-month follow-
up.  This suggests that for some individuals MET may have contributed to increased 
knowledge.  Increased knowledge, however does not necessarily translate to 
behaviour change or improved diabetes control (Rubin et al., 1991; Bahru & 
Abdulkadir, 1993). 
 
Participants in both interventions were fairly evenly distributed between those 
experiencing low to moderate levels of diabetes-related distress and those 
experiencing high levels of distress at baseline as measured by the PAID.  Statistical 
analysis of the group data did not reveal a statistical difference between PE and MET 
participants’ PAID results at baseline, post-intervention or at 12-month follow-up, 
although the results were statistically indeterminate at baseline, with higher levels of 
distress for the PE participants.   Group data, however, suggest that there may have 
been improvement in the participants’ emotional adjustment to their diabetes over the 
longer term, with a statistically significant difference between baseline and 12-month 
follow-up results for both interventions.   For PE, however, this may simply be the 
effect of the individual with poor emotional adjustment (near the diabetes burn-out 
range) being lost to 12-month follow-up.   Additionally, although statistical analysis 
of MET group data found a statistical difference, the results were also statistically 
equivalent and therefore statistically indeterminate.  Again, this failure to find 
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statistical significance (at baseline and 12-month follow-up) may be a function of a 
lack of power.   
 
Group data, however, suggests no statistically significant change in PE and 
MET participants’ emotional adjustment post-intervention, which is supported by the 
individual case data which suggest no clinically significant change in individual 
participants’ emotional adjustment to diabetes pre- and post-intervention.  
Nevertheless, the changes in the participants PAID scores for both interventions from 
baseline to post-intervention (PE d=.30, MET d=.47) and to 12-months follow-up (PE 
d=.62, MET d=.65) were similar to the small (d=.32) to moderate (d=.65) effect sizes 
reported for the PAID following a range of interventions (educational and 
psychological) for diabetes (Welch et al., 2003).   
 
The mean composite scores on the PMDI at baseline for the PE and MET 
participants were similar to those reported by Clark et al. (2001), with patients with 
Type 2 diabetes (i.e., seriousness=2.70, effectiveness=3.80).  The scores indicated that 
the participants perceived their diabetes as only slightly serious and that they were 
only slightly worried about its threat to their future (PE=2.08, MET=2.99), but that 
their beliefs about the effectiveness of treatment for diabetes were somewhat stronger 
(PE=3.01, MET=3.60). 
 
The MET participants were more concerned at baseline about the current 
seriousness of their diabetes, future complications, and the effect on their lives than 
the PE participants.   This may reflect the MET participants’ poorer glycaemic control 
at baseline (i.e. their HbA1c tended to be higher than the PE participants, although the 
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difference was not statistically significant), and longer duration of diabetes (i.e. 10-15 
years post-diagnosis compared to 3-11 years for the PE participants), and therefore 
longer exposure to the effects of hyperglycaemia contributing to more diabetes-related 
complications.  That is, while a similar number (about half) of PE and MET 
participants had experienced complications from diabetes, the MET participants had 
experienced more diabetes-related complications (on average two per participant with 
complications) than the PE participants (only one complication per participant with 
complications).   
 
Post-MET individual data indicate that four MET participants experienced a 
decrease in concern about diabetes, with group data indicating a statistically 
significant decrease in their concern such that they were no longer statistically 
different, although still not statistically equivalent, to the PE group.  This decrease in 
concern, however, appeared to wane at 12-month follow-up.    
 
The MET participants may have had lowered concern about the seriousness of 
their diabetes, future complications, and the effect on their lives post-intervention 
because they had successfully made changes in their diabetes self-management, which 
they considered likely to be permanent.  Therefore, they may have believed that they 
had reduced the risk of future diabetes-related complications, thereby altering their 
beliefs about the seriousness of their diabetes.   On the other hand, their beliefs about 
the seriousness of their diabetes may have increased at 12-months when the 
improvements in glycaemic control achieved at 6-month follow-up were not being 
maintained.   
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Previous research suggests that a higher level of concern about the serious of 
diabetes is likely to contribute to greater engagement in diabetes self-management 
behaviour (Hampson et al., 1990; Hampson et al., 1995; Skinner & Hampson, 2001).    
The baseline PMDI results in the current study appear to support these findings.  The 
MET participants were more concerned about the seriousness of their diabetes, and 
subsequently were more successful in achieving their diabetes self-management goals, 
including increased SMOBG.   It may therefore be that the better outcome for the 
MET participants was due to their beliefs about the seriousness of their diabetes, 
rather than a function of having received MET.  Future research would need to 
explore this, using groups of participants who were matched for beliefs about 
diabetes’ seriousness at baseline.   
 
The fact that the participants were referred for further assistance with diabetes 
management, however, suggests that the participants were maintaining inadequate 
diabetes self-management despite their concerns about the seriousness of their 
diabetes.  Therefore it is likely that MET contributed to the improvements in diabetes 
self-management during the study, rather than their concerns about their diabetes.   
The subsequent improvements in their diabetes self-management behaviour, coupled 
with the improvements in blood glucose, may then have led to the decrease in concern 
about the seriousness of diabetes after MET. 
 
Considering Hampson et al’s (1995) results showing a relationship between 
beliefs about treatment effectiveness and diabetes self-management behaviour, it 
might have been expected that the MET participants would have considered MET 
more effective than TAU, given that they made changes in their diabetes self-
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management during MET.  Individual and group data, however, suggest no clinical or 
statistical difference between the PE and MET participants’ perceptions of the 
effectiveness of TAU and PE or MET, and both interventions were rated highly in 
terms of credibility (TEI).   
 
Limitations of the Study 
 
The number of participants in the study is small (n=9 in each intervention 
group, with n=2 staff providing the interventions), however, limiting the strength of 
the conclusions that can be drawn from the current study.  Additionally, the variability 
in the goals for change selected by the participants also limited the number of 
replications.  The conclusions that can be drawn from the current study, especially 
regarding the generalisability of the results, should therefore be treated with caution.    
 
Part B, however, provides a replication of the results in Part A, and therefore 
further support for the conclusions, with similar findings (especially regarding MET 
leading to improvements in SMOBG).    A limitation in Part B, however, is that it is 
unclear why these three participants took up the offer of further intervention and the 
other six did not.  For example, it could be that the participants in Part B were more 
motivated or compliant, and hence the reason for their agreeing to participate in a 
second study.  Yet, examination of the demographic, questionnaire and blood glucose 
data suggests that these three participants were more similar than different to the other 
six PE participants at baseline for both PE and MET.  At baseline for PE the three 
participants who agreed to partake in Part B, however, tended to have lower 
knowledge about diabetes, lower HbA1c, and appeared to be more ready to change 
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than the other PE participants.  This, however, did not appear to contribute to 
improved outcome with PE, with all three failing to make improvements in their 
diabetes self-management or improved blood glucose with PE.   Interestingly, at 
baseline for MET the three participants appear to have been more satisfied with the 
treatment they were receiving at that point and were experiencing less emotional 
distress related to diabetes when compared to the PE participants at baseline, yet they 
agreed to participate in Part B.     
 
As it happened, when the same participants received PE and MET provided by 
the same DNE, results similar to Part A were obtained.  Through replicating the 
results the probability that something other than MET caused the change is reduced 
(Cooper, Heron & Heward, 1987).  Thus, further support is provided for the findings 
that MET may be an effective intervention for enhancing diabetes self-management 
and diabetes outcome.   
 
The small sample size in the current study also meant that there was a lack of 
power for both the statistical tests and effect size calculations, inflating the risk of 
type 2 error.   Despite, the small sample size, however, statistically significant 
differences and moderate to large effect sizes were found.  Conversely, the large 
number of pair-wise comparisons of means (especially for the lipid results) to test 
hypotheses may have inflated the risk of type 1 error in the current study.  The use of 
Tryon’s (2001) inferential confidence interval approach in the current study to test for 
statistical difference, equivalence, and indeterminacy that is algebraically equivalent 
to standard null hypothesis statistical testing (NHST), however, decreases the risk of 
type 1 as well as type 2 error.  For example, Tryon’s approach requires that in order 
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for statistical difference to be claimed, it has to be established that the data is 
statistically not equivalent as well as statistically different, thereby reducing the risk 
of type 1 error.  Tryon also points out that it is common practice to interpret 
“marginally” (near the .05 level for example) significant results as trends, and then 
discuss them as differences, whereas the inferential confidence interval approach 
provides access to a third alternative; namely that the results are statistically 
indeterminate.  Thus, while ‘this alternative has always been technically available’ 
(p.373), ‘standard NHST procedures emphasise accepting or rejecting the null 
hypothesis’ (p.373), whereas the methods proposed by Tryon (2001) ‘clearly 
incorporate statistically indeterminacy and should make this alternative more salient’ 
(p.373).  Tyron’s (2001) approach also addresses a ‘misuse of NHST procedures’ 
(p.373) related to reporting of p values in which ‘to correctly conduct NHST and 
properly establish grounds for falsification, one must specify the type 1 alpha level 
(e.g., .05 or .01) in advance of conducting analysis’ (p.373), whereas ‘this classic 
NHST step is rarely, if ever taken’ (p.373).  Instead, ‘investigators typically select the 
p value after computing the test statistic and then report the highest significance level’ 
(p.373).  Tryon’s procedure avoids this error by ‘requiring the user to establish a level 
of statistical significance as a necessary condition for calculating test statistics and 
then report results as significant or not’ (p.373).   
 
Another limitation of the current study related to data analysis, was the 
reliance on visual analysis for the data related to diabetes self-management behaviour 
(e.g., frequency of SMOBG, dietary compliance, exercise).  Behaviour analysts have 
suggested that visual analysis of single-case data is generally reliable and 
conservative (Baer, 1977; Micheal, 1984; Parsonson & Baer, 1978; 1986), arguing 
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that visual inspection will reveal any intervention effects large enough to be important 
to clinicians, and that visual analysis yields low error rates (Huitema, 1986) and is 
conservative in identifying treatment effects (Baer, 1977), however the results of 
empirical studies (Franklin, Gorman, Beasley & Alison, 1996) suggest that this may 
not always be true.  The results of the current study should therefore by treated with 
caution as visual analysis was the sole means of interpreting the self-management 
data. 
 
A further limitation in the current study was that the participants were not 
randomly assigned to condition, instead nine consecutive referrals to received PE and 
then after the Nurse Educators had received training in MI, nine consecutive referrals 
received MET.  Thus, while there was a lack of random assignment, the intervention 
condition each participant received was not selected by the researcher. 
 
There was also a lack of control regarding phase change criteria which again 
arose as a consequence of conducting research within a natural clinical environment.  
For clinical reasons, baseline was set at a minimum of one week, with the move to 
intervention dependent the availability of both the participant and DNE in terms of 
scheduling intervention appointments. The move from intervention for the PE 
participants was determined jointly between the participant and the DNE, whereas the 
move from intervention for the MET participants was determined by time (i.e., the 
completion of four MET sessions, preferably conducted over six weeks).   This, 
therefore, limited the integrity of the design and interpretations which can be made. 
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Additionally, in some cases baseline data was limited (or non-existent), and it 
was not possible for clinical and ethical reasons (i.e., the participants were individuals 
who had been identified as already struggling with diabetes self-management and to 
have blood glucose levels which were of concern) to wait for stable baselines before 
the intervention was introduced as might be expected in single-case design.  This, 
therefore, further limited the conclusions that could be drawn.   Furthermore, the 
blood glucose levels obtained from the memory meters were highly variable which 
also made interpretation difficult.   This high variability within the data, while making 
interpretation difficult, reflected the reality of the clinical situation with considerable 
variability in data from self-monitoring of blood glucose.  At least using single-case 
methodology this variability was made evident rather than obscured.  HbA1c, 
however, was used as the primary means of measuring blood glucose data in the 
current study and is a well accepted measure of diabetes outcome.  Additionally, 
coefficients of variation (Fraser, 2001) were used in calculating delta (the maximum 
difference that is unimportant or can be dismissed on substantive grounds), to account 
for known biological variation in the blood glucose and lipid data. 
 
Conclusions 
 
Thus, the conclusions that can be drawn from the current study are highly 
tentative, however the conclusions that can be drawn, particularly regarding the 
generality of the results, are strengthened by the fact that it was a clinically-based 
study.  Thus, the external validity of the current study was strong because participants 
were recruited directly from a real-life clinical setting.   Additionally, exclusionary 
criteria were minimal (i.e., participants aged 16-69 years, and diabetes diagnosed for 
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at least 12 months).  Therefore, the participants (males and females, aged 21-68 years) 
in the current study are likely to be typical of persons who are experiencing difficulty 
with diabetes self-management, having been referred (typically by their GP) to the 
hospital-based secondary treatment centre because there were problems with diabetes 
self-management.  Specifically, their diabetes (Type 1 or Type 2) had been diagnosed 
for a mean of 10 years (range 1-21 years), and just under half were experiencing 
diabetes-related complications, ranging from recurrent vaginal thrush through to 
retinopathy, peripheral neuropathy and nephropathy.   Furthermore, the study was 
conducted in a hospital-based clinic setting. Appointment sessions were scheduled 
within usual clinic time, and clinic staff performed the interventions without extensive 
training (i.e. only two days training, plus supervision of audio-taped sessions for 
MET).   
 
In conclusion, while it is not proven, it appears that MET, conducted by usual 
clinical staff (i.e., DNEs) in a hospital-based clinic, has promise as an effective 
intervention to improve diabetes outcome (Hypothesis 1), through enhanced diabetes 
self-management (Hypothesis 2), particularly SMOBG, for individuals with diabetes 
(particularly Type 2 diabetes), and may have been more effective than the then current 
standard treatment of PE (Hypothesis 3).  There was also evidence that MET was 
well-received by the participants (Hypothesis 4), and there were no adverse effects 
from MET (Hypothesis 5), but rather that MET contributed to increased motivation 
(Hypothesis 6) and a decrease in concern about the seriousness of diabetes and worry 
about future complications.  Contrary to expectations, there was no evidence that PE 
contributed to improved knowledge about diabetes (Hypothesis 7).   
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STUDY 2: GENERALISATION 
 
Establishing the generality of single-case research is important if the findings 
of earlier studies are to be extrapolated to other individuals or to future contexts and 
circumstances (Barlow et al., 1984; Blampied, 1999).  One important aspect of 
generality within single-case research is concerned with whether an intervention that 
was successful with one individual will be successful with others (Kazdin, 1978).  As 
successful between-subject replications accumulate, it can be inferred that the 
intervention has generality over the range of individual variation represented by the 
participants (Hersen & Barlow, 1976).  A second important aspect of generality is the 
ability of a variety of practitioners/intervention agents to deliver the intervention.  
This aspect of generality is examined when the effect of MET provided by different 
health practitioners (e.g., dietitians compared to nurse educators) is studied.  This 
enables exploration of how variation in the type of practitioner impacts on outcome 
(Blampied, 1999).  In so doing systematic replication is being employed (Sidman, 
1960).   
 
The aim of Study 2, therefore, was to further evaluate the effectiveness of 
MET by testing whether the results achieved for MET in Study 1 could be generalised 
to another professional context, in this case dietetics applied to diabetes.  Study 1 
investigated MET provided by nurse educators, whose focus tends to be on improving 
diabetes self-management via behaviours such as SMOBG and medication use.  Study 
2, in comparison, investigated MET provided by dietitians, whose focus tends to be 
on diet and exercise as major contributions to diabetes self-management.   
 
  168
In summary, Study 2 tests for the generality of the earlier findings by testing 
for the effects on outcome of individual variation within participants, and the effects 
of variation of the health practitioner providing the intervention.  Specific hypotheses 
were that, similar to the results of Study 1, MET would lead to improved diabetes 
outcome (i.e., lower HbA1c and improved lipid profile) (Hypothesis 1) through 
improved diabetes self-management (which in Study 2 it was predicted would mostly 
comprise dietary changes) (Hypothesis 2), and would be more effective than PE 
(Hypothesis 3).  Additional hypotheses were that MET would be considered an 
acceptable intervention to participants (Hypothesis 4), and there would not be any 
adverse effects from MET on the participants’ adjustment to diabetes (Hypothesis 5), 
but that (based on the results of Study 1) there would be an improvement in the 
participants beliefs about the seriousness of diabetes after MET (Hypothesis 6).  It 
was also hypothesised that there would be an increase in motivation to change in 
MET participants (Hypothesis 7), and (based on the results of Study 1) that neither 
intervention would contribute to an increase in diabetes knowledge (Hypothesis 8). 
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Method 
 
 
Procedure 
 
Participants 
 
Patients (aged 16-69 years) who had been referred to dietitians at the Diabetes 
Centre (i.e., the same setting as in Study 1) for further assistance with managing their 
diabetes (Type 1 or Type 2), and who had been diagnosed with diabetes for at least 12 
months, were approached regarding participation in the study.  Participants were not 
randomly assigned to intervention.  All participants continued to receive TAU from 
their GP. 
 
Initially, seven consecutive individuals referred to the dietitians were 
approached regarding participation in the PE phase, all of whom agreed to participate, 
but one subsequently withdrew (a female Caucasian, aged 48 years, with Type 2 
diabetes) agreed to participate, but failed to attend scheduled appointments with the 
Dietician and so was withdrawn from the study (Table 23).  Thus, six participants 
participated in the PE phase.  They all had Type 2 diabetes (Table 23).  Three were 
male and two female, with ages ranged from 38-69 years.  One PE participant was 
Maori, with the rest being Caucasian.   
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Table 23.  Characteristics of participants 
 
  Declined Withdrew Completed 
Diabetes PE    
 Type 1 
Type 2 
0 
0 
0 
1 
0 
6 
Gender Male 
Female 
0 
0 
0 
1 
3 
3 
Ethnicity Maori 
Caucasian 
 1 
0 
1 
5 
Age (years) Mean 
Range 
 
 
48 
 
48.6 
38–69 
Diabetes MET    
 Type 1 
Type 2 
0 
0 
0 
2 
0 
5 
Gender Male 
Female 
0 
 
1 
1 
2 
3 
Ethnicity Maori 
Caucasian 
 0 
2 
0 
5 
Age (years) 
 
Mean 
Range 
 
 
34.5 
32–37 
54 
36–63 
  
 
Once the intervention in the PE phase had been completed and the dietitians 
had received training in MET, seven further consecutive individuals referred to the 
dietitians were approached regarding participation in the MET phase, all of whom 
agreed to participate, but two subsequently withdrew - one because she had a young 
child and found it difficult attending appointments, and the other after experiencing a 
head injury.  Thus, there were five participants in the MET phase of the study. 
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All participants in the MET phase also had Type 2 diabetes, and were 
Caucasian (Table 23).  Two were male and three female, with ages ranging from 36-
63 years of age.  The participants who withdrew from the MET phase were 
Caucasian, aged 32 and 37 years of age, one of whom was male and the other female, 
both with Type 2 diabetes. 
 
Thus, the MET participants tended to be a little older (mean of 54.0 years) 
than the PE participants (mean of 48.6 years).  The MET participants also tended to 
have a slightly longer duration since diagnosis of their diabetes (Table 24).   
 
 
Table 24.  Duration (years) since diagnosis of diabetes 
 
Participants Mean (years) 
PE 4.6 
MET 6.8 
 
For more detailed description (i.e., reason for referral, diabetes complications, 
other health problems, medication and employment status) of PE and MET 
participants, and individual case descriptions see Appendix 12. 
 
Staff 
 
Two dietitians agreed to participate in the study, one of whom had practiced 
dietetics for one year following qualification, and the other for five years. 
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Intervention 
 
 Both interventions were similar to those in Study 1.  PE was the standard 
intervention provided at the Diabetes Centre at the time that this research began, and 
comprised the provision of information and advice about diabetes and diabetes self-
management, specifically diet and exercise.  As in Study 1, the duration, number and 
frequency of sessions were determined, according to usual clinic practice, by the 
dietitian in consultation with each participant however, PE typically comprised and 
initial appointment of 60 minutes, followed by 30 minute sessions, on a monthly 
basis.  MET was provided as in Study 1 (i.e., four 30-40 minutes sessions on weeks 1, 
2, 4 and 6). 
 
Training 
 
The dietitians received two days (12 hours) training in MET (as previously 
described in Study 1), and were provided with the manual (Appendix 1) which 
outlined key MI principles, strategies and techniques, and the process for MET.  
 
Design and Measures 
 
A non-concurrent multiple baseline design (Watson & Workman, 1981) across 
individuals was used.  Outcome measures and analyses were the same as for Study 1.  
Group comparisons using inferential statistics, however, were not used in Study 2 due 
to the small (i.e. PE n=6, MET n=5) sample size, so the focus for interpretation of 
Study 2 results was on clinically significant change.   
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Results 
  
As in Study 1, results will now be reported beginning with primary outcome 
measures (i.e., diabetes outcome, comprising HbA1c and lipids), followed by the 
intermediate process variables (i.e., diabetes self-management behaviour and 
psychosocial measures).  
 
 
Primary Outcome Measures: Diabetes Outcome 
 
Blood glucose 
 
HbA1c.  Changes in HbA1c are shown in Figure 24.  Four PE (Case 19, 21, 
22, and 24) and two MET (Case 25 and 28) participants had clinically significant 
decreases in HbA1c post-intervention.  Mixed results were obtained for the PE 
participants during follow-up, with two PE participants for whom there was little 
change in HbA1c (Case 19 and 24), one (Case 20) whose whom HbA1c improved, 
and the remaining three (case 21, 22, and 23) whom HbA1c experienced a 
deterioration in HbA1c over follow-up (Figure 24).  In contrast, all MET participants 
had clinically significant improvements in HbA1c during follow-up, and for the four 
participants for whom 12-month follow-up data was available the clinical significant 
decrease was present at 12-month follow-up.  The improvement for one (Case 26) of 
these MET participants, however, is more likely attributable to change in medication, 
rather than improved diabetes self-management (Figure 24).  It should also be noted 
that baseline data was not available for Case 29. 
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Figure 24.  Average blood glucose  
 
 Data from SMOBG.    Three PE participants (Cases 20, 21 and 24) did not 
engage in SMOBG at baseline, limiting the conclusions that can be drawn regarding a 
change in their self-monitored blood glucose over the course of the study.  Results 
from the remaining PE participants, however, were mixed (Figure 25).   
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Figure 25.  Self-monitored blood glucose level – PE 
  175
  
There was a decrease in self-monitored blood glucose during PE for two 
participants (Cases 19 and 22), with both obtaining blood glucose results within the 
target range. Yet, for another participant (Case 23), there appears to have been no 
change in self-monitored blood glucose level during PE.   
 
 
Only one MET participant (Case 26) did not engage in SMOBG at baseline 
(Figure 26), although baseline data were also limited for one other MET participant 
(Case 27).  The results, however, suggest that there was a downward trend in self-
monitored blood glucose during MET for two (Cases 28 and 29) of the MET 
participants, both of whom obtained blood glucose results in the target range.  
Furthermore, although the results fluctuated over time, both of these participants had 
lower self-monitored blood glucose at 12-month follow-up, with Case 28 obtaining 
results all within the target range. 
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Figure 26.  Self-monitored blood glucose level – MET 
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For Case 25 there appears to have been a downward trend in self-monitored 
blood glucose results in the middle stages of MET.  Yet, this was not maintained 
during the later stages of MET, or during 2-week and 6-month follow-up, although 
results at 3- and 12-month follow-up were lower (mostly within the target range) than 
at baseline. 
 
 Where there are sufficient data, it appears that MET may have contributed to a 
decrease in blood glucose as measured by SMOBG for at least two MET participants, 
which tended to be maintained during follow-up.  Overall, however, there were mixed 
results obtained for both PE and MET.   
 
Lipids 
 
Mixed results were also obtained for the PE participants’ lipids.  There were 
clinically significant improvements in lipids for three PE participants (Case 19, 20, 
and 21) post-PE, but a deterioration (Case 23), or little or no change (Case 22 and 24), 
in lipids for the other three PE participants (Figure 28-32).  The improvement in lipids 
was maintained for two of the participants (Case 19 and 20) during follow-up.  In 
contrast, all but one (Case 29), whose lipids were unchanged, of the MET participants 
had clinically significant improvements in their lipids post-MET (Figure 27-31).  
Three MET participants maintained the improvements in lipids at 3- (Case 26 and 27) 
and 6-month (Case 25) follow-up, and one (Case 26) participant had further 
improvements (especially in the risk ratio) over follow-up.  
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Figure 27.  Total cholesterol  
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Figure 28.  Triglycerides  
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Figure 29.  HDL cholesterol 
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Figure 30.  LDL cholesterol 
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Figure 31. Risk ratio  
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Intermediate Process Variables 
 
Diabetes self-management goals 
 
All PE and all but one of the MET, participants selected dietary compliance as 
their diabetes self-management goal (Table 25).  This is consistent with their referral 
to a Dietician, and is in contrast to Study 1 in which increased SMOBG was the most 
frequent goal.  Increased exercise was the next most frequent goal selected by both PE 
(n=2) and MET (n=3) participants, although three MET participants also selected 
weight loss as a goal. 
 
Table 25.  Diabetes self-management goal 
Goal PE MET 
Increase SMOBG 1 0 
Increase exercise 2 3 
Dietary compliance 6 4 
Regular eating 1 1 
Weight loss 0 3 
 
Dietary compliance.  The data do not support PE as a means of improving 
dietary compliance, with mixed results for PE participants (Figure 32).  The data 
suggest that two participants (i.e., Case 19 and 22) improved their dietary compliance 
during PE, although the improvement in dietary compliance does not appear to have 
been maintained beyond the end of PE. 
  180
Case 21
Day
0 50 100 150 200
0
20
40
60
80
100
Case 19
0
20
40
60
80
100
Case 20
C
om
pl
ia
nc
e 
(%
)
0
20
40
60
80
100
Baseline
Intervention
2wk follow up
3m follow up
6m follow up
12m follow up
Case 24
Day
0 100 200 300 400
Case 23
Case 22
 
 
Figure 32.  Self-management goal: dietary compliance – PE 
  
 
For two PE participants (Cases 23 and 24), however, dietary compliance 
appears to have deteriorated with PE.  The data are less clear for the remaining two 
PE participants (Case 20 and 21) due to inconsistent self-monitoring of food.  
 
Although Case 21 did not record her food intake during PE (or at 6- and 12-
month follow-up), there does not appear to have been any change in dietary 
compliance from baseline to 2-week and 3-month follow-up (Figure 32).  Case 20, on 
the other hand, did not self-monitor his food during baseline, so it is not possible to 
determine if there was an improvement in dietary compliance with intervention.  Yet, 
he began (although inconsistently) to record his food intake during PE and maintained 
this throughout follow-up, indicating that perhaps he was paying more attention to his 
food intake.  The data available suggest 50% or more compliance on five out of seven 
days recording occurred during PE, with compliance improving to 50% or more on all 
days in which recording occurred during follow-up.   
  181
 In contrast, the data suggest that MET may have contributed to improved 
dietary compliance (Figure 33).  Three (Cases 25, 26 and 29) of the four MET 
participants who selected dietary compliance as a goal appear to have improved their 
compliance during MET.  Furthermore, the improvements in dietary compliance 
appear to have been maintained (Case 29) or further enhanced (Cases 25 and 26) 
during follow-up.  
 
 Although Case 28 did not self-monitor her food intake during baseline, 
preventing conclusions being drawn regarding any changes in dietary compliance 
with intervention, that she commenced self-monitoring during MET is possibly an 
indication that she began to pay more attention to her diet during MET.  Self-
monitoring during follow-up indicates that there were improvements in dietary 
compliance from that achieved during MET up to 6-month follow-up.   
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Figure 33.  Self-management goal: dietary compliance – MET 
  
 Exercise.  The data also do not support PE as a means of increasing the 
participants’ exercise (Figure 34).  Although Case 23 appears to have been achieving, 
or exceeding, his exercise goal on approximately 50% of days at baseline, his 
bicycling appears to have decreased during PE.   He did not self-monitor his exercise 
during 2-week follow-up, but it appears that at 3-month follow-up his bicycling was at 
a similar level to as at baseline, and that at 6- and 12-month follow-up, his bicycling 
decreased to below baseline.  
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Figure 34.  Self-management goal: increase exercise 
 
 Case 24 did not regularly self-monitor her exercise, however, it appears from 
the data available, that at baseline and the early part of PE she was not walking for 
exercise, but in the later stage of PE, she was able to achieve her goal of walking once 
per day, although this increase does not appear to have been maintained during the 
remainder of PE.  Data during follow-up suggest that up to 6-month follow-up she 
was achieving her goal on approximately 50% of days, although at 12-month follow-
up her walking appears to have decreased to a similar level to baseline. 
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The effectiveness of MET as a means of increasing exercise is unclear (Figure 
34).  While baseline data suggest that Case 25 was achieving his goal of bicycling 
daily approximately 50% of days, the frequency of bicycling does not appear to have 
increased during MET.  Unfortunately he experienced a back injury on the third day 
of 2-week follow-up necessitating a change in goal to a daily walk for exercise.  He 
appears to have achieved this goal on most days during the 2-week follow-up period, 
and data at 3-month follow-up (during which the goal was to exercise daily by either 
walking or bicycling), suggest that he further increased his exercise.  Data at 6-month 
follow-up, however, suggest that the increase in exercise was not maintained, and 12-
month follow-up data were not available. 
 
Self-monitoring indicates that Case 27 was exceeding her goal of engaging in 
water-based exercise twice per week at 6- and 12-month follow-up, but that prior to 
this (i.e. baseline through to 3-month follow-up) she was not engaging in this type of 
exercise. Therefore, it is unclear if the increase in exercise was due to MET or some 
other factor that came into play by 6-month follow-up.  
 
Case 28 did not record her exercise during baseline, so conclusions regarding 
any changes in exercise from baseline cannot be drawn.  Yet, she did start recording 
her exercise during the earlier stages of MET, which perhaps suggests that this at least 
became more of a focus for her.  The data collected suggest that during MET she was 
approximating her goal of walking six days per week.  Unfortunately, she did not 
continue to record her exercise, so it is unclear as to what happened for the remainder 
of MET.  Data at 2-week, 3- and 6-month follow-up, however, suggest that she was 
continuing to maintain the increase in exercise at the target level.  
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Regular eating.  The data also do not support PE as a means of increasing the 
regularity of eating (Figure 35).  Case 19 appears to have already been achieving his 
goal of eating regularly (i.e., six times per day) during baseline on approximately 25% 
of days, although there was considerable variability (range 0-7) in the number of 
meals/snacks per day.  During PE, however, there appear to have been only two days 
in which he achieved his goal, although there appears to have been some reduction in 
the variability of the number of meals/snacks per day during PE.  It is unclear what 
occurred beyond PE as self-monitoring did not occur during follow-up, with the 
exception of four days at 12-month follow-up in which the number of meals/snacks 
appears to have increased to near target. 
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Figure 35.  Self-management goal: regular eating  
 
Unfortunately Case 28 did not record her eating during baseline, so 
conclusions as to the effect of MET on increasing the regularity of eating cannot be 
drawn (Figure 35).  Yet, she did commence self-monitoring her eating during MET, 
which suggests that she at least may have started paying more attention to her eating, 
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although the number of meals/snacks consumed per day was less during follow-up 
than during MET, suggesting that any improvements may not have been maintained.   
 
Weight loss.  Three MET participants also selected weight loss as one of their 
goals.  While the lack of multiple data points does not enable a true single-case design 
analysis, the results were still graphed for analysis (Figure 36).  The data suggest that, 
as in Study 1, MET did not have any significant effect on the participants’ weight, 
with all participants’ weights remaining fairly stable over the course of the study. 
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Figure 36.  Self-management goal: weight loss 
 
 
Increase SMOBG.  Case 21 also had the goal of increasing SMOBG to four 
times per day, which she appears to have achieved during PE (Figure 37).  SMOBG 
increased from no testing at baseline and in the earlier stages of PE to approximately 
50% of days during PE.  This increase was maintained at 2-week follow-up, with 
further increases in the frequency of SMOBG at 3-, 6- and 12-month follow-up. She 
achieved the goal of testing four times per day on more than 50% of days at 3-month 
follow-up, but did not achieve this goal at 6-month follow-up, and achieved this less 
frequently at 12-month follow-up. 
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Figure 37.  Self-management goal: increase SMOBG  
 
 
 
Psychosocial measures 
 
PMDI.    Most of the PE participants considered PE to be as effective as the 
TAU they received at baseline (n=4), with one participant considering PE more 
effective, and one participant (Case 19) considering PE less effective, than TAU at 
baseline (Table 26).  Two participants (Case 22 and 24), however, considered PE 
more effective than the TAU they received at 12-month follow-up.  In contrast, two 
MET participants (Case 25 and 26) considered MET more effective than the TAU 
they received at baseline, with the remainder considering both interventions similarly 
effective (Table 26).  All, but one participant (Case 28) considered MET as effective 
as the TAU they received at follow-up.   
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Table 26.  Clinically significant change on the PMDI, PAID and DKT – PE and MET 
 
 
 PMDI PAID DKT 
 Treatment Effectiveness Seriousness     
 Post 12 month Post 12 month Post 12 month Post 12 month 
PE         
Case 19 +2.77    +5.84 -4.43  +6.59 
Case 20     +3.02  +2.56  
Case 21         
Case 22  -3.09 +3.02 -2.01 +2.82 -2.62  -2.56 
Case 23  +3.93   -3.83 -2.42  +3.84 
Case 24 -5.49 -7.32 +2.01 -2.01  +4.23   
MET         
Case 25 +4.39  +2.01      
Case 26 +2.28   -2.01  -2.42  -2.75 
Case 27    -3.52 -4.53   +2.56 -2.56 
Case 28  +3.42  -5.03 -8.06 -7.65   
Case 29     -3.22 -4.23   
+ =clinically significant increase in score (i.e., RC>1.96) from baseline 
 - =clinically significant decrease in score (i.e., RC>1.96) from baseline 
NB: empty cell means there was no clinically significant change in the score from baseline 
 
 
 
For most PE (n=4) and MET (n=3) participants, their concern about the 
seriousness of their diabetes did not change post-intervention (Table 26).  At 12-
month follow-up, however, three of the MET participants (Case 26, 27 and 28) 
showed a decrease in concern, whereas there was no change in concern for all the PE 
participants.  
 
 
 
PAID.  Three PE participants (Case 19, 20 and 22) experienced a deterioration 
in their emotional adjustment to diabetes post-PE, whereas two MET participants 
(Case 28 and 29) experienced an improvement in their emotional adjustment to 
diabetes post-MET (Table 26).  Additionally, at 12-month follow-up three MET 
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participants’ (Case 26, 27 and 28) emotional adjustment to diabetes showed an 
improvement from baseline, whereas this was the case for only one PE participant 
(Case 23), with most (n=4) PE participants’ emotional adjustment remaining 
unchanged.  
 
DKT.  Only one participant from PE (Case 20) and MET (Case 27) had an 
increase in knowledge about diabetes post-intervention, with no change in diabetes 
knowledge for the remaining participants (Table 26).  Whilst at 12-month follow-up 
one participant from PE (Case 22) and MET (Case 26) had a decrease in knowledge 
about diabetes from baseline, suggesting they had forgotten some facts about diabetes, 
two PE participants (Case 19 and 23) also had increased diabetes knowledge.  
Nevertheless, the majority of PE and MET participants showed little change in their 
knowledge about diabetes throughout the study. 
 
SOCRATES.  All, but one (who was in the maintenance stage of change), of 
the PE participants were in the action stage of change at baseline, suggesting that they 
were already engaging in behaviour change related to diabetes self-management.  In 
contrast, the MET participants were spread between the contemplation (i.e., 
ambivalent about behaviour change, n=1), preparation (i.e., ready to engage in 
behaviour change, n=2), and action (n=2), stages of change.  The motivation for 
change for three PE (Case 22, 23, and 24) and three MET (Case 27, 28 and 29) 
participants’ appears to have increased post-intervention, although one PE participant 
Case 19) appears to have become less motivated to change (Figure 38).  At 12-month 
follow-up, most (n=4) MET participants’ motivation was the same as post-
intervention, with one MET participant’s motivation to change increasing further 
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Case 27).  Three PE participants’ (Case 22, 23, and 24) motivation decreased at 12-
month follow-up and two PE participants’ (Case 19, 21) motivation increased at 12-
month follow-up.  
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Figure 38.  SOCRATES: Stages of change  
 
 
Treatment Credibility 
 
 Both interventions were rated highly overall by participants, with mean total 
credibility ratings on the TEI of 89% and 94% for PE and MET respectively (Table 
27).  This suggests that both interventions were considered to have high credibility.   
 
On only four items of the TEI (items 4-7) was MET rated less than six out of 
seven.  These items related to the risks associated with the treatment, how much the 
procedures were liked, how effective the treatment was likely to be, and how likely it 
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was to make permanent improvements.  In contrast, PE was rated less than six out of 
seven on all but two items (i.e., items 9 and 10, which relate to the discomfort 
experienced during the treatment and the participant’s general reaction to the 
treatment).  The lowest rating (score of 3) received was for PE on item 7, which 
relates to how likely the intervention was to help make permanent improvements. 
  
Table 27.  TEI: summary of results  
Mean Range Item 
PE MET PE MET 
1 5.500 6.800 6–7 6–7 
2 6.500 6.800 4–7 6–7 
3 6.333 6.800 4–7 6–7 
4 6.333 6.400 4–7 4–7 
5 5.500 6.600 4–7 5–7 
6 5.833 6.400 4–7 4–7 
7 5.667 5.800 3–7 4–7 
8 6.500 6.800 4–7 6–7 
9 6.833 7.000 6–7 7 
10 6.000 6.800 4–7 6–7 
Total 89%  94% 77-100% 81-100% 
 
 
Treatment Integrity 
 
All of the audiotapes reviewed by the independent rater, blind to condition, 
were accurately identified as either PE or MET sessions.  This is consistent with the 
findings of Study 1 and suggests that these were distinct interventions.  
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Resource Utilisation 
 
 Similar to Study 1, MET required more appointments than PE (Table 28).  The 
MET appointments also tended to be of longer duration than the PE appointments, 
although the difference between PE and MET does not appear to have been as large as 
in Study 1, with PE in Study 2 tending to be longer than that in Study 1 (MET mean 
of 38.9 minutes compared to PE mean of 22.9 minutes).     
  
Table 28.   Resource utilisation  
Appointment PE MET 
Total attended 2.714 4.000 
Duration (mins) 38.882 42.750 
Extra 1.667 2.2 
Missed 1.0 0.4 
 
 
 Again similar to Study 1, PE participants tended to miss more appointments 
than the MET participants (Table 28).  Unlike Study 1, however, MET participants 
appear to have attended more extra appointments during follow-up than PE 
participants (Table 28), although the extra appointments for the MET group were all 
attributable to only one participant. 
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Discussion 
 
Similar to Study 1, there were clinically significant improvements in diabetes 
outcome (HbA1c and lipids) following MET provided by dietitians (Hypothesis 1).   
The improvements in metabolic control, however, occurred during the course of 
follow-up, rather than immediately post-MET.  This is consistent with Hettema et al’s 
(2005) finding that the effect of MI may be delayed for behaviours such as diet and 
exercise due to ‘sleeper effects’ (i.e., effects which accumulate and take time to 
produce measurable change). 
 
PE participants also appear to have had improved blood glucose (i.e., HbA1c), 
and, to a lesser extent, improved lipids post-PE.  In contrast to the MET participants, 
the PE participants did not experience further improvements in metabolic control 
(HbA1c or lipids) over follow-up.   
 
These findings are similar to those reported by Burg et al (2007) who 
compared MI to usual care, both provided by dietitians with patients newly diagnosed 
with Type 2 diabetes and found that patients in both groups improved their saturated 
fat intake levels and HbA1c, with no significant difference between the groups.  The 
measures in that study, however, were obtained only up to 6-weeks post-intervention.  
It is possible, had Burg et al (2007) had extended their follow-up, that they may have 
found continued improvements for the MI group, given the results of the current study 
and Rubak et al’s (2005) meta-analysis of MI and disease which that the likelihood of 
finding an effect for MI increased with longer follow-up. 
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Also consistent with the findings of Study 1, there is evidence that MET led to 
somewhat improved diabetes self-management (Hypothesis 2), in this case via dietary 
compliance.  In contrast, the data do not support PE as a means of improving diabetes 
self-management.   
 
 The results of the psychosocial measures were also similar to the findings of 
Study 1.  Most PE participants considered PE as effective as the TAU they received at 
baseline and 12-month follow-up, whereas more mixed results were obtained for the 
MET participants. While some MET participants considered MET more effective than 
TAU at baseline, most considered MET as effective as the TAU they received at 12-
month follow-up.   Both interventions were also rated highly in terms of credibility 
(Hypothesis 4).  MET, however, was consistently rated (on TEI item scores) higher 
than PE. 
 
Most of the participants in both interventions experienced low to moderate 
levels of diabetes-related distress at baseline, with the exception of one MET 
participant who was near the diabetes burn-out range.  In contrast to Study 1, the 
MET participants’ emotional adjustment to diabetes appears to have either remained 
unchanged or improved (post-MET and at 12-month follow-up), whereas half of the 
PE participants experienced a deterioration in emotional adjustment to diabetes post-
PE (Hypothesis 6).   The reason for this difference in results between Study 1 and 2 is 
unclear. 
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The MET participants experienced a decrease in concern about the seriousness 
of diabetes and future complications (Hypothesis 6).  In Study 2, however, this did not 
occur until 12-month follow-up, whereas there was a decrease in concern post-
intervention for the MET participants in Study 1.  A possible reason for this 
difference is that due to the ‘sleeper effects’ of dietary change mentioned above, the 
participants in Study 2 may have experienced delayed improvements in diabetes 
outcome, and hence the decrease in concern about their diabetes was also delayed, 
compared to the participants in Study 1 for whom improvements in diabetes outcome 
were more immediately obvious post-MET.   
 
As in Study 1, there appears to have been a differential effect on readiness for 
change (as measured by the SOCRATES) with the two interventions.  All of the MET 
participants’ motivation to change either remained the same, or increased immediately 
post-intervention and at 12-month follow-up (Hypothesis 7), whereas some PE 
participants’ motivation decreased.   
 
Additionally, for both interventions, there was no clinically significant change 
in most participants’ knowledge about diabetes (DKT) in Study 2 (Hypothesis 8).  
This contrasts with the results of Study 1, which found that clinically significant 
increases in four of the MET participants’ knowledge about diabetes at 12-month 
follow-up.  
 
Thus, although the number of participants in Study 2 is small (n=6 for PE, n=5 
for MET), the results lend further support to the findings of Study 1.  In particular, the 
replication of the findings of Study 1 with dietitians conducting the intervention 
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provides evidence for the generality of the findings of Study 1.   Additionally, 
treatment integrity data suggests that MET was successfully applied by the dietitians, 
and again after relatively brief training, followed by supervised practice.   
 
The MET participants in Study 2 tended to have had diabetes diagnosed for a 
shorter duration, had lower baseline blood glucose and fewer diabetes-related 
complications than the MET participants in Study 1.   They also had different diabetes 
self-management goals, tending to focus on dietary compliance and increased 
exercise, compared to the MET participants in Study 1, who tended to focus on 
increasing SMOBG.   Thus evidence is provided that MET may effectively be 
provided by dietitians as well as nurse educators, and may be effective for individuals 
with varying histories of diabetes diagnosis, control and disease progression, and with 
a variety of self-management goals, in particular dietary compliance and increased 
SMOBG. 
 
As in Study 1, the conclusions that can be drawn from the current study are 
highly tentative for the similar reasons as in Study 1.  Specifically the limitations of 
Study 2 include the small sample size, variability in the goals for change selected by 
the participants and in the data within individuals, contributing to a lack of stable 
baseline data, lack of random assignment to condition and control over phase change 
criteria, and reliance on visual analysis of the data. 
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STUDY 3: EVALUATION OF TRAINING 
 
The aim of Study 3 was to evaluate the effectiveness of the MI training 
provided in Study 1 and 2.  This involved an evaluation of the effects on practitioner, 
and patient, within session behaviour after the practitioner’s had received MI training 
comprising a two day (12 hours) workshop and supervised practice.   
 
 Knowles (1973) developed a theory of adult education, based on four main 
assumptions, each of which have implications for psychotherapy training (Kalafat & 
Neigher, 1983), and appear to be consistent with MI theory.  The first assumption is 
that adults experience an increasing need to be self-directed, and when in situations in 
which they are not allowed to be self-directed, they react with resistance, which may 
interfere with learning.  Training should therefore actively engage adult trainees in the 
learning process using experiential approaches, and allow the trainees to adapt the 
new approach into their own style, rather than be passive-recipients who are required 
to conform rigidly to the new method. 
 
 The second assumption is that “as individuals mature, they accumulate an 
expanding reservoir of experience that renders them a rich resource for learning and 
provides them with a broadening base to which to relate new learning” (Kalafat & 
Neigher, 1983, p.97).  The trainer should therefore act as a facilitator (Rogers, 1969), 
who draws knowledge and skill out of the trainee, rather than as an instructor. 
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The third assumption is that training must take the adult’s readiness to learn 
into account, which requires attending to, or stimulating, the trainee’s motivation to 
learn, with the recognition that adults learn what they want or need, not necessarily 
what they ought to learn.  Furthermore, Knowles (1973) fourth assumption is that 
adults’ motivation to learn is problem-centred rather than content centred, so that an 
adults’ motivation to learning is based on a current problem they need to solve.  
Kalafat and Neigher (1983) point out that, as a result of this problem-centred focus to 
learning, practitioners tend to ‘have an applied, “show me the practical significance” 
attitude about training’ (p.97). 
 
Consistent with Knowles (1973) theory of adult education, research on the 
effects of training in psychotherapy provides evidence that training which involves 
active training elements such as practice (Froehle, Robinson & Kurpius, 1983; Hazler 
& Hipple, 1981; Iwata, Wong, Riordan, Dorsey & Lau, 1982), modeling (Kurpuis, 
Foehle & Robinson, 1980; Robinson, Kurpuis & Foehle, 1981) and feedback 
(Hosford & Johnson, 1983), is associated with changes in therapist behaviour 
(Bootzin & Ruggill, 1988).  This has been found to be true for more complex therapist 
behaviours (Alberts & Edelstein, 1990) as well as specific therapist techniques such 
as the use of open-ended questions, reflections, and basic interviewing skills (Froehle 
et al., 1983; Hazler & Hipple, 1981; Iwata et al., 1982; Robinson & Cabianca, 1985).   
 
 There is also evidence that training in a workshop format (i.e., intensive 
practice-based training) can be effective.  Milne, Keegan Westerman & Dudley 
(2000) found, after a brief in-service training programme in psychosocial 
interventions for severe mental illness for multidisciplinary mental health staff, that 
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there were positive changes in the participants’ clinical practice.  Similarly, Davis, 
Kvern, Donen, Andrews & Nixon (2000) found that a workshop for physicians on 
best practices in treating oestoporosis produced modest positive changes in the 
participants’ clinical practice after the workshop.  Additionally, Davis, Thompson, 
Oxman & Haynes (1992) in a review of continuing education for medical 
practitioners found that workshop based training was effective, particularly when the 
participant activity and feedback during the training was high.  Furthermore, DeViva 
(2006) found that a 3- and 6-hour workshop for graduate students preparing for health 
care careers and practicing health practitioners (e.g., social workers, medicine, 
nursing) on techniques for increasing resistant clients’ motivation were associated 
with significant change in participant behaviour in analogue role-plays immediately 
after training.   Additionally, there was no difference in the effects between the 
students and health practitioners, suggesting that expert knowledge or clinical 
experience may not be a necessary prerequisite for benefiting from continuing 
education workshops.  It should be noted, however, that the evaluation in these studies 
occurred soon after the training, so it is unclear as to whether the effects of training 
were maintained over time. 
 
Earlier studies evaluating the outcome of training in MI (Rubel, Sobell & 
Miller, 2000) and those that have used treatment adherence ratings to assess treatment 
integrity (Bien, Miller & Burroughs, 1993; Carroll, Kadden, Donovan, Zweben & 
Rounsaville, 1994) also support the effectiveness of  MI training.  The results of these 
studies suggest a change in therapist behaviour post-training consistent with MI.  
These studies, however, used only global ratings of MI consistent and MI non-
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consistent therapist behaviour, rather than measures of specific MI skills (e.g., 
frequency and type of reflections). 
 
These results are supported by more recent studies (Brug et al., 2007; Miller & 
Mount, 2001; Miller et al., 2004) evaluating the effectiveness of MI training using the 
MISC, which operationalises the principles of MI and includes specific behaviour 
counts of therapist and client within session behaviour (Catley et al., 2006).  These 
studies found that after training, comprising a two-day workshop on MI, health 
practitioners (probation counselors, alcohol and drug counselors, and dietitians) 
showed significant changes in their behaviour as therapists consistent with MI lasting 
up to eight months post-training, although Miller et al’s (2004) findings suggest that 
the maintenance of changes post-training is dependent on feedback and/or coaching 
being included post-training.   
 
In addition to demonstrating that there were positive changes in the 
practitioners’ behaviour post-training, Miller et al (2004) also provided evidence of 
client within-session behaviour consistent with MI theory four months post-training, 
with less resistance and more change talk.  This was only true, however, when the 
training was followed by feedback and/or coaching. 
 
In summary, there is evidence that, with two days training, practitioners are 
able to develop an understanding of the spirit and method of MI.  The effectivess of 
MI training as a means of promoting both practitioner and client behaviour change 
consistent with MI theory, however, is significantly increased by adding feedback 
(e.g., from audio-taped practice) and/or coaching (Miller et al., 2004).   
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Yet, few studies on the effectiveness of MI evaluate the integrity of the MI 
provided (Burke et al., 2004).  Miller, in a commentary on the Dunn et al (2001) 
meta-analysis (Rollnick, Miller, Heather, Longabaugh & Dunn, 2001), suggests ‘that 
appropriate assessment of MI practice is neccesary in studies on MI in order to 
explore the effects of “true” MI practice, and that direct monitoring of practice is the 
gold standard, since self-reports of MI practitioners are unreliable’ (Burg et al., 2007, 
p.11).  Additionally, as Dunn et al (2001) point out, without knowing what skill level 
is achieved through MI training, and the optimal training duration, it is difficult to 
estimate the cost-effectiveness of MI interventions.  
 
The current study evaluated the effectiveness of MI training provided in Study 
1 and 2, by evaluating the effect of MI training on both health practitioner and client 
behaviour in a real life clinical setting.   More specifically, this involved evaluating 
health practitioners’ responses to MI training and the knowledge they acquired as a 
result of the training.  Additionally, there was an evaluation of whether there was a 
change in the practitioners’ clinical practice (i.e., MI-consistent, use of specific MI 
skills), and whether this resulted in changes in the clients’ behaviour (e.g., less 
resistance, more change talk) within session. 
 
Specific hypotheses were that, with two days training plus supervised practice, 
involving feedback and coaching, the practitioners’ would be more patient-centred 
during MET (Hypothesis 1), and that there would be more collaboration (i.e., 
agreement) between the practitioners and participants when setting intervention goals 
during MET compared to PE (Hypothesis 2).   It was also hypothesised that the 
practitioners would demonstrate greater MI adherence (Hypothesis 3) during MET 
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and that this would be associated with more positive practitioner-client interactions 
within session (Hypothesis 4).  Specifically, it was hypothesised that the practitioners 
would ask more open questions (Hypothesis 3a), and use more reflective listening 
(Hypothesis 3b) and MI-consistent responses (Hypothesis 3c) during MET compared 
to PE.  Additionally, it was hypothesised that patients would show more signs of 
readiness to change (Hypothesis 4a), including engaging in increased frequency of 
change talk, and less resistance (Hypothesis 4b).   Furthermore, it was hypothesis that 
two days training in MI only (i.e., with no supervised practice) would increase the 
practitioners’ beliefs about the usefulness (importance) of MI to their work 
(Hypothesis 5), knowledge about MI (Hypothesis 6), and confidence in using MI 
(Hypothesis 7), but that the practitioners may not feel ready to practice MI without 
ongoing support in the form of supervised practice (Hypothesis 8).   
  
Method 
 
Procedure 
 
Participants 
 
Data collected in association with Study 1, involving the two DNEs, were used 
as part of Study 3.  Additionally, another 13 diabetes health practitioners subsequently 
received the same training in MET as provided in Study 1, and were also included in 
the evaluation of training.  The additionally health practitioners were seven DNEs, 
five dietitians and three podiatrists.  Of these, two specifically worked with Pacific 
Island People, two with Maori, and three with adolescents with diabetes.   
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Training 
 
 The training was similar to that conducted in Study 1 and 2, using the same 
trainers (i.e., two trainers experienced in training MI, one of whom was the author).  
The training was conducted over two days (12 hours total), and was consistent with 
‘adult education models (Kolb, 1984, Knowles, 1973; Reece & Walker, 1997) which 
reflect domains of learning, the importance of experiential learning cycles, and the 
need to match teaching strategy to specific learning objectives’ (Doherty et al., 2000, 
p. 265).  Hence, the training consisted of didactic teaching, modelling by the trainers, 
video-taped demonstrations, and role-playing (using everyday clinical experiences) 
with feedback.  A list of topics covered in the training is provided in Appendix 8.   
Additionally, the health practitioners were referred to Rollnick, Mason and Butler 
(1999) as a resource book.   
 
Considerable time was spent in training on the rationale for, and spirit and 
principles of, MI, with a view affecting cognitive change, such that there was a shift 
in practitioners’ perceptions about the importance of MI and whether if would be 
helpful and relevant to their practice.    Another main focus of the training was on 
developing reflective listening skills.  It was only after the practitioners had 
demonstrated increased proficiency in the basic skills of open-ended questions, 
affirmation, reflections and summarising, that any specific MI strategies were taught. 
 
 The process of training modelled the process (i.e., spirit, principles, skills and 
strategies) of MI, with the trainers conveying “a respect for and curiousity about the 
learning needs and perspectives” of the practitioners and facilitating a learning 
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environment that had “a collaborative, exploratory feeling” (Miller & Rollnick, 2002, 
p.186).  The training was also consistent with the guiding principles for MI training 
suggested by Miller and Rollnick (2002).  This included listening “to the experiences, 
concerns and expectations” (Miller & Rollnick, 2002 p.187) of the practitioners, 
expecting and tolerating disagreement and ambivalence, with focus on learning how 
to do MI (not just learning about it).   
 
Design and Measures 
 
 The design of the study permitted the evaluation of training in MET based on 
ratings for the clinical practice of the DNEs in Study 1, plus the additional health 
practitioners trained subsequently.  The additional data about the actual 
implementation of MET was available from the audiotapes collected and rated as part 
of Study 1.  This permitted the analysis of both therapist and client data obtained from 
the same two DNEs when providing PE and then subsequent to them being trained in 
MET.  In this context, therapist (and client) behaviour in PE constitute a baseline 
against which acquisition of MET skills can be compared. 
 
Treatment integrity 
 
In order to measure the consistency with which the therapists delivered the 
two interventions (PE and MET), they were trained to deliver, the independent rater 
from Study 1 rated one randomly selected audio-tape from each participant from 
Study 1 (i.e. PE: n=9, MET: n=9, total 18 audio-tapes) on the following scales: 
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Risk Factor Interview Checklist (RFIC).  A measure of patient-centred 
interviewing, with a focus on enhancing “the practitioner’s ability to reinforce the 
patient’s active participation in planning, initiating and maintaining adaptive lifestyle 
change” (Nolan, 1995, p.17A).  The RFIC was modified for the current study for use 
with diabetes and for rating of audio-tapes (Appendix 9).  The RFIC consists of 15 
items (two of which were omitted in the modification as they did not apply to the 
current situation), which cover factors included in medical school curricula on a 
patient-centred approach to clinical interviewing (Nolan, 1995).  Each item reflects a 
behaviour consistent with a patient-centred approach and is rated on a 3-point scale as 
1, not demonstrated; 2, partially demonstrated; or 3, fully demonstrated. 
 
MET Audit.  A rating scale to audit MET sessions (Sellman et. al., 1996) 
which was modified for use with diabetes (Appendix 10).  The MET Audit consists of 
10 items reflecting key MI skills and behaviour consistent with an MI approach.  Each 
item is rated on a 5-point scale in terms of how much it occurred, from 1 (not at all) to 
5 (extremely). 
 
As a reliability check, the author also rated the audio-tapes using the above 
scales.  Intra-class correlations (ICCs), using a two-way mixed effects model (Shrout 
& Fleiss, 1979), were calculated for item and total scores of each rating scale.  An 
ICC greater than .70 was considered acceptable reliability, with a coefficient of .40-
.59 considered moderate, .60-.79 high, and greater than.80 considered excellent 
reliability (Landis & Koch, 1977). 
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The ICCs for the total score on the RFIC and MET Audit were both greater 
than .90 (Table 29), suggesting excellent reliability between the two raters for the 
total score on these scales.  The ICCs for item scores suggested acceptable reliability 
(i.e., >.70) for eight of the thirteen items on the RFIC and seven of the ten items on 
the MET Audit (Table 29).  Of those items with an ICC less than .70, only one item 
on the RFIC (item 2) and MET Audit (item 9) obtained an ICC less than .40, 
suggesting less than moderate reliability.  These items refer to the patient being 
explicitly invited to collaborate in assessing their readiness to begin or continue with 
lifestyle change (RFIC item 2) and how much the practitioner actively explored non-
diabetes issues of the patient in depth (MET Audit item 9).   
 
Table 29.  Intra-class correlations – RFIC and MET Audit 
Item RFIC Met Audit 
 1 .51 .68 
 2 .35 .84 
 3 .70 .94 
 4 .79 .81 
 5 .86 .63 
 6 .95 .84 
 7 .85 .76 
 8 .74 1.00 
 9 .88 .23 
 10 .67 .74 
 11 .88  
 12 .47  
 13 .62  
 Total .96 .92 
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The frequency of ratings on individual items on both scales was calculated.  
Additionally, statistical tests on inferential confidence intervals (Tryon, 2001) for total 
and item scores were used to evaluate statistical difference and equivalence between 
PE and MET ratings.   
 
Therapy process  
 
The independent rater was also asked to code for type of resistance behaviour 
observed, or any signs of readiness to change (Appendix 11).   The frequency of 
occurrence of each type of resistance behaviour and signs of readiness for change 
(from the independent ratings) were then graphed.  Again, as a reliability check the 
author also recorded this and ICCs (two-way mixed effects model) were calculated to 
compare the two sets of ratings.   
 
There was also acceptable reliability for the total number of signs of resistance 
behaviour and of readiness for change (Table 30).  The reliability was also excellent 
for the signs of readiness across cases, but only moderate for the signs of resistance 
(Table 30).   
 
Table 30.  Intra-class correlations – signs of resistance and readiness to change 
       Resistance Readiness 
Individual cases             .44 .84 
Total .74 .97 
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Furthermore, all PE (n=22) and MET (n=36) audiotapes from Study 1 were 
transcribed and analysed using the MISC version 1.0 (Miller, 2000), a measure of 
proficiency in using MI, which also includes measures of client behaviour that are 
predictive of client behaviour change (Amrhein, Miller, Yahne, Palmer & Fulcher, 
2003).    The MISC is currently considered ‘the “gold standard” for measuring MI-
consistent behaviour’ (Burke et al., 2004, p.315). Madson and Campbell (2006), 
however, in their review of measures of fidelity in MI suggest that, while ‘the MISC 
appears useful for deconstructing the interaction between clients and therapists, 
further examination of the psychometric properties is needed’ (p.69). 
 
In the current study, only the Behaviour Counts (therapist and client) section 
of MISC was used.  Full MISC coding, which requires at least three passes through an 
audio-tape, requires considerable training time for raters as well as time performing 
the actual coding.   For example, Moyers, Miller and Hendrickson (2005) report that 
an average of 40 hours instruction was needed to achieve proficiency in rating with 
the MISC, and Tappin et al (2002) report that it can take up to four hours to evaluate a 
single sessions using the MISC.  Instead, in the current study, coders (i.e., two post-
graduate clinical psychology students, blind to condition) were trained to code the 
therapist and client behaviour according to the MISC using transcripts of each 
session.  Coding from transcripts, rather than the audio-tapes, facilitated consistency 
between coders as each client or therapist utterance and code was readily available for 
examination.  Thus, to maintain reliability of coding, the author reviewed the coding 
of one in six (i.e. 15%) of transcripts and any discrepancy in coding was discussed 
with the coder.  This approach of using transcripts to code MI practice using the 
MISC was also utilised by Brug et al (2007), although they only analysed transcripts 
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from the first 15 minutes of the audio-taped sessions and did not include client 
behaviour in their analysis. 
 
The following MISC summary scores were calculated from the behaviour 
counts: 
 
Ratio of reflections to questions.  The ratio of the number of reflective 
responses to the total number of questions asked. 
 
Percent open questions.  A ratio in which the numerator is the number of open 
questions asked, and the denominator is the total number of questions asked (open + 
closed). 
 
Percent complex reflections.  A ratio in which the numerator is the number of 
paraphrase + summarise reflections, and the denominator is the total number of 
reflections. 
 
Percent MI-consistent responses.  A ratio in which the numerator is the 
number of MI-consistent responses (MICO) and the denominator is the MICO plus 
MI-inconsistent responses (MIN).   
 
Percent client change talk (%CCT).  A ratio in which the numerator is the 
number of client change talk responses, divided by the sum of client change talk 
responses plus client resist change responses.  The total %CCT was calculated as well 
as the %CCT for each third of sessions as the absolute level of %CCT  is less 
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informative than the pattern of change in %CCT over the course of the session 
(Miller, Moyers, Ernst & Amrhein, 2003), with increasing %CCT over the course of a 
session associated with behaviour change. 
 
The MISC summary scores for PE and MET were graphed.  Additionally, 
statistical tests on inferential confidence intervals (Tryon, 2001) were used to evaluate 
statistical difference and equivalence between the DNE’s MICO and MIN behaviour 
during PE and MET.  Furthermore, the therapist behaviour counts were graphed for 
each DNE post-training (i.e., during MET), enabling evaluation of the DNE’s use of 
each of these key MI responses over time (i.e., with supervised practice and 
feedback). 
 
Lastly, data from the Goals for Change Checklist (GCC) from Study 1 were 
used to calculate the degree of collaboration (i.e., agreement on goals for change) 
between the DNE and participants.  For analysis, the percentage agreement over time 
for each DNE was graphed separately, thus creating a multiple-baseline design.   
 
Trainees’ ratings and knowledge 
 
The 13 diabetes health practitioners who received subsequent training in MET 
completed the following ratings pre- and post-training:  
 
Importance.  How important MET was for enhancing diabetes self-management 
on a 1-10 scale, with 1 indicating not important at all, and 10 indicating very 
important. 
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 Confidence.  Confidence in using MET on a 1-10 scale, with 1 indicating not 
confident, and 10 indicating very confident. 
 
Readiness.  Readiness to use MET on a 1-7 scale, with 1 indicating not ready, 4 
indicating unsure, and 7 indicating ready. 
 
These scales (Appendix 12) are a modified version of Rollnick et al’s (1999) 
rating scales for evaluating a person’s motivation to change.  In the current study, the 
scales are used to measure the health practitioners’ motivation to use MI.  Broers et al 
(2005) used these scales similarly as a measure of GPs’ confidence in using behaviour 
change counselling techniques (agenda setting, exploration of reasons for non-
adherence, information exchange, readiness and confidence rulers, brain-storming) 
after training, and found a statistically significant improvement in GPs confidence in 
their own skills after training. 
 
Additionally, the diabetes health practitioners were given a Motivational 
Interviewing Knowledge Test (MIKT) pre- and post-training.  The MIKT was 
developed for the current study to assess the knowledge about MI acquired during 
training (Appendix 13). 
 
Descriptive statistics of the results of each of these scales are reported, and 
inferential confidence intervals were used to evaluate statistical difference and 
equivalence between the pre- and post-training results.  
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Results 
 
Treatment Integrity 
 
Risk Factor Interview Checklist 
 
 The total scores derived from the independent ratings (total score) on the 
RFIC and MET were statistically different for PE and MET, with MET receiving 
higher ratings than PE (Table 31).  This suggests that when the DNE performed MET, 
their interviewing style was more patient-centred than when they performed PE.  This 
is consistent with MET being a patient-centred intervention. 
 
Table 31.  Independent ratings means, confidence intervals, and results of statistical tests  
 Mean 95% CI Different  Equivalent 
RFIC    Δ = 6.853 
PE 6.444 4.7001–8.188   
MET 8.444 16.856–20.033 * ns 
MET Audit    Δ = 6.730 
PE 18.7782 16.092–20.864   
MET 29.889 27.995–31.783 * ns 
Resistance    Δ = 1.665 
PE 3.667 2.936–4.395   
MET 2.778 1.716–3.840 ns ns 
Readiness    Δ = 1.295 
PE 1.111 0.5378–1.6844   
MET 2.556 1.9412–3.1704 * ns 
Δ = 1 standard deviation of PE and MET samples 
*=statistically significant at .05 level 
ns=not statistically significant at .05 level 
 
On no items on the RFIC were PE and MET statistically equivalent (Table 
31).  On five items (i.e., Items 5, 7, 9, 10, and 11), however, PE and MET were 
statistically different (Table 32).   
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Table 32.  RFIC item means, confidence intervals, and results of statistical tests 
 Mean 95% CI Different Equivalent 
Δ = 0.883 
Item 1: Style  facilitated patient understanding and comfort     
 PE 1.667    
 MET 2.000    
Item 2: Explicit invitation to the patient to collaborate      
 PE 1.111 -0.941–0.316   
 MET 0.333 -0.102–0.769 ns ns 
Item 3: Inquired about the patients objective for the interview      
 PE 0.222 0.220–0664   
 MET 0.778 0.133–1.423 ns ns 
Item 4: Opened questions to explore relevant issues      
 PE 0.667    
 MET 2.000    
Item 5: Occasional silence enabling the patient to reflect on issues 
related to lifestyle change 
    
 PE 0.556 0.091–1.021   
 MET 1.778 1.496–2.059 * ns 
Item 6: Periodic summary statements to clarify potential barriers 
or supports for change 
    
 PE 0.000    
 MET 1.778    
Item 7: Validated the patients feelings about health behaviours     
 PE 0.444 0.062–0.827   
 MET 1.889 1.713–2.065 * ns 
Item 8: Helped the patient view unsuccessful efforts to change as 
learning experience 
    
 PE 0.000    
 MET 1.000    
Item 9: Invited the patient to note issues that may not have been 
identified in the interview 
    
 PE 0.444 0.144–0.745   
 MET 1.444 1.079–1.809 * ns 
Item 10: Reviewed supports or barriers, and state change could be 
achieved in manageable steps 
    
 PE 0.556 0.282–0.829   
 MET 1.333 0.966–1.700 * ns 
Item 11: Expressed support for the patients freedom of choice     
 PE 0.222 -0.060–0.504   
 MET 1.444 0.980–1.909 * ns 
Item 12: Negotiated next step for counseling about change     
 PE 0.778 0.130–1.073   
 MET 1.333 0.950–1.716 ns ns 
Item 13: Verbally reinforced the patients efforts to discuss, 
prepare for, or initiate change 
    
 PE 0.778 0.416–1.140   
 MET 1.333 0.957–1.710 ns ns 
Δ = 1 standard deviation of item scores for PE and MET 
*=statistically significant at .05 level 
ns=not statistically significant at .05 level 
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The use of occasional silence so that the participant could reflect upon issues 
related to lifestyle change (Item 5) was fully demonstrated on all MET audiotapes. 
Yet, it was only partially, or not demonstrated, on all but one of PE audiotapes (Table 
32).  All, but one, of the MET audiotapes were rated as fully demonstrating the 
identification and validation of positive and negative feelings about health risk 
behaviours (Item 7).  In contrast, this was either partially or not demonstrated on all 
but one PE audiotapes (Table 32).  Before the end of the interview, an invitation to 
note personally relevant issues not identified in the interview was fully demonstrated 
on the majority (n=6) of MET audiotapes (Item 9).  This was not demonstrated on the 
majority (n=6) of PE audiotapes (Table 32).   The majority of MET audiotapes were 
rated as partially or fully demonstrating a review of supports and barriers, and a 
statement how change can be achieved in manageable steps (Item 10).  This was rated 
as occurring only partially or not at all on PE audiotapes (Table 32).  Similarly, there 
was partial or full expression of support for the participant’s freedom to make an 
informed choice about whether to proceed with a plan for change (Item 11) on all, but 
one, of MET audiotapes.  In contrast, this was either partially or not demonstrated on 
all PE audiotapes (Table 32).  
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Table 32.  Frequency of responses on RFIC items 
  Demonstrated  
 Not at all Partially Fully 
Item 1: Style  facilitated patient understanding and comfort    
 PE 0 3 6 
 MET 0 0 9 
Item 2: Explicit invitation to the patient to collaborate    
 PE 1 8 0 
 MET 7 2 1 
Item 3: Inquired about the patients objective for the interview    
 PE 8 0 1 
 MET 5 1 3 
Item 4: Opened questions to explore relevant issues    
 PE 4 4 1 
 MET 0 0 9 
Item 5: Occasional silence enabling the patient to reflect on issues related to 
lifestyle change 
   
 PE 5 3 1 
 MET 0 2 7 
Item 6: Periodic summary statements to clarify potential barriers or supports for 
change 
   
 PE 9 0 0 
 MET 0 2 7 
Item 7: Periodic summary statements to clarify potential barriers or supports for 
change 
   
 PE 6 2 1 
 MET 0 1 8 
Item 8: Helped the patient view unsuccessful efforts to change as learning 
experience 
   
 PE 9 0 0 
 MET 3 3 3 
Item 9: Invited the patient to note issues that may not have been identified in the 
interview 
   
 PE 6 2 1 
 MET 2 1 6 
Item 10: Reviewed supports or barriers, and state change could be achieved in 
manageable steps 
   
 PE 4 5 0 
 MET 1 4 4 
Item 11: Expressed support for the patients freedom of choice    
 PE 7 2 0 
 MET 1 3 5 
Item 12: Negotiated next step for counseling about change    
 PE 3 5 1 
 MET 2 2 5 
Item 13: Verbally reinforced the patients efforts     
 PE 4 3 2 
 MET 2 2 5 
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Statistical tests for difference and equivalence were not possible on four items 
(i.e., Items 1, 4, 6, and 8) as the lack of variance for either the PE or MET ratings 
meant that correlations, and hence the inferential confidence interval for dependent 
samples, could not be calculated (Table 31).  For example, all the MET audiotapes 
were rated as fully demonstrating a communication style that facilitated participant 
understanding and comfort (Item 1).  While the majority (i.e., n=6) of PE audiotapes 
also fully demonstrated this, a third were rated as only partially demonstrating such a 
communication style (Table 32).  The use of open-ended questions to explore relevant 
issues and facilitate the participant’s involvement (Item 4) was fully demonstrated on 
all MET audiotapes. In contrast, this was demonstrated either only partially or not at 
all on all but one PE audiotapes (Table 32).   All of the PE audiotapes were rated as 
not demonstrating periodic summary statements to clarify potential barriers or 
supports for change (Item 6).  This, however, was demonstrated fully on all but two 
MET audiotapes (Table 32).  Similarly, none of the PE audiotapes were rated as 
helping the participant view prior unsuccessful change efforts as important learning 
experiences (Item 8). In contrast, this was either partially, or fully, demonstrated on 
most (n=6) MET audiotapes (Table 32).  
 
PE and MET scores were statistically indeterminate (i.e., neither statistically 
different nor equivalent) on four items (i.e., Items 2, 3, 12, and 13; Table 31).  For 
example, the majority of PE and MET audiotapes were rated as not demonstrating an 
explicit invitation to collaborate in assessing readiness to begin or to continue lifestyle 
change at the beginning of the session (Item 2).  One MET audiotape, however, was 
rated as fully demonstrating this (Table 32).   Note, however, that the inter-rater 
reliability for this item was low, so these results should be treated with caution. 
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Similarly, most of the PE and MET audiotapes were rated as not inquiring 
about the participant’s objectives at the beginning of the session (Item 3).  This, 
however, was fully demonstrated on a third of the MET audiotapes (Table 32).   
Negotiation about the next step for counselling about change (Item 12) was fully 
demonstrated on five MET audiotapes, but was also not demonstrated on another two 
MET audiotapes.  This was either partially or not demonstrated on all but one PE 
audiotapes (Table 32).  Reinforcement of the participant’s effort to discuss, prepare 
for, or initiate change (Item 13) was fully demonstrated on five MET audiotapes, but 
was also not demonstrated on two MET audiotapes.  This was not demonstrated on 
four PE audiotapes, but was also fully demonstrated on another two PE audiotapes 
(Table 32).   
 
MET Audit 
 
 The total scores given by the independent rater on the MET Audit were also 
statistically different for PE and MET, with MET receiving higher ratings than PE 
(Table 33).  This suggests that the DNEs were using key MI skills during the MET 
sessions.   
 
PE and MET were statistically different (Table 33) on half of the MET Audit 
items (i.e., Items 3, 4, 6, 7, and 10).  For example, the majority of MET audiotapes 
were rated as eliciting self-motivational statements (Item 3) moderately to a lot, 
whereas self-motivational statements were not elicited on all but one of the PE 
audiotapes (Table 34).   
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Table 33.  MET Audit item confidence intervals and results of statistical tests 
 Mean 95% CI Different  Equivalent 
Δ=1.379 
Item 1: Session was actively directed by the therapist     
 PE 2.333 1.619–3.048   
 MET 3.222 2.885–3.559 ns ns 
Item 2: Session was focused by the therapist on the patient’s diabetes      
 PE 3.222 2.686–3.759   
 MET 3.778 3.534–4.021 ns * 
Item 3: Therapist elicited self-motivational statements      
 PE 0.111 -0.067–0.289   
 MET 2.383 1.871–2.796 * ns 
Item 4: Therapist used summaries     
 PE 0.444 0.097–0.792   
 MET 2.444 1.775–3.113 * ns 
Item 5: Therapist praised or affirmed the patient     
 PE 1.889 1.592–2.186   
 MET 2.333 1.453–2.714 ns * 
Item 6: Therapist gave advice, direction or education to the patient     
 PE 1.111 0.359–1.863   
 MET 2.444 1.922–2.967 * ns 
Item 7: Therapist used reflective listening     
 PE 1.111 0.789–1.433   
 MET 2.778 2.434–3.121 * ns 
Item 8: Therapist used dynamic interpretations     
 PE 4.000    
 MET 4.000    
Item 9: Therapist actively explored non-diabetes issues     
 PE 3.000    
 MET 4.000    
Item 10: Therapist style was empathic     
 PE 1.556 1.190–1.923   
 MET 2.556 1.983–3.129 * ns 
Δ=1 standard deviation of item scores for PE + MET 
*=statistically significant at .05 level 
ns=not statistically significant at .05 level 
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Table 34.  Frequency of responses on MET Audit items 
 
   Rating   
 Not at all A little Moderately A lot Extremely 
Item 1: Session was actively directed by the therapist      
 PE 0 4 1 1 3 
 MET 0 0 1 5 3 
Item 2: Session was focused by the therapist on the patient’s diabetes      
 PE 0 0 4 1 5 
 MET 0 0 0 2 7 
Item 3: Therapist elicited self-motivational statements      
 PE 8 1 0 0 0 
 MET 0 2 1 6 0 
Item 4: Therapist used summaries      
 PE 5 4 0 0 0 
 MET 0 2 2 4 1 
Item 5: Therapist praised or affirmed the patient      
 PE 0 3 4 2 0 
 MET 0 1 6 0 2 
Item 6: Therapist gave advice, direction or education to the patient      
 PE 0 2 1 2 4 
 MET 0 6 2 1 0 
Item 7: Therapist used reflective listening      
 PE 2 4 3 0 0 
 MET 0 0 4 3 2 
Item 8: Therapist used dynamic interpretations      
 PE 9 0 0 0 0 
 MET 9 0 0 0 0 
Item 9: Therapist actively explored non-diabetes issues      
 PE 0 2 1 1 5 
 MET 0 0 0 0 9 
Item 10: Therapist style was empathic      
 PE 0 5 2 3 0 
 MET 0 2 2 3 2 
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Summaries (Item 4) were either not used or used only a little on all PE 
audiotapes.  In contrast, summaries were used on all MET audiotapes, and were used 
a lot or extremely on five of these (Table 34).  Advice, direction or education was 
given (Item 6) during both PE and MET.  This, however, was rated as being provided 
a lot or extremely on the majority (i.e. n=6) of PE audiotapes, but only a little or not at 
all on the majority (i.e., n=6) of MET audiotapes (Table 34).   Similarly, reflective 
listening (Item 7) was rated as occurring a lot to extremely on five of the MET 
audiotapes (Table 34).  It, however, was rated as not occurring or occurring only a 
little on the majority (i.e., n=6) of PE audiotapes.   
 
While the DNEs style was rated as empathic (Item 10) during both 
interventions, the style was more empathic during MET than PE (Table 34).  On five 
MET audiotapes the DNEs were rated as a lot to extremely empathic, whereas they 
were rated as only a little empathic on five PE audiotapes.  
 
 PE and MET, however, were statistically equivalent (Table 33) on two MET 
Audit items (i.e., Items 2 and 5).  Both interventions were rated as focusing on the 
participant’s diabetes (Item 2), with all the MET, and the majority (i.e. n-=6) of PE, 
audiotapes rated as doing this a lot or extremely (Table 34).  
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Praise and affirmation (Item 5) were used similarly during PE and MET.  
While praise and affirmation was rated as occurring extremely on two MET 
audiotapes, it was rated as occurring moderately for the majority (i.e., n=6) of MET 
audiotapes, and a little to a lot for all PE audiotapes (Table 34).  
 
 Statistical tests for difference and equivalence were not possible for two items 
(i.e., Items 8 and 9) as the lack of variance meant that correlations, and hence the 
inferential confidence interval for dependent samples, could not be calculated (Table 
33).  There was no difference between PE and MET on Item 8 as dynamic 
interpretations did not occur during either intervention (Table 34).   
 
Non-diabetes issues (Item 9) were never actively explored during MET.  
These, however, were explored (a little to a lot) on four PE audiotapes (Table 34).   
Note, however, that the inter-rater reliability was low for this item, so these results 
should be treated with caution.  Lastly, PE and MET were statistically indeterminate 
(i.e., neither statistically different nor equivalent) on Item 1 (Table 33).  The session 
was actively directed by the DNE moderately to extremely on all MET audiotapes, 
and on five PE audiotapes (Table 34).   
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Therapy Process 
 
Resistance and readiness for change 
 
 Resistance behaviour in the form of arguing was not observed on any MET 
audiotape, but was observed on PE audiotapes (Table 35).   The arguing, which 
involved challenging (i.e., the participant directly challenged the accuracy of what the 
DNE said), was observed on five PE audiotapes.  Arguing in the form of discounting 
and hostility was not observed on either the PE or MET audiotapes. 
 
Table 35.  Number of sessions in which signs of resistance was observed 
 
Signs of resistance PE MET 
Arguing   
 Challenging 5 0 
 Discounting 0 0 
 Hostility 0 0 
Interrupting   
 Talking over 6 0 
 Cutting off 0 0 
Denying   
 Blaming 2 2 
 Disagreeing 2 2 
 Excusing 6 8 
 Claiming impunity 0 0 
 Minimising 1 1 
 Pessimism 5 5 
Ignoring   
 Inattention 1 0 
 Non-answer 1 0 
 No response 0 0 
 Side-tracking 2 1 
 
Similarly, resistance behaviour in the form of interrupting was not observed on 
any MET audiotapes, but was observed on PE audiotapes (Table 35), with 
interrupting by talking over (i.e., the participant spoke while the DNE was still 
  223
talking, without waiting for an appropriate pause or silence) occurring on the majority 
(n=6) of the PE audiotapes.  Interrupting in the form of cutting off (i.e., the participant 
breaking in with words obviously intended to cut the DNE off, e.g., “now wait a 
minute”, “I’ve heard enough”) was not observed on either the PE or MET audiotapes.  
 
Resistance behaviour in the form of denying, however, was observed, and for 
a similar number, on both PE and MET audiotapes (Table 35).  Excusing and 
pessimism were observed the most (i.e., n=5) on PE and MET audiotapes, with 
blaming, disagreeing, and minimising occurring on only one or two audiotapes from 
both interventions.   Denying in the form of claiming impunity (i.e., the participant 
claiming that s/he was not in danger from diabetes) was not observed on either the PE 
or MET audiotapes. 
 
Resistance behaviour in the form of ignoring was observed during both 
interventions (Table 35).  Ignoring, which involved sidetracking (i.e. the participant 
changing the direction of the conversation that the DNE had been pursuing), however, 
was observed on only one MET audiotape.  In contrast, ignoring, which took the form 
of sidetracking, inattention (i.e., the participant’s response indicated that s/he had not 
been following or attending to the DNE) and a non-answer (i.e., the participant gave 
no audible reply to the DNE’s query), was observed on four PE audiotapes. 
 
Signs of readiness for change were observed during both interventions (Table 
36).  Self-motivational statements, envisioning (i.e., the participant begins to talk 
about how life might be after a change, to anticipate difficulties if a change were 
made, or to discuss advantages of change), and experimenting (i.e., the participant 
reported they had begun experimenting with possible change approaches between 
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sessions) were observed on the majority (n=6) of MET audiotapes.  In contrast, self-
motivational statements and experimenting were observed less frequently (i.e., n=3) 
on PE audiotapes, and envisioning was not observed on any PE audiotape.    
 
Table 36.  Number of sessions in which signs of readiness for change were observed 
 
Signs of readiness to change PE MET 
Decreased resistance 0 0 
Decreased questions about the problem 0 0 
Resolve 1 1 
Self-motivational statements 3 8 
More questions about change 3 0 
Envisioning 0 7 
Experimenting 3 7 
 
Increased questions about change were observed (i.e., n=3) on PE audiotapes, 
but on none of the MET audiotapes.  Signs of readiness for change in the form of 
decreased resistance (i.e., the participant stops arguing, interrupting, denying, or 
objecting) and decreased questions about the problem were not observed on any PE or 
MET audiotape, and resolve (i.e. the participant appears to have reached a resolution, 
and may seem more peaceful, relaxed, calm, unburdened, or settled) was observed on 
only one audiotape from each intervention. 
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MISC behaviour counts 
 
Therapist behaviour.  Analysis of the transcripts shows that during PE there 
were 0.31 reflections to a question, whereas for MET the ratio of reflections to 
questions was higher at 1.17 reflections to a question.   Additionally, during MET 
sessions there were more open questions, complex reflections (paraphrasing and 
summarising), and MI-consistent responses than during PE (Figure 39).   
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Figure 39.  DNE use of key MI responses during PE and MET   
 
The DNE’s behaviour was statistically different for four of the six MI-
consistent responses (Table 37), with the DNEs providing advice with permission, 
emphasising control, and using open questions and reflections more during MET 
compared to during PE.  There was also a statistically significant difference on two of 
the five MI-inconsistent responses, with the DNEs providing advice without 
permission and directing or ordering the patient more during PE compared to during 
MET (Table 37). 
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Table  37.  MISC means (per minute), inferential confidence intervals, and results of statistical tests –  
                  MICO and  MIN responses during PE vs MET  
 
Therapist Behaviour Mean 95% CI Different Equivalent 
MI-consistent responses 
 
     Advice with permission 
 PE 
 MET 
 
 
 
.112 
.026 
 
 
 
.067–.156 
.017–.036 
 
 
 
 
* 
 
 
∆=.080 
           
           ns 
     Affirmation 
 PE 
 MET 
 
.375 
.219 
 
.256–.494 
.177–.260 
 
 
ns 
∆=.252 
 
ns 
     Emphasize control 
 PE 
 MET 
 
.022 
.080 
 
.011–.033 
.059–.102 
 
 
* 
∆=.060 
 
ns 
     Open questions 
 PE 
 MET 
 
.267 
.726 
 
.189–.344 
.629–.823 
 
 
* 
∆=.341 
 
ns 
     Reflections – total 
 PE 
 MET 
 
.661 
1.321 
 
.410–.909 
1.136–1.505 
 
 
* 
∆=.740 
 
ns 
     Reframe 
 PE 
 MET 
 
.020 
.342 
 
.004–.035 
.023–.045 
 
 
ns 
∆=.040 
 
ns 
     Support 
 PE 
 MET 
 
.169 
.086 
 
.104–.235 
.062–.111 
 
 
ns 
∆=.138 
 
ns 
MI-inconsistent responses 
 
   Advice without permission 
 PE 
 MET 
 
 
 
.281 
.106 
 
 
 
.165–.396 
.070–.142 
 
 
 
 
* 
 
 
∆=.218 
 
ns 
   Confront 
 PE 
 MET 
 
.047 
.030 
 
.025–.069 
.001–.060 
 
 
ns 
∆=.082 
 
* 
   Direct 
 PE 
 MET 
 
.256 
.054 
 
.160–.352 
.025–.084 
 
 
* 
∆=.185 
 
ns 
   Raise concern – without    
   permission 
 PE 
 MET 
 
 
.006 
.031 
 
 
.002–.013 
.007–.050 
 
 
 
ns 
 
∆=.045 
 
          ns 
   Warn 
 PE 
 MET 
 
.007 
.003 
 
-.002–.015 
.000–.005 
 
 
ns 
∆=.016 
 
* 
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Client behaviour.  During MET there was a greater percent of change talk 
overall (Figure 40).  Additionally, when the pattern of change talk was examined 
across session time, there was more change talk in each third of MET compared to 
PE, and the percent of change talk was highest in the last third of MET, whereas there 
was a decline in change talk in the last third of PE. 
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Figure 40.  Percent change talk during PE and MET sessions 
 
Collaboration 
 
Collaboration was low during PE.  For both DNEs agreement on the goals for 
change was 50% or less for all PE sessions, but one (in which 100% agreement was 
obtained; Figure 41).   Collaboration was higher during MET, with between 50-100% 
agreement on all sessions but two, and 100% agreement on more than 50% of 
sessions for both DNEs. 
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Figure 41.  Collaboration between DNE and participants 
 
 
Training 
 
Trainees’ Ratings and Knowledge 
 
Importance.  Prior to training some of the health practitioners were uncertain 
how important MET was for enhancing diabetes self-management (i.e. ratings ranged 
from 4-10 on the 1-10 scale, with 1=not very important, and 10=very important).  As 
a group, however, they considered that MET was important (Table 38).  Post-training 
results were statistically equivalent to pre-training (Table 38), but the range of scores 
narrowed (i.e. range of 8-10).  This suggests that the health practitioners continued to 
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consider MET important for improved diabetes self-management, but that those who 
were uncertain about the importance of MET prior to training shifted to considering 
MET as important post-training.   
 
Table 38. Confidence intervals and results of statistical tests - Importance, confidence, readiness, and 
knowledge  
 
Scale Mean 95% CI Different Equivalent 
Importance (1-10)    Δ = 1.97 
 Pre-training 8.308 7.411–9.205   
 Post-training 8.769 8.348–9.190 ns * 
Confidence (1-10)    Δ = 1.81 
 Pre-training 2.806 2.073–3.619   
 Post-training 5.000 4.186–5.814 * ns 
Readiness (1-7)    Δ = 1.79 
 Pre-training 4.231 3.465–4.996   
 Post-training 5.192 4.535–5.850 ns ns 
Knowledge (%)    Δ = 8.42 
 Pre-training 10.000 6.211–13.789   
 Post-training 53.077 45.524–60.630 * ns 
Δ = 1 standard deviation of PE and MET samples 
*=statistically significant at .05 level 
ns=not statistically significant at .05 level 
 
 
Confidence.  Pre-training the diabetes health workers had little confidence in 
using MET.  While still not high, post-training confidence in using MET increased, 
such that the pre- and post training scores were statistically different (Table 38).  
 
Readiness.  As a group the diabetes health workers were unsure as to whether 
they were ready to use MET at baseline.  This uncertainty, although still present post-
training, appears to have reduced (Table 38), with the pre- and post-training scores 
not statistically equivalent, but the difference was not large enough to reach statistical 
significance. 
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MI knowledge test   
 
Pre-training results suggest that the diabetes health workers’ knowledge about 
MI was low.  Post-training, however, their knowledge showed a marked increase such 
that, while their knowledge about MI as a group could still not be considered high 
post-training, the pre- and post-training scores were statistically different (Table 38).  
This suggests that they gained an increased understanding of MI as a result of the 
training. 
 
Training plus supervised practice and feedback (DNE performance only) 
 
Percent open questions.  After MI training, the percent of open questions used 
by Nurse A achieved beginning proficiency in 75% of sessions (Figure 42), reaching 
competence in one session (session two).   In contrast, the percent of open questions 
used by Nurse B was low (mostly below beginning proficiency) initially, but 
increased with supervised practice and feedback, such that the percent open questions 
was mostly (i.e., 71% of sessions) above beginning proficiency from session seven 
onwards (Figure 42), reaching competence in session 19.   
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Figure 42.  Percent open questions post-training (MET) 
 
 Both nurses did not consistently reach beginning proficiency for the ratio of 
reflections to questions in the initial (i.e., first four sessions) sessions post-training 
(Figure 43).  Yet, with supervised practice and feedback, the ratio of reflections to 
questions for Nurse B was above beginning proficiency from session four onwards, 
reaching competency in 25% of sessions.  Nurse A, however, took longer to achieve 
beginning proficiency for the ratio of reflections to questions, with this criteria being 
met on all but one session from session nine onwards, and reaching competence in the 
last session (session 16).    
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Figure 43.  Ratio of reflections to questions post-training (MET)  
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 Both nurses, however, achieved competence in the percent of complex 
reflections immediately post-training (Figure 44), with the exception of two earlier 
sessions (session five and six) in which Nurse A did not achieve beginning 
proficiency.  Furthermore, both nurses appear to have maintained this over time, with 
an upwards trend in the percent complex reflections over time for both of them. 
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Figure 44.  Percent of complex reflections post-training (MET) 
 
 Similarly, both nurses achieved beginning proficiency for the percent of MI-
consistent responses immediately post-training (Figure 45), with 67% and 75% of 
sessions in which this was achieved by Nurse A and B, respectively.  Competence, 
however, was achieved in only one session (session 12 by Nurse B). 
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Figure 45.  Percent on MI-consistent response post-training (MET) 
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Discussion 
 
The statistically significant differences between PE and MET total scores on 
the RIFC and the MET Audit suggest that the DNEs’ behaviour during PE and MET 
were qualitatively different.  This is consistent with the findings of Study 1 and 2 in 
which the independent rater, blind to condition, correctly identified 94% and 100% of 
sessions respectively, suggesting that PE and MET were qualitatively and 
distinguishably different interventions. 
 
The higher ratings that MET received on the RFIC are evidence that the DNEs 
were being more patient-centred (Hypothesis 1).  Specifically, during MET (in 
contrast to PE) the DNEs allowed occasional silence so that the participant could 
reflect upon issues related to lifestyle change; used periodic summary statements to 
clarify potential barriers or supports for change; identified and validated the 
participant’s positive and negative feelings about health risk behaviours; and tended 
to help the participant view prior unsuccessful efforts to change as important learning 
experiences.  Then, before ending the interview, they invited the participant to note 
personally relevant issues that may not have been identified during the interview; 
reviewed supports and barriers, and stated how change could be achieved in 
manageable steps; and expressed support for the participant’s freedom to make an 
informed choice about whether to proceed with a plan for change at that time. 
 
Consistent with the MET sessions being more patient-centred, there also 
appears to have been greater collaboration between the participants and the DNEs 
during MET compared to PE (Hypothesis 2).    Furthermore, the higher ratings MET 
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received on the MET Audit, compared to PE, suggest that the DNEs were not just 
being more patient-centred, but were also behaving in a way that was consistent with 
MI (Hypothesis 3).  In particular, they elicited self-motivational statements, used 
summaries and reflective listening, and were more empathic than during PE.  These 
are all key MI skills (Miller & Rollnick, 2002, 1991). 
 
While advice, direction or education were provided during both interventions, 
this occurred less frequently during MET compared to PE.  This again lends support 
to the integrity of the interventions as the provision of education is a primary goal of 
PE.  In contrast, the provision of advice, direction or education is not the focus of 
MET.   Instead, advice, direction or education may be given in MET, but when the 
participant is ready to receive it (i.e., with consideration of their readiness for change) 
and in small doses (Miller & Rollnick, 2002; 1991).   
 
During the MET sessions, the DNEs’ behaviour was also consistent with MI, 
as measured by the MISC.  There was a three-fold increase in the ratio of reflections 
to questions during MET.  They also used more open questions (Hypothesis 3a), 
complex reflections (Hypothesis 3b) and MI-consistent responses (Hypothesis 3c) 
during MET compared to PE. Furthermore, the ratio of reflections to questions and 
the percent open questions satisfied criteria for beginning proficiency in MI, and the 
percent complex reflections and MI consistent responses reached criteria for 
competent MI (Moyers, Martin, Manuel & Miller, 2005).   
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Furthermore, these changes in the DNE behaviour appear to have led to 
changes in the participants’ behaviour consistent with MI theory (Hypothesis 4).  
Participants during MET engaged in more change talk than participants during PE 
(Hypothesis 4a).   Additionally, MET participants engaged in more change talk 
towards the end of the sessions.  This latter finding is particularly significant as 
Amrhein et al (2003) found that client speech toward the end of session was the 
strongest predictor of behaviour change. 
 
Additionally, PE appears to have elicited active resistance in the form of 
arguing (challenging), interrupting (talking over), and ignoring (side-tracking), 
whereas these behaviours were not observed on the MET audiotapes (Hypothesis 4b).  
This is consistent with Patterson and Forgatch’s (1985) research which found that 
education elicited resistance, and is also consistent with MI’s goal of avoiding 
eliciting resistance.   
 
Resistance in the form of excusing or pessimism was observed similarly on 
both the PE and MET audiotapes.  This suggests that both groups of participants were 
similar with regards to their unwillingness to accept responsibility for their behaviour 
and their belief in the possibility of change, and therefore were likely to be equally 
difficult to engage in behaviour change.  That this type of resistance behaviour was 
observed on the MET audiotapes is not unexpected as part of the focus of MI is to 
openly explore barriers to change.  The primary focus of MET, however, is to elicit 
self-motivational statements.  Consistent with this, self-motivational statements, 
envisioning and experimenting were observed on all but one of the MET audiotapes, 
but on only three PE audiotapes.   
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While, in general, the health practitioners considered MET an important 
intervention to enhance diabetes self-management pre- and post-training, individuals 
who were uncertain about the usefulness of MET pre-training considered it important 
after training (Hypothesis 5).  Thus their uncertainty may have been due to a lack of 
knowledge or understanding about what MET involved, so that once they had gained 
a better understanding of MET, they too considered it an important intervention to 
enhance diabetes self-management. 
 
Training increased the practitioners’ knowledge of MI (Hypothesis 6) and 
their confidence in using MET (Hypothesis 7).  This statistically significant increase 
in confidence is similar to that achieved by Broers et al (2005) who provided two 4.5 
hour training sessions for GPs on behaviour change counselling, which included MI 
techniques.  Despite the statistically significant increase in confidence in the current 
study, the health practitioners’ confidence in using MI after the two days training was 
still low (i.e. mean of 5 out of 10, with 1 being not confident at all, and 10 being very 
confident).   Doherty et al (2000) report a similar finding, stating that, after a training 
programme in behaviour change counselling (which included MI) for diabetes health 
professionals, comprising monthly one hour workshops, fortnightly one hour 
individual supervision, and monthly one hour peer supervision over a six month 
period, ‘the perception of incompetence, came up repeatedly’ and that ‘six of the nine 
respondents reported that they were not very confident in their ability to facilitate 
behaviour change’ (p.268).   This suggests the importance of post-training supervised 
practice, which includes feedback on actual practice. 
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It should be noted, however, that the level of confidence in using MI in the 
current study appears higher after two days training than that reported by Doughty et 
al (2000).  Several factors may have contributed to these differing results.  The 
workshop based training in the current study was more intensive (i.e, twelve hours 
over two consecutive days versus one hour per month for six months), which may 
have allowed for greater skill development and consolidation.  While Doherty et al 
(2000) only have the practitioners self-report of their skill level post-training, rather 
than actual measure of their skill in clinical practice, their results suggest that the 
majority of the practitioners reported using ‘basic consultation skills’, such as patient-
centred summaries, but ‘fewer had acquired or used more complex competencies’ 
(p.268) and included MI in a list of topics about which they wished to receive more 
training.   
 
Additionally, while Doherty et al (2000) report that they utilised ‘adult 
education models’ (p.265) in their training, the greater time available for the initial 
training workshop in the current study, meant that more time would have been 
available for the training to have been conducted consistent with Knowles (1973) 
theory of adult education.  Thus, it is likely that the trainers in the current study would 
have had more opportunity to act as a facilitator (Rogers, 1969) drawing knowledge 
and skill out of the trainees, and to pay more attention to the trainees’ readiness to 
learn.  The training in the current study was also solely focused on MI, with the 
trainers modelling the spirit and practice of MI throughout the training. 
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Despite the increase in confidence in using MET in the current study, as a 
group, the health practitioners, however, were still feeling unsure as to whether they 
were ready to use MET post-training (Hypothesis 8).  Doherty et al (2000) also found 
that, despite their training programme, which included post-training individual and 
peer supervision, the diabetes professionals in their study also considered that they 
needed more time to develop the necessary skills for practice.  The findings of both 
these studies further suggest the importance of supervised practice post-training. 
 
Additionally, research suggests that upwards shifts in readiness are associated 
with shifts in the perceived importance of change (Rollnick, Morgan & Heather, 
1996).  If these results can be generalised to the case of the health practitioners in the 
current study, it would be expected that their readiness to use MET would be higher 
given that they considered MI important for enhancing diabetes self-management.  
Since their baseline ratings of importance were already high, however, it may be that 
increased confidence (and knowledge), through further training or ongoing support 
(i.e., supervised practice), would increase their readiness to use MET.   
 
Furthermore, there may be other barriers which were limiting their readiness 
to use MET.  Doherty et al (2000), for example, identified that “organisational issues 
such as balancing other commitments, covering for absent colleagues at short notice, 
managing overbooked clinics and concerns that longer consultations might result in 
longer waiting times” (p.268) as barriers to the implementation of behaviour change 
counselling in diabetes.  Future research needs to explore if these perceived barriers 
do exist and develop ways of overcoming or minimising any such barriers.   
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Yet, the current study provides evidence that, with supervised practice, the 
DNE’s were able to develop and practice MI skills to the level of at least beginning 
proficiency up to 12 months post-training.  This finding is again similar to that of 
Doherty et al (2000) who found that, while diabetes practitioners ‘found it difficult to 
resist informing or advising people rather than eliciting thoughts, feelings and patient 
generated plans’ (p.275), many were able to acquire change counselling skills by six 
months with training plus supervised practice.   
 
The findings of the current study are also consistent with Miller et al’s (2004) 
research on MI training, which suggests that post-training supervision (feedback 
and/or coaching) was necessary for significant and sustained (up to eight months post-
training) changes in practitioners’ behaviour.  Additionally, the current study found 
evidence of client within session behaviour (e.g., increased change talk) up to 12 
months post-training consistent with MI theory (Miller & Rollnick, 2002), which 
Miller et al (2004) also found, but only when training was combined with supervised 
pratice.    
 
The results for the DNEs in the current study, however, should be treated with 
caution as the DNEs were self-selected.  They volunteered to be involved in the 
research, knowing that it would involve learning MI and the expectation that post-
training they would utilise MI in their clinical practice, which would be audio-taped.  
It is therefore likely that they were motivated to learn MI and were willing to adapt 
their clinical practice.  The same results may not be achieved with health 
professionals who are less motivated to learn new skills and apply these in their 
clinical practice. 
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Conclusions 
 
 Diabetes is a chronic illness that requires ongoing medical care and patient 
self-management to prevent acute complications and to reduce the risk of long-term 
complications (American Diabetes Association - ADA, 2003).   In their guidelines for 
standards of care for people with diabetes the ADA (2003) recommended that all 
persons with diabetes attain and maintain recommended metabolic outcomes, 
including glucose and HbA1c levels; LDL cholesterol, HDL cholesterol, and 
triglyceride levels; blood pressure; and body weight.   They further recommend that all 
persons with diabetes improve health through healthy food choices and physical 
activity.  Thus, diabetes care is complex and requires that many issues, beyond 
glycaemic control, be addressed. 
 
In order to achieve this, the ADA (2003) recommends that a diabetes management 
plan be formulated as an “individualised therapeutic alliance” (p.s35) between the 
patient and his or her health practitioner(s), so that the individual with diabetes 
assumes an active role in his or her own diabetes care.  Thus, they suggest that patient 
self-management be emphasised; the plan emphasise the involvement of the patient in 
problem solving as much as possible; each aspect of the management plan is 
understood and agreed on by the patient and the health practitioner(s); and the goals 
and treatment plan are reasonable.   They also suggest that consideration be given to 
the individual’s personal and cultural preferences and lifestyle, and wishes and 
willingness to change.  
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 The ADA (2003) does not suggest any particular interventions by which the 
above recommendations might be met.  While PE continues to be the standard 
intervention for diabetes self-management, over the last 10-15 years, PE approaches 
to diabetes have developed to include patient empowerment, participation and 
collaboration (Norris et al., 2002).  The present research included an evaluation of PE 
in routine clinical care, which was provided within a patient participation and 
collaboration context, and also included behavioural counselling techniques, such as 
setting small achievable goals in routine clinical care, producing mixed results 
concerning the effectiveness of PE.   
 
The results of Study 1 suggest that there was no statistically significant 
difference in blood glucose following PE, although moderate (d=.62 post-PE) to large 
(d=.84 at 6-month follow-up) effect sizes were obtained.  Taken together, this 
suggests that while there appears to have been an effect, it is not possible to draw 
conclusions regarding whether PE produced the effect.  There was, however, a 
statistically significant decrease in triglycerides post-PE and at 12-month follow-up, 
again with moderate (d=.58, at 12-month follow-up) to large (d=.88 post-PE) effect 
sizes, suggesting that PE may have contributed to an improvement in this aspect of 
metabolic control.  The mechanism(s) by which this change was achieved, however, 
is unclear as there was a lack of evidence supporting PE as a means of promoting 
changes in diabetes self-management behaviour, with mixed results for PE, and there 
was no evidence of improved diabetes knowledge following PE.  There was, however, 
a statistically significant improvement in the PE participants emotional adjustment to 
diabetes, with a large effect size (d=.84) 12-months after PE. 
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MI appears to have potential as an alternative means of facilitating the APA’s 
(2003) recommendations for the diabetes management plan particularly for those 
individuals with diabetes who know what is required in terms of diabetes self-
management, but struggle with implementing and maintaining the necessary 
behaviour change.  MI provides a means of developing a collaborative relationship 
between the individual with diabetes and his or her health practitioner, which includes 
an exploration of the individual’s beliefs about diabetes, and the importance of 
behaviour change and metabolic control.  Additionally, MI provides a means of 
working with individuals who might otherwise seem unwilling to change. 
 
Indeed, Study 1 provides preliminary/tentative evidence that MI in the form of 
MET may be an effective intervention to improve diabetes outcome.  In Study 1, the 
mean decrease in HbA1c over the 12-month period after MET was .67%.  This is 
higher than the mean decrease (-.43%) in HbA1c reported in a recent meta-analysis of 
education and behavioural interventions for Type 2 diabetes (Gary et al., 2003).  
Additionally, the greatest improvement in blood glucose (i.e., -1.25% in HbA1c) 
occurred 6-months post-MET, whereas a recent meta-analysis of research on self-
management education for Type 2 diabetes found that the decrease in HbA1c tended 
to have been lost by 4-months follow-up (Norris et al., 2002).  Furthermore, the 
magnitude of this decrease in blood glucose was both statistically and clinically 
significant, with a large effect size (d=-1.0), and at a level consistent with that 
achieved in the DCCT and UKPDS, which was shown to decrease the risk of 
diabetes-related complications (DCCT Group, 1993; Turner, et al., 1996; UKPDS 
Group, 1998).   
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While there was no statistically significant decrease in blood glucose with PE, 
the mean decrease in HbA1c in the present research was -.70% which is also larger 
than that reported by Gary et al (2003) in their meta-analysis of education and 
behavioural interventions for Type 2 diabetes.  Additionally, the effect for PE in the 
present research was greatest (i.e., mean decrease in HbA1c of -1.28%) 6-months 
post-intervention, which is a longer effect than that found by Norris et al’s (2002) in 
their meta-analysis of self-management education for Type 2 diabetes.  In contrast to 
MET, any effects of PE in the present research, however, were lost by 12-month 
follow-up. 
 
The mean reduction in HbA1c after MET of .67% over 12 months also 
compares favourably with that reported in recent meta-analyses of psychological 
interventions (mostly comprising CBT) with Type 1 and Type 2  diabetes (Ismail et 
al., 2004; Winkley et al., 2006).  Ismail et al (2004), for example, report a mean 
decrease in HbA1c of .76% for psychological interventions for Type 2 diabetes, while 
Winkley et al (2006) report only a small (.22%) decrease in HbA1c for adults with 
Type 1 diabetes following psychological intervention.   The decrease in HbA1c of 
1.25% at 6-month follow-up in the present research is also comparable to the decrease 
(mean of 1.2%) in HbA1c obtained in other studies of MI with diabetes (Smith et al., 
1997; Viner et al., 2003; Channon et al., 2007). 
 
The results of the present research are more notable given that in these studies 
the MI and psychological interventions were typically much longer (i.e., mean MI of 
4.7 session, but up to 16 sessions, for up to 6-months, and a mean of 11 sessions for 
the psychological interventions) than the four sessions of MET provided in the present 
  244
research.  Additionally, the psychological interventions and MI were typically 
provided by specialist interventionists, such as psychologists, whereas the MET in the 
present research was provided by usual clinical staff.   
 
Even though the numbers in the present studies were small, statistically 
significant differences were found when group data were analysed, however.   In 
particular, MET participants had statistically significant decreases in diabetes 
outcome measures which are considered markers of an individual’s diabetes status 
and risk of experiencing complications from diabetes, with a statistically significant 
decrease in HbA1c at 6-month follow-up, and total cholesterol and LDL cholesterol at 
12-month follow-up.   
  
The MET participants also had a statistically significant decrease in the beliefs 
about the seriousness of diabetes post-intervention, with a moderate effect size 
(d=.62)  These results are similar to that of Knight et al (2006) who found shifts in 
illness perceptions following intervention comprising MI and externalising 
conversations for adolescents with Type 1 diabetes, such that they were ‘the 
consequences of diabetes were seen as having a less restrictive influence on their 
lifestyle than previously’ (p.149).    In the present research, the decrease in concern 
about the seriousness of diabetes after MET may have arisen from the participants 
successful attempts to change their diabetes self-management, leading them to be less 
concerned about the current seriousness of their diabetes, future complications, and 
the effect on their life.  Further research exploring these findings is recommended.   
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The above findings suggest that MET may be more cost-effective than 
intensive, specialist-based psychological interventions.  Additionally, the present 
research provides evidence that MI in the form of MET may be amenable to wider 
scale application, with usual clinical staff able to provide the intervention.  This, 
however, contrasts with the findings of two previous studies (Clark et al., 2004; 
Rubak, 2005) evaluating the effectiveness of MI as an intervention for diabetes 
provided by usual clinical staff, which found no statistically significant decreases in 
HbA1c.  The reason for this difference in findings is unclear, but may be a function of 
the MI training provided, as well as how MI was actually implemented, and the type 
of patients involved in the research.  Ongoing supervision of MI practice, for 
example, was not provided as part of the training package in either of these other 
studies. Additionally, there is evidence that the practitioners providing the MI 
intervention in both these studies tended to be technique focused, rather than 
focussing on the core skills and spirit of MI, which was emphasised in the present 
research.  Also, the present research targeted individuals who had been diagnosed 
with diabetes for some time (at least 12 months), and who had been identified as 
struggling with diabetes self-management.  It may, therefore, be that MI was more 
relevant to the participants in the present research, as they could be considered as less 
motivated for, or more ambivalent about, engaging in the necessary diabetes self-
management behaviours, whereas this was not the case in either of the other studies.  
The participants in Rubak’s (2005) study, for example, were individuals newly 
diagnosed with Type 2 diabetes.   Motivation may be not be as great an issue in the 
initial stages post-diagnosis, but may become more of an issue after the individual 
with diabetes has had more experience with the difficulties of maintaining the 
  246
necessary behaviour changes required for diabetes self-management.  It is 
recommended that future research explores when MI is most relevant and effective. 
 
This finding that MET was similarly effective as longer psychological 
interventions is consistent with wider research on MI, which has typically found MI to 
be as effective as other credible treatments (Burke et al., 2002, 2003, 2004).  In 
Project MATCH, for example, four sessions of MET was found to be as effective as 
12 sessions of CBT for alcohol dependence (Project MATCH Research Group, 1993, 
1997).  Rubak et al’s (2005) meta-analysis of MI with disease also found that the 
longer the follow-up the increased likelihood of finding an effect for MI.  This too 
appears to have bourn out in the present research, with the greatest effect at 6-month, 
rather than immediately post-intervention or at 3-month follow-up.   
 
In contrast to Rubak et al’s (2005) finding of only a small, non-clinically 
significant effect for MI on cholesterol, both interventions in the present research 
appear to have led to statistically (and clinically) significant improvements in 
cholesterol.  Following PE there was a statistically significant decrease in 
triglycerides, with a large effect size (d=-.89) post-intervention and a moderate effect 
size (d=-.58) at 12-month follow-up, whereas following MET there was a statistically 
significant decrease in both total cholesterol and LDL cholesterol at 12-month follow-
up, with large effect sizes (d=-.81 and d=-.79, respectively).  These results suggest 
that both interventions may have contributed to a decrease risk of macro-vascular 
complications associated with diabetes, but perhaps more so for MET (i.e., large, 
sustained effect over the 12-month follow-up). 
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 Additionally, Studies 1-2 provide evidence of the process of change, with 
changes in self-management behaviour (particularly SMOBG in Study 1 and dietary 
compliance in Study 2) with MET consistent with improved blood glucose and 
cholesterol.   Note, however, that SMOBG in itself would not be expected to produce 
changes in the metabolic data.  This suggests that the MET participants altered other 
aspects of their diabetes self-management (e.g., diet, exercise, medication) as a 
function of the information provided from SMOBG.   
 
Similarly, while the data did not support PE in terms of improved diabetes 
self-management, there was evidence of improved metabolic data.  This suggests that 
they may have altered some other aspect(s) of their diabetes self-management, other 
than that selected as the target for change.  This also leads to another important 
process finding in the present research – there appears to have been greater agreement 
between the practitioners and the participants in terms of the target behaviour for 
change with MET compared to PE.  Additionally, the targets for change selected by 
the participants during MET tended to be consistent with the specialisation of the 
practitioner.  SMOBG was the most frequent target for change when MET was 
provided by the DNEs (Study 1), and dietary compliance was the most frequent target 
for change when the dietitians provided MET (Study 2). 
 
Study 3 provides evidence that a minimum of two days (12 hours) training 
was required for diabetes health practitioners to gain increased knowledge and 
confidence in using MI, although both knowledge and confidence were still not high 
post-training.  It therefore appears that post-training supervised practice may be 
important for increasing MI skills.  Following two days training plus supervised post-
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training practice, the DNEs were able to practice MET in a manner that was 
consistent with the general principles of MI and satisfy criteria for at least beginning 
proficiency in MI.  Compared to PE, during MET they were more patient-centred, 
elicited more self-motivational statements, engaged in more reflective listening, with 
more complex reflections, and were more empathic.   It should be noted, however, 
that the DNEs self-selected into the research, and therefore were likely to have been 
highly motivated to learn MI.  The generalisability of these results is therefore 
unclear. 
 
The increase in reflective listening in the present research contrasts with the 
findings of Miller et al (2004) who found a reduction in MI-inconsistent responses 
(e.g. confrontation) rather than a substantial increase in reflective listening, and Miller 
& Mount (2001) who found a modest increase in reflections but no decrease in 
confrontational MI-inconsistent responses.  This may be a function of the different 
practitioners being studied as well the different settings in which they worked.  The 
practitioners in the present research were health professionals with minimal prior 
training in counselling and therefore had plenty of room to move in terms of 
development of reflective listening skills, whereas the practitioners in the other two 
studies had previous counselling skills and therefore were perhaps already utilising 
reflective listening.  Additionally, in the previous studies the practitioners were 
working in settings providing assistance for people with substance abuse problems 
(Miller et al., 2004) or in community probation services (Miller & Mount, 2001) in 
which a MI-inconsistent confrontational style might be more likely to occur, than 
perhaps in a health service providing care to persons with diabetes as in the present 
research. 
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The present research also provides evidence that the changes in the nurse 
educators’ behaviour may have led to changes in the participants’ behaviour during 
MET sessions consistent with MI theory.   For example, participants during MET 
exhibited less resistance and engaged in more change talk than during PE, and the 
frequency of client change talk increased during MET sessions but decreased during 
PE.  Furthermore, as recommended by Moyers et al (2005), the present research 
provides evidence that these in-session interactions were linked to post-intervention 
outcomes, with the participants who received MET making more changes in their 
diabetes self-management behaviour, with consequent improvements in diabetes 
outcome, than the participants who received PE.   
 
Additionally, all but one participant in Studies 1-2 who received MET (n=17) 
either had an increase in their motivation to change or their motivation, as measured 
by the SOCRATES, remained unchanged post-intervention.  In contrast, more than 
one third of participants who received PE had a decrease in motivation to change 
post-intervention.  As well as providing further support for MI, this finding is also 
consistent with previous research which found that advice-giving may lead to 
increased resistance (Patterson & Forgatch, 1985).    
 
MI theory would predict that advice-giving to individuals, particularly in the 
pre-contemplation or contemplation stage of change, may negatively impact on 
motivation (Miller & Rollnick, 1991, 2002).  The results from the present research, 
howevever, suggest that there was no particular stage of change which was more 
vulnerable to the deleterious effects of advice-giving on motivation.   
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Further research is needed on whether stages of change are useful in predicting 
when advice-giving may have a deleterious effect on motivation, or whether there is a 
stage of change when advice may be beneficial, as well as the best way of measuring 
motivation to change.   Answering these questions would enable health practitioners 
to be more targeted as to whom they give advice so that it can be maximally effective, 
and instead to focus on motivation to change for those individuals who are less likely 
to benefit from advice.   
 
Additionally, it appears that the process of MI, which included the nurse 
educators and participants working more collaboratively, led to targets for behaviour 
change which were more specific, realistic and achievable.  This may have resulted 
from the participants playing a greater role in setting the behaviour change targets and 
therefore setting targets that they considered achievable, as well as the health 
practitioners being encouraged to facilitate goals that were concrete, small and 
achievable.   Thus, the successful behaviour change outcomes with MET may have, at 
least in part, been due to the more realistic goals that were set.  It is unlikely, 
however, that the nature of the targets set was the only factor in the successful 
outcomes with MET, as MET was also superior to PE when less concrete goals (such 
as dietary compliance) were set. 
 
The two days of training, plus supervised practice of MET, appears sufficient to 
have enabled the nurse educators to increase their MI skills to the level of beginning 
proficiency for the ratio of reflections to questions, and competency for the percent of 
complex reflections and MI consistent responses.  Additionally, these changes in the 
health practitioners' practice appears sufficient to have led to improved self-
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management and in turn improved metabolic control.  It is unclear, however, whether 
further enhancement of their MI skills (e.g., to competency for the ratio of reflections 
to questions) through further training and/or supervision would lead to even greater 
improvements in diabetes self-management and diabetes outcome.   It is also unclear 
whether the addition of a booster session for participants, for example, 6-months post-
MET when the effects appear to have been waning, would have further enhanced the 
outcome.   
 
In their meta-analysis Hettema et al (2005) found there was an average training 
time of 10 hours, similar to the present research, with 29% of studies including post-
training supervision.  They, however, also found better outcomes for studies that did 
not include a manual to guide MI (i.e., d=.65 for studies with no manual compared to 
d=.37 for studies using a manual).   It may then be that the outcomes achieved with 
MET in the present research could be enhanced if a manual was not used.   It may, 
however, be that the manuals used in the studies reviewed by Hettema et al (2005) 
were overly prescriptive and therefore did not encourage individualised treatment.   A 
standardised manual-based approach to MI, if overly prescriptive, runs the risk of not 
adhering to the spirit of MI through losing sight of the individual client’s readiness to 
change which may fluctuate within session.   
 
The manual used in the present research was not prescriptive, but rather provided 
a summary of key MI skills and techniques, and strategies as a base from which the 
health professionals could add or remove elements dependent on the participants’ 
readiness to change and individual characteristics.  As well as this flexibility being 
important for good MI practice, Doherty et al’s research on change counselling in 
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diabetes “highlighted individual differences and the importance of tailoring any 
intervention to a person’s specific needs” (p. 266). 
 
A similar debate exists regarding standardised manual-based or individualised 
CBT (Kendall, Holmbeck & Verduom, 2004).  Some studies suggest the superiority 
of individualised interventions to standardised manual-based interventions (e.g., 
Ghaderi, 2006; Jacobson, Schmaling, Holtzworth-Munroe, Wood & Follette, 1989), 
but other studies suggest the superiority of manual-based interventions (e.g., Schulte, 
Kunzel, Pepping & Schulte-Bahrenberg, 1992; Emmelkamp, Bouman & Blaauw, 
1994).  Further research into the role, nature, and effect on outcome of manual-guided 
MI is recommended. 
 
Weaknesses of the present research 
 
The results of the present research should be treated with caution, however, as 
only a small number of participants were involved in the research.  This meant that 
the statistical analyses were limited by a lack of power.  Additionally, the high 
variability in the goals for change selected by the participants limited the number of 
replications.  The conclusions that can be drawn from the present research, especially 
regarding the generalisability of the results, should therefore be treated with caution. 
 
There was also a lack of random assignment to condition, although the 
condition was not selected by the researcher, instead it was based on consecutive 
referrals.  Additionally, for clinical reasons, it was not possible to wait for stable 
baselines, and lack of control regarding stage change criteria.  Furthermore, some of 
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the self-management data were highly variable, all of which limit the strength of the 
conclusions which can be drawn.  This variability, however, is presumably 
representative of the variability seen in real clinical experience.  This has implications 
for how research in diabetes self-management is developed and interpreted (i.e., care 
needs to be taken that observed change is not attributed to an intervention effect, 
when it may only be a function of the high variability in the data).  The present 
research used coefficients of variation as part of the statistical tests for the metabolic 
data (HbA1c and lipids), thereby accounting for biological variation (Fraser, 2001). 
 
A further weakness of the present research was the reliance on visual analysis 
as the sole means of interpreting the diabetes self-management data.   While it has 
been suggested that visual analysis of single-case data is generally reliable and 
conservative (Baer, 1977; Micheal, 1984; Parsonson & Baer, 1978; 1986), results of 
empirical studies (Franklin, Gorman, Beasley & Alison, 1996) suggest that this may 
not always be true.  The results of the current study should therefore by treated with 
caution.  
 
There was also a heavy reliance for the diabetes self-management behaviour 
on data gathered from self-monitoring.  There were few other sources of data 
available for some of the target behaviours, such as diet and exercise.  This, however, 
was not the case for all of the data.  In particular, the use of a blood glucose meter 
with a built-in memory provided an independent and reliable source of data on both 
the frequency of SMOBG and blood glucose level.   
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Additionally, a relatively crude measure of dietary compliance was used.  This 
comprised rating the participants' food records as to whether they were consistent with 
general recommendations for a diabetic diet, which is a diet that is low in sugar and 
fat, but high in fibre.  A full nutritional analysis of participants' food records would 
have provided a more thorough measure of dietary compliance.  A nutritional 
analysis, however, would have increased the demands on the participants' self-
monitoring, requiring them to be more detailed as to the ingredients and quantity of 
food consumed.  Such demands may then have reduced the frequency and reliability 
of self-monitoring. 
 
A possible confounding factor in the present research is that the interventions 
were not similar in terms of intensity, with MET tending to comprise more 
appointments, and appointments which were of longer duration than PE.  It could 
therefore be argued that the superior outcome for MET was simply due to the duration 
of intervention, rather than the specific nature of the intervention itself.  Treatment 
duration, however, is unlikely to be the sole factor leading to improved diabetes 
management, especially given the differential effect MET appeared to have on client 
change talk and resistance.    
 
Another confounding factor is that the participants in Study 1 were dissimilar 
at baseline, with MET participants tending to have a longer duration of diagnosis of 
diabetes, higher average blood glucose, and more diabetes complications.   Thus, the 
results for MET participants may have been overly inflated when compared to PE, 
with MET participants having more room for improvement than the PE participants.   
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It can also be argued, however, that the poor status of the MET participants' 
diabetes compared with the PE participants is evidence of their poor compliance.   
That the MET participants were able to make changes in their diabetes self-
management, with consequent improved metabolic control, after a relatively brief 
intervention, could be seen as evidence as to the power of MET.  Additionally, the 
participants in Study 2 were more alike at baseline, yet similar results were obtained 
in Study 2 as in Study 1, with results suggesting the superiority of MET over PE both 
in terms of improved diabetes self-management and improved metabolic control. 
 
Strengths of the present research 
  
While the numbers are small in the present research, evidence of the 
replicability (Part B, Study 1) and generality (Study 2) of the findings is provided.  
MET was found to improve diabetes outcome and enhance diabetes self-management 
and for patients aged 21-69 years of age with Type 1 and Type 2 diabetes who 
received MET from either a DNE (Study 1) or dietitian (Study 2), and for whom 
improvement in a range of diabetes self-management behaviours (e.g., SMOBG, 
dietary compliance) was a goal.   
 
In the context of working in a routine clinical service, and given the evidence 
of high variability in some of the dependent measures (especially data from SMOBG), 
the use of single-case research design also enabled the complexity of, and individual 
variability in, diabetes treatment to be accommodated, further strengthening the 
applicability of the findings to real-life clinical situations.  The use of single-case 
design enabled participants’ individualised targets for change to be included as 
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outcome measures, and allowed the consideration of other variables, such as 
medication changes, which may have influenced outcome.   
 
Additionally, the present research is consistent with the call for more practice 
based evidence in health care (Glasgow et al., 2006, Glasgow, Davidson, Dobkin, 
Ockene & Spring, 2006, Green & Glasgow, 2006, Tunis et al., 2003), and follows the 
recommendations for Practice-based Clinical Trials (PCTs) and Practice-based 
Behavioural Trials (PBTs) as suggested by Tunis et al (2003) and Glasgow et al 
(2006), respectively.  This meant that two clinically meaningful alternative 
interventions (i.e., PE and MET) provided by representative clinical staff were 
compared, with a heterogeneous sample.  Additionally multiple outcomes were 
assessed, including measures of behaviour change at the patient and clinician level; a 
variety of psychosocial measures; the degree of implementation of the intervention by 
clinical staff; generalisation across participants, intervention staff and outcomes; as 
well as cost (i.e., resource utilisation) and patient preferences.   
 
In order to do so a number of barriers for PCTs and PBTs as outlined by 
Glasgow et al (2006) had to be overcome.  In order to maximise generalisability, in-
house clinic staff provided the interventions.  This meant that the intervention and 
data collection needed to be planned to fit in with usual clinic practice.  The inclusion 
of clinical staff from the beginning of conceptualisation of the research using 
principles of PAR facilitated this.  As Glasgow et al (2006) point out, “the inclusion 
of clinical colleagues in target settings is critical….., not only because they can 
sabotage it (the research) if they are against it but also because they know their 
clientele and the logistics of working in their setting” (p.10). 
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Thus, the action research nature of the studies strengthened the applicability of 
the present research to the real life clinical situation.  It enabled the identification of 
the potential application of MI to diabetes self-management and made use of the 
interest the diabetes health practitioners had in learning MI skills.  A number of 
important questions were also identified with the diabetes practitioners, including the 
applicability of MI to their busy clinical situation, training and supervisory needs, the 
acceptability of MI to patients, and its effectiveness when applied to diabetes.  The 
research was then designed to explore these questions.  Additionally, when other 
opportunities arose to further explore these questions (e.g., the opportunity to run 
additional training with a larger number of health practitioners), these were built into 
the research. 
 
Another strength in the present research was that treatment integrity was 
evaluated, with results suggesting that PE and MET were distinct interventions, and 
that MET was practiced in a manner consistent with MI.   Very few studies examining 
the application of behaviour change interventions to diabetes self-management 
provide evidence that the health practitioners engaged in the research were employing 
the intervention in a consistent fashion (Doherty et al., 2000).  Additionally, Hettema 
et al (2005) in a meta-analysis of 72 MI treatment trials found only 36% of these 
studies included treatment fidelity checks.   
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Additional recommendations for future research 
 
The practice-based evidence for the effectiveness of MET and the use of PAR 
principles in the present research, contributed to the buy-in of clinical staff and 
management.  Thus, in the true nature of PAR (i.e., an ongoing cyclical process of 
reflection, planning, action, and evaluation) there have been discussions with the 
author regarding how the MET can be sustained and become part of routine clinical 
practice, which have raised more questions for future research.  These questions 
include whether the way MI was provided (i.e. in the MET format, with a limited 
number of sessions over a relatively short time period) is important for positive 
outcome, and how can greater numbers of health practitioners receive MI training 
plus the supervised practice which appears important for skills development and 
transfer into clinical practice (Miller et al., 2004). 
 
Future research also needs to explore whether the results obtained in the present 
research can be generalised to adolescents with diabetes or ethnic groups with a high 
incidence of diabetes, such as Maori and Pacific Island People in New Zealand.   
Although the inclusion age for the present research extended down to 16 years of age, 
the youngest participants were 21 years of age.   There were also no Pacific Island 
participants in the present research.  Additionally, while there were three Maori 
participants in Study 1, (one of whom was also a participant in Study 2 having 
received PE in Study 1), the results were mixed for these individuals.    
 
There is reason to believe that MI may be a useful intervention with Maori and 
Pacific Island People with diabetes.  For example, Hettema et al’s (2005) meta-
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analysis found greater ES for ethnic minority samples (d=.79) compared to Caucasian 
samples (d=.39).   This is also consistent with Longshore et al’s (1999) conclusion 
that MI was a "culturally congruent" (p.1223) intervention for African Americans 
because of its emphasis on personal choice, and avoidance of advice-giving and 
confrontation.     
 
Additionally, research with Pacific Island People with diabetes in New 
Zealand found that 22% felt uninvolved in their diabetes care (Paddison, Vae’au, Flett 
& Stephens, 2004) and that the ‘doctor-patient’ relationship was an important 
determinant of self-care and health outcomes (Paddison, Faimalie, Flett, Alpass & 
Stephens, 2004).  Given that diabetes is three times more common in Maori and 
Pacific Island People and their mortality rate in the 40-65 year age range is nearly ten 
times higher than for other New Zealanders (Ministry of Health, 2000), further 
research into MI applied to diabetes self-management with Maori and Pacific Island 
Peoples is recommended. 
 
Adolescence poses a particular challenge for diabetes management.  The 
failure of medication regimens to significantly improve metabolic control during 
adolescence has led to a focus on educational and psychosocial interventions to 
optimise treatment for adolescents with diabetes (Viner et al., 2003).   Hampson et al 
(2001), in a systematic review of educational and psychosocial interventions with 
adolescents with diabetes, however, found very small effect sizes, suggesting that 
existing treatments are not very effective for this group.   
As mentioned in the introduction, MI may be particularly suited to adolescents 
because of its emphasis on personal responsibility and avoidance of an authoritarian 
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stance.  MI has been used successfully with adolescents with substance abuse 
problems (Colby et al., 1998; Lawendowski, 1998), and Berg-Smith et al (1999) 
report positive results with brief MI focused on dietary adherence with adolescents.  
Additionally, Viner et al (2003) in a pilot non-randomised controlled trial report 
significant improvements in HbA1c 4-6 months post-intervention compared to no 
change in controls for adolescents with Type 1 diabetes who attended a group 
intervention which comprised MET plus solution-focused therapy.   It would therefore 
be useful to evaluate the efficacy of MET applied to diabetes self-management for 
adolescents with diabetes. 
 
Lastly, MET appears to have been a more expensive intervention (i.e., MET 
comprised more sessions and sessions of longer duration than PE), as well as the 
additional costs of training and supervision.  Doherty et al (2000) suggest that the 
extra costs associated with training and extra time with patients associated with 
behaviour change counselling in diabetes is not unreasonable if it can be justified with 
evidence, as in the present research, that change counselling leads to actual behaviour 
change, and subsequent clinically significant improvements in HbA1c, as well as 
improvements to quality of life. 
 
Working on the premise that most complications of diabetes can be delayed, it 
has been argued that the increased cost of interventions which delay the onset of 
diabetes itself or improve diabetes self-management can be expected to save more 
than they cost (Tuomilehto, Lindstrom, Eriksson, Valle, Hamalainen et al., 2001).   
Price Waterhouse-Coopers, in a report commissioned by Diabetes New Zealand (an 
independent association of individuals diagnosed with diabetes, and diabetes health 
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professionals), estimated that diabetes services in New Zealand cost $247 million a 
year (Breakthrough, 2001).  This figure does not include the costs of diminished 
productivity and quality of life.   Furthermore, Price Waterhouse-Coopers’ projections 
indicate that the total cost of diabetes can be reduced over 20 years if existing services 
are increased (Breakthrough, 2001).  Under their enhanced services model, if funding 
was increased and provided for specific and targeted services (MET being a possible 
example), the predicted outcome over 20 years would be an improvement in the 
health of those diagnosed with diabetes, with a reduction in diabetes-related 
complications.  Thus, the savings from fewer severe complications in later years 
would offset the additional spending in earlier years (Breakthrough, 2001). 
 
“We, people with diabetes, are a group of individuals who are unique one from 
the other.  The only thing we have in common is our diabetes and even that 
might be a different type or might behave differently...; but all of us want to live 
a good quality life.  It is not for you, health professionals, to provide this quality 
of life.  You cannot do this for us.  We have to do it for ourselves.  You can 
counsel us with information and advise but it is for us to act and achieve...We 
need for all health providers to know that the world is changing and the way 
medicine is provided is changing as well.  Chronic disorders like diabetes 
require the active participation of the affected individual to achieve good 
results.  Many people with diabetes are beginning to awaken.  We no longer 
want to sit on the other side of the desk, quietly nodding our heads.  From 
patients we have become actors.  We have become more demanding and 
understand that our health is in our hands...We have to awaken health 
professionals who stubbornly insist to act like judges and dictators to become 
counselors and partners.” (De Alva, M., 2000).   
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Appendix 1: Description of Study 1 participants 
 
Reason for referral 
 
 PE and MET participants had similar reasons for referral to the DNE (Table 
38), with assistance with diabetes management being the main reason for referral.  
Compliance was specifically mentioned as a problem for one PE and two MET 
participants, and problems with blood glucose control was mentioned for three PE and 
two MET participants.  GPs were the most frequent referral source (Table 38), 
although more MET participants were referral from a Diabetes Physician. 
 
Table 38.  Summary of referral information  
  
 PE MET 
Reason   
Assistance with diabetes management 5 5 
Compliance problem 1 2 
High blood glucose control 3 2 
Source   
GP 6 5 
Diabetes physician 2 4 
Other physician 1 0 
 
 
 
Diabetes Complications 
 
 MET participants experienced more diabetes complications than the PE 
participants (Table 39).  This suggests that their blood glucose is likely to have been 
higher than the PE participants, but may also reflect the longer duration since 
diagnosis of diabetes for the MET participants. 
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Table 39.  Diabetes complications experienced by participants 
Complications PE MET 
Retinopathy 4 2 
Peripheral neuropathy 0 3 
Peripheral vascular disease 0 3 
Nepticopathy 0 1 
Infections 1 0 
Nil 4 4 
 
Other health problems 
 
 PE and MET participants, however, were fairly similar in the other health 
problems they experienced (Table 40), with heart disease and asthma the most 
frequent health problem experienced by participants in addition to diabetes.  While 
MET participants were experiencing more diabetes-related complications, more PE 
participants tended to experience multiple health problems (i.e. had more than one 
health problem in addition to diabetes).   
 
Table 40.  Other health problems experienced by participants 
 
Health problem PE MET 
Hearth disease 2 3 
Chronic pain 2 0 
Psychiatric disorder 0 0 
Epilepsy 1 0 
Asthma 3 2 
Sleep apnoea 1 0 
Nil 3 4 
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Medications 
 
 The majority (n=7) of PE participants were prescribed oral medication for 
their diabetes (Table 41), with only two PE participants prescribed insulin (one in 
combination with oral diabetes medication) for their diabetes, which is consistent with 
most PE participants’ diagnosis of Type 2 diabetes.  Six MET participants, however, 
were prescribed insulin for their diabetes (Table 41).  This in part is due to more (i.e. 
n=4) MET participants being diagnosed with Type 1 diabetes, but also suggests the 
worsening status of some of the MET participants’ Type 2 diabetes.  A small number 
(i.e., PE n=3, MET n=2) of participants were prescribed lipid-lowering medication 
(Table 41).  No participants were prescribed no medication at all, with a number of 
participants also prescribed a number (i.e., PE n=6, MET n=4) of other medications 
(Table 41). 
 
Table 41.  Summary of participants’ medications 
 
Medication PE MET 
Oral diabetes 7 3 
Insulin 1 6 
Combined insulin and oral diabetes 1 0 
Lipid lowering 3 2 
Antithypertensive 1 1 
Other 6 4 
Nil 0 0 
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Employment 
 
 PE and MET participants were similar in their employment status (Table 42), 
with only one PE and MET participant in receipt of welfare assistance due to illness.  
Participants were engaged in a range of work, with manual work the most common 
(i.e. PE n=3, MET n=4). 
 
Table 42.  Employment status of participants 
 
Employment PE MET 
Manual 3 4 
Retail 1 1 
Business 0 1 
Unpaid work 2 0 
Tertiary student 0 1 
Retired 2 1 
Sickness beneficiary 1 1 
 
 
Case Descriptions 
 
Case 1.  A 40 year old Caucasian female with Type 2 diabetes diagnosed at 35 
years of age.  She had a history of recurrent vaginal thrush which was attributed to her 
diabetes, but no other known diabetes-related complications.  Her diabetes was 
managed through diet and oral medication (Glipizide and Metformin).  She was also 
prescribed Bezafibrate for dyslipidaemia.  Her diabetes medication remained 
unchanged through the study.  She was seen for ongoing support by the DNE three 
times during the 3-month follow-up period.  
 
  317
Case 2.  A 59 year old Caucasian female, with Type 2 diabetes diagnosed at 
55 years of age.  She had no known diabetes-related complications.  Her diabetes was 
managed by diet and oral medication (Metformin and Glibenclamide).  She was also 
prescribed Bezafibrate for dyslipidaemia, the dose of which had been increased at 12-
month follow-up.  She was commenced on Metformin by her GP during the 3-month 
follow-up period.  Also, she was referred by the DNE to a dietitian who saw her on 
one occasion only.   
 
Case 3.  A 41 year old Caucasian male with Type 2 diabetes diagnosed at 37 
years of age.  He had no known diabetes-related complications.  His diabetes was 
managed by diet, oral medication (Metformin), and insulin injections (Penmix).  He 
was referred by the DNE to a dietitian whom he saw on only one occasion during the 
3-month follow-up period.  At 12-month follow-up he was no longer taking oral 
medication for his diabetes. 
 
Case 4.  A 54 year old Caucasian female with Type 2 diabetes diagnosed at 33 
years of age.   She had diabetic retinopathy.  Her diabetes was managed by diet and 
oral medication (Metformin and Glipizide). Her diabetes medication remained 
unchanged throughout the study.     
 
Case 5.  A 31 year old Caucasian female with Type 1 diabetes diagnosed at 13 
years of age.  She had progressive diabetic retinopathy.  Her diabetes was managed by 
diet and insulin injections (Humalog and Humulin N), which remained unchanged 
throughout the study.  She was referred by the DNE to a clinical psychologist and was 
seen for assessment of psychological factors affecting diabetes management on two 
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occasions during the 2-week follow-up period and for three treatment sessions during 
the 3-month follow-up.  She was also seen by a dietitian on two occasions during the 
3-month follow-up period.  Unfortunately, 12-month follow-up questionnaire data are 
not available. 
 
Case 6.  A 50 year old Caucasian female with Type 2 diabetes diagnosed at 45 
years of age.  She had no known diabetes-related complications.  Her diabetes was 
managed by diet and oral medication (Glipizide and Metformin).  Her diabetes 
medication remained unchanged throughout the study. 
 
Case 7.  A 45 year old Maori male with type 2 diabetes diagnosed at 44 years 
of age.  There were no diabetes-related complications noted in his file, although he 
reported erectile dysfunction which can be a diabetes-related complication. His 
diabetes was managed by diet and oral medication (Metformin).   His diabetes 
medication remained unchanged throughout the study.  He was referred by the DNE 
to a dietitian and seen on two occasions, once in the 2-week follow-up and once 
during the 3-month follow-up period.   
 
Case 8.  A 64 year old Caucasian male with Type 2 diabetes diagnosed at 61 
years of age.  He had diabetic retinopathy.  His diabetes was managed by diet and oral 
medication (Glipizide and Metformin).  His diabetes medication remained unchanged 
throughout the study.  He was seen by the DNE for support on one occasion during 
the 3-month follow-up period. 
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Case 9.  A 56 year old Caucasian female with Type 2 diabetes diagnosed at 52 
years of age.  She had no known diabetes related complications. Her diabetes was 
managed by diet alone.  She was, however, prescribed Simvastatin for dyslipidaemia, 
which had been stopped at 12-month follow-up.  She was referred by the DNE to a 
dietitian and was seen three times during follow-up.   In the intervening period 
between the end of PE and being contacted about participation in Part B (MET) of the 
study she had been diagnosed with, and received treatment for, mental health 
problems of anxiety and depression. 
 
Case 10.  A 30 year old Caucasian male with Type 1 diabetes diagnosed at 13 
years of age.  He had retinopathy, nephropathy, and sensory peripheral neuropathy, all 
attributed to his diabetes.  His diabetes was managed by diet and insulin injection 
(Actrapid and Monotard), which was changed to Humulog and Humlin as a result of 
discussions with the DNE during MET.  He was referred by the DNE to a dietitian 
with whom he had one appointment in the fourth week of treatment.   
 
Case 11.  A 68 year old Caucasian male with Type 2 diabetes diagnosed at 53 
years of age.  He had peripheral vascular disease and peripheral neuropathy, which 
were attributed to his diabetes.  His diabetes was managed by diet and insulin 
injections (Protaphane and Penmix).  At 12-month follow-up he was also prescribed 
Benzafibrate for dyslipidaemia. 
 
Case 12.  A 60 year old Caucasian male with Type 2 diabetes diagnosed at 41 
years of age.  He had diabetic retinopathy and peripheral vascular disease attributed to 
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his diabetes. His diabetes was managed by diet and insulin (Humulin and Humulog).  
His diabetes medication remained unchanged throughout the study. 
 
Case 13.  A 21 year old Caucasian female with Type 1 diabetes diagnosed at 
14 years of age.  She had no known diabetes-related complications.  Her diabetes was 
managed by diet and insulin injections (Humulin and Humulog).  Her diabetes 
medication remained unchanged throughout the study. 
 
Case 14.  A 54 year old Caucasian female with Type 2 diabetes diagnosed at 
41 years of age.  She had retinopathy, with threatened maculopathy, which were 
attributed to her diabetes.   Her diabetes was treated by diet and oral medication 
(Metformin and Glipizide).  She was also prescribed Simvastatin for dyslipaemia.  
Her medication, however, was altered for the last 6-months of follow-up, with the 
addition of insulin injections (Penmix) and Glipizide was stopped.  
 
Case 15.  A 21 year old Caucasian female with Type 1 diabetes diagnosed at 
14 years of age. She had no known diabetes-related complications.   Her diabetes was 
managed with diet and insulin injections (Humulog and Humulin).  Her diabetes 
medication remained unchanged throughout the study. 
 
Case 16.  A 36 year old Maori male with Type 2 diabetes diagnosed at 25 
years of age.  He had peripheral neuropathy and vascular disease, attributed to his 
diabetes.  His diabetes was managed with diet and oral medication (Metformin and 
Glipizide).   His diabetes medication remained unchanged throughout the study. 
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Case 17.  A 59 year old Maori woman with Type 2 diabetes diagnosed at 48 
years of age.  She had no known diabetes-related complications.   Her diabetes was 
managed by diet and oral medication (Metformin and Glicazide).  At 3-month follow-
up, however, her diabetes medication was changed with the addition of insulin 
injections (Penmix), and Glicazide was stopped.  Bezafibrate for dyslipaemia was also 
added at this time. 
 
Case 18.  A 47 year old Caucasian male with Type 1 diabetes diagnosed at 32 
years of age.  He had no known diabetes-related complications.  His diabetes was 
managed by diet and insulin injections (Humulog and Humulin).   At 12-month 
follow-up he was also being prescribed Atorvasatin for dyslipidaemia. 
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Appendix 2: MET therapist manual (Adapted from Sellman et al., 1996) 
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1 INTRODUCTION  TO  MOTIVATIONAL  ENHANCEMENT  THERAPY  
(MET) 
 
MET is a brief, systematic psychotherapeutic intervention based on the principles of motivational 
interviewing.  It is a treatment approach which aims to motivate patients to make changes rather than 
provide a detailed step-by-step guide to behaviour change.  MET was developed for the purposes of 
Project MATCH, a large US multisite, study of three outpatient treatments for alcohol dependence, 
including motivational enhancement therapy. 
 
1.1 Nonspecific factors of MET 
Six general therapeutic factors hypothesized to be active ingredients of effective brief therapies are 
summarized by the acronym FRAMES as outlined below.  These factors guide the MET therapist in 
their general stance and therapeutic interaction in therapy. 
• 
• 
• 
• 
• 
• 
FEEDBACK of personal impairment and risk 
emphasis on personal RESPONSIBILITY for change 
clear ADVICE to change 
a MENU of alternative change options 
therapist EMPATHY 
facilitation of patient SELF-EFFICACY or optimism 
 
1.2 Specific principles of MET 
The MET approach begins with the assumption that the responsibility and capability for change lie 
within the patient.  The therapist’s task is to create a set of conditions that will enhance the patient’s 
own motivation for and commitment to change.  Rather than relying on therapy sessions as the primary 
locus of change, the therapist seeks to mobilize the patient’s inner resources as well as those inherent in 
the patient’s natural helping relationships. 
In motivational interviewing, the therapist does not confront the patient who denies that their behaviour 
(e.g. inadequate diabetes self-care) is a problem.  Instead, the therapist uses techniques designed to 
increase the patient’s own level of self-confrontation and reappraisal about their behaviour.  The 
therapist avoids taking an authoritarian, paternalistic role and reinforces the principle that responsibility 
for change lies with the individual.  Although motivational interviewing is not coercive or 
confrontational, it involves clear strategies and skills aimed at increasing patients’ motivation for 
change. 
Five key clinical principles guide the conduct of MET from a technical point of view. 
*Express Empathy 
*Develop Discrepancy 
*Avoid Argumentation 
*Roll with Resistance 
*Support Self-efficacy 
 
*Express Empathy 
The MET therapist seeks to communicate respect for the patient.  Communications that imply a 
superior/inferior relationship between therapist and patient are avoided.  The patient’s freedom of 
choice and self-direction are respected and promoted so that the message given is that only they can 
decide to make a change in their behaviour and carry out that choice.  Much of MET is listening rather 
than telling.  Persuasion is gentle, subtle, always with the assumption that change is up to the patient.  
Reflective listening (accurate empathy) is a key skill in motivational interviewing.  It communicates an 
acceptance of patients as they are, while also supporting them in the process of change. 
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*Develop Discrepancy 
Motivation for change occurs when people perceive a discrepancy between where they are and where 
they want to be. The MET approach specifically seeks to enhance and focus the patient’s attention on 
such discrepancies.  In certain cases (e.g. precontemplative patients) it may be necessary first to 
develop such discrepancy by raising patients’ awareness of the personal consequences of their 
behaviour. When patients enter treatment in the later contemplative stage, it takes less time and effort 
to move them along to the point of determination for change. 
* Avoid Argumentation 
If handled poorly, ambivalence and discrepancy can resolve into defensive coping strategies that reduce 
the patient’s discomfort but do not alter their behaviour (e.g. diabetes self-care and related risks). The 
MET style explicitly avoids direct argumentation which tends to evoke resistance. The therapist does 
not seek to prove or convince by force of argument. When MET is conducted properly, the patient and 
not the therapist voices the arguments for change. 
* Roll with Resistance 
How the therapist handles patient “resistance” is a crucial and defining characteristic of the MET 
approach. MET strategies do not meet resistance head on, but rather “roll with” the momentum, with a 
goal of shifting patient perceptions in the process. New ways of thinking about problems are invited, 
but not imposed. Ambivalence is viewed as normal, not pathological, and is explored openly. Solutions 
are usually evoked from the client rather than provided by the therapist. 
* Support Self-efficacy 
People who are persuaded that they have a serious problem will still not move toward change unless 
there is hope for success. “Self-efficacy” is a critical determinant of behaviour change. Self-efficacy is 
the belief that one can perform a particular behaviour or accomplish a particular task as opposed to 
whether or not they see the goal or outcome as desirable. In this case, patients must be persuaded that it 
is possible to change their own behaviour and thereby reduce diabetes related problems.  In other 
words, the patient’s perception of helplessness, even in the face of acceptance that they need to 
improve their management of their diabetes, is the focus. 
 
1.3 Measurement of motivation 
Motivational interviewing has been linked with the stages-of-change model [Prochaska & DiClemente 
1982] where motivation is viewed as a person’s current “readiness for change”. Six separate stages of 
change have been described as precontemplation, contemplation, determination, action, maintenance 
and relapse [Prochaska & DiClemente 1986]. Latterly, “determination” has been replaced by 
“preparation” to emphasize the cognitive adjustments patients make prior to action phase [Prochaska et 
al. 1994]. The determination stage will be referred to as preparation in this manual. People who are not 
considering change in their behaviour (e.g. diabetes self-care) are described as Precontemplators. The 
Contemplation stage entails individuals’ beginning to consider both that they have a problem and the 
feasibility and costs of changing that behaviour. As individuals progress, they move on to the 
Preparation stage, where the decision is made to take action and change. Once individuals begin to 
modify the problem behaviour, they enter the Action stage before moving to a Maintenance stage 
where change is sustained. If these efforts fail, a Relapse occurs and the individual begins another 
cycle. Most people who relapse go through the cycle again and it is observed that several revolutions 
through this cycle are often needed to learn how to maintain change successfully.  
For the MET therapist the Contemplation and Preparation stages are most critical. The objective is to 
help patients seriously consider two basic issues. The first is how much of a problem their behaviour 
(inadequate diabetes self-care) is, and how it is affecting them (both positively and negatively). Tipping 
the balance of these pros and cons of diabetes self-care toward change is essential for movement from 
contemplation to preparation. Second, the patient in contemplation assesses the possibility and the 
costs/benefits of changing the problem behaviour.  Patients consider whether they will be able to make 
a change and how that change will affect their lives. In the Preparation stage, patients develop a firm 
resolve to take action. That resolve is influenced by past experiences with change attempts. Individuals 
who have made unsuccessful attempts to change their diabetes self-care in the past need encouragement 
to decide to go through the cycle again. 
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1.4 Differences between MET and Patient Centred Therapy (PCT) 
In PCT the therapist does not direct treatment but follows the patient’s direction wherever it may lead, 
using the specific principles of PCT. In contrast, MET employs systematic strategies toward specific 
goals. In MET the therapist actively works to create discrepancy and to channel it toward behaviour 
change. MET is a directive and gently persuasive approach focused on the patient’s problematic 
behaviour (diabetes self-management), in contrast to PCT, which is essentially nondirective, more 
passive and not necessarily focused on problem behaviour). The following are key differences between 
the two therapies in tabular form [adapted from Miller and Rollnick 1991]. 
 
 
PATIENT-CENTRED MOTIVATION ENHANCEMENT 
Allows the patient to determine the content 
and direction of sessions, which may not be 
focused on diabetes at all. 
Systematically directs the patient toward 
motivation for change with a focus on diabetes 
self-care. 
Avoids injecting any advice or feedback from 
the therapist. 
Offers the therapist’s own advice and feedback 
where it is likely to facilitate or consolidate 
change. 
Empathic reflection is used noncontingently 
and thus not used to specifically focus on 
changing diabetes self-care behaviour. 
Empathic reflection is used selectively to elicit 
self-motivational statements and reinforce 
change intentions. 
Explores the patient’s conflicts and feelings in 
the present. 
Seeks to create and amplify the patient’s 
discrepancy in order to enhance motivation for 
change. 
 
 
 
2. THE PRACTICE OF MOTIVATIONAL ENHANCEMENT THERAPY 
 
 
 
Motivational counselling can be divided into two major phases: building motivation for change and 
strengthening commitment to change. 
 
2.1 Phase 1: Building Motivation for Change 
Although patients will vary widely in their readiness to change, most are likely to enter the treatment 
process somewhere in the contemplation stage. They may be dabbling with taking action but still need 
consolidation of motivation for change. Phase 1 may be thought of as tipping the motivational balance. 
One side favours the status quo (e.g. maintaining previous unhealthy diet), whereas the other favours 
change. The former side is weighed down by perceived positive benefits from not changing and feared 
consequences of change. Weights on the other side consist of perceived benefits of changing diabetes 
self-care behaviour and feared consequences of continuing unchanged. The therapist’s task is to shift 
the balance in favour of change. Eight techniques to achieve this are now described. 
 
2.1.1 Eliciting Self-Motivational Statements 
When people speak in a new way, their beliefs and values tend to shift in that direction. The 
worst persuasion strategy is one that evokes defensive argumentation from the person. The 
MET therapist seeks to elicit from the patient certain kinds of statements that are self-
motivating, such as, being open to input about diabetes self-care, acknowledging real or 
potential problems related to not changing, expressing a need, desire or willingness to change. 
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There are several ways to elicit such statements from patients. One is to ask for them directly, 
via open-ended questions for example “what makes you think you need to make a change to 
your diabetes management”. Once this process is rolling, simply keep it going by using 
reflective listening (see below). If things slow down then invite comment about general areas 
such as health problems, relationship difficulties, work difficulties, financial issues etc. 
If you encounter difficulties in eliciting patient concerns, another strategy is to employ gentle 
paradox to evoke self-motivational statements. In this table-turning approach, you subtly take 
on the voice of the patient’s resistance and thereby evoking from the patient the opposite side. 
For example, “I’m not sure how much you are interested in changing, or even in taking a careful 
look at your diabetes. It sounds like you might be happier just going on as before”. 
In general, however, the best opening strategy for eliciting self-motivational statements is to 
ask for them; for example, “Tell me what concerns you about your diabetes”. 
 
2.1.2 Listening with Empathy 
Eliciting self-motivational statements is one thing to begin with, but it is crucial how you 
respond to what patients initially say. The therapeutic skill of accurate empathy or reflective 
listening is an optimal response within MET. The therapist listens carefully to what the patient 
says then reflects it back, often in a slightly modified form. Acknowledgement of the patient’s 
feeling state may also be included. The advantages of this strategy include: 
it is unlikely to evoke resistance • 
• 
• 
• 
• 
it encourages the patient to keep talking 
it communicates respect and caring and builds a working therapeutic alliance 
it clarifies for the therapist exactly what the patient means, and 
it can be used to reinforce ideas expressed by the patient. 
 
This last characteristic is particularly important because you can reflect quite selectively self-
motivational statements related to changing behaviour. 
 
2.1.3 Questioning 
Questioning is an important therapist response in MET. Rather than telling patients how they 
should feel or what to do, the therapist asks patients about their own feelings, ideas, concerns 
and plans. Elicited information is then responded to with empathic reflection, affirmation or 
reframing (see below). 
 
2.1.4 Presenting Personal Feedback 
In the first session of MET, key feedback is given, with opportunity made for discussion. 
Information should be provided in a neutral and non-personal way, with consideration of the 
patient’s readiness to receive information.  This should be preceded with a question such as: “I 
wonder, would you be interested in knowing more about ...?”   
An important part of this process is monitoring and responding to the patient during the 
feedback. Allow time for the patient to respond verbally. Use reflective listening to reinforce 
self-motivating statements that emerge during this time. Also respond reflectively to resistance 
statements, perhaps reframing them or embedding them in a double-sided reflection. 
Often a patient will respond nonverbally, and it is possible also to reflect these reactions. A 
sigh, a frown, a slow sad shaking of the head, a snort or tears can communicate a reaction to 
the feedback. The therapist can respond to these with a reflection of the apparent feeling. 
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If the patient is not volunteering reactions, either verbally or non-verbally, it is wise to pause 
periodically during the feedback process and ask a question such as “What do you make of 
this?” or “Does this make sense to you?”. 
 See Appendix 2 for outline of technique. 
 
2.1.5 Affirming the Patient 
You should seek opportunities to affirm and compliment the patient sincerely. Such 
affirmations can be beneficial in a number of ways, including: 
strengthening the working relationship • 
• 
• 
• 
• 
• 
• 
• 
• 
enhancing the attitude of self-responsibility and empowerment 
reinforcing effort and self-motivational statements, and 
supporting patient self-esteem. 
 
Some examples are, “I’m impressed how you’ve hung in there during this feedback which 
must’ve been pretty rough” or “You’ve really had some good ideas for how you might change 
today”. 
 
2.1.6 Handling Resistance 
Patient resistance is a legitimate concern. Failure to comply with a therapist’s instructions and 
resistance behaviours within treatment sessions (e.g. arguing, interrupting, denying a problem) 
are responses that predict poor treatment outcome. What too few therapists realize however, is 
the extent to which such patient resistance is powerfully affected by the therapist’s own style. 
An important goal in MET is to avoid evoking patient resistance (antimotivational statements) 
in the first instance. A first rule of thumb is never meet resistance head on. Don’t argue, judge, 
threaten, attempt to persuade with logic or evidence, interpret, confront or be sarcastic. Even 
direct questions as to why the patient is “resisting” generally serve to elicit further defense of 
the antimotivational stance of the patient. If a therapist finds themselves in the position of 
arguing with the patient, shift strategies, deflect resistance. This can be done in the following 
five ways. 
simple reflection – simply reflecting what the patient is saying sometimes elicits the 
opposite 
reflection with amplification – a modification is to reflect but exaggerate or amplify what 
the patient is saying to the point where the patient is likely to disavow it. Subtlety is 
required as exaggeration can elicit hostility. 
double-sided reflection – it a patient offers a resistance statement, reflect it back with the 
other side included (based on previous statements made by the patient in the session if 
possible). 
shifting focus – another strategy is to defuse resistance by shifting attention away from the 
problematic issue. 
rolling with resistance – resistance can also be met by rolling with it instead of opposing it. 
There is a paradoxical aspect to this strategy which often will bring the patient back to a 
balanced or opposite perspective. This strategy can be particularly useful with patients who 
present in a highly oppositional manner and seem to reject every idea or suggestion. 
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2.1.7 Reframing 
Reframing is a strategy whereby the patient is invited to examine their perceptions in a new 
light or reorganized form. The general idea in reframing is to place the problem behaviour in a 
more positive light, which in itself can have a paradoxical effect (prescribing the symptom), 
but to do so in a way that causes the person to take action to change the problem. Placing 
problems in a more positive or optimistic frame helps communicate that the problem is 
solvable and changeable. 
 
2.1.8 Summarizing 
It is useful to summarize periodically during a session, particularly toward the end of a 
session. This amounts to a longer, summary reflection of what the patient has said. It is 
especially useful to repeat and summarize the patient’s self-motivational statements. Elements 
of reluctance or resistance, may be included in the summary, to prevent a negating reaction 
from the patient. 
 
2.2 Phase 2: Strengthening Commitment to Change 
 
2.2.1 Recognizing Change Readiness 
The eight strategies above are designed to build motivation and to help tip the patient’s 
decisional balance in favour of change. A second major process in MET is to consolidate the 
patient’s commitment to change, once sufficient motivation is present. Timing is a key issue.  
Within the Prochaska and DiClemente model, this is the Preparation stage, when the balance 
of contemplation has tipped in favour of change and the patient is ready for action. 
There are no universal signs of crossing over into the Preparation stage. Some changes you 
might observe include, the patient stops resisting and raising objections, the patient asks fewer 
questions, the patient appears more settled, resolved, unburdened or peaceful, the patient 
makes self-motivational statements indicating a decision to change, the patient begins 
imagining life after a change. 
Here is a checklist of issues to assist the therapist in determining a patient’s readiness to 
accept, continue in, and comply with a change programme. 
has the patient missed previous appointments or cancelled prior sessions without 
rescheduling? 
• 
• 
• 
• 
• 
• 
if the patient was coerced in some way into treatment, have they discussed with you their 
reactions to this involuntariness? 
does the patient show indecision or hesitancy about scheduling future sessions? 
is the treatment being offered quite different from what was expected or what the patient 
has experienced in the past? If so, have these differences and the patient’s reactions been 
discussed? 
does the patient seem to be very guarded during sessions or otherwise seem to be hesitant 
or resistant when a suggestion is offered? 
does the patient perceive involvement in treatment to be a degrading experience rather than 
a “new lease on life”. 
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If the answers to these questions suggest a lack of readiness for change, it might be valuable to 
explore further the patient’s uncertainties and ambivalence about change. It is also wise to 
delay any decision-making or attempts to obtain firm commitment to a plan of action. For 
many patients, there may not be a clear point of decision or determination; the shift from 
contemplation to action may be a gradual, tentative transition rather than a discrete decision. 
It is also important to remember that even when a patient appears to have made a decision and 
is taking steps to change, ambivalence is still likely to be present. Avoid assuming that once a 
client has decided to change, Phase 1 strategies are no longer needed. Likewise, you should 
proceed carefully with patients who make a commitment to change too quickly or too 
emphatically. 
In any event, a point comes when you should move toward strategies designed to consolidate 
commitment. The following seven strategies are useful once the initial phase has been passed 
and the patient is moving toward change. The goal in Phase 2 is to elicit from the patient some 
ideas and ultimately a plan for what to do about their diabetes.  
 
2.2.2 Discussing a Plan 
The key shift for the therapist is from focusing on reasons for change (building motivation) to 
negotiating a plan of change. Patients may initiate this by stating a need or desire to change or 
by asking what they could do. Alternatively, the therapist may signal this shift (and test the 
water) by asking a transitional question such as, “Where does this leave you in terms of your 
diabetes? What have you been thinking of doing?” 
It is not your task to prescribe a plan for how the patient should change or to teach specific 
skills for doing so. The overall message remains “Only you can change your behaviour 
(diabetes self-care), and its up to you”. Reflecting and summarizing continue to be good 
therapeutic responses as more self-motivational statements and ideas are generated. 
 
2.2.3 Communicating Free Choice 
An important and consistent message throughout MET is the patient’s responsibility and 
freedom of choice. Reminders of this theme should be included during Phase 2. “No one can 
change your behaviour for you. Only you can do it”. 
 
2.2.4 Consequences of Action and Inaction 
A useful strategy is to ask the patient to anticipate the result if they continue as before. What 
would be the likely consequences? It may be useful to make a written list of the possible 
negative consequences of not changing. Similarly, the anticipated benefits of change can be 
generated by the patient. A complete picture will be gained by also discussing what the patient 
fears about changing. 
One possibility here is to construct a formal “decisional balance” sheet, by having the patient 
generate (and write down) the pros and cons of change options. What are the positive and 
negative aspects of continuing as before? What are the possible benefits and costs of making a 
change in diabetes management? 
 
2.2.5 Information and Advice 
Often patients will ask for key information as important input for their decisional process. The 
therapist should provide accurate, specific information. It is also helpful afterwards to ask for 
the patient’s response to this information, with an open-ended question such as:  “What do you 
make of this?” 
Patients may also ask for advice. “What do you think I should do?”  It is quite appropriate to 
provide your own views in this circumstance, with a few caveats. 
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It is often helpful to provide qualifiers and permission to disagree. “I can certainly give you my 
opinion, but you’re the one who has to make up your mind in the end”. 
Being just a little resistive in this situation can be useful. “I guess I’m concerned that if I give 
you my advice, then it looks like I’m the one deciding instead of you. Are you sure you want my 
opinion?”  Within this general set, feel free to give the patient your best advice as to what 
change should be made, specifically with regard to the patient’s diabetes management, (e.g. “I 
think you need to take your insulin”); the need for the patient and their “significant other” to 
work together, general kinds of changes, (e.g. find new ways to spend time that don’t involve 
eating). 
The therapist, however, should not prescribe specific strategies or attempt to train specific 
skills. This challenge is turned back on the patient, “How do you think you might be able to do 
that?” 
A patient may ask for information you do not have. Do not feel obliged to know all the 
answers. It is fine to say that you do not know, but will find out, You can offer to research a 
question and get back to the patient at the next session or by telephone. 
 
2.2.6 Dealing with Resistance 
The same principles used for defusing resistance in Phase 1 also apply here. Reluctance and 
ambivalence are not challenged directly but rather can be met with reflection or reframing. 
Gentle paradoxical statements may also be useful during the commitment phase of MET. One 
form of such statements is permission to continue unchanged, “Maybe you’ll decide that it’s 
worth it to you to keep on the way you have been, even though it’s costing you”. 
 
2.2.7 The Change Plan Worksheet 
The Change Plan Worksheet (CPW) is to be used during Phase 2 to help in specifying the 
patient’s action plan (see Appendix 1). You can use it as a format for taking notes as the 
patient’s plan emerges. Do not start Phase 2 by filling out the CPW. Rather, the information 
needed for the CPW should emerge through the use of the skills described above. Use the 
CPW as a guide to ensure that you have covered the following aspects of the patient’s plan. 
The changes I want to make are... 
In what ways or areas does the patient want to change? Be specific. It is wise to include 
goals that are positive (wanting to begin, increase, improve, do more of something) and not 
only goals that could be accomplished through general anaesthesia (to stop, avoid, or 
decrease behaviours) 
• 
• 
• 
• 
The most important reasons why I want to make these changes are... 
What are the likely consequences of action and inaction? Which motivations for change 
seem most impelling to the patient? 
The steps I plan to take in changing are... 
How does the patient plan to achieve the goals? Within the general plan and strategies 
described, what are some specific, concrete first steps that the patient can take? When, 
where, and how will these steps be taken? 
The ways other people can help me are... 
In what ways could other people help the patient in taking the steps toward change? How 
will the patient arrange for such support? 
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I will know that my plan is working if... 
What does the patient hope will happen as a result of this change in plan? What benefits 
could be expected from this change? 
• 
• 
Some things that could interfere with my plan are... 
Help the patient to anticipate situations or changes that could undermine the plan. What 
could go wrong? How could be patient stick with the plan despite these problems or 
setbacks? 
It is important to make a copy so that the original is given to the patient and a copy retained 
for the file. 
 
2.2.8 Recapitulation 
Toward the end of the commitment process, as you sense that the patient is moving toward a 
firm decision for change, it is useful to offer a broad summary of what has transpired. This 
may include a repetition of the reasons for concern uncovered in Phase 1, as well as new 
information developed during Phase 2. Emphasis should be given to the patient’s self-
motivational statements, the patient’s plans for change and the perceived consequences of 
changing and not changing. Use your notes on the Change Plan Worksheet as a guide. End 
with an inquiry whether this is right or not. “Do I have it right? What have I missed out?” 
If the patient offers additions or changes, reflect these and integrate them into your 
recapitulation. Also note them on the Change Plan Worksheet. 
 
2.2.9 Asking for Commitment 
After you have recapitulated the patient’s situation and responded to additional points and 
concerns raised by the patient, move toward getting a formal commitment to change. In 
essence, the patient is to commit verbally to take concrete, planned steps to bring about the 
needed change. The key question (not necessarily in these words) is: “Are you ready to commit 
yourself to doing this?”  
As you discuss this commitment, also cover the following points: 
Clarify what, exactly, the patient plans to do. Give the patient the completed Change Plan 
Worksheet and discuss it. 
Reinforce what the patient perceives to be likely benefits of making a change, as well as the 
consequences of inaction. 
Ask what concerns, fears, or doubts the patient may have that might interfere with carrying out 
the plan. 
Ask what other obstacles might be encountered that could divert the patient from the plan. Ask 
the patient to suggest how they could deal with these. 
Remind the patient that you will be seeing them for two follow-through sessions (scheduled in 
two weeks and four weeks time respectively) to see how she/he is doing. 
If the patient is willing to make a commitment, ask him/her to sign the Change Plan 
Worksheet and give them the signed original, retaining a copy for your file. 
Some patients are unwilling to commit themselves to a change goal or program. When patients 
remain ambivalent or hesitant about making a written or verbal commitment to change their 
behaviour, you may ask them to defer the decision until later. A specific time should be agreed 
upon to re-evaluate and resolve the decision. Such flexibility provides patients with the 
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opportunity to explore more fully the potential consequences of change and prepare 
themselves to deal with the consequences. Patients should not feel coerced into making a 
commitment before they are ready to take action. If they feel coerced, patients may withdraw 
prematurely from treatment, rather than “lose face” over the failure to follow through on a 
commitment. When arranging a deferment, it is helpful to express explicit understanding and 
acceptance of patients’ ambivalence, as well as confidence in their ability to resolve the 
dilemma. 
 
2.3 Phase 3: Follow-through Strategies 
Once a strong base of motivation for change has been established (Phase 1) and the patient’s 
commitment to change has been obtained (Phase 2), MET focuses on follow-through. This may occur 
as early as the second session, depending on the patient’s progress. Three processes are involved in 
follow-through. 
 
2.3.1 Reviewing Progress 
Begin a follow-through session with a review of what has happened since your last session. 
Discuss with the patient what commitment and plans were made and explore what progress the 
patient has made toward these. Respond with reflection, questioning, affirmation and 
reframing as before. Determine the extent to which previously established goals and plans 
have been implemented. 
 
2.3.2 Renewing Motivation 
The Phase 1 processes can be used again to renew motivation for change. The extent of this 
renewal depends on your judgement of the patient’s current commitment to change. This may 
be assessed by asking patients what they remember as the most important reasons for changing 
their diabetes self-care behaviour. 
 
2.3.3 Redoing Commitment 
The Phase 2 processes can also be continued during follow-through. This may simply be a 
reaffirmation of the commitment made earlier. If the patient has encountered significant 
problems or doubts about the initial plan, however, this is a time for re-evaluation, moving 
toward a new plan and commitment. Seek to reinforce the patient’s own sense of autonomy 
and self-efficacy – an ability to carry out self-chosen goals and plans. 
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3. THE STRUCTURE AND CONDUCT OF MOTIVATIONAL 
ENHANCEMENT THERAPY SESSIONS 
 
 
3.1 Introduction 
This section of the manual describes how the four sessions of MET are to be conducted over the six 
weeks treatment period in the Brief Treatment Programme. 
Prior to these four sessions, the patient will have been briefed on what MET entails at the time of 
giving consent to participate in the study. It is important, however, to check that the patient understands 
the rationale for MET at the outset. 
 
 
3.2 Aims of the Therapy 
The three overall aims of the four sessions of MET are linked with the three phases of  therapy as 
follows: 
 Phase 1: building motivation for change 
 Phase 2: strengthen commitment to change 
 Phase 3: facilitate follow-through of change 
 
 
3.3 Specific Techniques to be used 
The overall aims of MET are to be achieved by utilizing the following specific therapy techniques 
(outlined in the previous section): 
 
Phase 1:  Building Motivation for Change 
Eliciting Self-Motivational Statements 
Listening with Empathy 
Questioning 
Presenting Personal Feedback 
Affirming the Patient 
Handling Resistance 
Reframing 
Summarizing 
 
In this initial phase the strategies from the Menu of Strategies (Table 1), using the specific techniques 
above, may be helpful in building motivation for change. They should be used flexibly to fit with each 
patient’s situation and state of change and are ordered according to degree of readiness to change. 
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Table 1.  Motivational interviewing strategies 
 
  MENU OF STRATEGIES 
Phase 1 1. Typical day 
 2. Agenda setting chart 
 3. Personal dissonance 
 4. Good things and the less good things 
Phase 2 5. Problems and concerns 
 6. Life satisfaction – the present and the future 
 7. Costs and benefits 
 8. Constructing a decision balance 
 9. Helping with decision-making 
 
 
Specific Strategies: 
 
(i) TYPICAL DAY 
The patient is encouraged to talk about their current behaviour in detail within a non-pathological 
framework.  This can be introduced with the following: 
“Can we spend the next 5-10 minutes going through a typical day from beginning to end.  (Identify a 
recent typical day, e.g. yesterday).  What happened, how did you feel, and where did your diabetes fit 
in?  Let’s start at the beginning...” 
 
(ii) AGENDA SETTING 
The patient is encouraged to make decisions about where to take the consultation by the use of an 
agenda setting card (Appendix 1), which is used to structure the initial discussion.  The card can be 
introduced as follows: 
“These are some of the things which we like to talk with people with diabetes about.  What about you 
today?”  Would you like to talk about any of these, or do you have something else (pointing to the blank 
spaces) you would prefer to talk about?” 
Should the patient choose an issue in the blank space, this does not mean that the remainder of the 
session should be used with this topic.  Patients should be encouraged to move onto the topic of 
diabetes management. 
 
(iii)   PERSONAL DISSONANCE 
The aim of this strategy is to create dissonance between the patient’s positive image of themselves as a 
person on the one hand and a negative image of themselves on the other. A suggested line of 
questioning is as follows: 
“Give me some words that describe your positive points as a person.” 
“Now give me some words that describe you as you have been with managing your diabetes.” 
“How do these two fit together?” 
 
(iv) GOOD THINGS – LESS GOOD THINGS 
The patient is invited to firstly outline the positive things about continuing as they are and then 
conversely the negative things. Some suggested questions are: 
 “What are the less good things that managing your diabetes does for you.” 
“Let’s flip the coin.  Tell me about the good things that managing your diabetes does for you.” 
See Appendix 2 for outline of strategy. 
NB Remember that in practical terms the outcome sought from Phase 1 is that the patient is beginning 
to get ready to take action. 
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Phase 2: Strengthening Commitment to Change 
Recognizing Change Readiness 
Discussing a Plan 
Communicating Free Choice 
Consequences of Action and Inaction 
Information and Advice 
Dealing with Resistance 
The Change Plan Worksheet 
Recapitulation 
Asking for Commitment 
 
In this phase the Phase 2 strategies from the Menu of Strategies (Table 1) can be used. They are 
essentially aspects of the techniques “Consequences of Action and Inaction”. 
 
(v) PROBLEMS AND CONCERNS 
The patient is encouraged to talk about specific individualized problems and concerns they have about 
their diabetes. A suggested line of questioning is as follows: 
“What problems are you experiencing from your diabetes?” 
“What concerns do you have about your diabetes?” 
“What else, what other concerns, do you have?” 
This strategy ends with a summary which highlights not only these problems and concerns, but also the 
positive benefits of continuing as they are currently (not changing diabetes self-care). 
See Appendix 2 for strategy outline. 
 
(vi) LIFE SATISFACTION 
In this strategy, the patient is encouraged to think about their current satisfaction with life and what the 
future looks like both if the continue as they are and if they improve their management of their 
diabetes. 
Suggested questions are: 
“How have things changed for you because of your diabetes?” 
“What will happen if you continue as you are now?” 
“If things are to improve, what needs to be different?” 
 
(vii) COSTS AND BENEFITS 
For this, the patient is invited to weigh up the pros and cons of changing their behaviour (diabetes self-
care). 
Suggested questions are: 
“What would be some of the costs of changing?” 
“What would be the benefits of changing?” 
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(viii) CONSTRUCTION OF DECISION BALANCES 
These involve generating the pros and cons of change options which may be the outcome of the two 
strategies above “Life Satisfaction” and “Costs and Benefits”. It is often good to write these down in 
the form of balance sheets and given to the patient. They may include: 
(a) reasons to continue as before and reasons to change; 
(b) short term and long term +ve and –ve consequences of changing or staying the same; 
(c) +ve and –ve consequences for self and for others, and self-approval rating for self and from 
others. 
In each of these balances the factors which support change are to be emphasized over those that may 
maintain the status quo. 
The patient should be given a copy of the balance sheet (Appendix 1) at the end of the session. 
NB Remember that in practical terms the outcome sought from Phase 2 is that a plan of action 
has been developed. 
 
(ix) HELPING WITH DECISION MAKING 
 
This should only be used with patients who indicate some desire to make a decision to change.  The 
interviewer needs to be careful not to push too far and produce a retreat from the patient.  Therefore the 
following opening question is recommended: 
“Where does that leave you now?” 
This can then be followed up by questions which elicit, rather than impose, possible solutions/targets 
for behaviour change, such as: 
“There is no one solution to this problem, but many.  I can tell you about what has worked for others, but 
in the end, you will be the best guide of what is going to work for you.  Shall we look at some of the 
options together?  What might work for you?” 
Care should be taken to offer support and information without falling into the ‘expert problem-solver 
trap’. 
See Appendix 2 for guidelines when helping with decision making. 
 
Phase 3:  Follow-through Strategies 
Reviewing Progress 
Renewing Motivation 
Redoing Commitment 
NB Remember that in practical terms the outcome sought from Phase 3 is to ensure that the 
plan of action has been undertaken. 
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3.4 Therapy Rules 
The Brief Treatment Programme is a scientific research study. As such it is vital that the therapy 
provided to patients in the study is not only of a high professional standard but that it is conducted 
under strictly controlled and consistent conditions. The rules below have been kept to a necessary 
minimum. Therapists must diligently endeavour to adhere to the rules and report any significant 
deviations if, and when, they occur. 
3.4.1 General MET rules for the Brief Treatment Programme 
The therapist must adhere to the treatment protocol. 
MET is four sessions over six weeks. Try to schedule the four sessions at 1, 2, 4 and 6 weeks 
respectively. 
Sessions last 40 minutes. 
All sessions will be audiotaped. 
Minimize interruptions during sessions. Use a DO NOT DISTURB sign on your door and call-
forward your phone. 
The treatment is both general and specific. Tailor the general principles and techniques of the 
treatment to the specific individual who is your patient. 
Always give an appointment card to your patient and write it in your diary. 
Phone contact is allowed. Ring patient once they are half an hour late for any session. Allow 
patient or “significant other” to ring you between sessions, but keep calls brief. 
3.4.2 Specific therapist rules 
The therapist must adhere to the treatment protocol and to the specific objectives of each 
session. 
The therapist must give 100% in all their contacts with all patients in this study. 
The therapist must actively involve themselves in the formal supervision sessions as well as 
between sessions where necessary. 
If the therapist has an idea about the study, write it down and present it at your next meeting 
with the investigator. 
Try and anticipate problems with each patient and seek guidance before they happen. 
If you have any concerns about a patient, particularly their health, suicidality or violence, raise 
the issue immediately with all relevant people (e.g. Consultant Physician, Clinical 
Psychologist, GP and the investigator) according to usual practice standards. 
 
3.5 The first session 
3.5.1 Introduction 
The MET approach may be surprising for some patients, who come with an expectation of 
being led step by step through an intensive process of therapist-directed change. For this 
reason, you must be prepared to give a clear and persuasive explanation of the rationale for 
this approach. The timing of this rationale is a matter for the therapist’s own judgement. It 
may not be necessary at the outset of MET. At least some structuring of what to expect, 
however, should be given to the patient at the beginning of the first session. 
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The following standard introduction is to be used for the start of the first session. 
  “Before we begin, I’d like to briefly explain the way we will be working together over the next six 
weeks. 
This is the first of our sessions each of which will last about 40 minutes. 
During these sessions we will be taking a close look at your diabetes together and I will be 
helping you to understand how you think and feel about your situation. 
I want you to know I will not be trying to change you or your management of your diabetes; only 
you can do that. I may give you some advice along the way, but what you do with it will be 
completely up to you. 
Do you have any questions before we begin? ...... 
Perhaps we could start by you updating me about how you see your situation now in terms of 
your diabetes?” 
Many patients find MET a very comfortable approach. Some in fact will express relief, having 
feared being castigated or coerced. Others, however, may be uneasy with this approach and 
may need additional explanation and assurance. Several lines of follow-up discussion can 
include:  
 “Even with very extensive kinds of treatment, it is still the person who, in the end, decides what 
happens. You will determine what happens with your diabetes management.” 
 “Longer and shorter treatment programmes don’t seem to produce different results. People in 
longer or more intensive programmes don’t do any better, overall, than those getting good 
consultation like this. Again, no one can “do it to you”.  In fact, many people change their 
behaviour without any formal treatment at all.” 
 “You are not alone. We will be keeping in touch with you to see how you are doing. If at follow-
up visits, you still need more help, this can be arranged.” 
 “You can call if you need to. I’m available here by telephone.” 
 “I understand your worries, and it’s perfectly understandable that you would be unsure at this 
point. Let's just get started, and we'’ll see where we are after we’ve had a chance to work 
together.”  
 
3.5.2 Getting Underway 
Remember MET is therapist-directed; you call the shots. After the introduction, proceed by 
asking the patient to “put you in the picture” as best as they can by describing how they now 
see their situation. This can involve asking them to go over the main points of their diabetes 
history as well as inviting them to comment on what they thought of their recent appointment 
with their General Practitioner or Diabetes Consultant, and what (if anything) they have done 
since assessment. Respond to the patient’s comments with strategies for Eliciting Self-
Motivational Statements (2.1.1). Use reflection Listening with Empathy (2.1.2) as your 
primary response during this early phase. Other strategies described under Questioning (2.1.3), 
Presenting Personal Feedback (2.1.4), Affirming the Patient (2.1.5), Handling Resistance 
(2.1.6) and Reframing (2.1.7) are also appropriate here. 
If the patient is not particularly forthcoming or dries up quickly, then ask them to describe a 
typical day to get the ball rolling. Continue until you have elicited the major themes of 
concern from the patient and then offer a summary statement, see Summarizing (2.1.8). 
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If the patient does not seem to be expressing major concern about their diabetes and/or 
beginning to talk about their desire to change, then utilize some or all of the Phase 1 strategies:  
(ii) AGENDA SETTING (iii) PERSONAL DISSONANCE, (iv) GOOD THINGS – LESS 
GOOD THINGS,  in order to build motivation for change (see p. 14-15). These strategies can 
also be used for patients who initially show some motivation for change but for whom further 
building up of motivation is judged to be appropriate. 
Continue to focus on eliciting self-motivational statements during this process, drawing 
attention to them as they arise and noting them down. When you sense that genuine concern is 
being expressed by the patient about their management of their diabetes and the consequences 
associated with it as well as the desire to change then offer a summary statement; see 
Summarizing (2.1.8). This is the transition point to the second phase of MET: consolidating 
commitment to change. You may not get this far in the first session. 
If there is time, continue the therapy process by using cues from the patient (see Recognizing 
Change Readiness 2.2.1) to elicit thoughts, ideas and plans for what might be done to address 
the problem (see Discussing a Plan 2.2.2). During this phase, also use procedures outlined 
under Communicating Free Choice (2.2.3), Information and Advice (2.2.5), and Dealing with 
Resistance (2.2.6) when necessary. Specifically elicit from the patient what are perceived to be 
the possible benefits of action and the likely negative consequences of inaction; see 
Consequences of Action and Inaction (2.2.4). Use the Phase 2 strategies outlined, (v) 
PROBLEMS AND CONCERNS, (vi) LIFE SATISFACTION, (vii) COSTS AND 
BENEFITS, (viii) CONSTRUCTING A DECISIONAL BALANCE and (ix) HELPING 
WITH DECISION MAKING (see p. 15-17). 
The goal nominated by the patient should be included in discussion in this phase at an 
appropriate time. 
 The basic stance of reflection, questioning, affirming, reframing and dealing with resistance 
indirectly is to be maintained throughout this and all MET sessions. 
 This phase proceeds toward the confirmation of a plan for change and the therapist should 
seek to obtain whatever commitment they can in this regard (see Asking for Commitment 
(2.2.9)). It can be helpful to write down the patient’s goals and planned steps for change on the 
Change Plan Worksheet (2.2.7), a copy of which should be provided to the patient at the end 
of the session. If appropriate, this plan can be signed by the patient. The therapist, however, 
needs to be careful not to press prematurely for a commitment. If a plan is signed before 
commitment is firm, a patient may drop out of treatment rather than renege on the agreement. 
 
3.5.3 Ending the Session 
Always end the first session by summarizing what has transpired. The content of this summary 
will depend upon how far you have proceeded. In some cases, progress will be slow, and you 
will spend most of the first session presenting feedback and dealing with concerns or 
resistance. In other cases, the patient will be well along toward determination and you may be 
into Phase 2 (strengthening commitment) strategies by the end of the first session. The speed 
with which this session proceeds will depend upon the patient’s current stage of change. 
Where possible, it is desirable to elicit some self-motivational statements from the patient 
about change within the first session and to take some steps toward discussing a plan for 
change (even if tentative and incomplete). Also discuss what the patient will do and what 
changes will be made (if any) between the first and second sessions. Do not hesitate to move 
toward commitment to change in the first session if this seems appropriate. On the other hand 
do not feel pressured to do so. Premature commitment is ephemeral and pressuring patients 
toward change before they are ready will evoke resistance and undermine the MET process. 
 
3.5.4 The Follow-up Note 
After the first session, prepare a handwritten note to be mailed to the patient. This is not a 
form letter, but rather a personalized message in your own (neat) handwriting. Several 
personalized elements can be included in this note including a “joining message”, affirmations 
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of the patient, a reflection of the seriousness of the problem, a brief summary of the highlights 
of the first session, especially self-motivational statements that emerged, a statement of 
optimism and hope, and a reminder of the next session. An example might be as follows: 
 “Dear Mr Smith 
This is just a short note following our first session today. I agree with you that there are some 
serious concerns for you to deal with, and I’m impressed at how openly you are exploring 
these. You are already seeing some of the ways in which you might make a healthy change 
and I think you’re going to find a way through these problems. I look forward very much to 
meeting with you again on Monday 24 at 2pm.” 
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3.5.5 Checklist for Session 1 
1. Check patient is to receive MET. 
2. PLEASE DO NOT DISTURB sign, call-forward phone.  
3. Check the tape-recorder is on and tape in.  
4. Give an introduction and check that patient understands the MET rationale.  
5. Begin Phase 1 Building Motivation for Change. 
Invite patient to give an updated overview of their situation and elicit self-motivational 
statements, listen with empathy and affirm the patient as you go, handling resistance, 
reframing as appropriate and utilizing summaries.  
6. If appropriate, use the Phase 1 strategies.  
7. Make a final summarizing statement.  
8. Move on to Phase 2 Strengthening Commitment to Change – if time. 
Use cues to recognize change readiness and then begin to discuss a plan for change, 
maintaining the basic stance of reflection, questioning, affirming, reframing and dealing 
with resistance indirectly, throughout.  
9. If appropriate, use the Phase 2 strategies.  
10. End session with a summarizing statement. 
11. Give patient copy of decision balance sheet and/or change plan worksheet if completed. 
12. Give patient appointment card for Session 2 in a week’s time and write it in your diary. 
13. Give patient Goals for Change Checklist and Readiness to Change Ruler to complete in 
waiting room before leaving. 
14. Complete staff version of Goals for Change Checklist and Readiness to Change Ruler. 
15. Write and post follow-up note immediately following the session. 
 
3.6 The Second Session 
The second session is scheduled a week after the first session and should begin with a brief summary of 
what transpired during the first session. Then proceed with the MET process, picking up where you left 
off. Continue with personal feedback from assessment if this was not completed during the first 
session. Proceed toward Phase 2 strategies and commitment to change if this was not completed in the 
first session. If a firm commitment was obtained in the first session, then proceed with follow-through 
procedures. 
 
At the end of the second session, in all cases, offer a closing summary of the patient’s reasons for 
concern, the main themes of the feedback, and the plan that has been negotiated, see Recapitulation 
(2.2.8). This marks the closing of the second session. 
If no commitment to change has been made, indicate that you will see how the patient is doing at the 
next session in two weeks time and will continue discussion at that point. In any event, remind the 
patient of the third session in two weeks time. 
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3.6.1 Checklist for Session 2 
1. Check patient is receiving MET. 
2. PLEASE DO NOT DISTURB sign, call-forward phone. 
3. Check the tape-recorder is on and tape in. 
4. Give a brief summary of first session. 
5. Continue towards completion of Phase 2 Strengthening Commitment to Change. Use 
cues to recognize change readiness and continue discussion of a plan for change, 
maintaining the basic stance of reflection, questioning, affirming, reframing and dealing 
with resistance indirectly, throughout. 
6. If appropriate, use the Phase 2 strategies. 
7. Complete the Change Plan Worksheet and if appropriate sign it. 
8. Offer a closing summary (patient’s reasons for concern, main themes of the feedback, 
and negotiated plan). 
9. Give patient copy of decision balance sheet and/or change Plan Worksheet if completed. 
10. Give patient appointment card for session 3 in two weeks time and write it in your diary. 
11. Give patient Goals for Change Checklist and Readiness to Change Ruler to complete in 
waiting room before leaving. 
12. Complete staff versions of Goals for Change Checklist and Readiness to Change Ruler. 
 
3.7 The Third and Fourth Sessions 
Sessions three and four are to be scheduled for weeks 4 and 6 respectively. They are important as 
“booster” sessions to reinforce the motivational processes begun in the initial sessions. As before, the 
therapist does not offer skill training or prescribe a specific course of action unless requested to do so 
by the patient. Rather, the same motivational principles are applied throughout MET. Specific use is 
made in each session of the follow-through-strategies outlined earlier:  
(1)  reviewing progress 
(2)  renewing motivation 
(3)  redoing commitment 
 
Begin each session with a discussion of what has transpired since the last session and a review of what 
has been accomplished in previous sessions. Complete each session with a summary of where the 
patient is at present, eliciting the patient’s perceptions of what steps should be taken next. The prior 
plan for change can be reviewed, revised and (if previously written down) rewritten. 
During these sessions, the therapist needs to be careful not to assume that ambivalence has been 
resolved and commitment is firm. It is safer to assume that the patient is still ambivalent and to 
continue using the motivation-building strategies of Phase 1 as well as the commitment-strengthening 
strategies of Phase 2. 
 
There should be a clear sense of continuity of care. The four sessions of MET should be presented as 
progressive consultations, so that the initial session build motivation and strengthen commitment and 
the subsequent sessions serve as periodic checkups of progress toward change. It can be helpful during 
sessions 3 and 4 to discuss situations, which have occurred when the patient’s goal was broken or 
threatened. 
 
If the goal was broken, discuss how it occurred. It is important for the therapist to remain empathic and 
to avoid a judgmental tone or stance. Consistent with the MET style, the therapist must not prescribe 
coping strategies for the patient. Rather, the discussion should be used to review the goal, renew 
motivation, eliciting from the patient further self-motivational statements by asking for the patient’s 
thoughts, feelings, reactions and realizations. Key questions can be used to renew commitment such as, 
“So what does this mean for the future?” or “I wonder what you will need to do differently next time?” 
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Patients may also find it helpful and rewarding to review situations in which they managed their 
diabetes well previously. Reinforce self-efficacy by asking patients to clarify what they did to cope 
successfully in these situations. Therapists should praise patients for small steps, little successes, even 
minor progress. 
 
3.7.1 Checklist for Session 3 
1. Check patient is receiving MET. 
2. PLEASE DO NOT DISTURB sign, call-forward phone. 
3. Check the tape-recorder is on and tape in. 
4. Give a brief summary of Session 2 based on the closing summary (patient’s reasons for 
concern, main themes of the feedback, and negotiated plan). 
5. Review progress, maintaining the basic stance of reflection, questioning, affirming, 
reframing and dealing with resistance indirectly,  throughout. 
6. If appropriate, facilitate renewing motivation and/or redoing commitment. 
7. If appropriate, discuss situations where patient’s goal was broken or threatened, 
maintaining the basic stance of reflection, questioning, affirming, reframing and dealing 
with resistance indirectly, throughout. 
8. End session with a summarizing statement. 
9. Give patient copy of Decision Balance Sheet and/or Change Plan Worksheet if 
completed. 
10. Give patient appointment card for Session 4 in two weeks’ time and write it in your 
diary. 
11. Give patient Goals for Change Checklist and Readiness to Change Ruler to complete in 
waiting room before leaving.  
12. Complete staff versions of Goals for Change Checklist and Readiness to Change Ruler.  
 
3.8 Termination 
Formal termination should be acknowledged and discussed at the end of the fourth session. This is 
generally accomplished by a final recapitulation of the patient’s situation and progress through the 
MET sessions. The final summary should include the following elements: 
Review the most important factors motivating the patient for change and reconfirm these 
self-motivational themes. 
• 
• 
• 
• 
• 
• 
• 
• 
Summarize the commitments and changes that have been made thus far. 
Affirm and reinforce the patient for commitments and changes that have been done. 
Explore additional areas for change that the patient wants to accomplish in the future. 
Elicit self-motivational statements for the maintenance of change and for further change. 
Support patient self-efficacy, emphasizing the patient’s ability to change. 
Deal with any special problems that are evident (see below). 
Remind the patient of the follow-up sessions at 3 and 6 months, following the final session 
and their usual clinic follow-up 12-15 months since their last appointment with the 
consultant physician. 
 
  345
Review in the final session the major points that have come up in the prior three sessions. It may be 
useful to ask patients about the worst things that could happen if they went back to managing their 
diabetes as before. Help patients look to the immediate future, to anticipate upcoming events or 
potential obstacles to continuing with their goal of improved diabetes management. 
 
3.8.1 Checklist for Session 4 
1. Check patient is receiving MET. 
2. PLEASE DO NOT DISTURB sign, call-forward phone. 
3. Check the tape-recorder is on and tape in. 
4. Give a brief summary of session 3, based on the closing summary of session 2 (patient’s 
reasons for concern, main themes of the feedback, and negotiated plan) with any 
modifications from session 3. 
5. Review progress, maintaining the basic stance of reflection, questioning, affirming, 
reframing and dealing with resistance indirectly, throughout. 
6. If appropriate, facilitate a renewing motivation and/or redoing commitment. 
7. If appropriate, discuss situations where patient’s goal was broken or threatened, 
maintaining the basic stance of reflection, questioning, affirming, reframing and dealing 
with resistance indirectly, throughout. 
8. Termination consisting of a final recapitulation of the patient’s situation and progress 
through the four MET sessions. 
9. Give patient copy of Decision Balance Sheet and/or Change Plan Worksheet if 
completed. 
10. Give patient Goals for Change Checklist, Readiness to Change Ruler, and Post-treatment 
questionnaires (4) to complete in waiting room before leaving. 
11. Weigh patient and give form for blood test (HbA,c, lipids). 
 
 
4. DEALING WITH SPECIAL PROBLEMS 
 
Special problems can arise during any treatment. Below are general trouble-shooting procedures for 
handling four situations that may arise. 
 
4.1 Treatment Dissatisfaction 
Patients may report thinking that the assigned treatment is not going to help or wanting a different one. 
Under these circumstances, you should first reinforce patients for being honest about their feelings. 
You should also confirm that they have the right to withdraw from the study, stop treatment at any 
time, seek help elsewhere or decide to work on the problem on their own. 
 
Concerns of this kind that arise during the first session are probably reservations about an approach 
they have not yet tried. It is appropriate to assure the patient that the treatments in the study are 
expected to be successful and that the therapist will be offering all the help they can. No one can 
guarantee that any particular treatment will work, but you can encourage the patient to give it a good 
try for the planned period and see what happens. You can add that should the problem continue or 
worsen, you will discuss other possible approaches. 
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If a patient expresses reservations after two or three sessions, consider whether there have been new 
developments. Have new problems arisen? Did the plan for change that was previously developed with 
the patient fail to work, and if so, why? Was it properly implemented? Was it tried for long enough? Is 
there input or pressure from someone else for a change in approach or for discontinuation of treatment? 
Is the patient discouraged? 
 
If the patient’s diabetes management has shown improvement but new problems, not previously 
identified, have appeared, these new problems can be discussed following (and not departing from) the 
treatment procedures outlined above. The discussion of new problems and concerns, or a review of 
how prior implementation failed, can set the stage for continuation of treatment. You can suggest that it 
may be too early to judge how well this approach will work and that the patient should continue the 
therapy over the six week period as arranged. After that, if the patient still feels a need for additional 
treatment, he or she could certainly obtain it. If other parties are concerned about this treatment and are 
pressuring the patient, you can explore this problem by following the treatment guidelines outlined 
above. It is also permissible for the therapist to telephone the concerned party (with written consent 
from the patient) to discuss the concerns and provide assurances, along the same lines as those outlined 
above for similar patient concerns. 
 
In the Brief Treatment Programme, a limit of no more than two additional “emergency” MET sessions 
may be provided at the therapist’s discretion. These must remain consistent with the MET guidelines as 
described above and can be viewed as an extension or intensification of MET. All sessions, including 
any emergency sessions, must be completed within six weeks of the first session. After that date, 
therapists are no longer permitted to see the patient for any session, even if MET has not been 
completed. In the event of patients wanting further help, beyond that provided in the Brief Treatment 
Programme, despite attempts to retain them within the research protocol, referral to an outside agency 
or to another Diabetes Centre staff member, who is not involved in the Brief Treatment Programme, 
should be actively  facilitated. 
 
4.2 Missed Appointments 
When a patient misses a scheduled appointment, respond immediately. First try to reach the patient by 
telephone, once the patient is half an hour late, and when you do, cover these points: 
 
Clarify the reasons for the missed appointment. • 
• 
• 
• 
• 
• 
• 
• 
Affirm the patient – reinforce, for coming in the first instance. 
Express your eagerness to see the patient again. 
Briefly mention serious concerns that emerged and your appreciation (as appropriate) that 
the patient is exploring these. 
Express your optimism about the prospects for change. 
Reschedule the appointment. 
 
If no reasonable explanation is offered for the missed appointment (e.g. illness, transportation 
breakdown) explore with the patient whether the missed appointment might reflect any of the 
following: 
Uncertainty about whether or not treatment is needed 
Ambivalence about making a change 
 
Handle such concerns in a manner consistent with MET (e.g. with reflective listening, reframing). 
Indicate that it is not surprising in the beginning phase of consultation for people to express their 
reluctance by not showing up for appointments, being late etc. Encouraging the patient to voice these 
concerns directly may help to reduce their expression in future missed appointments. Use Phase 1 
strategies to handle any resistance that is encountered. Affirm the client for being willing to discuss 
concerns. Then summarize what you have discussed, add your own optimism about the prospects for 
positive change, and obtain a recommitment to treatment. It may be useful to elicit some self-
motivational statements from the patient in this regard. Reschedule the appointment. 
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In all cases, unless you regard it as a duplication of the telephone contact that might offend the patient, 
also send a personal, individualized (neatly) handwritten note with the essential points. This should be 
done within two days of the missed appointment. Place a copy of this note in the clinical file. 
This procedure should be used when any of the four appointments are missed. Three attempts (new 
appointments) should be made to reschedule a missed session. 
 
 
4.3 Telephone Consultation 
Some patients and their significant others may contact you by telephone between sessions for 
additional consultation. This is acceptable and all such contacts should be carefully documented in the 
patient’s file. An attempt should be made to keep such contacts brief, rather than providing additional 
sessions by telephone. All telephone contacts must also comply with the basic procedures of MET. 
Specific change strategies should not be prescribed, unless specifically requested. Rather, your 
approach emphasizes elicitation and reflection. 
 
 
4.4 Crisis Intervention 
If at any time, in the therapist’s opinion, the immediate welfare and safety of the patient or another 
person is in jeopardy (e.g. health, suicidality, violence), the therapist must intervene immediately and 
appropriately for the protection of those involved, with appropriate consultation with other Diabetes 
Centre Staff and/or GP, and the investigator.  In the Brief Treatment Programme, the therapist’s 
involvement in crisis interventions cannot exceed two sessions above and beyond those prescribed by 
the treatment condition. If a patient’s urgent needs require more additional treatment than this, referral 
is arranged. 
  348
APPENDIX A 
 
 
Change Plan Worksheet ..................................................................... • 
• 
• 
Agenda Setting Chart .......................................................................... 
Decision Balance Worksheet ............................................................. 
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 Participant# ................................... Date ................................. 
 
 
CHANGE PLAN WORKSHEET 
 
 
Goals (changes I want to make) 
 
 
 
Reason for change 
 
 
 
 
Steps (how will I achieve the goals?) 
 
 
 
 
Support (how others can help me) 
 
 
 
 
Benefits (how will I know if it is working?) 
 
 
 
 
Possible problems (what could interfere with my plan?) 
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Participant# ................................... Date ................................. 
 
 
DECISION BALANCE WORKSHEET 
 
 
CONSEQUENCES NO CHANGE CHANGE 
 
 
 
 
 
Positive 
 
 
Short term 
 
 
 
  
  
 
Long term 
 
 
 
  
 
 
 
 
 
Negative 
 
 
Short term 
 
 
 
  
  
 
Long term 
 
 
 
  
 
REASONS 
(Importance 1-10) 
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Table 2:  Presenting Personal Feedback........................................... • 
• 
• 
• 
Table 3:  Problems and Concerns...................................................... 
Table 4:  Good things, less good things ........................................... 
Table 5:  Helping with decision-making ............................................ 
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Table 2:  Presenting Personal Feedback 
 
TECHNIQUE  OUTLINE 
Aim 
To provide information about diabetes in a sensitive manner. 
 
How not to do it! 
The worst way to provide information is to “wag your finger” at the patient, for example 
“You are……and if you are not careful, you will……and then you will find that……” 
With a moralistic tone to your voice, you risk pushing the patient into a corner.  They will have no choice 
but either to agree with you (or pretend to), or to disagree. 
 
How to do it 
1. Choose the right moment and ask permission. 
• 
• 
• 
Best when patient seems curious, actually asks for information, or is at least not in a defensive 
frame of mind. 
Your voice tone should be neutral.  If the patient decides not to receive information, that’s their 
choice. 
Ask permission, for example: 
“I wonder, would you be interested in knowing more about …..? 
2. Provide information in a neutral and non-personal way, referring generally to “what happens to 
people” rather than to this particular person.  Also useful to refer to what experts think, rather than 
yourself. 
3. When finished, ask: 
 “I wonder, what do you make of all this?  How does it tie in with your diabetes management?” 
 
Note 
• 
• 
• 
Take your time when discussing the personal implications in Step 3 above. 
Some people don’t need or want information: because they already know the facts, or because 
they are not ready to receive them.  That’s why it’s important to ask permission and gauge their 
reaction first. 
Giving people potentially “frightening” information does not necessarily motivate them to change.  It 
can have the opposite effect. 
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Table 3:  Problems and Concerns 
 
STRATEGY OUTLINE 
Aim 
To help patients express for themselves what concerns they have about their diabetes. 
 
Functions 
This is a key strategy, often the foundation for building motivation.  It highlights elements of the 
ambivalence conflict, and can lead to the generation of discrepancy – a sense of discomfort – which often 
precedes the decision to make a change.  It can only be used with patients who are concerned about their 
behaviour. 
 
What to do 
1. Ask the key question: 
 “What concerns to you have about your diabetes/diabetes management?” 
• 
• 
• 
• 
• 
• 
Explore in detail whatever concern is raised.  (If more than one concern is raised simultaneously, 
take them one at a time).  Use open questions and reflective listening. 
Summarize this concern (in “you” language).  Highlight contrast with the “good things” about 
diabetes for this person. 
2. Ask: 
 “What other concerns do you have about your diabetes/diabetes management?” 
Explore in detail, as above. 
Summarize both this and the first concern, and highlight the “good things” as well (if appropriate). 
3. Ask: 
 “What else, what other concerns do you have….?” 
Explore, as above. 
Having covered all concerns, summarize them and highlight contrast with good things about 
diabetes. 
 
Reminders 
• 
• 
• 
Don’t rush.  Use simple open questions to encourage patient: e.g. “Why does this concern 
you?”, “Can you give me an example?”, “What concerns you the most about this?” 
Don’t move too far away from exploring concerns. 
Highlighting discrepancy, often most evident after using this strategy, can lead to discomfort.  Be 
supportive, and don’t rush the person into a decision to change.  Let them raise this topic. 
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Table 4:  Good things, less good things 
 
STRATEGY OUTLINE 
Aim 
To explore patients’ feelings about the behaviour in question, without imposing on them any assumptions 
about it being problematic.  They, rather than you, identify problem areas or reasons for concern. 
 
Functions 
Often used soon after first raising the subject, this strategy serves the following functions. 
1. Useful for building rapport, and for understanding context of substance use. 
2. Useful with patients who seem unconcerned, or when you are unsure about what they feel about their 
diabetes management.  Resistance is minimised because: 
• 
• 
You start with the positive things about person’s diabetes management. 
You talk about “less good things” rather than “concerns”.  This allows the patient to identify 
problem areas without feeling that these are being labelled as problematic. 
 
How to do it 
1. Ask the key question: 
 “What are some of the good things about your diabetes/diabetes management?” 
 These usually emerge quite quickly.  Summarize them, if necessary. 
2. Ask: 
 “What are some of the less good things about your diabetes/diabetes management?” 
 Elicit these one by one, with the aim of finding out why this patient things these are “less good 
things.”  Open questions are useful here, for example, “How does this affect you” or “What don’t you 
like about it?” 
3. Summarize the good things and the less goods things, in “you” language, as succinctly as possible, 
and leave the person time to react.  For example: “So managing your diabetes can be a hassle, 
especially taking regular blood sugar tests and eating regularly.  On the other hand, you say 
you feel so much better, you have more energy when you do, and since you have made 
changes to your eating you have been feeling much healthier”. 
 
Note 
• 
• 
• 
Avoid using words like “problem” or “concern” unless the patient does.  If this happens, consider 
moving soon on to the “Problems and Concerns” strategy.  Don’t assume that “a less good thing” is a 
cause for a concern to patient. 
Keep to task at hand, and avoid raising new topics or hypothesis of your own. 
An alternative format is to ask, “What do you like/dislike about your diabetes?” 
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Table 5:  Helping with decision-making 
 
GUIDELINES  
 
• 
• 
• 
• 
• 
• 
• 
• 
Do not rush patients into decision-making.  
Present options for the future rather than a single course of action. 
Describe what other patients have done in a similar situation. 
Emphasise that “you are the best judge of what will be best for you.” 
Provide information in a neutral non-personal manner. 
Failure to reach a decision to change is not a failed consultation. 
Resolutions to change often break down.  Make sure that patients understand this and do not avoid 
future contact if things go wrong. 
Commitment to change is likely to fluctuate.  Expect this to happen and empathise with the patient’s 
predicament. 
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MET Session Checklists 
 
Session 1.............................................................................................. • 
• 
• 
• 
Session 2.............................................................................................. 
Session 3.............................................................................................. 
Session 4.............................................................................................. 
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MET Session Checklists 
 
 
Checklist for Session 1 
 
1. Check patient is to receive MET. 
2. Collect completed SOCRATES from patient. 
3. PLEASE DO NOT DISTURB sign, call-forward phone. 
4. Check the tape-recorder and microphone is on, and tape in. 
5. Give an introduction and check that patient understands the MET rationale. 
6. Begin Phase 1 Building Motivation for Change. 
Invite patient to give an updated overview of their situation and elicit self-
motivational statements, listen with empathy and affirm the patient as you go, 
handling resistance, reframing as appropriate and utilizing summaries. 
7. If appropriate, use the Phase 1 strategies. 
8. Make a final summarizing statement. 
9. Move on to Phase 2 Strengthening Commitment to Change – if time. 
Use cues to recognize change readiness and then begin to discuss a plan for 
change, maintaining the basic stance of reflection, questioning, affirming, reframing 
and dealing with resistance indirectly, throughout. 
10. If appropriate, use the Phase 2 strategies. 
11. End session with a summarizing statement. 
12. Give patient copy of decision balance sheet and/or change plan worksheet if 
completed. 
13. Give patient sufficient Food Record Sheets to keep a daily record until next 
session, with encouragement to keep recording.   
14. Collect completed Food Record Sheets.  Check patient number and dates are on 
these.  
15. Give patient appointment card for Session 2 in a week’s time. 
16. Give patient Goals for Change Checklist and Readiness to Change Ruler to 
complete in waiting room, with instructions to place in envelope and leave with 
reception before leaving. 
17. Complete staff version of Goals for Change Checklist and Readiness to Change 
Ruler. 
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18. Write and post follow-up note immediately following the session. 
19. Put the following in Eileen's pigeon-hole: tape (labelled with patient number and 
date); envelope containing SOCRATES; Food Record Sheets, and staff version of 
GCC and RCR. 
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Checklist for Session 2 
 
1. Check patient is receiving MET. 
2. Collect completed SOCRATES. 
3. PLEASE DO NOT DISTURB sign, call-forward phone. 
4. Check the tape-recorder and microphone is on, and tape in. 
5. Give a brief summary of first session. 
6. Continue towards completion of Phase 2 Strengthening Commitment to Change. 
Use cues to recognize change readiness and continue discussion of a plan for 
change, maintaining the basic stance of reflection, questioning, affirming, reframing 
and dealing with resistance indirectly, throughout. 
7. If appropriate, use the Phase 2 strategies. 
8. Complete the Change Plan Worksheet and if appropriate sign it. 
9. Offer a closing summary (patient’s reasons for concern, main themes of the 
feedback, and negotiated plan). 
10. Give patient copy of decision balance sheet and/or change Plan Worksheet if 
completed. 
11. Give patient sufficient Food Record Sheets to keep daily record until next session, 
with encouragement to keep recording.  
12. Collect completed Food Record Sheets.  Check patient number and dates are on 
these.  
13. Give patient appointment card for session 3 in two weeks time. 
14. Give patient Goals for Change Checklist and Readiness to Change Ruler to 
complete in waiting room before leaving, with instructions to place in envelope and 
leave with reception before leaving. 
15. Complete staff version of Goals for Change Checklist and Readiness to Change 
Ruler 
16. Put the following in Eileen's pigeon-hole: tape (labelled with patient number and 
date); envelope containing SOCRATES; Food Record Sheets, and staff version of 
GCC and RCR. 
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Checklist for Session 3 
 
1. Check patient is receiving MET. 
2. Collect completed SOCRATES. 
3. PLEASE DO NOT DISTURB sign, call-forward phone. 
4. Check the tape-recorder and microphone is on, and tape in. 
5. Give a brief summary of Session 2 based on the closing summary (patient’s 
reasons for concern, main themes of the feedback, and negotiated plan). 
6. Review progress, maintaining the basic stance of reflection, questioning, affirming, 
reframing and dealing with resistance indirectly,  throughout. 
7. If appropriate, facilitate renewing motivation and/or redoing commitment. 
8. If appropriate, discuss situations where patient’s goal was broken or threatened, 
maintaining the basic stance of reflection, questioning, affirming, reframing and 
dealing with resistance indirectly, throughout. 
9. End session with a summarizing statement. 
10. Give patient copy of Decision Balance Sheet and/or Change Plan Worksheet if 
completed. 
11. Give patient sufficient Food Record Sheets to keep a daily record until next 
session, with encouragement to keep recording.  
12. Collect completed Food Record Sheets.  Check patient number and dates are on 
these.  
13. Give patient appointment card for Session 4 in two weeks’ time. 
14. Give patient Goals for Change Checklist and Readiness to Change Ruler to 
complete in waiting room, with instructions to place in envelope and leave with 
reception before leaving.  
15. Complete staff version of Goals for Change Checklist and Readiness for change 
Ruler. 
16. Put the following in Eileen's pigeon-hole: tape (labelled with patient number and 
date); envelope containing SOCRATES; Food Record Sheets, and staff version of 
GCC and RCR. 
 
  361
  
 
Checklist for Session 4 
 
1. Check patient is receiving MET. 
2. Collect completed SOCRATES. 
3. PLEASE DO NOT DISTURB sign, call-forward phone. 
4. Check the tape-recorder and microphone is on, and tape in. 
5. Give a brief summary of session 3, based on the closing summary of session 2 
(patient’s reasons for concern, main themes of the feedback, and negotiated plan) 
with any modifications from session 3. 
6. Review progress, maintaining the basic stance of reflection, questioning, affirming, 
reframing and dealing with resistance indirectly, throughout. 
7. If appropriate, facilitate a renewing motivation and/or redoing commitment. 
8. If appropriate, discuss situations where patient’s goal was broken or threatened, 
maintaining the basic stance of reflection, questioning, affirming, reframing and 
dealing with resistance indirectly, throughout. 
9. Termination consisting of a final summary of the patient’s situation and progress 
through the four MET sessions. 
10. Give patient copy of Decision Balance Sheet and/or Change Plan Worksheet if 
completed. 
11. Give patient sufficient Food Record Sheets to keep daily record until two week 
follow-up, with encouragement to keep recording.   
12. Collect completed Food Record Sheets.  Check patient number and dates are on 
these.  
13. Remind patient of post-treatment assessment in two weeks with Eileen (Eileen will 
contact to make a time). 
14. Weigh patient and give form for blood test (fasting HbA1c, lipids) 
15. Give patient Goals for Change Checklist and Readiness to Change Ruler, to 
complete in waiting room, with instructions to place in envelope and leave with 
reception before leaving. 
16. Complete staff version of Goals for Change Checklist and Readiness for Change 
Ruler. 
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17. Put the following in Eileen's pigeon-hole: tape (labelled with patient number and 
date); envelope containing SOCRATES; Food Record Sheets, and staff version of 
GCC and RCR 
18. Notify Eileen that MET has been completed and leave research folder for Eileen to 
collect. 
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 Appendix 3:  Evaluating statistical difference, equivalence, and 
indeterminacy using inferential confidence intervals  
(Tryon, 2001) 
 
 
Statistical Difference 
 
Two Independent Means 
 
 
A reduced inferential CI about each mean is constructed so that non-overlap equates 
to statistical difference by a standard t test: 
 
 
N
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E is defined as the ratio of the standard error of the difference between two groups to 
the sum of the standard errors of both groups: 
 
 tx = t95 
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The first step is to establish the level of statistical significance to determine how to 
calculate descriptive CIs about each mean.  In this case it is set at 5% level of 
statistical significance for 95% confidence.   
 
The next step is to calculate E, the extent to which the descriptive CI must be reduced 
to obtain an inferential CI on the basis of the experimental design used.   
 
 
e.g. 8191.
7054.06920.2
2)7054.0(2)6920.2( =+
+=E  
 
The inferential CI is 81.91% as large as the descriptive CI.   
 
The next step is to calculate the critical t value for df = N – 1  
 
e.g.  N=20, df=N-1=19 at the 5% significance (95% confidence) level t =2.0930.  
 
The inferential CI is then constructed using a proportionately reduced critical t value.   
 
The reduced t value is:  
 
tx = .8191 (2.0930) = 1.7144  
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The resulting inferential CIs for each of the two groups are as follows: 
 
Group A:  68 + 1.7144 (2.6920) = 63.385 to 72.615 
 
Group B:  75 + 1.7144 (0.7054) = 73.791 to 76.209 
 
Statistical difference is said to exist between the two groups because the two 
inferential CIs do not overlap; the upper limit of the lesser mean (72.615) is less than 
the lower limit of the greater mean (73.791).  The probability value associated with 
this statistical difference is p < .05 because the critical value for the 5% significance 
level (95% confidence level) was the initial t value. 
 
 
Two Dependent Means 
 
The previous analysis for two independent means can be extended to two dependent 
means of equal or unequal sample sizes.  The E term has the same meaning as above.  
The only difference is the presence of a term that is twice the correlation between the 
two variables multiplied by the standard errors of each variable.  The correlation 
between the two variables further reduces E below what is possible in the 
independent-groups design, thereby further narrowing the inferential CIs about each 
mean: 
  
 tx = t95 
21
211221
22
YY
YY
SS
SS r 2
Y
S
Y
S
+
−+
 = E t95 
 
e.g.       E = 
2552119161
255211916152102225521219161
..
).)(.)(.().().(
+
−+
        = .4899 
 
                         
The critical t value for N = 20, df = 19, at the 5% significance level is 2.0930.   
 
This results in a value of:  
 
            tx = .4899 (2.0930) = 1.0254  
 
and the following two inferential CIs: 
 
Group E:  50 + 1.0254 (1.1916) = 48.778 to 51.222 
 
Group F:  54 + 1.0254 (1.2552) = 52.713 to 55.287 
 
Evidence of statistical difference exists because these two inferential CIs do not 
overlap.  Again, the p value associated with this statistical difference is .05 because 
the critical t value was set at the 5% significance level before multiplying by E. 
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Statistical Equivalence 
 
The first step is to specify the maximum amount of difference (Rg) that one is willing 
to ignore in the name of equivalence on substantive grounds.  For illustrative 
purposes, Δ= 3.0.  This means that the difference between the lower limit of the lesser 
mean and the upper limit of the greater mean must be less than or equal to 3.0 for 
statistical equivalence to exist.   
 
The standard errors for each group are obtained by dividing the standard deviation of 
each group by the square root of the number of subjects in each group.   
 
e.g. E =
5293.07054.0
)5293.0()7054.0( 22
+
+
  = .7143 
 
The equal sample size of 20 subjects resulting in 19 degrees of freedom is associated 
with a 5% critical t value of 2.0930.  This results in: 
 
  tx = .7143 (2.0930) = 1.4950  
 
and the following inferential CIs: 
 
Group B:  75 + 1.4950 (0.7054) = 73.945 to 76.055 
 
Group C:  76 + 1.4950 (0.5293 = 75.209 to 76.791 
 
The difference between the lower limit of the lesser mean of 73.945 and the upper 
limit of the greater mean of 76.791 is Rg = 2.846, which is less than the stipulated 
Delta value of 3.0, and therefore we conclude that the means of these two groups are 
statistically equivalent.   
 
The p value for this statement is .05 because the critical value associated with the 5% 
significance level was initially chosen before being reduced by the E factor to obtain 
the inferential CI. 
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Appendix 4: Goals for change checklists 
Participant#………….                                                 Date…………………… 
 
 
Goals for Change Checklist:  Participant 
 
 
Please indicate (by putting a tick in the space provided) which of 
the following you consider to be the main goal(s) you have as a 
result of your last appointment.  Do not indicate more than two 
goals.  If you have more than two goals, indicate the two goals you 
consider to be most important. 
 
 
          [     ]     No change – stay same 
 
          [     ]     Change foot wear    
 
          [     ]     Decrease exercise/activity 
  
          [     ]     Increase exercise 
 
          [     ]     Take medication as instructed 
 
        [     ]     Record medication use 
 
[     ]     Test blood sugars regularly 
 
[     ]     Record blood sugars 
[     ]     Eat more healthily 
 
[     ]     Eat more regularly 
 
[     ]     Record food intake 
 
           [     ]     Lose weight 
 
[     ]     Decrease alcohol intake 
 
[     ]     Stop smoking 
 
[     ]     Other – please specify ………………………………… 
 
[     ]     Other – please specify ………………………………… 
 
 
 
Staff name: …………………..                            Date…………………… 
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Participant#:……………                                                       
 
 
 
Goals for Change Checklist: Staff 
 
 
Please indicate (by putting a tick in the space provided) which of 
the following you consider to be the main goal(s) resulting from 
your last appointment.  Do not indicate more than two goals.  If 
there are more than two goals, indicate the two goals you consider 
to be most important. 
 
 
          [     ]     No change – stay same 
 
          [     ]     Change foot wear    
 
          [     ]     Decrease exercise/activity 
  
          [     ]     Increase exercise 
 
          [     ]     Take medication as instructed 
 
           [     ]     Record medication use 
 
[     ]     Test blood sugars regularly 
 
[     ]     Record blood sugars 
[     ]     Eat more healthily 
 
[     ]     Eat more regularly 
 
[     ]     Record food intake 
 
           [     ]     Lose weight 
 
[     ]     Decrease alcohol intake 
 
[     ]     Stop smoking 
 
[     ]     Other – please specify ………………………………… 
 
[     ]     Other – please specify ………………………………… 
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Appendix 5: Treatment Evaluation Inventory (modified) 
Participant # ......................................... Date ................................. 
 
 
 
 
Please complete the items listed below.  The items should be completed by placing a 
checkmark on the line under the question that best indicates how you feel about the 
treatment.  Please read the items very carefully because a checkmark accidentally placed 
on one space rather than another may not represent the meaning you intended. 
 
 
 
 
 
1. How acceptable to you find this treatment? 
 _____ _____ _____ _____ _____ _____          _____ 
  
 
 not at all moderately very 
 acceptable acceptable acceptable 
 
 
 
 
2. How consistent is this treatment with common sense or everyday notions about what 
treatment should be? 
 _____ _____ _____ _____ _____ _____          _____ 
  
 very different moderately very consistent 
 or inconsistent consistent with everyday  
   notions 
 
 
 
 
 
3. To what extent does this procedure treat you humanely? 
 _____ _____ _____ _____ _____ _____          _____ 
  
 does not treats me treats me  
 treat humanely moderately very  
 at all humanely humanely 
 
 
 
 
4. To what extent do you think there might be risks in undergoing this kind of treatment? 
 _____ _____ _____ _____ _____ _____          _____ 
  
 lot of risks some risks no risks 
 are likely are likely are likely 
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5. How much do you like the procedures used in this treatment? 
 _____ _____ _____ _____ _____ _____          _____ 
  
 do not like moderately like them 
 them at all like them very much 
 
 
  T
 
 
6. How effective is this treatment likely to be? 
 _____ _____ _____ _____ _____ _____          _____ 
  
 not at all moderately very 
 effective effective effective 
 
 
 
 
 
7. How likely is this treatment to help you make permanent improvements? 
 _____ _____ _____ _____ _____ _____          _____ 
  
 unlikely moderately very 
  likely likely 
 
 
 
 
 
8. To what extent are undesirable side effects likely to result from this treatment? 
 _____ _____ _____ _____ _____ _____          _____ 
  
 many undesirable some undesirable no undesirable 
 side effects side effects side effects 
 likely likely would occur 
 
 
 
 
 
9. How much discomfort did you experience during the course of treatment? 
 _____ _____ _____ _____ _____ _____          _____ 
  
 very much moderate no discomfort 
 discomfort discomfort at all 
 
 
 
 
 
10. Overall, what is your general reaction to this form of treatment? 
 _____ _____ _____ _____ _____ _____          _____ 
  
 very ambivalent very 
 negative  positive 
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Appendix 6: Calculating of Reliable Change Index (Truax, 1991) 
 
   
χ2  –  χ1
  RC     = 
        Sdiff
   
 
 
Where χ1 represents a subject’s pre-test score, χ2 represents that same subject’s post-
test score, and Sdiff is the standard error of difference between the two test scores.  Sdiff 
can be computed directly from the standard error of measurement SE according to 
this: 
  
 Sdiff  =   √  2(SE )2
 
 
Sdiff describes the spread of the distribution of change scores that would be expected if 
no actual change had occurred.  An RC larger than 1.96 would be unlikely to occur (p 
< .05) without actual change.  
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Appendix  7: Description of Study 2 Participants 
 
PE and MET participants had similar reasons for referral to the dietitian (Table 
43), with assistance with diabetes management the main reason for referral.  Problems 
with diet and/or weight were specifically mentioned for most participants (n=4 for PE 
and MET), with poor diabetes control specifically mentioned as a problem for two PE 
participants.  All participants (i.e. PE and MET) were referred by their GP (Table 43).  
 
Table 43:  Summary of referral information 
 
 PE MET 
Reason   
Assistance with diabetes management 5 5 
Poor diabetes control 2 0 
Diet / weight problems 4 4 
Source   
GP 6 5 
Diabetes physician 0 0 
 
 
Only one participant (a PE participant) experienced diabetes-related 
complications (Table 44).  This is consistent with the relatively short duration (i.e., PE 
n=4.6, MET n=6.8) since diagnosis of their diabetes. 
 
Table 44.  Diabetes complications experienced by Participants 
 
Complications PE MET 
Nil 5 5 
Infections 1 0 
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PE and MET participants were also fairly similar in the other health problems 
experienced, with about half (i.e., PE n=3, MET n=2) of participants not experiencing 
any other health problems in addition to diabetes (Table 45).  Only one participant (a 
MET participant) experienced multiple health problems (i.e. had more than one health 
problem in addition to diabetes). 
 
Table 45.  Other health problems experienced by participants 
 
Health problem PE MET 
Hearth disease 2 0 
Chronic pain 1 1 
Psychiatric disorder 0 1 
Asthma 0 2 
Nil 3 4 
 
 Most participants were prescribed oral medication for their diabetes (Table 
46).  No participants were prescribed insulin for their diabetes and some participants 
(i.e., PE n=1, MET n=2) were not prescribed any medication for their diabetes.   This 
is consistent with their relatively short duration of diagnosis of Type 2 diabetes 
combined with the lack of diabetes-related complications.  Only two participants 
(both PE participants) were prescribed lipid lowering medication. 
 
Table 46.  Summary of participants’ medication 
 
Medication PE MET 
Oral diabetes 5 3 
Insulin 0 0 
Lipid lowering 2 0 
Antihypertensive 2 1 
Other 2 2 
Nil 0 0 
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 PE and MET participants were similar in their employment status (Table 47), 
with only one participant in each group in receipt of welfare assistance due to illness.  
Participants were engaged in a range of work, with manual work the most common 
(i.e., n=2 for both PE and MET).    
 
Table 47.  Employment status of participants 
Employment PE MET 
Manual 2 2 
Office 1 0 
Business 0 1 
Tertiary student 0 1 
Retired 2 0 
Sickness beneficiary 1 1 
 
Case Descriptions 
 
Case 19.  A 59 year old Maori male with Type 2 diabetes diagnosed at 48 
years of age. He was described as having minimal tinea (fungal skin infection) which 
was attributed to his diabetes. At baseline, he was also prescribed Bezalip for 
dyslipidaemia, which was altered to Simvastatin during PE (i.e., week 8).  His 
diabetes medication remained unchanged throughout the study. 
 
Case 20.  A 69 year old Caucasian male with Type 2 diabetes diagnosed at 68 
years of age.  He had no known diabetes-related complications.  His diabetes was 
managed through diet and oral medication (Metformin).  His diabetes medication 
remained unchanged throughout the study. 
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Case 21.  A 55 year old Caucasian female with Type 2 diabetes diagnosed at 
50 years of age.  She had no known diabetes-related complications.  At baseline, her 
diabetes was managed through diet and oral medication (Metformin and 
Glibenclamide).  At 12-month follow-up, however,  her diabetes medication had been 
altered to include insulin (Penmix) injections along with oral diabetes medication 
(Metformin only).  Simvastatin for dyslipidaemia was also added at this time.  She 
attended 10 further appointments (i.e. in addition to the PE sessions with the dietitian) 
at the Diabetes Centre (two each with a DNE, dietitian, podiatrist, and physician) over 
the course of follow-up. 
 
 Case 22.  A 49 year old Caucasian female with Type 2 diabetes diagnosed at 
41 years of age.  She had no known diabetes-related complications.   Her diabetes was 
managed through diet and oral medication (Metformin).  Her diabetes medication 
remained unchanged throughout the study. 
 
 Case 23.  A 38 year old Caucasian male with Type 2 diabetes diagnosed at 34 
years of age.  He had no known diabetes-related complications.  His diabetes was 
managed through diet and oral medication (Metformin).  His diabetes medication 
remained unchanged throughout the study.  He attended two further appointments 
with a dietitian during follow-up. 
 
Case 24.  A 44 year old Caucasian female with Type 2 diabetes diagnosed at 
43 years of age.  She had no known diabetes-related complications.  Her diabetes was 
managed through diet alone, which remained unchanged throughout the study.   
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Case 25.  A 51 year old Caucasian male with Type 2 diabetes diagnosed at 46 
years of age.  He had no known diabetes-related complications.  His diabetes was 
managed through diet and oral medication (Metformin).  His diabetes medication 
remained unchanged throughout the study.  Unfortunately, he was not able to be 
contacted for 12-month follow-up because of his work commitments consequently no 
12-month follow-up data are available. 
 
Case 26.  A 63 year old Caucasian female with Type 2 diabetes diagnosed at 
55 years of age.  She had no known diabetes-related complications.  At baseline, her 
diabetes was managed through diet and oral medication (Metformin).   Her diabetes 
medication had been altered at 12-month follow-up to include Glipizide.   
Additionally, over the course of follow-up she was seen by a Clinical Psychologist for 
seven treatment sessions between 3- and 6-month follow-up focusing on her marital 
situation and binge eating.  She also received four further dietetic appointments.   
 
Case 27.  A 53 year old Caucasian female with Type 2 diabetes diagnosed at 
45 years of age.  She had no known diabetes-related complications.  Her diabetes was 
managed through diet alone.  This remained unchanged throughout the study.  
 
Case 28.  A 36 year old Caucasian female with Type 2 diabetes diagnosed at 
35 years of age.  She had no known diabetes-related complications.   Her diabetes was 
managed through diet and medication (Metformin).  Her diabetes medication 
remained unchanged throughout the study.    
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Case 29.  A 43 year old Caucasian male with Type 2 diabetes diagnosed at 35 
years of age.  He had no known diabetes-related complications.  His diabetes was 
managed through diet alone, which remained unchanged throughout the study. 
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Appendix  8: Topics covered during MI training (Studies 1-3) 
 
Health belief model 
      Perceived probability and seriousness of consequences  
      Perceived severity of risk 
      Self-efficacy 
 
Dangerous assumptions about behaviour change 
      This person ought to change 
      This person is ready to change 
      This person’s health is a prime motivating factor for him/her 
      If he/she decides not to change the consultation has failed 
      Patients are either motivated to change or not 
      Now is the right time to consider change 
      A tough approach is always best 
      I’m the expert – the patient must follow my advice 
 
Principles of good practice when negotiating behaviour change 
      Respect for the autonomy of patients and their choices 
      Readiness to change needs to be taken into account 
      Ambivalence is common and needs to be understood 
      Targets for change should be selected by the patient 
      The expert (i.e., health practitioner) is the provider of information and support 
      The patient is the active decision-maker 
 
Ingredients for effective brief interventions (FRAMES) 
       Feedback - personalised 
       Responsibility for change lies with the patient 
       Advice – provided in small doses when the patient is ready 
       Menu of options provided 
       Empathy – conveyed through reflective listening 
       Self-efficacy – needed for behaviour change 
        
Principles of MI (REDS) 
      Role with resistance 
      Express empathy 
      Develop discrepancy 
      Support self-efficacy 
 
Stages of change 
      Pre-contemplation 
      Contemplation 
      Determination 
      Action 
      Maintenance 
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Resistance 
      Not an inherent part of pathology 
      Observable behaviour 
      Fluctuates 
      Influenced by practitioner’s behaviour  
       
MI skills 
      Open-ended questions 
      Affirmation 
      Reflections 
      Summaries 
 
MI strategies 
      Importance, confidence and readiness rulers 
      Agenda setting 
      Typical day 
Personal dissonance 
Good things and the less good things 
Providing information 
Life satisfaction – the present and the future 
Costs and benefits 
Constructing a decision balance 
Helping with decision-making 
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Appendix 9: Risk Factor Interview Checklist (modified) 
 
At the beginning of the interview, did the practitioner: 
 
  N/A
 
N
ot 
dem
onstrated 
P
artially 
dem
onstrated 
C
learly 
dem
onstrated 
1 Communicate in a style that facilitated patient understanding 
and comfort? (eg vocabulary, avoiding highly technical terms) 
    
2 Explicitly invite the patient to collaborate in assessing their 
readiness to begin or continue with lifestyle change? 
    
3 Inquire about the patient’s objective for the interview and 
negotiate focusing on risk factors for diabetes? 
    
 
 
 
When discussing risk behaviours did the practitioner: 
 
1 Use open-ended questions to explore relevant issues and to 
facilitate the patient’s active involvement? 
    
2 Allow for occasional silence so that the patient could reflect 
upon issues related to lifestyle? 
    
3 Use periodic summary statements to clarify potential barriers or 
supports for change? 
    
4 Identify and validate the patient’s positive and negative feelings 
about health risk behaviours? 
    
5 Help the patient to view prior unsuccessful efforts to change as 
important learning experiences? 
    
 
 
 
Before ending the interview, did the practitioner: 
 
1 Invite the patient to note personally relevant issues that may not 
have been identified in the interview? 
    
2 Review supports and barriers, and state how change could be 
achieved in manageable steps? 
    
3 Express support for the patient’s freedom to make an informed 
choice about whether to proceed with a plan for change at this 
time? 
    
4 Negotiate the next step for counselling about change?  
                               
    
5 Verbally reinforce the patient’s effort to discuss, prepare for, or 
initiate change? 
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Appendix 10: MET Audit 
 
RATING  SCALE  TO  AUDIT  MET  SESSIONS  (MODFIED) 
 
 
1. How much was this therapy session actively directed by the therapist? 
 not at all a little moderately a lot
 extremely 
 
 
 
2. How much was this therapy session focused by the therapist on the patient’s 
diabetes? 
 not at all a little moderately a lot
 extremely 
 
 
 
3. How much did the therapist elicit self-motivational statements by the patient? 
 not at all a little moderately a lot
 extremely 
 
 
 
4. How much did the therapist use summaries? 
 not at all a little moderately a lot
 extremely 
 
 
 
5. How much did the therapist praise or affirm the patient? 
 not at all a little moderately a lot
 extremely 
 
 
 
6. How much did the therapist give advice, direction or education to the patient? 
 not at all a little moderately a lot
 extremely 
 
 
 
7. How much did the therapist use reflective listening? 
 not at all a little moderately a lot
 extremely 
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8. How much did the therapist use dynamic interpretations? 
 not at all a little moderately a lot
 extremely 
 
 
 
9. How much did the therapist actively explore non-diabetes issues of the patient in 
depth? 
 not at all a little moderately a lot
 extremely 
 
 
 
10. How much was the therapist’s style empathic? 
 not at all a little moderately a lot
 extremely 
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Appendix 11: Signs of resistance and readiness to change (Miller & Rollnick, 1991) 
 
Four Categories of Client Resistance Behaviour 
 
 
1. ARGUING.  The client contests the accuracy, expertise, or integrity of the therapist. 
 1a. Challenging.  The client directly challenges the accuracy of what the therapist has said.  
 1b. Discounting.  The client questions the therapist’s personal authority and expertise. 
 1c. Hostility.  The client expresses direct hostility toward the therapist. 
 
 
2. INTERRUPTING.  The client breaks in and interrupts the therapist in a defensive manner.  
 2a. Talking over.  The client speaks while the therapist is still talking, without waiting for an appropriate 
pause or silence. 
 2b. Cutting off.  The client breaks in with words obviously intended to cut the therapist off (e.g., “Now 
wait a minute.  I’ve heard about enough”). 
 
  
3. DENYING.  The client expresses an unwillingness to recognize problems, cooperate, accept responsibility, 
or take advice. 
 3a. Blaming.  The client blames other people for problems. 
 3b. Disagreeing.  The client disagrees with a suggestion that the therapist has made, offering no 
constructive alternative.  This includes the familiar “yes, but…” which explains what is wrong with 
suggestions that are made. 
 3c. Excusing.  The client makes excuses for his or her own behaviour. 
 3d. Claiming impunity.  The client claims that he or she is not in any danger (e.g. from drinking). 
 3e. Minimizing.  The client suggests that the therapist is exaggerating risks or dangers, and that it “really 
isn’t so bad.” 
 3f. Pessimism.  The client makes general statements about self or others that are pessimistic, defeatist, or 
negativistic in tone. 
 3g. Reluctance.  The client expresses reservations and reluctance about information or advice given. 
 3h. Unwillingness to change.  The client expresses a lack of desire or an unwillingness to change, or an 
intention not to change. 
 
 
4. IGNORING.  The client shows evidence of not following, or ignoring the therapist. 
 4a. Inattention.  The client’s response indicates that he or she has not been following or attending to the 
therapist. 
 4b. Nonanswer.  In answering a therapist’s query, the client gives a response that is not an answer to the 
question. 
 4c. No response.  The client gives no audible or nonverbal reply to a therapist’s query. 
 4d. Sidetracking.  The client changes the direction of the conversation that the therapist has been pursuing. 
 
  383
 
 
Signs of Readiness for Change 
 
 
1. Decreased resistance   
 The client stops arguing, interrupting, denying, or objecting. 
 
2. Decreased questions about the problem  
The client seems to have enough information about his or her problem, and stops asking questions.  There 
is a sense of being finished. 
 
3. Resolve   
The client appears to have reached a resolution, and may seem more peaceful, relaxed, calm, unburdened, 
or settled.  Sometimes his happens after the client has passed through a period of anguish or tearfulness. 
 
4. Self-motivational statements   
The client makes direct self-motivational statements (see Chapter 6), reflecting recognition of a problem (I 
guess this is serious), concern (This worries me), openness to change (I need to do something), or optimism 
(I’m going to beat this). 
 
5. Increased questions about change 
The client asks what he or she could do about the problem, how people change if they decide to, or the 
like. 
 
6. Envisioning   
The client begins to talk about how life might be after a change, to anticipate difficulties if a change were 
made, or to discuss the advantages of change. 
 
7. Experimenting  
If the client has had time between sessions, he or she may have begun experimenting with possible change 
approaches. 
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Appendix 12: Importance, Confidence and Readiness Rulers 
 
Staff:  ………………….                                Date:………………….... 
 
 
 
Importance 
 
 
Please indicate (by placing circling the appropriate number) how important 
you consider Motivational Enhancement Therapy (MET) is to enhancing 
diabetes self-management, with 1 indicating not important at all and 10 
indicating very important: 
 
 
           1        2        3        4        5        6        7        8        9        10     
 
 
 
 
 
Confidence 
 
 
Please indicate (by placing an X in the appropriate space) where you consider 
you are in terms of your confidence to use MET, with 1 indicating not 
confident and 10 indicating very confident: 
 
 
           1        2        3        4        5        6        7        8        9        10     
 
 
 
 
 
Readiness Ruler 
 
 
Please indicate (by placing an X in the appropriate space) where you consider 
you are in terms of your readiness to use MET, with 1 indicating not ready and 
7 indicating ready now. 
 
 
1        2        3        4        5        6        7 
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Appendix 13: Motivational Interviewing Knowledge Test 
 
Name:…………………………………….                         Date:………………….. 
 
 
 
Motivational Interviewing Knowledge Test  
 
 
1. What is the underlying philosophy of motivational interviewing (MI)? 
 
……………………………………………………………………. 
 
……………………………………………………………………. 
 
2. What is the goal of MI? 
 
…………………………………………………………………….. 
 
……………………………………………………………………... 
 
 
3. How is empathy expressed in MI? 
 
…………………………………………………………………….. 
 
…………………………………………………………………….. 
 
 
4. What key client statements should be reflected in MI? 
 
…………………………………………………………………….. 
 
…………………………………………………………………….. 
 
 
5. List 3 signs of resistance 
 
1.…………………………………………………………………….. 
 
2.…………………………………………………………………….. 
 
3.…………………………………………………………………….. 
 
  
6. What do you do in MI if you meet resistance? 
 
……………………………………………………………………… 
 
……………………………………………………………………… 
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7. How is ambivalence dealt with in MI? 
 
……………………………………………………………………… 
 
……………………………………………………………………… 
 
 
8. Give 3 examples of change talk 
 
1………………………………………………………………………. 
 
2………………………………………………………………………. 
 
3………………………………………………………………………. 
 
 
9. List 3 techniques for eliciting change talk 
 
1..……………………………………………………………………….. 
 
2………………………………………………………………………… 
 
             3…………………………………………………………………………. 
 
 
10.  List 3 things you should do when giving advice in MI 
 
1.………………………………………………………………………….. 
 
2.………………………………………………………………………….. 
 
3…………………………………………………………………………… 
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